{"meta":{"query_hash":"76b5e2e4f1f4","filters":{"venue":"Journal of Oncology Pharmacy Practice"},"cohort_total":250,"direct_labels_cover":0,"predictions_cover":250,"exported":250,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/76b5e2e4f1f4","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Oncology+Pharmacy+Practice"},"results":[{"id":"W1119150976","doi":"10.1177/1078155215598854","title":"Tolerability of Vidaza (azacitidine) subcutaneous administration using a maximum volume of 3 ml per injection","year":2015,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Celgene","keywords":"Medicine; Tolerability; Azacitidine; Injection site; Anesthesia; Subcutaneous injection; Internal medicine; Adverse effect","score_opus":0.09519557321429206,"score_gpt":0.42182037277965306,"score_spread":0.326624799565361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1119150976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99309653,0.0026118483,0.00086599,0.000076790384,0.000019062974,0.000149724,0.00026264452,0.00003500221,0.0028824508],"genre_scores_gemma":[0.9984263,0.00049277354,0.00033142712,0.00006445432,0.00002229154,0.000034028424,0.00010340024,0.000006182621,0.0005191294],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99951625,0.0001619535,0.000054611082,0.000044140754,0.00019178659,0.000031300777],"domain_scores_gemma":[0.9984652,0.000660048,0.000558403,0.00007057257,0.00015104779,0.00009486439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069549517,0.00014115445,0.00045745762,0.00012932612,0.00013294542,0.0003273149,0.00011643571,0.00019918274,0.0016474074],"category_scores_gemma":[0.0022510611,0.00010722598,0.00038092368,0.00019565584,0.00014607538,0.00024745407,0.00008825005,0.000505517,0.00024577454],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0462972,0.008494568,0.30770913,0.001873711,0.0011526278,0.0013971039,0.0013371891,0.0040737875,0.15464404,0.0002823921,0.002064013,0.47067422],"study_design_scores_gemma":[0.001375955,0.1570147,0.80612427,0.00010020654,0.0006035331,0.0035618716,0.0002953064,0.0016561096,0.023817478,0.000100303296,0.0053086686,0.00004155171],"about_ca_topic_score_codex":0.00042521505,"about_ca_topic_score_gemma":0.00058238715,"teacher_disagreement_score":0.0016474074,"about_ca_system_score_codex":0.00015680987,"about_ca_system_score_gemma":0.00016915136,"threshold_uncertainty_score":0.0055111647},"labels":[],"label_agreement":null},{"id":"W1517518767","doi":"10.1191/1078155202jp100cr","title":"Cyclophosphamide-induced nasopharyngeal discomfort (wasabi nose): a report of two cases","year":2002,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Olfactory and Sensory Function Studies","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Nose; Cyclophosphamide; Adverse effect; Surgery; Anesthesia; Chemotherapy; Internal medicine","score_opus":0.27606341183008,"score_gpt":0.42436785421444684,"score_spread":0.14830444238436685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1517518767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579115,0.0137824565,0.0054811607,0.0017602287,0.0009921807,0.00044892353,0.00019435785,0.00035072907,0.019078346],"genre_scores_gemma":[0.99094814,0.0035078991,0.0015053217,0.00085518305,0.0009982263,0.00012795356,0.00013662137,0.000047080324,0.0018736353],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9978181,0.00024426138,0.00034269862,0.0004616702,0.00031591087,0.0008173578],"domain_scores_gemma":[0.9962614,0.0008497275,0.0009531351,0.0005675018,0.0002967105,0.0010716355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008879255,0.00398627,0.0015873241,0.002788832,0.0033584451,0.0027094716,0.002194688,0.0069299657,0.0027876056],"category_scores_gemma":[0.006525287,0.002126024,0.0016968384,0.0022495494,0.0027194086,0.0026097952,0.0026182476,0.0038675808,0.002215287],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049694594,0.00020274185,0.010230206,0.00007558863,0.000030186113,0.98493713,0.0005056998,0.000048536847,0.00075171294,0.00016396817,0.00037848295,0.0026260715],"study_design_scores_gemma":[0.000017134254,0.00007750997,0.0028188492,0.000015589165,0.000016954462,0.99588495,0.00015848098,0.00006519485,0.00030190416,0.000050512077,0.0005813453,0.000011620814],"about_ca_topic_score_codex":0.0027363435,"about_ca_topic_score_gemma":0.0023807327,"teacher_disagreement_score":0.0069299657,"about_ca_system_score_codex":0.0015231052,"about_ca_system_score_gemma":0.0010589376,"threshold_uncertainty_score":0.01105094},"labels":[],"label_agreement":null},{"id":"W1539630599","doi":"10.1177/1078155215589980","title":"Evidence-based practice in times of drug shortage","year":2015,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Economic shortage; Medicine; Drug; Pharmacodynamics; Intensive care medicine; Clinical Practice; Pharmacokinetics; Drug development; Pharmacology; Family medicine","score_opus":0.6899323120443571,"score_gpt":0.6156431659316067,"score_spread":0.07428914611275039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1539630599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000234955,0.9841818,0.0012041018,0.010605757,0.0005323562,0.0000622027,0.000060283342,0.0000139377535,0.0031046127],"genre_scores_gemma":[0.01061495,0.98034817,0.0040967036,0.0037241587,0.0006662839,0.00011925287,0.000095486044,0.0000073119754,0.00032774924],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9885075,0.006514279,0.0019668483,0.00055182196,0.0022268125,0.00023277436],"domain_scores_gemma":[0.90122986,0.08380975,0.0065941503,0.0018508316,0.005708724,0.000806588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018243702,0.0009602513,0.002974088,0.006951553,0.00054554205,0.0045139543,0.002904508,0.0057782354,0.0060561383],"category_scores_gemma":[0.09030285,0.00072847377,0.001766754,0.006070864,0.0021234914,0.00451239,0.002395476,0.0042054835,0.0012640535],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009706084,0.00008763449,0.0007493428,0.13917424,0.0010393395,0.00048210192,0.000535418,0.0012384225,0.00016704334,0.030650316,0.03175198,0.79402715],"study_design_scores_gemma":[0.00013161502,0.00007931609,0.0024024844,0.48106366,0.0010115488,0.0010733248,0.00079391355,0.00055598316,0.00024398338,0.06412571,0.4484554,0.000062998595],"about_ca_topic_score_codex":0.0030510533,"about_ca_topic_score_gemma":0.0046395836,"teacher_disagreement_score":0.018243702,"about_ca_system_score_codex":0.0031132423,"about_ca_system_score_gemma":0.010089369,"threshold_uncertainty_score":0.09648305},"labels":[],"label_agreement":null},{"id":"W1848562960","doi":"10.1177/1078155215587345","title":"Effects of gender on capecitabine toxicity in colorectal cancer","year":2015,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; CancerCare Manitoba; Alberta Cancer Foundation","funders":"National Institutes of Health","keywords":"Capecitabine; Medicine; Colorectal cancer; Toxicity; Oncology; Internal medicine; Cancer","score_opus":0.07408878974539229,"score_gpt":0.4382115780210747,"score_spread":0.3641227882756824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1848562960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931619,0.004272169,0.00017097665,0.00022646147,0.000038275924,0.0000110697965,0.00033956004,0.0000070035935,0.0017725625],"genre_scores_gemma":[0.9991738,0.0004904714,0.000050491715,0.000033403267,0.000017592753,0.0000028745462,0.00008042279,0.0000031597824,0.00014771435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994105,0.00021298134,0.00004877058,0.000092742746,0.00014839,0.00008658377],"domain_scores_gemma":[0.99628615,0.0015099476,0.0016318875,0.00009649641,0.00020071362,0.00027482008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000953118,0.00018379929,0.00026158357,0.0005667409,0.0001976025,0.00041199004,0.00017753172,0.00019625899,0.0029246828],"category_scores_gemma":[0.0052971393,0.000099006844,0.00058748503,0.00059177575,0.00023390913,0.00027842622,0.0002567177,0.00027821393,0.00021999721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007246331,0.000020433017,0.9920604,0.000030736137,0.00007370046,0.00030354378,0.00006805292,0.00005040993,0.0002693222,0.000036963367,0.00014150926,0.006220244],"study_design_scores_gemma":[0.000009486514,0.00024708823,0.99768734,0.000026261412,0.00006779477,0.0010824247,0.000106010775,0.00017035703,0.00010304562,0.00005485477,0.00044136716,0.000004027583],"about_ca_topic_score_codex":0.0015679201,"about_ca_topic_score_gemma":0.0022291108,"teacher_disagreement_score":0.0029246828,"about_ca_system_score_codex":0.00040778203,"about_ca_system_score_gemma":0.00031377675,"threshold_uncertainty_score":0.009784043},"labels":[],"label_agreement":null},{"id":"W1969258524","doi":"10.1177/1078155211402106","title":"Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning","year":2011,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":60,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health; Vancouver Coastal Health; University of British Columbia","funders":"University of British Columbia","keywords":"Contamination; Antineoplastic Drugs; Medicine; Drug; Toxicology; Pharmacology","score_opus":0.07159032852732863,"score_gpt":0.4467621365994111,"score_spread":0.3751718080720825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969258524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977763,0.0001323799,0.00042794502,0.00005745105,0.0000035170551,0.00033920974,0.00025607925,0.000022259785,0.0009846879],"genre_scores_gemma":[0.9936515,0.0002499245,0.003385823,0.00016104299,0.0000075438275,0.00017693827,0.00044027987,0.000008604893,0.0019181756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967552,0.0004382766,0.00014857271,0.0003972086,0.0018764568,0.00038429446],"domain_scores_gemma":[0.9948606,0.0007486193,0.0008675494,0.00019834998,0.0029496762,0.0003751196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010368866,0.00054272526,0.00035352234,0.0007867346,0.0011077098,0.0010057238,0.00082516164,0.0007177968,0.0025146885],"category_scores_gemma":[0.0029474164,0.00044635579,0.00022262534,0.0010028463,0.00083073584,0.00034279632,0.0010160857,0.00054407347,0.00044727963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018886745,0.0011278848,0.8439284,0.00069853006,0.00009749666,0.0011165763,0.004113825,0.00039248084,0.09997993,0.000060787315,0.0007057894,0.04588957],"study_design_scores_gemma":[0.000022307713,0.0029903834,0.9759439,0.00003636392,0.000044798868,0.00040811294,0.002934792,0.0004595829,0.0154970335,0.000014866945,0.0016293583,0.000018329205],"about_ca_topic_score_codex":0.1506052,"about_ca_topic_score_gemma":0.2344379,"teacher_disagreement_score":0.8493948,"about_ca_system_score_codex":0.0028754536,"about_ca_system_score_gemma":0.0037106515,"threshold_uncertainty_score":0.2994572},"labels":[],"label_agreement":null},{"id":"W1973988504","doi":"10.1177/1078155209102339","title":"Assessment of gentamicin 7 mg/kg once daily for pediatric patients with febrile neutropenia: a pilot project","year":2009,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health; Surrey Memorial Hospital","funders":"","keywords":"Medicine; Gentamicin; Neutropenia; Febrile neutropenia; Pediatric oncology; Context (archaeology); Pediatrics; Intensive care medicine; Internal medicine; Emergency medicine; Antibiotics; Chemotherapy; Cancer","score_opus":0.049933720408659114,"score_gpt":0.4426054996223499,"score_spread":0.3926717792136908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973988504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999345,0.000052552798,0.00012886574,0.00003884828,0.000001272095,0.00022460312,0.000039142964,0.000006281645,0.0001634942],"genre_scores_gemma":[0.99717987,0.00017568137,0.0021265792,0.00008076632,0.000008124532,0.0002560726,0.00008944749,0.0000028614133,0.00008055777],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99899143,0.0005285994,0.00010743031,0.00009698043,0.00016486831,0.00011078556],"domain_scores_gemma":[0.99575883,0.0009649599,0.0013944734,0.00016635172,0.0007968359,0.0009184055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014296861,0.0003954826,0.0003533136,0.0005370311,0.0007575759,0.00042535958,0.00038595282,0.00042048865,0.001279823],"category_scores_gemma":[0.0064432346,0.00029969178,0.0002736862,0.00044377844,0.00031440318,0.0005619515,0.0005056932,0.00065999286,0.00023273341],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014511017,0.0041234354,0.95023435,0.00013864883,0.0000323857,0.001859835,0.0021091236,0.0003019861,0.002882843,0.0000376757,0.00036717844,0.036461513],"study_design_scores_gemma":[0.00074018363,0.05758585,0.92637795,0.000078770914,0.00007787904,0.0051669525,0.0036402536,0.0016281363,0.0030319148,0.00007181782,0.0015693017,0.000030975043],"about_ca_topic_score_codex":0.002238493,"about_ca_topic_score_gemma":0.004583359,"teacher_disagreement_score":0.002238493,"about_ca_system_score_codex":0.0011236854,"about_ca_system_score_gemma":0.00247724,"threshold_uncertainty_score":0.008152902},"labels":[],"label_agreement":null},{"id":"W1976511979","doi":"10.1191/1078155204jp137oa","title":"Role of dimethylsulfoxide for management of chemotherapy extravasation","year":2004,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Extravasation; Medicine; Erythema; Antidote; Tissue necrosis; Chemotherapy; Adverse effect; Dimethyl sulfoxide; Surgery; Dermatology; Anesthesia; Toxicity; Pharmacology; Internal medicine; Pathology","score_opus":0.03141923979721942,"score_gpt":0.40923492479148804,"score_spread":0.37781568499426865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976511979","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0060627568,0.97824484,0.00061290036,0.0039515295,0.0004644991,0.000060951337,0.00011368157,0.000040604322,0.010448177],"genre_scores_gemma":[0.06823865,0.92156386,0.004255886,0.0018179351,0.0015210928,0.00008605841,0.00020778574,0.000026980495,0.002281843],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992268,0.00035540646,0.00015374731,0.00004449715,0.00020058894,0.000018892899],"domain_scores_gemma":[0.9971424,0.0015921338,0.00085316814,0.00006500258,0.00024762846,0.00009977547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00153739,0.00031375402,0.0009736369,0.0014619617,0.00028566332,0.0009738007,0.00047486738,0.0006979509,0.0058762277],"category_scores_gemma":[0.0037081703,0.000112256144,0.00055969495,0.0011515865,0.0002998238,0.0012278763,0.00038212503,0.00076325954,0.0010752431],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010355611,0.0002492869,0.00133205,0.016282817,0.00017601355,0.001188588,0.00014240993,0.00015984988,0.0049008005,0.0015519578,0.01358437,0.9593963],"study_design_scores_gemma":[0.0013416817,0.0035203628,0.015230086,0.018893862,0.00090514263,0.013047056,0.00052258297,0.0005862869,0.0109945685,0.0044712513,0.9304015,0.0000856139],"about_ca_topic_score_codex":0.00061268685,"about_ca_topic_score_gemma":0.0011902909,"teacher_disagreement_score":0.0058762277,"about_ca_system_score_codex":0.0005350923,"about_ca_system_score_gemma":0.0008840523,"threshold_uncertainty_score":0.01965791},"labels":[],"label_agreement":null},{"id":"W1979820749","doi":"10.1191/1078155203jp105oa","title":"Next-day chemotherapy scheduling: a multidisciplinary approach to solving workload issues in a tertiary oncology center","year":2003,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Pharmacy; Workload; Chemotherapy; Schedule; Ambulatory; Family medicine; Medical emergency; Internal medicine","score_opus":0.1461205958696747,"score_gpt":0.48738882819010915,"score_spread":0.34126823232043446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979820749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8265504,0.004499631,0.011930064,0.11059481,0.0032433681,0.0024689096,0.0005782511,0.0012641775,0.03887036],"genre_scores_gemma":[0.8918149,0.0052258414,0.04215438,0.032188084,0.0018755577,0.0007748742,0.0007591845,0.00023799465,0.02496921],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977143,0.00072455325,0.00017050287,0.00021737364,0.00037363503,0.0007997016],"domain_scores_gemma":[0.9885592,0.0004011042,0.0006230867,0.00010990971,0.00074639637,0.009560303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024065583,0.0005012753,0.00024556913,0.0008482234,0.0072168326,0.0023770889,0.0030429242,0.0013171127,0.013951722],"category_scores_gemma":[0.0030295367,0.00055500446,0.0005046187,0.0007704088,0.0008268148,0.0015741588,0.0053534685,0.003353197,0.001174505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039239635,0.007790086,0.15233776,0.0018257676,0.000120427765,0.013537531,0.041675627,0.003773569,0.0060651866,0.0020264029,0.26219338,0.5082619],"study_design_scores_gemma":[0.00034526008,0.006101984,0.33312526,0.0021701157,0.00016269366,0.014841099,0.26327357,0.011719335,0.004631163,0.004965133,0.35819212,0.0004722653],"about_ca_topic_score_codex":0.015542057,"about_ca_topic_score_gemma":0.06063522,"teacher_disagreement_score":0.015542057,"about_ca_system_score_codex":0.009867366,"about_ca_system_score_gemma":0.025564928,"threshold_uncertainty_score":0.071593106},"labels":[],"label_agreement":null},{"id":"W1981256536","doi":"10.1177/1078155214522143","title":"Clinical efficacy of generic imatinib","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Imatinib; Medicine; Myeloid leukemia; Imatinib mesylate; Internal medicine; Oncology; Pharmacology","score_opus":0.09526435613282552,"score_gpt":0.48579286121924914,"score_spread":0.3905285050864236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981256536","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18600723,0.5705131,0.002826524,0.016242333,0.00087348366,0.00040723782,0.005732285,0.00019605439,0.21720175],"genre_scores_gemma":[0.91113466,0.07021441,0.0017172953,0.0055320472,0.0011202081,0.00013505758,0.0038427222,0.00005528118,0.0062483856],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99806803,0.00064879865,0.00029951616,0.0002114988,0.00064561743,0.00012662637],"domain_scores_gemma":[0.99495476,0.002157473,0.0016956194,0.00019105032,0.0007350009,0.00026607682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029703618,0.00020006116,0.0006002914,0.00056028925,0.00023967633,0.0009651405,0.00035823186,0.0005549015,0.019260569],"category_scores_gemma":[0.008260211,0.00007577784,0.0006147027,0.000870136,0.0005508759,0.0007279755,0.0004966143,0.0008193108,0.0018333469],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068432274,0.00022560553,0.041759405,0.009347323,0.00069784274,0.0011648968,0.00034342767,0.0006246242,0.0067606834,0.004480594,0.023425587,0.90432674],"study_design_scores_gemma":[0.0033140471,0.015326178,0.26044577,0.0077353413,0.003598189,0.026721148,0.0009169302,0.0018166519,0.012364171,0.0074720806,0.6601747,0.000114683346],"about_ca_topic_score_codex":0.00058683695,"about_ca_topic_score_gemma":0.0007171934,"teacher_disagreement_score":0.019260569,"about_ca_system_score_codex":0.0012759318,"about_ca_system_score_gemma":0.00066876574,"threshold_uncertainty_score":0.06443298},"labels":[],"label_agreement":null},{"id":"W1986632087","doi":"10.1191/1078155204jp138oa","title":"Temozolomide for malignant gliomas in British Columbia: A population-based cost-effectiveness analysis","year":2004,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Temozolomide; Lomustine; Medicine; Progression-free survival; Internal medicine; Dacarbazine; Population; Glioma; Chemotherapy; Oncology; Surgery; Vincristine; Cyclophosphamide","score_opus":0.04685100890727064,"score_gpt":0.41508613146085466,"score_spread":0.36823512255358404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986632087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918881,0.0022775987,0.00022754875,0.0004315899,0.000012314772,0.00026756848,0.003178926,0.000013416883,0.0017028851],"genre_scores_gemma":[0.99604684,0.0010567958,0.00033990399,0.00018477034,0.000010599237,0.00012801256,0.0017889763,0.0000035666772,0.00044058007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987639,0.0005680826,0.000082890016,0.00010364602,0.00024056883,0.0002408489],"domain_scores_gemma":[0.9983228,0.00059458474,0.0003810268,0.00004793943,0.00030622262,0.00034737712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014613012,0.0005969154,0.0010170329,0.0015917077,0.00047692668,0.0014851219,0.0009766336,0.0007727024,0.0024221588],"category_scores_gemma":[0.004929312,0.00047183732,0.0015821168,0.0026209697,0.00033460825,0.0003794587,0.00068568444,0.00075144955,0.00010351351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021227619,0.0014074211,0.8477611,0.0018592404,0.012983211,0.001243942,0.0002902619,0.051118072,0.0011093215,0.0013627105,0.00753484,0.05210238],"study_design_scores_gemma":[0.0033350112,0.0020954816,0.92096806,0.00058204494,0.005722989,0.000803433,0.0011472434,0.061190058,0.00025291077,0.000588084,0.0031835877,0.00013102258],"about_ca_topic_score_codex":0.7249555,"about_ca_topic_score_gemma":0.76700103,"teacher_disagreement_score":0.2750445,"about_ca_system_score_codex":0.019297864,"about_ca_system_score_gemma":0.0077065644,"threshold_uncertainty_score":0.5533286},"labels":[],"label_agreement":null},{"id":"W1987479288","doi":"10.1191/1078155202jp093oa","title":"Chemotherapy order review and documentation: let’s put the anDROIDs to work!","year":2002,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Documentation; Medicine; Pharmacy; Acronym; Pharmacy practice; Medical education; Oncology; Computer science; Family medicine","score_opus":0.1695471220418957,"score_gpt":0.5000999234577579,"score_spread":0.3305528014158622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987479288","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11285538,0.009371649,0.21387608,0.4641066,0.014387424,0.00515244,0.0012432323,0.041128937,0.13787827],"genre_scores_gemma":[0.2603812,0.0072620213,0.6170397,0.031694364,0.0034185369,0.0018126593,0.0009162059,0.002299426,0.0751759],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9847594,0.0067905216,0.0010803336,0.0008167173,0.005773355,0.00077957346],"domain_scores_gemma":[0.96576136,0.012046788,0.0046099997,0.004659733,0.007983826,0.004938255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009884773,0.0012892755,0.0007233535,0.0018364018,0.002786099,0.0044447174,0.0018565959,0.002988464,0.029340627],"category_scores_gemma":[0.056586128,0.00087439606,0.00089278055,0.0010509508,0.0023889395,0.009191809,0.004535617,0.0035687606,0.019665444],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026664292,0.00047084034,0.00645039,0.0009750704,0.00003241592,0.00063704886,0.0048414874,0.00026393888,0.0039417758,0.0023179455,0.16544573,0.81435674],"study_design_scores_gemma":[0.00045189788,0.0031188028,0.023723826,0.0042738277,0.00012648397,0.005260632,0.017605923,0.0025254523,0.012730579,0.009478945,0.92026776,0.00043594727],"about_ca_topic_score_codex":0.0034483252,"about_ca_topic_score_gemma":0.005765249,"teacher_disagreement_score":0.029340627,"about_ca_system_score_codex":0.001417439,"about_ca_system_score_gemma":0.006489748,"threshold_uncertainty_score":0.09815419},"labels":[],"label_agreement":null},{"id":"W1989949685","doi":"10.1191/1078155205jp164oa","title":"Leaching of diethylhexyl phthalate from polyvinyl chloride materials into etoposide intravenous solutions","year":2005,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Phthalate; Polyvinyl chloride; Leaching (pedology); Medicine; Chlorinated polyvinyl chloride; Nuclear chemistry; Toxicology; Environmental chemistry; Waste management; Chromatography; Chemistry; Environmental science; Organic chemistry; Soil water","score_opus":0.20775544299665336,"score_gpt":0.5581298923391756,"score_spread":0.35037444934252227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989949685","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013099577,0.9967393,0.00022859251,0.00010132295,0.00004985718,0.000013653274,0.000025903582,0.000009304813,0.0015220939],"genre_scores_gemma":[0.003687424,0.994768,0.00030608618,0.000056351815,0.000025285604,0.000013785238,0.000040344403,0.000001176163,0.0011015434],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997367,0.000046897032,0.00004597466,0.000036831814,0.0001138852,0.000019543775],"domain_scores_gemma":[0.9996909,0.00012639408,0.00009101289,0.000009011306,0.00006859997,0.000014019391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004728348,0.00056951697,0.0012101163,0.002080725,0.00020225455,0.0004689915,0.00061309926,0.0006048587,0.002708615],"category_scores_gemma":[0.0006370917,0.00032581767,0.0005319007,0.0021791023,0.00023325346,0.000594625,0.00032096956,0.00037633337,0.0017760583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112252106,0.00012165635,0.0006678801,0.033567242,0.00017766037,0.00060563465,0.00009208113,0.00034198753,0.009175303,0.0006540059,0.007043421,0.94744086],"study_design_scores_gemma":[0.00007075872,0.00051862985,0.0071195955,0.0066053676,0.0005322342,0.005483063,0.00021486741,0.00017641774,0.017087178,0.0009220288,0.96123177,0.000038096838],"about_ca_topic_score_codex":0.0012481182,"about_ca_topic_score_gemma":0.002455386,"teacher_disagreement_score":0.002708615,"about_ca_system_score_codex":0.00029086048,"about_ca_system_score_gemma":0.00059552625,"threshold_uncertainty_score":0.009061217},"labels":[],"label_agreement":null},{"id":"W1990795133","doi":"10.1177/1078155211426198","title":"Temozolomide plus radiotherapy for glioblastoma in a Canadian province: Efficacy versus effectiveness and the impact of O6-methylguanine-DNA-methyltransferase promoter methylation","year":2011,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"National Comprehensive Cancer Network","keywords":"Temozolomide; Medicine; Hazard ratio; Oncology; Population; Internal medicine; Regimen; Methyltransferase; Radiation therapy; Progression-free survival; Clinical trial; Methylation; Overall survival; Confidence interval","score_opus":0.045917709710597936,"score_gpt":0.4119399948427777,"score_spread":0.36602228513217977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990795133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891115,0.0075969943,0.00004586579,0.0006717287,0.000017970056,0.00010367903,0.00068772084,0.0000049651258,0.0017595901],"genre_scores_gemma":[0.9955966,0.0031128654,0.00019636987,0.0002022454,0.000026495853,0.000016754353,0.00057556445,0.0000025696963,0.0002705762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918824,0.00013946943,0.000047209105,0.00009717398,0.00033202756,0.00019583124],"domain_scores_gemma":[0.9986482,0.00018547052,0.00040034496,0.000027579697,0.00035700225,0.00038131277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013371017,0.00033693982,0.0005929464,0.00071471016,0.0011194929,0.0008073755,0.00079167366,0.00041936757,0.0011816814],"category_scores_gemma":[0.0031676136,0.00019248022,0.0005572867,0.0024477167,0.0006957906,0.00027197876,0.0004238973,0.00042790934,0.00007823903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035415042,0.00092761294,0.7968062,0.0011704502,0.0014874667,0.000364334,0.0008126999,0.0013037234,0.0028669622,0.00044959068,0.003989836,0.15440595],"study_design_scores_gemma":[0.0013783993,0.0032417355,0.98925847,0.00015601571,0.0011133668,0.00025167046,0.0005946241,0.0008448004,0.0004280971,0.00008426392,0.0026033514,0.000045136097],"about_ca_topic_score_codex":0.9509868,"about_ca_topic_score_gemma":0.98280346,"teacher_disagreement_score":0.049013197,"about_ca_system_score_codex":0.028426088,"about_ca_system_score_gemma":0.03495924,"threshold_uncertainty_score":0.20624667},"labels":[],"label_agreement":null},{"id":"W1990845522","doi":"10.1191/1078155205jp146oa","title":"Vinorelbine and venous irritation: optimal parenteral administration","year":2005,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Vinorelbine; Irritation; Intensive care medicine; Chemotherapy; Anesthesia; Pharmacology; Surgery; Cisplatin","score_opus":0.10616627253436649,"score_gpt":0.5099528220016883,"score_spread":0.40378654946732184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990845522","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000226618,0.9990578,0.00009292067,0.00014857308,0.000033742595,0.000004348159,0.000005616305,0.000003523185,0.00042684365],"genre_scores_gemma":[0.0018690391,0.9974596,0.00020598691,0.00011951753,0.00006635209,0.000008042294,0.000011033495,0.0000010934916,0.00025937322],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996666,0.00009013001,0.00006355309,0.00004691879,0.000108180255,0.000024666717],"domain_scores_gemma":[0.9997008,0.00013310711,0.00009668357,0.000007884557,0.000044802724,0.000016800717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065485545,0.00071901816,0.00246552,0.0013136469,0.00017521283,0.00089761,0.0007546282,0.0012848373,0.0026985083],"category_scores_gemma":[0.0009319977,0.00032739603,0.0005805378,0.0013945777,0.0004915316,0.0011540969,0.00041484312,0.0011421144,0.001230394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002463954,0.000099253084,0.00023860582,0.029762916,0.00014217335,0.00043011399,0.000053575663,0.00033683152,0.0017333155,0.0011478438,0.009403212,0.95640576],"study_design_scores_gemma":[0.00042271003,0.0009035064,0.006433174,0.025416536,0.00096954836,0.011518829,0.00027943982,0.00043449344,0.002893645,0.0035989727,0.9470722,0.000057009278],"about_ca_topic_score_codex":0.0010020188,"about_ca_topic_score_gemma":0.0020381846,"teacher_disagreement_score":0.0026985083,"about_ca_system_score_codex":0.0005147885,"about_ca_system_score_gemma":0.000783945,"threshold_uncertainty_score":0.0090274215},"labels":[],"label_agreement":null},{"id":"W1991042912","doi":"10.1177/1078155207082017","title":"Impact on patient satisfaction with a structured counselling approach on natural health products","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Patient satisfaction; Family medicine; Pharmacy; Workload; Intervention (counseling); Breast cancer; Physical therapy; Cancer; Nursing; Internal medicine","score_opus":0.08270727782431302,"score_gpt":0.4417445579801573,"score_spread":0.3590372801558443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991042912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981895,0.00016444494,0.00013569457,0.00020026074,0.000010440517,0.00004858749,0.000084615676,0.0000115429075,0.0011549487],"genre_scores_gemma":[0.99892384,0.00008153684,0.00039135205,0.00011986192,0.000016239037,0.00003820917,0.00010206268,0.0000019492186,0.00032486286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984811,0.00092494796,0.00008783322,0.00006569634,0.00030609363,0.00013423784],"domain_scores_gemma":[0.9959299,0.00229244,0.0007635355,0.00011631944,0.00031660058,0.0005811531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016272971,0.00016068181,0.00031845373,0.00022446345,0.0002200421,0.00035222294,0.0001829124,0.00039259696,0.0073464313],"category_scores_gemma":[0.005672054,0.00008984299,0.00048965146,0.00029955892,0.0002047467,0.00019501479,0.0003383776,0.00052323827,0.00031576699],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019262413,0.014929975,0.59360766,0.0011038262,0.00084314914,0.00055467384,0.0020746433,0.0011945843,0.008562093,0.0001764254,0.003027078,0.35466355],"study_design_scores_gemma":[0.0011406395,0.029463617,0.9622106,0.000081943515,0.0003081294,0.00080166385,0.00089791557,0.0012491278,0.0014673518,0.00009017278,0.0022542174,0.000034605797],"about_ca_topic_score_codex":0.000674652,"about_ca_topic_score_gemma":0.00077767274,"teacher_disagreement_score":0.0073464313,"about_ca_system_score_codex":0.00030155902,"about_ca_system_score_gemma":0.00038885546,"threshold_uncertainty_score":0.024576247},"labels":[],"label_agreement":null},{"id":"W1992093804","doi":"10.1177/1078155213497070","title":"Examining factors that influence the effectiveness of cleaning antineoplastic drugs from drug preparation surfaces: A pilot study","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Workers Compensation Board of British Columbia; Fraser Health; Toronto Metropolitan University; University of British Columbia","funders":"WorkSafeBC","keywords":"Drug; Cleaning agent; Contamination; Medicine; Antineoplastic Drugs; Drug packaging; Isopropyl alcohol; Contamination control; Pharmacology; Chemistry","score_opus":0.10877103830834663,"score_gpt":0.45743917685341395,"score_spread":0.34866813854506734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992093804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99918264,0.00009909681,0.00031564405,0.000014175204,0.0000056690465,0.00022834919,0.000036813646,0.0000029242424,0.00011460381],"genre_scores_gemma":[0.99423707,0.0004535722,0.003873241,0.00007202698,0.000022004519,0.00041148358,0.00021985569,0.000010673314,0.0007000949],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99828476,0.00064717745,0.00016733464,0.0002954183,0.0004216012,0.00018366097],"domain_scores_gemma":[0.9944125,0.0028646996,0.0011288872,0.00035302987,0.00090491987,0.00033595937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023239309,0.0006080846,0.00072224316,0.0004315291,0.00045804822,0.0007072405,0.00045930172,0.0005949036,0.0017152808],"category_scores_gemma":[0.004822132,0.00034508095,0.0009365724,0.00039691446,0.0005583668,0.00055241416,0.0005096037,0.0006171995,0.00028186472],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025253555,0.06547955,0.16274635,0.0015615454,0.00043471594,0.0010816468,0.0028579354,0.00076383364,0.6640738,0.00013221905,0.00047291972,0.0751419],"study_design_scores_gemma":[0.0004920167,0.4481828,0.3663914,0.0000543941,0.00074653956,0.00077597675,0.0020842461,0.0018034199,0.17706789,0.00008118281,0.0022475366,0.000072622184],"about_ca_topic_score_codex":0.0010239742,"about_ca_topic_score_gemma":0.0016038731,"teacher_disagreement_score":0.0023239309,"about_ca_system_score_codex":0.000342161,"about_ca_system_score_gemma":0.0008078211,"threshold_uncertainty_score":0.012290239},"labels":[],"label_agreement":null},{"id":"W1992816765","doi":"10.1177/1078155214556008","title":"Abraxane® versus Taxol® for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Breast cancer; Adverse effect; Premedication; Cancer; Paclitaxel; Emergency medicine; Internal medicine; Surgery","score_opus":0.011455966854408016,"score_gpt":0.41087533716621105,"score_spread":0.399419370311803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992816765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986205,0.0005973538,0.000041971074,0.000065795866,0.0000044822837,0.00002908796,0.0004101737,9.354483e-7,0.00022959233],"genre_scores_gemma":[0.99896216,0.00024738556,0.00004258252,0.000056607973,0.000014691178,0.000025656736,0.0005725537,8.5071235e-7,0.00007769328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99918157,0.00021600357,0.00009101451,0.00013340464,0.00013743344,0.00024058498],"domain_scores_gemma":[0.9971239,0.0005436263,0.0015841484,0.00006534995,0.00023332497,0.00044965302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014243848,0.00038584854,0.0006724239,0.0017931234,0.00054061157,0.0007652649,0.00034649085,0.0004654639,0.0024085152],"category_scores_gemma":[0.002457909,0.0002316387,0.002568061,0.0027810321,0.00039529375,0.0005759411,0.0006949751,0.00064209773,0.00013070859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002463322,0.00011869611,0.9936841,0.000070249436,0.0005142503,0.00010315152,0.00011315028,0.00036556987,0.00009880613,0.000055604058,0.00013939374,0.0022735687],"study_design_scores_gemma":[0.00015495018,0.0014562763,0.99577725,0.00001907568,0.00058046007,0.00009079511,0.0004307923,0.0011592081,0.000045907924,0.000051414434,0.00021719301,0.000016596727],"about_ca_topic_score_codex":0.017700754,"about_ca_topic_score_gemma":0.016652854,"teacher_disagreement_score":0.017700754,"about_ca_system_score_codex":0.0019618173,"about_ca_system_score_gemma":0.0016929124,"threshold_uncertainty_score":0.03519547},"labels":[],"label_agreement":null},{"id":"W1994040984","doi":"10.1177/1078155207080804","title":"Overview of targeted therapies in Oncology","year":2007,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Research and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Monoclonal antibody; Angiogenesis; Targeted therapy; Cancer; Pharmacology; Cancer therapy; Oncology; Bioinformatics; Cancer research; Immunology; Internal medicine; Antibody","score_opus":0.16274462792214772,"score_gpt":0.5536878884596593,"score_spread":0.3909432605375116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994040984","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002694495,0.9889465,0.0011185015,0.002156409,0.00037877227,0.00002569547,0.00006683394,0.000024161669,0.007013757],"genre_scores_gemma":[0.001650879,0.99434894,0.001323236,0.00092354696,0.00051730877,0.000031386055,0.00008833788,0.0000034044217,0.0011129569],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993781,0.00020237491,0.000085660366,0.00005162388,0.00024334832,0.000038861832],"domain_scores_gemma":[0.9992506,0.000415109,0.0000888289,0.0000206713,0.00018441744,0.00004033642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001058509,0.0007406394,0.0011007515,0.0037354147,0.0003239463,0.001189532,0.00059971015,0.0012267733,0.007297239],"category_scores_gemma":[0.0011264542,0.00020329027,0.0005749133,0.0035347643,0.00037783416,0.0014097434,0.0005612318,0.0012787483,0.002348118],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007112045,0.000060897666,0.00031679234,0.012946186,0.00007983249,0.00047466112,0.000073570045,0.0004317188,0.0011050351,0.007723528,0.039860122,0.93685645],"study_design_scores_gemma":[0.000028388336,0.00011567863,0.001082424,0.00517841,0.000095177435,0.0031341156,0.0000771513,0.00014657622,0.00035146854,0.00646212,0.98331404,0.000014488285],"about_ca_topic_score_codex":0.00094835606,"about_ca_topic_score_gemma":0.0021235663,"teacher_disagreement_score":0.007297239,"about_ca_system_score_codex":0.001007906,"about_ca_system_score_gemma":0.0016897476,"threshold_uncertainty_score":0.024411738},"labels":[],"label_agreement":null},{"id":"W1995674745","doi":"10.1177/1078155213506478","title":"Trastuzumab therapy in breast cancer: To reload or not to reload?","year":2013,"lang":"en","type":"editorial","venue":"Journal of Oncology Pharmacy Practice","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Trastuzumab; Breast cancer; Oncology; Internal medicine; Cancer","score_opus":0.10153406861746643,"score_gpt":0.5481237729204406,"score_spread":0.4465897043029741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995674745","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058975755,0.013154421,0.00009286483,0.090186834,0.8953042,0.000017544546,0.00003479434,0.000030231111,0.0011201797],"genre_scores_gemma":[0.00047391033,0.0069758766,0.00008654346,0.037503555,0.952476,0.000016460657,0.000013320359,0.00001499512,0.0024392812],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99288696,0.0017191159,0.0013170289,0.0007236043,0.0027423804,0.0006108856],"domain_scores_gemma":[0.96796083,0.015317364,0.0027086767,0.00063097116,0.008682745,0.0046994374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011403116,0.0031372805,0.0049174516,0.003214007,0.003304812,0.007574312,0.0042942306,0.030305777,0.006762201],"category_scores_gemma":[0.04550127,0.0013538019,0.003119068,0.0021170508,0.0029350787,0.0045613134,0.0017013354,0.0334405,0.004996333],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000612627,0.000024535982,0.000055844408,0.0003765856,0.000045925713,0.00017739211,0.000014627482,0.00002961561,0.00003458412,0.0002655682,0.98987216,0.009042054],"study_design_scores_gemma":[0.00039714528,0.00011023153,0.0007620802,0.0021344458,0.00036279368,0.0008061547,0.00010298812,0.0003772479,0.00018647531,0.0013152693,0.99339193,0.000053145915],"about_ca_topic_score_codex":0.0031911207,"about_ca_topic_score_gemma":0.009810247,"teacher_disagreement_score":0.030305777,"about_ca_system_score_codex":0.00605291,"about_ca_system_score_gemma":0.005501956,"threshold_uncertainty_score":0.06030613},"labels":[],"label_agreement":null},{"id":"W1997842736","doi":"10.1191/1078155202jp090oa","title":"Development of a pharmacist-coordinated system of chemotherapy protocols in an integrated healthcare delivery organization","year":2002,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Protocol (science); Pharmacist; Intranet; Credibility; Health care; Pharmacy; The Internet; Nursing; Alternative medicine; Computer science; World Wide Web; Pathology","score_opus":0.32126986827349624,"score_gpt":0.5543952731209133,"score_spread":0.23312540484741706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997842736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57255566,0.0006577742,0.33363298,0.013743447,0.0004111281,0.05292637,0.00059207674,0.0052745915,0.02020588],"genre_scores_gemma":[0.3905874,0.00032159218,0.59670746,0.001023933,0.000109309214,0.007737012,0.0006811012,0.000095840216,0.0027363882],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9726308,0.017303351,0.0023552505,0.0018831674,0.0047286325,0.0010987624],"domain_scores_gemma":[0.96493995,0.0051939953,0.0052482253,0.005175917,0.0115802055,0.007861749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027971055,0.0005556435,0.0003525337,0.0020502382,0.0018682986,0.0024506475,0.002416635,0.0008959617,0.0024269845],"category_scores_gemma":[0.03766017,0.0007182488,0.0006053616,0.001133861,0.0009169775,0.0023733838,0.0032697453,0.0012025767,0.0007565875],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006710971,0.012121205,0.08586202,0.0010930271,0.00027025797,0.0006481149,0.004708286,0.013275703,0.009705665,0.003867409,0.021405913,0.84637135],"study_design_scores_gemma":[0.009464747,0.059256766,0.43982863,0.003515526,0.0013083724,0.0036485996,0.020281777,0.13966197,0.04383023,0.010110952,0.26829296,0.0007995304],"about_ca_topic_score_codex":0.009394369,"about_ca_topic_score_gemma":0.012641061,"teacher_disagreement_score":0.027971055,"about_ca_system_score_codex":0.005755535,"about_ca_system_score_gemma":0.03860038,"threshold_uncertainty_score":0.14792687},"labels":[],"label_agreement":null},{"id":"W2001399765","doi":"10.1177/107815520100600401","title":"Prospective evaluation of a policy of early discontinuation of antibiotics and discharge from hospital in children with cancer who develop fever","year":2001,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital; Hamilton Health Sciences","funders":"International Society of Oncology Pharmacy Practitioners","keywords":"Medicine; Discontinuation; Antibiotics; Prospective cohort study; Pediatrics; Cancer; Cohort; Emergency medicine; Intensive care medicine; Surgery; Internal medicine","score_opus":0.032808497806714014,"score_gpt":0.4200506473248311,"score_spread":0.3872421495181171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001399765","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962649,0.0003097582,0.0008946259,0.00031973518,0.000029947942,0.0012616585,0.0003459637,0.000029748202,0.0005437084],"genre_scores_gemma":[0.9937763,0.00017149979,0.0042256573,0.00014058355,0.000022687174,0.0011964084,0.00042070865,0.0000041817157,0.00004182332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97047406,0.022551093,0.002172867,0.0012192655,0.002509927,0.00107276],"domain_scores_gemma":[0.8987771,0.041296452,0.044607297,0.0030588915,0.0071365163,0.0051235976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029214052,0.00059767027,0.00072666793,0.0013386569,0.0007271386,0.0016213777,0.0009542234,0.001023252,0.0007452158],"category_scores_gemma":[0.07190623,0.00062031706,0.0011871413,0.0011928633,0.00089920306,0.0014632376,0.0011248693,0.0009791016,0.00012993514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020842548,0.0033895187,0.9346454,0.00023233375,0.00037347854,0.00010459877,0.0003402603,0.009362176,0.00042866517,0.00026134844,0.0005997349,0.029419921],"study_design_scores_gemma":[0.0068446645,0.11711576,0.8422045,0.0003094576,0.0005199928,0.00038750266,0.001161493,0.026141757,0.0031764428,0.00020016026,0.0018162534,0.00012200256],"about_ca_topic_score_codex":0.0036588016,"about_ca_topic_score_gemma":0.0043314793,"teacher_disagreement_score":0.029214052,"about_ca_system_score_codex":0.0050823316,"about_ca_system_score_gemma":0.0090573905,"threshold_uncertainty_score":0.15450054},"labels":[],"label_agreement":null},{"id":"W2005204505","doi":"10.1177/1078155214533367","title":"Tolerability of Velcade (Bortezomib) subcutaneous administration using a maximum volume of 3 mL per injection site","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bortezomib; Tolerability; Dosing; Subcutaneous injection; Anesthesia; Route of administration; Multiple myeloma; Adverse effect; Pharmacology; Internal medicine","score_opus":0.0622537412032568,"score_gpt":0.4347714572492852,"score_spread":0.37251771604602835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005204505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918616,0.0024728065,0.0012771621,0.00012020137,0.000032501524,0.00021970137,0.00044211582,0.00005712481,0.003516771],"genre_scores_gemma":[0.99761605,0.0004555032,0.0003592222,0.00012459654,0.000035884106,0.000068219386,0.0002051855,0.000014428681,0.0011209059],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9996363,0.00011193322,0.00003729437,0.000042027674,0.00013227867,0.000040142764],"domain_scores_gemma":[0.99888974,0.00043028354,0.00030596115,0.00007669291,0.00017659609,0.000120782446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006825953,0.00020752048,0.00061075005,0.00011684913,0.00018115278,0.0003778637,0.00013310043,0.00019425778,0.0025292449],"category_scores_gemma":[0.0017385059,0.000109468914,0.00042592967,0.00022241528,0.00015829006,0.00028088206,0.000122043486,0.0006522602,0.00041438977],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064304456,0.017189668,0.14171049,0.0019085108,0.0010819309,0.002409358,0.0017061982,0.004847711,0.28127244,0.00040510495,0.004773492,0.4783906],"study_design_scores_gemma":[0.0027350509,0.276772,0.6372052,0.00011284657,0.0008415123,0.0057519544,0.00051623036,0.002859123,0.058127068,0.00022625657,0.014776847,0.000075907694],"about_ca_topic_score_codex":0.0006420898,"about_ca_topic_score_gemma":0.0005796957,"teacher_disagreement_score":0.0025292449,"about_ca_system_score_codex":0.00021668119,"about_ca_system_score_gemma":0.00021244005,"threshold_uncertainty_score":0.008461118},"labels":[],"label_agreement":null},{"id":"W2006163699","doi":"10.1191/1078155204jp127oa","title":"Effects of flaxseed on breast cancer growth","year":2004,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Phytoestrogen effects and research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Breast cancer; Tamoxifen; Cancer; Oncology; Internal medicine; Traditional medicine; Gynecology","score_opus":0.02737077248091464,"score_gpt":0.44521561162457973,"score_spread":0.4178448391436651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006163699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7724464,0.20376329,0.0010836008,0.0012272553,0.0002894747,0.000064212145,0.001066176,0.0001292207,0.019930294],"genre_scores_gemma":[0.8921141,0.09267554,0.0010513696,0.00048949476,0.00009239681,0.000035005585,0.0007403407,0.000018500135,0.012783178],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99993587,0.000017795488,0.000006091961,0.00001170379,0.000018976105,0.000009603891],"domain_scores_gemma":[0.9998816,0.000053731826,0.00002595597,0.0000060636125,0.000021509308,0.000011184996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001326858,0.00025064946,0.00018513287,0.00034907085,0.00012598348,0.00021030598,0.00012597964,0.00029404627,0.0025744839],"category_scores_gemma":[0.00028491914,0.000061726074,0.0003124269,0.00024033124,0.00007348327,0.00014811275,0.00013460728,0.00022973023,0.00030150756],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030919847,0.00035864947,0.0023897155,0.0026672208,0.0001647643,0.0005986996,0.0001532074,0.00023934912,0.8752904,0.00038333732,0.0010522272,0.11361048],"study_design_scores_gemma":[0.0002203505,0.014536126,0.06296522,0.00060398615,0.000626665,0.0015482502,0.00030405223,0.0006207278,0.83361626,0.00053821254,0.084379636,0.000040600207],"about_ca_topic_score_codex":0.0017947725,"about_ca_topic_score_gemma":0.0028978377,"teacher_disagreement_score":0.0025744839,"about_ca_system_score_codex":0.00020174243,"about_ca_system_score_gemma":0.00013606138,"threshold_uncertainty_score":0.008612454},"labels":[],"label_agreement":null},{"id":"W2006689939","doi":"10.1177/1078155206075236","title":"Stability issues of parenteral chemotherapy drugs","year":2007,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; United States Pharmacopeia","keywords":"Medicine; Chemotherapy; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.06675610146510093,"score_gpt":0.49594687242619134,"score_spread":0.42919077096109043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006689939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33951512,0.28626043,0.2493436,0.03514266,0.005732044,0.0013600283,0.0026971675,0.0033095952,0.07663936],"genre_scores_gemma":[0.79971254,0.04932187,0.12599666,0.005790504,0.002600722,0.00044021616,0.001619474,0.0007773764,0.013740641],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97848684,0.0075078825,0.0038323386,0.0014908839,0.0083266,0.00035547142],"domain_scores_gemma":[0.9349234,0.034206215,0.014044159,0.003581995,0.012774901,0.00046930954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021894498,0.0004706451,0.0010876645,0.0025764755,0.0012096311,0.0036913392,0.0012703635,0.0016268146,0.00302054],"category_scores_gemma":[0.058827106,0.00044560182,0.0009240108,0.002540682,0.001913791,0.0030835615,0.0014335717,0.0024206708,0.0012902748],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023225376,0.00024254863,0.018310279,0.0039206077,0.00023945345,0.0025057453,0.0035605312,0.003692492,0.08843802,0.02692154,0.021135645,0.8287107],"study_design_scores_gemma":[0.00021614796,0.004657376,0.03375539,0.0026720879,0.0006195644,0.022817075,0.0018171583,0.013030047,0.43423644,0.030911732,0.45487884,0.00038812132],"about_ca_topic_score_codex":0.0017495303,"about_ca_topic_score_gemma":0.0014334884,"teacher_disagreement_score":0.021894498,"about_ca_system_score_codex":0.0021545948,"about_ca_system_score_gemma":0.002074237,"threshold_uncertainty_score":0.115790546},"labels":[],"label_agreement":null},{"id":"W2022953054","doi":"10.1177/1078155212442562","title":"Using expired supply in times of drug shortage","year":2012,"lang":"en","type":"letter","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Economic shortage; Drug; Intensive care medicine; Pharmacology; Emergency medicine","score_opus":0.18364378929511835,"score_gpt":0.4199983429826919,"score_spread":0.23635455368757355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022953054","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038984545,0.0020495502,0.004563506,0.9317858,0.003232935,0.00002611238,0.00040948243,0.0000962415,0.01885175],"genre_scores_gemma":[0.7256305,0.003333818,0.0043769125,0.22965008,0.01673655,0.000057233017,0.00022990764,0.00011163122,0.01987326],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976865,0.0013371753,0.0002532058,0.00016365947,0.00034824465,0.00021118642],"domain_scores_gemma":[0.9499095,0.041158672,0.0024843942,0.0013051505,0.0029945148,0.002147812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058822036,0.00021850337,0.0004530071,0.0007902853,0.0010589497,0.002543238,0.0009833964,0.008190811,0.008141291],"category_scores_gemma":[0.07387376,0.00031959458,0.0004671405,0.00077083585,0.0010247935,0.0052360916,0.0013593736,0.0085213445,0.0009513226],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012325463,0.0004532237,0.11112235,0.00042523755,0.00017146095,0.013361659,0.002927494,0.005763272,0.00097118045,0.060256798,0.6068021,0.1965127],"study_design_scores_gemma":[0.0005020916,0.00090270117,0.0731899,0.001676994,0.0001549231,0.010369713,0.0084899645,0.05716483,0.0030861911,0.2184698,0.6257133,0.00027963842],"about_ca_topic_score_codex":0.0037145973,"about_ca_topic_score_gemma":0.0060648704,"teacher_disagreement_score":0.008190811,"about_ca_system_score_codex":0.0013944681,"about_ca_system_score_gemma":0.0015990927,"threshold_uncertainty_score":0.031108439},"labels":[],"label_agreement":null},{"id":"W2023063845","doi":"10.1191/1078155202jp089oa","title":"Clinical effectiveness of trastuzumab: early experience","year":2002,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Baker Hughes (Canada); University of Alberta; Alberta Cancer Foundation","funders":"","keywords":"Medicine; Trastuzumab; Internal medicine; Cardiotoxicity; Clinical trial; Oncology; Breast cancer; Metastatic breast cancer; Adverse effect; Cancer; Incidence (geometry); Surgery; Chemotherapy","score_opus":0.25688355352266745,"score_gpt":0.5927217133347364,"score_spread":0.335838159812069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023063845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8461299,0.13812815,0.0009557775,0.0028200517,0.0000807398,0.00009842516,0.00016922054,0.000029922028,0.011587937],"genre_scores_gemma":[0.98589885,0.0124234995,0.00044761613,0.000646381,0.00013894809,0.000013904055,0.00012962482,0.000004723728,0.000296385],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978345,0.0010374968,0.00012821516,0.00012061735,0.0007090552,0.00017010178],"domain_scores_gemma":[0.99256,0.0039874036,0.0010587652,0.00025362297,0.0015864895,0.00055376097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056756935,0.00018343111,0.0003222506,0.00027359044,0.00019905459,0.0009823219,0.00042091412,0.00035352923,0.00051112636],"category_scores_gemma":[0.013213904,0.00006823319,0.0001283312,0.0005908089,0.00068399304,0.00041376948,0.00031715847,0.00045510998,0.00008274124],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006532611,0.0005594836,0.26742342,0.00081712863,0.00022277699,0.0011657383,0.0014685821,0.00084518275,0.0051883864,0.0015158515,0.0043503605,0.70991045],"study_design_scores_gemma":[0.0018842599,0.025315188,0.8384495,0.0012075058,0.00071362115,0.009598941,0.0013969719,0.001519795,0.011141067,0.0012055233,0.10750063,0.000066924826],"about_ca_topic_score_codex":0.0046257004,"about_ca_topic_score_gemma":0.0051007937,"teacher_disagreement_score":0.0056756935,"about_ca_system_score_codex":0.0022524002,"about_ca_system_score_gemma":0.0013281609,"threshold_uncertainty_score":0.030016243},"labels":[],"label_agreement":null},{"id":"W2023645024","doi":"10.1177/1078155213495285","title":"What do Canadian uro-oncologists believe patients should know about androgen deprivation therapy?","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Capital District Health Authority; University of Toronto; Dalhousie University; Princess Margaret Cancer Centre; University of British Columbia; University of Calgary","funders":"","keywords":"Medicine; Androgen deprivation therapy; Family medicine; Erectile dysfunction; Psychological intervention; Hormone therapy; Prostate cancer; Gynecology; Cancer; Psychiatry; Internal medicine; Breast cancer","score_opus":0.06334315318679806,"score_gpt":0.3973897417244644,"score_spread":0.33404658853766633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023645024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50955695,0.021690203,0.0004748181,0.39655325,0.0016196008,0.00019923813,0.0023035198,0.00007065024,0.06753173],"genre_scores_gemma":[0.96477747,0.0091315275,0.00070124975,0.022322759,0.00023787913,0.000034211746,0.0004791528,0.000013803904,0.0023020566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967908,0.00057748216,0.00015861001,0.00021718364,0.0014712845,0.0007844886],"domain_scores_gemma":[0.9779117,0.002989042,0.0028822955,0.00024048466,0.007767447,0.008208973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024979524,0.00016434019,0.00034816153,0.0009975557,0.006053151,0.0023314096,0.0011804383,0.0017507826,0.0074481894],"category_scores_gemma":[0.021566115,0.00026441703,0.00037796516,0.0020805944,0.0018961284,0.0010297681,0.0008153777,0.001990476,0.00047901564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019427379,0.0001872108,0.7059064,0.001123275,0.00011980006,0.0009812205,0.025399832,0.00025830706,0.00047341644,0.0011772232,0.14025451,0.12392462],"study_design_scores_gemma":[0.0000878621,0.0001381507,0.83524346,0.0026506702,0.00015254223,0.001021221,0.064219676,0.0004989899,0.00024980766,0.00061102083,0.094977565,0.00014908492],"about_ca_topic_score_codex":0.9355127,"about_ca_topic_score_gemma":0.962308,"teacher_disagreement_score":0.06448728,"about_ca_system_score_codex":0.029732252,"about_ca_system_score_gemma":0.056460332,"threshold_uncertainty_score":0.21572357},"labels":[],"label_agreement":null},{"id":"W2031514510","doi":"10.1177/1078155210381794","title":"Should the concomitant use of erlotinib and acid-reducing agents be avoided? The drug interaction between erlotinib and acid-reducing agents","year":2010,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; University of Toronto","funders":"","keywords":"Erlotinib; Medicine; Pharmacology; Famotidine; Drug interaction; Drug; Ranitidine; Cimetidine; Context (archaeology); Pharmacokinetics; Epidermal growth factor receptor; Internal medicine; Cancer","score_opus":0.25394962200006704,"score_gpt":0.5227555704228933,"score_spread":0.2688059484228263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031514510","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10647828,0.5148028,0.006815022,0.32677776,0.0069568064,0.00031255375,0.00068410655,0.00024728046,0.03692545],"genre_scores_gemma":[0.57250637,0.28412542,0.012298853,0.10363408,0.01729009,0.00033656886,0.0008256825,0.00009008841,0.008892874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986106,0.0005141286,0.0003340162,0.0001277732,0.00030575637,0.00010774121],"domain_scores_gemma":[0.9942622,0.002707124,0.0015165798,0.00019725197,0.000780614,0.00053633057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018650354,0.00029258235,0.001157337,0.0006339345,0.00057180953,0.0008770399,0.0006693785,0.004050618,0.004389641],"category_scores_gemma":[0.013566112,0.0001594363,0.0008918674,0.0005153074,0.00060841156,0.0021604677,0.00033356738,0.0024953955,0.0014259631],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044754893,0.00068334595,0.025773564,0.014529365,0.0008417395,0.020736003,0.00044297051,0.0006736485,0.00308376,0.004061284,0.11905314,0.8056458],"study_design_scores_gemma":[0.0023715324,0.0026765254,0.09462115,0.043190382,0.002836897,0.09566751,0.0029855524,0.0020444607,0.0074736574,0.0273726,0.7184133,0.00034653858],"about_ca_topic_score_codex":0.0011087334,"about_ca_topic_score_gemma":0.0026583804,"teacher_disagreement_score":0.004389641,"about_ca_system_score_codex":0.00064362766,"about_ca_system_score_gemma":0.0016875138,"threshold_uncertainty_score":0.014684796},"labels":[],"label_agreement":null},{"id":"W2036005566","doi":"10.1177/1078155213482602","title":"High-dose methotrexate in adult oncology patients: A case-control study assessing the risk association between drug interactions and methotrexate toxicity","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"London Health Sciences Centre","keywords":"Medicine; Methotrexate; Mucositis; Nephrotoxicity; Internal medicine; Toxicity; Regimen; Pharmacology; Renal function; Gastroenterology","score_opus":0.03695050119048455,"score_gpt":0.4405665699112882,"score_spread":0.40361606872080363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036005566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992536,0.00042590714,0.000098887744,0.000016666012,0.0000039058377,0.000024136541,0.000042110536,0.0000018838574,0.00013279416],"genre_scores_gemma":[0.9995158,0.0001775072,0.00012550096,0.000026332107,0.000015143366,0.000015906446,0.000072665774,9.386401e-7,0.000050297396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870527,0.00042162798,0.00016508489,0.0003664797,0.00021991583,0.00012157572],"domain_scores_gemma":[0.99732375,0.00082246173,0.001151719,0.0002299722,0.00019800242,0.00027418596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001339181,0.00034960904,0.00066599133,0.0008360338,0.0006130925,0.00078463973,0.000421595,0.00071513804,0.0013743319],"category_scores_gemma":[0.0036497358,0.00049189135,0.00049953477,0.0012556189,0.00045107215,0.00046407187,0.00038345077,0.0006039997,0.00015370581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042308003,0.00016024947,0.99752396,0.000020054973,0.00009087053,0.0004376388,0.00009606743,0.000013627311,0.00018743087,0.000014529886,0.000049975628,0.0009825655],"study_design_scores_gemma":[0.00014160256,0.0014673319,0.9934902,0.000018041676,0.00017259487,0.0036766008,0.00023890682,0.00032611933,0.000117360636,0.000022712678,0.0003203812,0.000008218969],"about_ca_topic_score_codex":0.0029841068,"about_ca_topic_score_gemma":0.0028524583,"teacher_disagreement_score":0.0029841068,"about_ca_system_score_codex":0.00045984192,"about_ca_system_score_gemma":0.0003707457,"threshold_uncertainty_score":0.007082343},"labels":[],"label_agreement":null},{"id":"W2044771549","doi":"10.1191/1078155204jp128oa","title":"Retinoic acid syndrome after one dose of all-transretinoic acid","year":2004,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network","funders":"","keywords":"Medicine; Retinoic acid; Acute promyelocytic leukemia; Chemotherapy; Pathophysiology; Tretinoin; Internal medicine; Pharmacology; Biochemistry; Gene","score_opus":0.023549602897649357,"score_gpt":0.34292394471747667,"score_spread":0.3193743418198273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044771549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9404015,0.009092414,0.012350243,0.008346982,0.00064550014,0.00030914866,0.00043800526,0.0012691969,0.027147023],"genre_scores_gemma":[0.98696274,0.0022171042,0.0012847963,0.0020078027,0.0002489956,0.000039706163,0.0001340083,0.00006926013,0.0070356163],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99956363,0.00008649964,0.0000446144,0.00008917483,0.00011394598,0.00010220346],"domain_scores_gemma":[0.998454,0.00054818153,0.00039019086,0.00015980555,0.00010273197,0.0003451517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023161796,0.0009773052,0.0010163845,0.0011497671,0.00083749567,0.0004220661,0.0006176255,0.0024749634,0.0013136131],"category_scores_gemma":[0.0021907922,0.00027513795,0.0008972616,0.0006313737,0.0009538393,0.0006338219,0.00068708364,0.003177065,0.00084698043],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028050705,0.00009984804,0.00455039,0.00006482338,0.000034526773,0.9775802,0.00024271743,0.0002834241,0.007615725,0.0008445043,0.0003930708,0.008010366],"study_design_scores_gemma":[0.000043068743,0.0004698924,0.004981881,0.00001691748,0.000028347016,0.9872291,0.0000648083,0.0003203882,0.0039543426,0.0003422712,0.002536335,0.0000126826],"about_ca_topic_score_codex":0.0014588118,"about_ca_topic_score_gemma":0.0012346333,"teacher_disagreement_score":0.0024749634,"about_ca_system_score_codex":0.0010406015,"about_ca_system_score_gemma":0.0007039731,"threshold_uncertainty_score":0.00755018},"labels":[],"label_agreement":null},{"id":"W2045798533","doi":"10.1191/1078155205jp145oa","title":"Alendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin’s lymphoma: results of a pilot study","year":2005,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; McMaster Children's Hospital","funders":"","keywords":"Medicine; Hodgkin lymphoma; Osteopenia; Lymphoblastic lymphoma; Lymphoma; Lymphoblastic Leukemia; Pediatrics; Internal medicine; Oncology; Osteoporosis; Leukemia; Immunology; Bone mineral","score_opus":0.07171028973288934,"score_gpt":0.44252300373742975,"score_spread":0.3708127140045404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045798533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99904054,0.00044228177,0.000095072246,0.000035367833,0.0000064530795,0.0001518251,0.00007106025,0.000007492467,0.00014988749],"genre_scores_gemma":[0.99810153,0.00064379396,0.00048666474,0.00008081267,0.00004385077,0.00017515052,0.00030048756,0.0000047947624,0.00016287039],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991304,0.0004472418,0.0000982412,0.000090755726,0.00009750346,0.0001357453],"domain_scores_gemma":[0.9984634,0.00063697906,0.00023328194,0.00012543795,0.00013049056,0.0004104144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018463851,0.0010462975,0.0011822764,0.00043176714,0.0004728035,0.00039232013,0.00052989955,0.00064913376,0.0009465177],"category_scores_gemma":[0.002004596,0.00031015807,0.0013117609,0.00045678875,0.00079324405,0.0004134406,0.0003285213,0.0007278673,0.00030180122],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18797295,0.12182982,0.4705193,0.0013584233,0.0020180119,0.01220476,0.0030773985,0.0014727233,0.06462683,0.0001451207,0.0009918633,0.13378286],"study_design_scores_gemma":[0.025368135,0.474716,0.4851667,0.00006253681,0.0009014456,0.005292376,0.0006241148,0.0006423246,0.00508465,0.000055841905,0.0020438912,0.000041952808],"about_ca_topic_score_codex":0.0034841495,"about_ca_topic_score_gemma":0.0029602959,"teacher_disagreement_score":0.0034841495,"about_ca_system_score_codex":0.0005972078,"about_ca_system_score_gemma":0.0008486996,"threshold_uncertainty_score":0.009764731},"labels":[],"label_agreement":null},{"id":"W2045984347","doi":"10.1191/1078155201jp078oa","title":"Spearheading clinical intervention documentation into the future: an Alberta Cancer Board study","year":2001,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Alberta","keywords":"Documentation; Medicine; Psychological intervention; Pharmacy; Interview; Data extraction; Medical education; Intervention (counseling); Family medicine; MEDLINE; Nursing; Computer science","score_opus":0.21251276514917697,"score_gpt":0.6067075707956135,"score_spread":0.3941948056464366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045984347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98283505,0.0017168273,0.00021086074,0.0049292883,0.000070286944,0.0006639351,0.0006604098,0.000011460522,0.008901959],"genre_scores_gemma":[0.99189925,0.0010887503,0.0004357905,0.0018602455,0.000037332255,0.00049994135,0.00057449815,0.000014096524,0.0035901514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9881743,0.0039557396,0.00047348748,0.00064124947,0.0042343866,0.0025208138],"domain_scores_gemma":[0.9665923,0.008886048,0.0060835597,0.0013620575,0.010106403,0.0069696354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016567986,0.00032079732,0.0006220135,0.0023681815,0.0057602627,0.0038750963,0.0028656076,0.0011483748,0.004545322],"category_scores_gemma":[0.04188329,0.0005437546,0.00049790594,0.007014595,0.0023292745,0.0022027588,0.0023695922,0.002602439,0.0004326249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008891969,0.0022858027,0.9044252,0.00041141603,0.00006971408,0.00046337215,0.03682898,0.00015647762,0.00017361938,0.0016200579,0.011811067,0.0408652],"study_design_scores_gemma":[0.00012745675,0.00068048993,0.9350708,0.0006722163,0.00008843359,0.00012080868,0.05170791,0.00033531382,0.000088056804,0.00026121965,0.010806632,0.00004065984],"about_ca_topic_score_codex":0.8967048,"about_ca_topic_score_gemma":0.9351275,"teacher_disagreement_score":0.10329521,"about_ca_system_score_codex":0.045059215,"about_ca_system_score_gemma":0.092889674,"threshold_uncertainty_score":0.32692903},"labels":[],"label_agreement":null},{"id":"W2046437108","doi":"10.1177/1078155206069925","title":"Dose conversion and cost effectiveness of erythropoietic therapies in chemotherapy-related anemia: a Canadian application","year":2006,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Darbepoetin alfa; Epoetin alfa; Medicine; Dosing; Anemia; Internal medicine; Chemotherapy; Regimen; Cost effectiveness; Oncology","score_opus":0.01595623342422359,"score_gpt":0.35424400997367267,"score_spread":0.3382877765494491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046437108","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3067573,0.6438387,0.008653193,0.009523189,0.0004441203,0.0019859322,0.009082269,0.00014910793,0.019566191],"genre_scores_gemma":[0.9123327,0.073182255,0.010317763,0.00084680354,0.00013117431,0.0003724724,0.0014017163,0.000038283168,0.0013768928],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9894332,0.0063514924,0.0005288611,0.00053618726,0.0028587156,0.00029144355],"domain_scores_gemma":[0.98369676,0.011298344,0.0018658373,0.00041700507,0.0024347524,0.00028724628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01133707,0.00128451,0.0028737492,0.0041984124,0.0006406649,0.0015483733,0.0017006918,0.0010187397,0.0027754374],"category_scores_gemma":[0.05706334,0.00066461356,0.007042896,0.0076199123,0.0007571241,0.0004999726,0.00077189464,0.0013603786,0.00006961551],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019475445,0.00049327704,0.19913726,0.047473487,0.14924489,0.0010104356,0.00077877654,0.08928728,0.0018039979,0.014156947,0.018290682,0.45884746],"study_design_scores_gemma":[0.022241458,0.00314897,0.50011015,0.012434979,0.31992418,0.0016988066,0.0005750898,0.078866914,0.0023458672,0.009985289,0.048143942,0.0005243613],"about_ca_topic_score_codex":0.87426305,"about_ca_topic_score_gemma":0.8320796,"teacher_disagreement_score":0.12573695,"about_ca_system_score_codex":0.039282292,"about_ca_system_score_gemma":0.031201527,"threshold_uncertainty_score":0.28501433},"labels":[],"label_agreement":null},{"id":"W2051908585","doi":"10.1177/1078155209354135","title":"Look-alike, sound-alike drugs in oncology","year":2010,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Formulary; Bigram; Levenshtein distance; Drug; Internal medicine; Oncology; Emergency medicine; Medical emergency; Family medicine; Algorithm; Pharmacology; Artificial intelligence","score_opus":0.1372158935252119,"score_gpt":0.5370151428571186,"score_spread":0.3997992493319067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051908585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87832916,0.017301362,0.056573384,0.016564453,0.0005962535,0.0011967669,0.000823472,0.0014352425,0.027179837],"genre_scores_gemma":[0.91126084,0.0033093942,0.081134394,0.0021137001,0.00017308859,0.00009373331,0.00036003714,0.00007048073,0.001484303],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9880322,0.004254233,0.0014030377,0.0009104357,0.005154286,0.00024578552],"domain_scores_gemma":[0.9370153,0.028024746,0.020644002,0.0025656933,0.0093731545,0.0023770437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007880087,0.00046551225,0.0005059728,0.005764577,0.0014964865,0.0024964393,0.0013120288,0.00088688004,0.0026089647],"category_scores_gemma":[0.055980552,0.00027750185,0.0004570207,0.0038285856,0.001388971,0.0019258086,0.0030145396,0.0010484343,0.0006447432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004238925,0.0003130547,0.5453779,0.0013013541,0.00015662401,0.0013329455,0.0031926949,0.0015571107,0.0033223603,0.0020778016,0.0068318276,0.4341124],"study_design_scores_gemma":[0.00010676292,0.002308734,0.8261527,0.0021511293,0.00062988565,0.023332229,0.010897116,0.025458183,0.01794182,0.01870812,0.072066955,0.0002464752],"about_ca_topic_score_codex":0.008573285,"about_ca_topic_score_gemma":0.023435343,"teacher_disagreement_score":0.008573285,"about_ca_system_score_codex":0.0028745953,"about_ca_system_score_gemma":0.006421911,"threshold_uncertainty_score":0.041674435},"labels":[],"label_agreement":null},{"id":"W2063247791","doi":"10.1177/1078155213517729","title":"Medication safety and the administration of intravenous vincristine: International survey of oncology pharmacists","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Administration (probate law); Vincristine; Intensive care medicine; Oncology; Internal medicine; Pharmacology; Chemotherapy; Cyclophosphamide","score_opus":0.03777028205804318,"score_gpt":0.42391691713200064,"score_spread":0.38614663507395747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063247791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959611,0.0006001792,0.00013666948,0.000783989,0.000009022474,0.00006405801,0.0006128244,0.0000073318556,0.0018246803],"genre_scores_gemma":[0.99825853,0.0007451386,0.00016755635,0.00023933091,0.000015768235,0.00002947142,0.0003046591,0.0000024121882,0.00023705163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975107,0.0007994972,0.00046903256,0.00024379544,0.0007469979,0.000230021],"domain_scores_gemma":[0.9868443,0.0015306764,0.009057721,0.00026674411,0.0013672188,0.00093324593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024876038,0.0001548506,0.00024806662,0.00097997,0.00024399912,0.0006675005,0.00031374505,0.00061664474,0.0015334396],"category_scores_gemma":[0.008382419,0.00023535249,0.00034795282,0.0019459641,0.00024184951,0.0011020892,0.0008395971,0.00073380885,0.00034287592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003287886,0.000056377216,0.99394727,0.00007029506,0.000025045598,0.00004831064,0.00050381717,0.00004978808,0.00011255659,0.000009222411,0.00035239424,0.004792047],"study_design_scores_gemma":[0.0000036266392,0.00012419486,0.997954,0.000030688774,0.0000069518833,0.0002406669,0.00087159954,0.000104830506,0.000042128548,0.0000053648673,0.0006122894,0.0000036852052],"about_ca_topic_score_codex":0.0042080204,"about_ca_topic_score_gemma":0.0032803253,"teacher_disagreement_score":0.0042080204,"about_ca_system_score_codex":0.00043463215,"about_ca_system_score_gemma":0.00066407473,"threshold_uncertainty_score":0.013155818},"labels":[],"label_agreement":null},{"id":"W2065783129","doi":"10.1177/1078155210385160","title":"Key components of intravenous chemotherapy labeling: A systematic review and practice guideline","year":2010,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Regional Municipality of Durham; University Health Network; University of Toronto; McMaster University; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"Solar Energy Technologies Office; Canadian Patient Safety Institute; Sanofi","keywords":"Medicine; Guideline; MEDLINE; Data extraction; Systematic review; Medical physics; Randomized controlled trial; Evidence-based medicine; Disk formatting; Intensive care medicine; Alternative medicine; Surgery; Pathology; Computer science","score_opus":0.22696104157454305,"score_gpt":0.5853660332115278,"score_spread":0.35840499163698475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065783129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009417496,0.94456923,0.006381782,0.01983736,0.002381006,0.021404658,0.002223475,0.00015513395,0.0021055955],"genre_scores_gemma":[0.014643382,0.8497127,0.08089179,0.009249829,0.00092545885,0.040587347,0.002408936,0.000062596955,0.0015179565],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8853167,0.045875777,0.048477266,0.004113637,0.014988824,0.0012277614],"domain_scores_gemma":[0.8313092,0.08110469,0.04206061,0.0029974484,0.03986265,0.002665344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08709937,0.004552782,0.012773274,0.036679227,0.002383671,0.007133918,0.008787565,0.007053515,0.0062486217],"category_scores_gemma":[0.2265406,0.0037058655,0.011415368,0.031935453,0.0036355308,0.012306934,0.0044260705,0.0046372083,0.0019257419],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029373183,0.00005730074,0.0013413985,0.84845,0.0025596216,0.00026544,0.0009599395,0.00048114802,0.000404822,0.0013116489,0.03255089,0.11132407],"study_design_scores_gemma":[0.00034170615,0.00007078003,0.0013144261,0.95613825,0.005358653,0.00019884705,0.00037179806,0.0002680487,0.00021456044,0.0015126081,0.0341615,0.000048792204],"about_ca_topic_score_codex":0.021437166,"about_ca_topic_score_gemma":0.057700846,"teacher_disagreement_score":0.08709937,"about_ca_system_score_codex":0.02162184,"about_ca_system_score_gemma":0.07108075,"threshold_uncertainty_score":0.460631},"labels":[],"label_agreement":null},{"id":"W2071188109","doi":"10.1177/1078155212464087","title":"Efficacy vs. effectiveness: Erlotinib in previously treated non-small-cell lung cancer","year":2012,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Erlotinib; Lung cancer; Internal medicine; Oncology; Regimen; Erlotinib Hydrochloride; Chemotherapy; Cancer; Randomized controlled trial; Surgery; Epidermal growth factor receptor","score_opus":0.0349619244226064,"score_gpt":0.4534841221746531,"score_spread":0.4185221977520467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071188109","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9342353,0.054737896,0.0005328558,0.0037067437,0.0011814975,0.00069996,0.0006928283,0.000047206766,0.0041656746],"genre_scores_gemma":[0.99409676,0.0033059835,0.00028031907,0.0006778138,0.00085841294,0.00017850054,0.00018066012,0.000004233212,0.00041727646],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956857,0.0028560488,0.0004057872,0.00036407085,0.00043619267,0.00025215108],"domain_scores_gemma":[0.9944817,0.0035870492,0.0011861994,0.00013595232,0.00015853743,0.00045055262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009004663,0.0006754394,0.0021620204,0.00065034156,0.00030340208,0.0013404136,0.00064581085,0.0018234253,0.0037344072],"category_scores_gemma":[0.00788203,0.00030411244,0.0028213207,0.00047228573,0.0009343592,0.0012494797,0.00038087394,0.001762696,0.00024380587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9397466,0.0012585364,0.007433599,0.0015174132,0.0046924585,0.000076336895,0.000052492407,0.000987032,0.00095461676,0.00042926773,0.0006635444,0.04218816],"study_design_scores_gemma":[0.73154736,0.17402714,0.06647163,0.0007959658,0.015922777,0.00030058116,0.00012557939,0.004543853,0.0015765671,0.0013291589,0.00329519,0.00006421201],"about_ca_topic_score_codex":0.0011941032,"about_ca_topic_score_gemma":0.0026070485,"teacher_disagreement_score":0.009004663,"about_ca_system_score_codex":0.0017547039,"about_ca_system_score_gemma":0.0009443401,"threshold_uncertainty_score":0.047621787},"labels":[],"label_agreement":null},{"id":"W2072050498","doi":"10.1177/1078155207085387","title":"Efficacy vs. effectiveness — docetaxel and prednisone in hormone refractory prostate cancer","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docetaxel; Medicine; Prednisone; Internal medicine; Prostate cancer; Oncology; Cancer; Chemotherapy; Clinical trial; Retrospective cohort study","score_opus":0.06481101481439419,"score_gpt":0.45124613304170885,"score_spread":0.3864351182273147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072050498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8660214,0.12908754,0.00017082944,0.0011576168,0.000093429415,0.00011160474,0.00028352987,0.0000070663273,0.003066989],"genre_scores_gemma":[0.99417686,0.005142676,0.00014283088,0.0001337034,0.0001647643,0.000019502484,0.000119436896,0.0000014689657,0.00009873001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99430805,0.0035929768,0.00052077044,0.00021361983,0.0012130731,0.00015153535],"domain_scores_gemma":[0.9844067,0.009627282,0.0045362203,0.00016891403,0.0007579051,0.00050310313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010736049,0.00018024168,0.0009046498,0.00089269516,0.00017085877,0.0008683632,0.00035383794,0.00033789081,0.0011359429],"category_scores_gemma":[0.020345788,0.00011358184,0.0006560598,0.0010094157,0.0005589901,0.0007906646,0.00021041228,0.00035612597,0.00009683151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07904911,0.000986269,0.5809864,0.004276377,0.0050063133,0.00047677755,0.00035319835,0.0013984955,0.0017105889,0.00082602096,0.0019950997,0.3229353],"study_design_scores_gemma":[0.005429674,0.025642939,0.95586246,0.0009112772,0.0029342156,0.0015616253,0.00040954168,0.0012174785,0.0011823844,0.00042896744,0.004374804,0.000044604854],"about_ca_topic_score_codex":0.0013042123,"about_ca_topic_score_gemma":0.0037779468,"teacher_disagreement_score":0.010736049,"about_ca_system_score_codex":0.0015414241,"about_ca_system_score_gemma":0.0008891217,"threshold_uncertainty_score":0.05677831},"labels":[],"label_agreement":null},{"id":"W2076151388","doi":"10.1191/1078155203jp104oa","title":"Implementation of a telephone callback service for ambulatory oncology patients","year":2003,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Cancer Foundation","funders":"Medical Research Council","keywords":"Callback; Medicine; Pharmacy; Ambulatory; Pharmacist; Workload; Service (business); Family medicine; Medical emergency; Surgery","score_opus":0.16839032234890056,"score_gpt":0.5364483731695158,"score_spread":0.3680580508206152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076151388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9508792,0.0001622295,0.008093142,0.0056612724,0.00030933542,0.022635529,0.00033915392,0.0010156711,0.010904534],"genre_scores_gemma":[0.9476167,0.0002356779,0.03428358,0.002326364,0.00025298324,0.011187114,0.00048117578,0.000042171345,0.0035743017],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9938273,0.0036745332,0.00035770936,0.00024336985,0.0009536751,0.0009434237],"domain_scores_gemma":[0.9861609,0.0040216804,0.0014575135,0.0010750284,0.0028338605,0.004451011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009823216,0.00042529203,0.0002816235,0.0005581441,0.0017983374,0.0010996615,0.0017323138,0.0013166299,0.008996986],"category_scores_gemma":[0.017045006,0.00039671472,0.00061569683,0.00024510853,0.00051363156,0.00104071,0.0016566167,0.0014205491,0.0011003137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031435338,0.033728525,0.06563575,0.0014993544,0.000068933936,0.0016489358,0.009686668,0.0014509528,0.0073871007,0.00054238836,0.017809978,0.85739785],"study_design_scores_gemma":[0.0051453155,0.26651022,0.6058502,0.001173286,0.00024380321,0.0033443898,0.027794402,0.0076087946,0.0116246035,0.00088618946,0.06954687,0.0002718447],"about_ca_topic_score_codex":0.0038638462,"about_ca_topic_score_gemma":0.0054056155,"teacher_disagreement_score":0.009823216,"about_ca_system_score_codex":0.002008616,"about_ca_system_score_gemma":0.007880415,"threshold_uncertainty_score":0.051950753},"labels":[],"label_agreement":null},{"id":"W2077187626","doi":"10.1177/1078155214556522","title":"Establishing an international baseline for medication safety in oncology: Findings from the 2012 ISMP International Medication Safety Self Assessment® for Oncology","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Oncology; Snapshot (computer storage); Family medicine; Internal medicine","score_opus":0.07633583662662666,"score_gpt":0.5294997772461671,"score_spread":0.45316394061954046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077187626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9170473,0.0024734207,0.012722302,0.012842877,0.0006037482,0.00474035,0.014735711,0.0002622006,0.034571994],"genre_scores_gemma":[0.9480801,0.001118616,0.031278864,0.0022107656,0.00013092041,0.004025804,0.011440314,0.000059846054,0.0016547878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98818564,0.0041780802,0.0017625847,0.00073029066,0.004219339,0.000924112],"domain_scores_gemma":[0.9352601,0.011996784,0.012211003,0.003303007,0.03108552,0.006143519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037120044,0.00033273431,0.00039676312,0.0027493292,0.001067042,0.0020176691,0.000874997,0.00072873104,0.0011561993],"category_scores_gemma":[0.043644827,0.00029724688,0.0006206574,0.003515253,0.000580708,0.0024412517,0.0042023696,0.0018752365,0.0003187681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004792874,0.000999811,0.7511331,0.0011700216,0.00011698024,0.00015582891,0.015019375,0.00059282273,0.0011427901,0.0015589842,0.029100433,0.19853055],"study_design_scores_gemma":[0.000036571953,0.00082250335,0.95774907,0.00053664367,0.000045341276,0.00011449763,0.014311282,0.00045740276,0.0009766103,0.00020032485,0.024714673,0.000035045276],"about_ca_topic_score_codex":0.008643549,"about_ca_topic_score_gemma":0.014500016,"teacher_disagreement_score":0.037120044,"about_ca_system_score_codex":0.0031088057,"about_ca_system_score_gemma":0.009814677,"threshold_uncertainty_score":0.19631189},"labels":[],"label_agreement":null},{"id":"W2081475049","doi":"10.1177/1078155214556009","title":"Worksheets with embedded checklists support IV chemotherapy safer practice","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"SAFER; Medicine; Usability; Chemotherapy; Patient safety; Adverse effect; Identification (biology); Intensive care medicine; Medical physics; Surgery; Pharmacology; Computer science; Human–computer interaction; Health care","score_opus":0.07100531266920483,"score_gpt":0.5073369435292618,"score_spread":0.436331630860057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081475049","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20549458,0.004259408,0.7005554,0.011290414,0.0028361387,0.023020208,0.0015824934,0.013657212,0.037304148],"genre_scores_gemma":[0.13828267,0.0019629688,0.84790856,0.0010325931,0.0005591293,0.0039590737,0.0005528865,0.00048780127,0.00525428],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9836963,0.009034444,0.0023456996,0.0006032271,0.003867965,0.00045232542],"domain_scores_gemma":[0.8611769,0.09550368,0.011173694,0.01186355,0.017039897,0.0032423555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015961729,0.0012518138,0.0010731022,0.0027103904,0.00087669527,0.0018413828,0.002955256,0.001359843,0.009652013],"category_scores_gemma":[0.13353486,0.00083250494,0.0013191295,0.0013318234,0.0006649386,0.0028029627,0.0029407411,0.0022632384,0.0031788612],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007676972,0.0032347592,0.010969098,0.0056740106,0.00016019543,0.0016230318,0.00954093,0.0052801264,0.016792329,0.002271763,0.027252935,0.9164331],"study_design_scores_gemma":[0.0025830038,0.020088082,0.16477159,0.025475701,0.0008821413,0.013488841,0.015822923,0.042672385,0.059103765,0.02820172,0.6254076,0.0015023041],"about_ca_topic_score_codex":0.0008777054,"about_ca_topic_score_gemma":0.002212381,"teacher_disagreement_score":0.015961729,"about_ca_system_score_codex":0.0008408529,"about_ca_system_score_gemma":0.0032911582,"threshold_uncertainty_score":0.08441466},"labels":[],"label_agreement":null},{"id":"W2085190055","doi":"10.1177/1078155211402104","title":"Optimizing pain relief in a specialized outpatient palliative radiotherapy clinic: Contributions of a clinical pharmacist","year":2011,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Pharmacist; Palliative care; Outpatient clinic; Clinical pharmacy; Pharmacy; Cancer pain; Opioid; Cancer; Morphine; Internal medicine; Physical therapy; Family medicine; Nursing","score_opus":0.22394029381555416,"score_gpt":0.5295370681369619,"score_spread":0.30559677432140775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085190055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9015897,0.0062075327,0.0062999465,0.05032412,0.00059308147,0.00074062264,0.0002727177,0.00040185472,0.03357041],"genre_scores_gemma":[0.9754372,0.002953186,0.0083354935,0.010385832,0.00059417327,0.00014433742,0.0001074485,0.000051095136,0.001991153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944799,0.0035052756,0.00036580628,0.00033492036,0.00088189705,0.00043218624],"domain_scores_gemma":[0.9838097,0.0053966544,0.002835849,0.0004273926,0.0022824826,0.005247925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028762387,0.0001841598,0.00025036573,0.0007472731,0.0016391105,0.0017875751,0.0007288863,0.00088493,0.0041320445],"category_scores_gemma":[0.0156408,0.00032287484,0.0002153285,0.00054128235,0.00057814573,0.0011247381,0.0017112152,0.0014054003,0.00059516163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040548277,0.0017557238,0.49218243,0.0011122642,0.00019904587,0.01595236,0.020809457,0.0007466702,0.0035443737,0.0007702497,0.04497562,0.41754618],"study_design_scores_gemma":[0.0003375423,0.004099483,0.681423,0.0031240734,0.00028283682,0.07357606,0.07792755,0.006220743,0.0017412106,0.001752244,0.14924464,0.00027070113],"about_ca_topic_score_codex":0.0032387176,"about_ca_topic_score_gemma":0.007924098,"teacher_disagreement_score":0.0041320445,"about_ca_system_score_codex":0.0018681429,"about_ca_system_score_gemma":0.0059521496,"threshold_uncertainty_score":0.015211165},"labels":[],"label_agreement":null},{"id":"W2089069721","doi":"10.1177/1078155208099284","title":"A Medication Error Prevention Survey: five years of results","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer prevention; Pharmacy; Family medicine; Pharmacist; Cancer; Medication error; Environmental health; Health care; Patient safety; Internal medicine","score_opus":0.29143253438943634,"score_gpt":0.5724556806054031,"score_spread":0.28102314621596675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089069721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666767,0.00061599625,0.0011221523,0.000610578,0.00007419283,0.0011219608,0.022295518,0.00012818554,0.007354782],"genre_scores_gemma":[0.9642798,0.00045176776,0.0021185542,0.0006966876,0.00006534281,0.0009305114,0.027170317,0.000015142805,0.0042720516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99237,0.0010165976,0.0011723316,0.00043369678,0.004228845,0.000778441],"domain_scores_gemma":[0.9813053,0.0022200497,0.004012731,0.00059956213,0.010226784,0.001635493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007320685,0.00039441878,0.0003760936,0.0034893714,0.0007567144,0.0010828561,0.00076727266,0.0007712579,0.0017337904],"category_scores_gemma":[0.013310098,0.0003333096,0.00067885005,0.0037568146,0.00026827096,0.000627866,0.0012410182,0.0006354831,0.00068333466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014260184,0.00034389834,0.977789,0.00009377038,0.00008061201,0.00006825877,0.00064708287,0.00026685014,0.00016526715,0.000034223922,0.0035563975,0.01681207],"study_design_scores_gemma":[0.000007332888,0.00024064386,0.99698716,0.00001949627,0.000018696475,0.000032751213,0.00038690816,0.0001568017,0.00012758226,0.0000075529706,0.002008064,0.000007057917],"about_ca_topic_score_codex":0.13040788,"about_ca_topic_score_gemma":0.10564504,"teacher_disagreement_score":0.13040788,"about_ca_system_score_codex":0.0035521665,"about_ca_system_score_gemma":0.0043165423,"threshold_uncertainty_score":0.2592976},"labels":[],"label_agreement":null},{"id":"W2092555277","doi":"10.1177/1078155214537926","title":"Adherence to imatinib among patients attending Saskatchewan Cancer Agency Pharmacies","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Medicine; Imatinib; Imatinib mesylate; Cancer; Pharmacy; Pharmacist; Myeloid leukemia; Family medicine; Internal medicine","score_opus":0.053762430460891374,"score_gpt":0.4259535604798781,"score_spread":0.37219113001898674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092555277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976078,0.00022728852,0.000055962955,0.00017498576,0.000003287827,0.000033965363,0.0009932971,0.0000030299052,0.0009002953],"genre_scores_gemma":[0.9989188,0.00017228683,0.000062383224,0.00011213645,0.000005157612,0.000019726116,0.0004913259,0.0000010744594,0.00021716088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905676,0.00020762104,0.0001512528,0.0001438452,0.00025759803,0.0001829234],"domain_scores_gemma":[0.9965706,0.00045924433,0.0021107085,0.00013233523,0.00036975316,0.00035740805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006337986,0.00015481621,0.00021094561,0.0007131281,0.0005803317,0.000577426,0.00039350486,0.0002786777,0.0023172507],"category_scores_gemma":[0.0026429722,0.00016205986,0.00022877066,0.0021178427,0.0003168369,0.00035744108,0.0004694535,0.00048227384,0.00019005888],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033794873,0.000021606329,0.99802303,0.000009634826,0.000021080352,0.000027825456,0.000089761634,0.00003064486,0.00007077912,0.00000818596,0.000155627,0.0015081025],"study_design_scores_gemma":[0.0000047424464,0.0000379121,0.9993026,0.000009152487,0.000009749138,0.00005877813,0.00021660095,0.00010853979,0.000041645086,0.000007080235,0.00020061717,0.0000026723521],"about_ca_topic_score_codex":0.27094063,"about_ca_topic_score_gemma":0.3750764,"teacher_disagreement_score":0.72905934,"about_ca_system_score_codex":0.0024672847,"about_ca_system_score_gemma":0.0032895352,"threshold_uncertainty_score":0.53872716},"labels":[],"label_agreement":null},{"id":"W2093894651","doi":"10.1177/1078155209337661","title":"Use of combined androgen blockade for advanced prostate cancer in British Columbia","year":2009,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Ottawa Hospital","funders":"","keywords":"Medicine; Prostate cancer; Antiandrogen; Androgen deprivation therapy; Agonist; Cancer; Population; Urology; Androgen; Blockade; Internal medicine; Goserelin; Gynecology; Oncology; Hormone; Receptor","score_opus":0.06731656353968259,"score_gpt":0.4495899731008029,"score_spread":0.3822734095611203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093894651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9493,0.02799011,0.00027507357,0.0020686372,0.00007493154,0.00016101707,0.007968575,0.000041990876,0.01211972],"genre_scores_gemma":[0.99039286,0.00568768,0.00029228654,0.00037573307,0.000018560186,0.000050863422,0.0018054349,0.0000069820485,0.0013694955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992681,0.00013876504,0.000067514615,0.00008740392,0.00031811226,0.00012015414],"domain_scores_gemma":[0.9990534,0.00019984484,0.00029915385,0.000029143395,0.00023792012,0.00018041758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046895057,0.00024967466,0.0004337028,0.0009544116,0.00064691686,0.0008915785,0.000800872,0.00036210872,0.0037884905],"category_scores_gemma":[0.0019558792,0.00023926857,0.00053579,0.0028424112,0.00030597896,0.00022223743,0.0004686713,0.000476834,0.00019206553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001343981,0.00024875687,0.8742705,0.0019284099,0.0012451789,0.0010845439,0.00014908348,0.0027677729,0.0010602917,0.00041292052,0.011233072,0.10425562],"study_design_scores_gemma":[0.0003963261,0.0003490734,0.9831798,0.00088416744,0.00088832155,0.0014936229,0.000450249,0.002607129,0.00028914676,0.000164333,0.009258151,0.00003958307],"about_ca_topic_score_codex":0.84819496,"about_ca_topic_score_gemma":0.92575955,"teacher_disagreement_score":0.84819496,"about_ca_system_score_codex":0.010958368,"about_ca_system_score_gemma":0.010671247,"threshold_uncertainty_score":0.30539805},"labels":[],"label_agreement":null},{"id":"W2095680003","doi":"10.1177/1078155214528830","title":"Oral chemotherapy practices at Ontario cancer centres","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Credit Valley Hospital; Cancer Care Ontario","funders":"Ontario Ministry of Health and Long-Term Care; Cancer Care Ontario","keywords":"Medicine; Medical prescription; Chemotherapy; Cancer; Family medicine; Phone; Regimen; Nursing; Surgery; Internal medicine","score_opus":0.12332332690882523,"score_gpt":0.4882904987376371,"score_spread":0.36496717182881183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095680003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755937,0.0029074918,0.0002793045,0.0029160779,0.000019339692,0.00022676004,0.0013290087,0.00008159212,0.016646834],"genre_scores_gemma":[0.99382037,0.0016886123,0.0009024167,0.00043700114,0.000011045774,0.00008464595,0.0004316032,0.000012122493,0.002612242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980603,0.00032791487,0.0001393888,0.00023131793,0.0008277212,0.00041332337],"domain_scores_gemma":[0.99052656,0.0011615605,0.0033945078,0.00022070888,0.0022301353,0.0024664302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011725053,0.00015061566,0.00019499098,0.00084395456,0.0033602922,0.0010832022,0.0010470139,0.0003164333,0.0048236977],"category_scores_gemma":[0.004658456,0.0002448124,0.00023535856,0.002751847,0.0011398683,0.00038158317,0.0010260292,0.00037578898,0.00028105752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020828277,0.00014048458,0.8586514,0.0010697482,0.00006336504,0.0009570656,0.038972363,0.00061815314,0.002013879,0.00047870394,0.011876817,0.08494975],"study_design_scores_gemma":[0.000032534033,0.00022483965,0.96161413,0.0003338165,0.000031617532,0.00036508826,0.013847009,0.0002740452,0.00035268159,0.000056722078,0.022833375,0.000034200697],"about_ca_topic_score_codex":0.9134924,"about_ca_topic_score_gemma":0.95683163,"teacher_disagreement_score":0.08650762,"about_ca_system_score_codex":0.03186234,"about_ca_system_score_gemma":0.042276103,"threshold_uncertainty_score":0.23117852},"labels":[],"label_agreement":null},{"id":"W2099297375","doi":"10.1191/1078155204jp126oa","title":"Rationing costly treatments: can it be fair?","year":2004,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Rationing; Medicine; Health care rationing; Health care; Actuarial science; Distribution (mathematics); Intensive care medicine; Risk analysis (engineering); Law and economics; Economics; Economic growth","score_opus":0.5389202458124981,"score_gpt":0.5647943332140691,"score_spread":0.025874087401571044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099297375","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015792781,0.019247876,0.0907239,0.7057768,0.008514839,0.00043802423,0.0002544517,0.0001910306,0.15906024],"genre_scores_gemma":[0.73301584,0.011375105,0.044281263,0.17758095,0.013343685,0.0010073533,0.00011335328,0.00024112764,0.019041361],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9177825,0.052369744,0.0038150938,0.0057175513,0.016091445,0.0042237258],"domain_scores_gemma":[0.83976066,0.12652057,0.009428661,0.012740054,0.008243275,0.0033067993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.113390006,0.0013540315,0.0037815338,0.00243132,0.0047697145,0.014126425,0.0033618752,0.020817662,0.01607413],"category_scores_gemma":[0.3095886,0.0007385004,0.0018258832,0.0022042205,0.036947493,0.024391184,0.0059695374,0.013582605,0.0016950946],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022423708,0.00008136958,0.0010918885,0.00029151354,0.00015981897,0.00010661418,0.0006443335,0.00202926,0.00010489674,0.9222547,0.02021954,0.052791823],"study_design_scores_gemma":[0.00008121509,0.00003982993,0.0002368005,0.00030444958,0.000033473025,0.00006650839,0.0001619055,0.0010514649,0.00008509248,0.98138696,0.016525595,0.000026748838],"about_ca_topic_score_codex":0.007406368,"about_ca_topic_score_gemma":0.0043491144,"teacher_disagreement_score":0.113390006,"about_ca_system_score_codex":0.0072980816,"about_ca_system_score_gemma":0.011670361,"threshold_uncertainty_score":0.5996708},"labels":[],"label_agreement":null},{"id":"W2101295467","doi":"10.1177/1078155214553143","title":"The effect of race on the CYP3A-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"International Society of Oncology Pharmacy Practitioners","keywords":"Medicine; Vincristine; Neurotoxicity; Internal medicine; Genotyping; Acute lymphocytic leukemia; Gastroenterology; Incidence (geometry); Leukemia; Chemotherapy; Lymphoblastic Leukemia; Genotype; Toxicity; Gene","score_opus":0.010044189550483045,"score_gpt":0.34122279438766634,"score_spread":0.3311786048371833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101295467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986339,0.000746869,0.000059671533,0.00004181957,0.000004096671,0.0000030436963,0.000051637566,0.0000017976297,0.0004571723],"genre_scores_gemma":[0.9995957,0.00018140773,0.000057580623,0.000022783452,0.000009352218,0.0000026136643,0.00004695208,0.0000017467803,0.00008203071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996024,0.0001915631,0.000036122765,0.000051607556,0.000068106325,0.000050258936],"domain_scores_gemma":[0.99903154,0.00028997255,0.00045285054,0.000035383408,0.000081053375,0.00010923132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003726688,0.00012891268,0.00016138077,0.00021500046,0.0001969616,0.00027395194,0.00010849238,0.00013030079,0.001569738],"category_scores_gemma":[0.0018399293,0.000059551698,0.00014396895,0.00031686167,0.00012575148,0.00018341362,0.00016356308,0.00019420426,0.00021052906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048300746,0.000020977475,0.991642,0.000011407279,0.000037341582,0.0001601564,0.000100555044,0.000035161163,0.0012073403,0.000019520143,0.00007876016,0.0062037697],"study_design_scores_gemma":[0.000010834572,0.000309564,0.9967642,0.00001019097,0.00004569397,0.0014704625,0.00012810559,0.000098318495,0.0005385334,0.000016757947,0.00060554134,0.0000017742736],"about_ca_topic_score_codex":0.00071595534,"about_ca_topic_score_gemma":0.001388729,"teacher_disagreement_score":0.001569738,"about_ca_system_score_codex":0.00018755281,"about_ca_system_score_gemma":0.0001486816,"threshold_uncertainty_score":0.005251348},"labels":[],"label_agreement":null},{"id":"W2103672719","doi":"10.1177/107815520100600402","title":"Documentation of capecitabine usage as a third-line chemotherapy option for metastatic breast cancer patients","year":2001,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Capecitabine; Medicine; Taxane; Metastatic breast cancer; Vinorelbine; Internal medicine; Nausea; Oncology; Cancer; Breast cancer; Chemotherapy; Colorectal cancer; Cisplatin","score_opus":0.04922793063149728,"score_gpt":0.47197149728347854,"score_spread":0.42274356665198126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103672719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98679954,0.0048621832,0.00017510672,0.0005454852,0.000021257263,0.00008887273,0.0026018159,0.000030625644,0.004875189],"genre_scores_gemma":[0.995194,0.0019434323,0.00048463058,0.00016379924,0.0000305978,0.000027939275,0.0012835494,0.000005531019,0.0008664802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993556,0.00010181547,0.00009843724,0.00005631505,0.0003072099,0.00008056825],"domain_scores_gemma":[0.99479055,0.0009992693,0.0029158082,0.000082462444,0.0007192602,0.0004926216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000617243,0.0001471078,0.00023958269,0.0014032099,0.0004065578,0.0005469121,0.00040422363,0.00025520002,0.0018771582],"category_scores_gemma":[0.0041950247,0.00011407277,0.00021381782,0.0015625717,0.00019199267,0.00025586394,0.00025257075,0.00042461796,0.00019101723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038358726,0.00003755941,0.9771119,0.00014697181,0.000025822577,0.0007871995,0.0003810934,0.0001548545,0.00057761336,0.00004074598,0.0014629348,0.018889766],"study_design_scores_gemma":[0.00002115781,0.00019648981,0.9913523,0.00012441992,0.000035156256,0.0025353334,0.00040074537,0.00025985306,0.000537401,0.000013665644,0.004514306,0.000009122313],"about_ca_topic_score_codex":0.0801661,"about_ca_topic_score_gemma":0.17038241,"teacher_disagreement_score":0.0801661,"about_ca_system_score_codex":0.0026927898,"about_ca_system_score_gemma":0.0028717304,"threshold_uncertainty_score":0.15939897},"labels":[],"label_agreement":null},{"id":"W2107358512","doi":"10.1191/1078155202jp108oa","title":"Interacting with drugs used in oncology: an Alberta Cancer Board initiative","year":2003,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Drug; The Internet; Cancer; Family medicine; Pharmacology; Medical education; World Wide Web; Internal medicine; Computer science","score_opus":0.21014512922801698,"score_gpt":0.5320286905245449,"score_spread":0.32188356129652795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107358512","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5974662,0.04255548,0.0015226131,0.27515578,0.0031000625,0.0022369495,0.0023397384,0.00019425807,0.075428896],"genre_scores_gemma":[0.80559784,0.05222798,0.008569297,0.049815368,0.0015933389,0.0012730007,0.0035661506,0.00011957384,0.07723753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926528,0.0018839868,0.00029258936,0.00046738354,0.0038602229,0.00084288366],"domain_scores_gemma":[0.9703103,0.0055572796,0.0029099504,0.0006959304,0.00938658,0.011139933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014054896,0.00025541935,0.0002466805,0.0033739852,0.0051915026,0.003066239,0.0019974369,0.0011156804,0.00442191],"category_scores_gemma":[0.016787285,0.00046634214,0.00029610668,0.0056588515,0.001968197,0.0015027105,0.0037101617,0.0017038188,0.00045905402],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045965886,0.001308339,0.28378546,0.0015834037,0.000056246787,0.0028299957,0.020699391,0.00023336247,0.0028098933,0.0032084114,0.20901337,0.47401246],"study_design_scores_gemma":[0.00006590886,0.00048257332,0.58652776,0.00058901875,0.00005699532,0.0010164502,0.018949548,0.00020302327,0.00047781752,0.00033398074,0.39125684,0.000040081257],"about_ca_topic_score_codex":0.48898774,"about_ca_topic_score_gemma":0.7867774,"teacher_disagreement_score":0.51101226,"about_ca_system_score_codex":0.022806175,"about_ca_system_score_gemma":0.088064566,"threshold_uncertainty_score":0.97228307},"labels":[],"label_agreement":null},{"id":"W2108304820","doi":"10.1191/1078155202jp099oa","title":"Physician order entry: a mixed blessing to pharmacy?","year":2002,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"University of Alberta","keywords":"Pharmacist; Medicine; Pharmacy; Medical prescription; Workload; Electronic prescribing; Order entry; Clinical pharmacy; Intervention (counseling); Psychological intervention; Computerized physician order entry; Family medicine; Medical emergency; Emergency medicine; Nursing; Health care","score_opus":0.2150804031220603,"score_gpt":0.4949927990087716,"score_spread":0.27991239588671124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108304820","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4001576,0.020950567,0.012320685,0.52137065,0.0043256357,0.00042815684,0.00054229086,0.0004950751,0.03940924],"genre_scores_gemma":[0.9083333,0.007233998,0.00645403,0.06646777,0.0030213953,0.00014921081,0.00022153444,0.00009829443,0.008020443],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98622084,0.0058690496,0.0008245956,0.0009885461,0.0051709414,0.00092603],"domain_scores_gemma":[0.96004695,0.018774236,0.010514399,0.001551081,0.0046470123,0.004466344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01164358,0.0004416611,0.00040324047,0.00091668795,0.0010048135,0.00415868,0.0010477927,0.0023698492,0.012885103],"category_scores_gemma":[0.07506906,0.00035774772,0.00058187474,0.001747716,0.0011824318,0.00446478,0.0013981296,0.0017080342,0.0015307845],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013907575,0.0015794864,0.16478758,0.001549345,0.00023295025,0.0008814798,0.002055926,0.0004478072,0.001529694,0.008039782,0.055175487,0.7623297],"study_design_scores_gemma":[0.0011192597,0.010146285,0.66542244,0.005502936,0.00061488326,0.011049294,0.01850467,0.0063065602,0.006226949,0.019605368,0.25523233,0.00026905895],"about_ca_topic_score_codex":0.0027902129,"about_ca_topic_score_gemma":0.008225526,"teacher_disagreement_score":0.012885103,"about_ca_system_score_codex":0.002821636,"about_ca_system_score_gemma":0.0044191396,"threshold_uncertainty_score":0.061577857},"labels":[],"label_agreement":null},{"id":"W2108578379","doi":"10.1177/1078155213501100","title":"Assessing adherence to oral chemotherapy using different measurement methods: Lessons learned from capecitabine","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Capecitabine; Medicine; Pill; Internal medicine; Prospective cohort study; Cancer; Oncology; Colorectal cancer; Pharmacology","score_opus":0.5500743065446398,"score_gpt":0.5845884328257962,"score_spread":0.034514126281156354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108578379","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23698159,0.49208492,0.10516838,0.14706714,0.00434714,0.0013872924,0.0004352078,0.00043618464,0.012092219],"genre_scores_gemma":[0.57581395,0.23108985,0.1659234,0.017075922,0.0066478904,0.0011902177,0.0002264167,0.00016823261,0.0018641207],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.986219,0.008977775,0.0011732314,0.00083168776,0.0025858728,0.00021251902],"domain_scores_gemma":[0.9646315,0.025413923,0.0022613346,0.0017293437,0.005135005,0.0008289114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024507646,0.001239927,0.0024365056,0.0017634856,0.00042531782,0.002319418,0.0022078173,0.0022524216,0.00072808407],"category_scores_gemma":[0.042453606,0.00059712474,0.0017727325,0.0016752923,0.0020890844,0.0031609582,0.0011970635,0.0046177316,0.00017888975],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008286641,0.00073794555,0.060782157,0.0026675598,0.000584471,0.00040329824,0.0018851488,0.0012895978,0.0015622323,0.0030146332,0.0069502573,0.9192939],"study_design_scores_gemma":[0.003146645,0.025609005,0.56723946,0.03883165,0.004460928,0.00857564,0.01282633,0.049053483,0.014262993,0.059927776,0.21467526,0.0013909392],"about_ca_topic_score_codex":0.0076783923,"about_ca_topic_score_gemma":0.008767444,"teacher_disagreement_score":0.024507646,"about_ca_system_score_codex":0.0014653682,"about_ca_system_score_gemma":0.0021139786,"threshold_uncertainty_score":0.12961036},"labels":[],"label_agreement":null},{"id":"W2109308320","doi":"10.1177/1078155214527145","title":"Does gastric acid suppression affect sunitinib efficacy in patients with advanced or metastatic renal cell cancer?","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Alberta","funders":"","keywords":"Sunitinib; Medicine; Internal medicine; Hazard ratio; Cancer; Progression-free survival; Proportional hazards model; Gastroenterology; Population; Univariate analysis; Retrospective cohort study; Tyrosine-kinase inhibitor; Oncology; Surgery; Chemotherapy; Multivariate analysis; Confidence interval","score_opus":0.03492748437011041,"score_gpt":0.38559231009288814,"score_spread":0.35066482572277774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109308320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913421,0.0070562623,0.0000883835,0.00038435715,0.000022543803,0.000018969504,0.0004554729,0.0000047680664,0.00062721],"genre_scores_gemma":[0.9988368,0.0007507367,0.000073311894,0.000066571134,0.000027162083,0.000005141881,0.00019848389,9.4859695e-7,0.000040823244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999408,0.00021301939,0.000089558744,0.00010555397,0.00013545813,0.00004832977],"domain_scores_gemma":[0.9971035,0.0008614952,0.0016536071,0.000043907934,0.0001830527,0.00015443822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010395086,0.00011336002,0.0005279198,0.00029992728,0.00022053655,0.00060132216,0.00023803824,0.0003162807,0.0009985532],"category_scores_gemma":[0.0044920105,0.0000943904,0.00060849014,0.0007794237,0.0002264676,0.00038696342,0.00017435038,0.00032489645,0.00012794827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018168772,0.000047008958,0.98750687,0.00013992291,0.00019746018,0.0000746714,0.0000501137,0.00013391147,0.00016907102,0.00001697898,0.00022774262,0.009619367],"study_design_scores_gemma":[0.00011564248,0.00077419495,0.9969463,0.000057387548,0.00027392744,0.00040072596,0.00010467673,0.00043402132,0.00019131336,0.00004743446,0.00064775615,0.000006606359],"about_ca_topic_score_codex":0.002174606,"about_ca_topic_score_gemma":0.0045117605,"teacher_disagreement_score":0.002174606,"about_ca_system_score_codex":0.000612109,"about_ca_system_score_gemma":0.0005590842,"threshold_uncertainty_score":0.005497515},"labels":[],"label_agreement":null},{"id":"W2112205736","doi":"10.1177/1078155208095141","title":"In vitro evaluation of the effects of gefitinib on the cytotoxic activity of selected anticancer agents in a panel of human endometrial cancer cell lines","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Texas MD Anderson Cancer Center; International Society of Oncology Pharmacy Practitioners","keywords":"Gefitinib; Medicine; Endometrial cancer; Cytotoxic T cell; In vitro; Cancer; Pharmacology; Oncology; Cancer research; Internal medicine; Epidermal growth factor receptor; Biology; Genetics","score_opus":0.1376462551986086,"score_gpt":0.4433970072707447,"score_spread":0.3057507520721361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112205736","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692665,0.020523885,0.004352219,0.00020436816,0.00014087849,0.00018737232,0.0014518993,0.00007883559,0.0037940403],"genre_scores_gemma":[0.96961784,0.012008057,0.01069336,0.00014121206,0.00005424837,0.000322253,0.003664413,0.000027871562,0.0034707335],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9993235,0.00020537917,0.00012430896,0.00007321616,0.00020571475,0.00006799718],"domain_scores_gemma":[0.99972576,0.000067283356,0.000040906947,0.000037344762,0.00010470681,0.000023987692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005815485,0.000494628,0.00080490735,0.0004008336,0.00035324137,0.00039920586,0.00022527754,0.00032361815,0.0011206601],"category_scores_gemma":[0.00030125416,0.00020801077,0.0005070814,0.0005225365,0.00015803926,0.00017303736,0.00017282052,0.0004013978,0.00043084202],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004500552,0.00024036663,0.0016465319,0.0003676163,0.00006742313,0.00014569063,0.00009278119,0.00055522274,0.9898649,0.00006417107,0.00025006576,0.006255231],"study_design_scores_gemma":[0.000045102468,0.002292042,0.008232196,0.000022570675,0.00015669082,0.00053156674,0.00007137353,0.00096974085,0.9831803,0.000018705323,0.0044654114,0.000014305806],"about_ca_topic_score_codex":0.0018957115,"about_ca_topic_score_gemma":0.0040182644,"teacher_disagreement_score":0.0018957115,"about_ca_system_score_codex":0.00038218623,"about_ca_system_score_gemma":0.0004257624,"threshold_uncertainty_score":0.0037693977},"labels":[],"label_agreement":null},{"id":"W2113176208","doi":"10.1177/1078155207077335","title":"Chemotherapy induced diarrhea","year":2007,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"National Cancer Institute","keywords":"Medicine; MEDLINE; Cochrane Library; Intensive care medicine; Diarrhea; Data extraction; Systematic review; Internal medicine; Randomized controlled trial","score_opus":0.35390555964002646,"score_gpt":0.6235067227358282,"score_spread":0.26960116309580173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113176208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024297017,0.9983638,0.000063230706,0.00023956945,0.00023502158,0.000044101045,0.000053225947,0.000005170832,0.00075286056],"genre_scores_gemma":[0.0029479032,0.9955226,0.00020647641,0.000563046,0.0002639028,0.0000517627,0.00007687008,0.0000014439568,0.00036590252],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99898356,0.00028628408,0.00033184842,0.00010388922,0.00023250816,0.000061899285],"domain_scores_gemma":[0.99794525,0.0009399992,0.0007646736,0.00003128277,0.00027074,0.000047985144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009834381,0.00094439863,0.0030628939,0.0027124665,0.00035866105,0.0015294745,0.0007260989,0.0013625622,0.0076867454],"category_scores_gemma":[0.0036535228,0.00028840348,0.0012520982,0.0036323057,0.000394566,0.0012752132,0.0007277178,0.00077319,0.0013024823],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026910886,0.00008511176,0.00119389,0.32622463,0.00054804457,0.0008465855,0.00010413442,0.00018925921,0.0006075379,0.001243693,0.028431842,0.6402561],"study_design_scores_gemma":[0.00036678204,0.000625228,0.011061898,0.28484216,0.003274507,0.02280716,0.0005349815,0.00020612651,0.0012119922,0.0016445315,0.67335737,0.00006724857],"about_ca_topic_score_codex":0.0017904387,"about_ca_topic_score_gemma":0.0027583675,"teacher_disagreement_score":0.0076867454,"about_ca_system_score_codex":0.0008878409,"about_ca_system_score_gemma":0.0024294008,"threshold_uncertainty_score":0.025714695},"labels":[],"label_agreement":null},{"id":"W2113298091","doi":"10.1177/1078155213504975","title":"Are community pharmacists equipped to ensure the safe use of oral anticancer therapy in the community setting? Results of a cross-country survey of community pharmacists in Canada","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dr. H. Bliss Murphy Cancer Centre","funders":"","keywords":"Medicine; Pharmacy; Family medicine; Medical prescription; Cancer; Pharmacist; Nursing; Internal medicine","score_opus":0.30676219689613604,"score_gpt":0.5024666138799242,"score_spread":0.19570441698378815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113298091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660194,0.00023894606,0.000035809742,0.00055629096,0.0000070672304,0.00009337454,0.0006801852,0.0000048633965,0.0017815237],"genre_scores_gemma":[0.9987884,0.00031504413,0.00007186691,0.00020126533,0.0000033127233,0.000015680114,0.00022557679,0.0000017516043,0.00037711728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843234,0.00016139277,0.000092892435,0.00014734776,0.0006610297,0.00050506555],"domain_scores_gemma":[0.9947042,0.0003417499,0.0010683677,0.000082416525,0.002302829,0.0015004463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009392013,0.00021784291,0.00029701256,0.00073454244,0.0022278987,0.0013719264,0.00086456747,0.0005655869,0.0017673991],"category_scores_gemma":[0.0047903727,0.00034358862,0.00034264656,0.0022615574,0.0006344522,0.0003979499,0.0008397404,0.00083155354,0.0002118298],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076472774,0.00013851235,0.98714113,0.00006526706,0.00002488145,0.00017934578,0.0032576446,0.000052006762,0.0002950433,0.00003286156,0.0011066999,0.007630028],"study_design_scores_gemma":[0.000008680447,0.000048792674,0.9925459,0.000022730681,0.0000068220597,0.00006187608,0.0063704895,0.00012271672,0.000038867274,0.0000052197215,0.0007617195,0.0000060973534],"about_ca_topic_score_codex":0.98210114,"about_ca_topic_score_gemma":0.9880838,"teacher_disagreement_score":0.017898858,"about_ca_system_score_codex":0.014000375,"about_ca_system_score_gemma":0.02964456,"threshold_uncertainty_score":0.10158026},"labels":[],"label_agreement":null},{"id":"W2115123976","doi":"10.1177/1078155208093929","title":"Pharmaceutical care in an inpatient pediatric hematopoietic stem cell transplant service","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Hematopoietic stem cell; Stem cell; Intensive care medicine; Haematopoiesis; Oncology","score_opus":0.06754681610924824,"score_gpt":0.3915713188160119,"score_spread":0.3240245027067637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115123976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269956,0.0011992337,0.0003309872,0.0008223659,0.00003219155,0.000114395065,0.0007288305,0.00005843168,0.004013887],"genre_scores_gemma":[0.99308866,0.0019560147,0.0014213376,0.0010690385,0.00015787993,0.00013242752,0.00087773957,0.000016222888,0.0012807002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991485,0.00021254204,0.000097066564,0.00012610258,0.00016465709,0.0002512091],"domain_scores_gemma":[0.9971096,0.00055189925,0.0011812776,0.00004408842,0.00014629732,0.00096678693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003366431,0.00037494197,0.0002831068,0.00061927066,0.0011708261,0.00078667694,0.0005259181,0.00056685385,0.010508861],"category_scores_gemma":[0.0025367048,0.00023077874,0.00023605186,0.00094680226,0.00035892066,0.0006047327,0.00095886627,0.00069932285,0.000965096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022587902,0.0007646466,0.9277744,0.000398383,0.000051335996,0.0061557945,0.0018526416,0.0003950958,0.00088010245,0.000179389,0.005091418,0.056230873],"study_design_scores_gemma":[0.000073195784,0.0013625526,0.9708101,0.0002546664,0.00005692649,0.011627721,0.0038844268,0.0008663575,0.00079416495,0.000110726476,0.01013438,0.000024704721],"about_ca_topic_score_codex":0.011692922,"about_ca_topic_score_gemma":0.016536597,"teacher_disagreement_score":0.011692922,"about_ca_system_score_codex":0.0021956435,"about_ca_system_score_gemma":0.0035410242,"threshold_uncertainty_score":0.035155654},"labels":[],"label_agreement":null},{"id":"W2117050757","doi":"10.1177/1078155208101097","title":"Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective Phase III","year":2009,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Pharmacy; Perspective (graphical); Cancer; Antineoplastic Drugs; Contamination; Phase (matter); Cancer drugs; Family medicine; Pharmacology; Internal medicine","score_opus":0.09178912142410763,"score_gpt":0.5349185322970967,"score_spread":0.4431294108729891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117050757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971632,0.0011904233,0.0011909838,0.0009834485,0.00008845518,0.016157659,0.0017943685,0.00006688329,0.006895814],"genre_scores_gemma":[0.9681484,0.0015866269,0.00585297,0.0031304706,0.00016896725,0.00791041,0.004391612,0.000029092571,0.008781519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970516,0.0009988527,0.00006536734,0.00021138077,0.001071824,0.00060086383],"domain_scores_gemma":[0.99602795,0.00030755802,0.00048594506,0.0002283965,0.0014582323,0.0014918768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043862867,0.0008417993,0.00086914795,0.0004587511,0.00201059,0.0011455226,0.001757315,0.0013420474,0.002514558],"category_scores_gemma":[0.0020542352,0.00049020204,0.00081607566,0.0010671812,0.0010697403,0.00037914756,0.000609854,0.001462188,0.00044869693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15379016,0.12894589,0.44093335,0.0018430756,0.0016198698,0.0022034924,0.0035234117,0.0035102107,0.058656383,0.00081873656,0.018085634,0.18606982],"study_design_scores_gemma":[0.044801764,0.2525803,0.66265965,0.00012485504,0.0008625916,0.0005470081,0.0014273499,0.0008719808,0.010155641,0.00018363776,0.025708709,0.000076441094],"about_ca_topic_score_codex":0.27955163,"about_ca_topic_score_gemma":0.49505782,"teacher_disagreement_score":0.7204484,"about_ca_system_score_codex":0.009735819,"about_ca_system_score_gemma":0.0346236,"threshold_uncertainty_score":0.5558489},"labels":[],"label_agreement":null},{"id":"W2121170439","doi":"10.1191/1078155204jp139oa","title":"Developing a targeted pharmacy oncology guide","year":2004,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Pharmacy; Oncology; Internal medicine; Agency (philosophy); Clinical pharmacy; Family medicine","score_opus":0.10681591881013026,"score_gpt":0.408982632555235,"score_spread":0.30216671374510473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121170439","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04989752,0.0043625548,0.2364699,0.11825854,0.0040294854,0.023263488,0.012559076,0.015759781,0.5353997],"genre_scores_gemma":[0.08382639,0.0072218496,0.5277878,0.025746163,0.0008223476,0.006783889,0.009952359,0.0010030271,0.33685613],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964012,0.0008353025,0.0003718034,0.0002154105,0.0018503527,0.00032600298],"domain_scores_gemma":[0.9910898,0.0013137169,0.00059327105,0.00048037592,0.0049083834,0.0016144546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035414416,0.0005994256,0.00035103425,0.0021947536,0.001925543,0.0019077003,0.0012335664,0.0016968505,0.03937602],"category_scores_gemma":[0.011109465,0.0005350831,0.00049463555,0.0012941764,0.0006364823,0.0020059855,0.002475399,0.0018664126,0.0242211],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031176773,0.0003298872,0.0029922612,0.0005910746,0.0000066308567,0.0005975629,0.0032573452,0.0006544815,0.0017945394,0.004598573,0.6488876,0.33625895],"study_design_scores_gemma":[0.000015252143,0.000087036264,0.0040338114,0.00024528705,0.000002966326,0.00067343545,0.0011654045,0.0003169782,0.00057930045,0.0014213499,0.9914398,0.000019296116],"about_ca_topic_score_codex":0.014880115,"about_ca_topic_score_gemma":0.035721444,"teacher_disagreement_score":0.03937602,"about_ca_system_score_codex":0.0044475896,"about_ca_system_score_gemma":0.018974738,"threshold_uncertainty_score":0.1317259},"labels":[],"label_agreement":null},{"id":"W2121301515","doi":"10.1177/1078155214531609","title":"Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients","year":2014,"lang":"en","type":"letter","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Tacrolimus; Medicine; Calcineurin; Transplantation; Pharmacology; Hematopoietic stem cell transplantation; Graft-versus-host disease; Sirolimus; Surgery","score_opus":0.11454234255156505,"score_gpt":0.38884682231072004,"score_spread":0.274304479759155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121301515","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13650066,0.21661268,0.048629068,0.42125532,0.010763541,0.0012297166,0.0005183403,0.0013110891,0.16317958],"genre_scores_gemma":[0.67930746,0.091628626,0.08201921,0.10044332,0.024206912,0.0017980449,0.00061947654,0.00039795443,0.019579034],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973042,0.0013466275,0.0003762921,0.0001866097,0.00060979323,0.00017648654],"domain_scores_gemma":[0.9958656,0.002088637,0.00046989854,0.0001482268,0.00060874084,0.000818902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040685474,0.00035588958,0.0005983605,0.00066931604,0.00082508376,0.0022704892,0.0008187266,0.0020972216,0.00792472],"category_scores_gemma":[0.009131167,0.000156194,0.00065025885,0.00041707937,0.0006198643,0.0012162871,0.0008288208,0.0027965512,0.002743939],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001174014,0.00087224756,0.026171524,0.0013176375,0.00011953753,0.013252632,0.0011246257,0.0013578921,0.004016805,0.005519811,0.11766945,0.82740384],"study_design_scores_gemma":[0.00066961325,0.0020174207,0.078300886,0.0074694497,0.0003748457,0.0577419,0.0046924176,0.0030164442,0.004878393,0.017291976,0.8233374,0.0002092797],"about_ca_topic_score_codex":0.0010538142,"about_ca_topic_score_gemma":0.0019407055,"teacher_disagreement_score":0.00792472,"about_ca_system_score_codex":0.00070236815,"about_ca_system_score_gemma":0.0015726014,"threshold_uncertainty_score":0.026510775},"labels":[],"label_agreement":null},{"id":"W2123031775","doi":"10.1177/1078155208099281","title":"A feasibility study to assess the integration of a pharmacist into neurooncology clinic","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Healthcare Decision-Making and Restraints","field":"Psychology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Cancer Foundation","funders":"","keywords":"Pharmacist; Medicine; Outpatient clinic; Family medicine; Neurooncology; Psychological intervention; Clinical pharmacy; Feeling; Nursing; Medical emergency; Pharmacy; Internal medicine; Surgery","score_opus":0.48830413709177123,"score_gpt":0.6271375867684428,"score_spread":0.13883344967667155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123031775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98734564,0.000072786526,0.00062320137,0.0004795244,0.00003886886,0.008503312,0.00016400086,0.000016230108,0.0027564713],"genre_scores_gemma":[0.9868471,0.00011984439,0.004499157,0.00050781213,0.00004029454,0.0073412056,0.000111120215,0.000004224352,0.00052920455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9868227,0.008627897,0.0010271793,0.0005222584,0.0017285044,0.0012714016],"domain_scores_gemma":[0.96877635,0.0095309885,0.007496889,0.0010888401,0.0040168692,0.009090141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015075793,0.00045406414,0.00039253788,0.0009080098,0.0016748888,0.0014879813,0.0010859232,0.0012831753,0.005963081],"category_scores_gemma":[0.02684505,0.00068283075,0.0005900473,0.00064861,0.0010520318,0.0017155145,0.0017020677,0.00146695,0.0010281198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014614421,0.1751968,0.6783063,0.001466584,0.00021994795,0.0016598608,0.012684674,0.0004653501,0.0036028416,0.0005049734,0.002472531,0.108805746],"study_design_scores_gemma":[0.005533131,0.26905376,0.6977731,0.00031771263,0.00015149484,0.0010856598,0.018014038,0.0016729152,0.0010873898,0.000168775,0.005052121,0.0000899307],"about_ca_topic_score_codex":0.0029116606,"about_ca_topic_score_gemma":0.004703374,"teacher_disagreement_score":0.015075793,"about_ca_system_score_codex":0.0020878194,"about_ca_system_score_gemma":0.009605794,"threshold_uncertainty_score":0.07972932},"labels":[],"label_agreement":null},{"id":"W2125833278","doi":"10.1177/1078155211429384","title":"Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients","year":2012,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Docetaxel; Pneumonitis; Breast cancer; Cyclophosphamide; Gemcitabine; Lung cancer; Incidence (geometry); Cancer; Adverse effect; Internal medicine; Oncology; Lung","score_opus":0.09187344097115692,"score_gpt":0.46291375392893713,"score_spread":0.3710403129577802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125833278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009759685,0.998346,0.000039957467,0.00008004571,0.000040733048,0.000004207857,0.000009548069,0.0000031387674,0.00050043483],"genre_scores_gemma":[0.0068968777,0.9925734,0.000115399496,0.00011020637,0.00008666993,0.0000050951667,0.00001986275,7.779235e-7,0.00019173429],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978894,0.00004111413,0.000058408106,0.00003080604,0.00006465799,0.00001603338],"domain_scores_gemma":[0.9996352,0.00016228524,0.00012669175,0.000008053789,0.000047635487,0.000020091746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025221365,0.00049256464,0.0008529737,0.0025250919,0.00022241169,0.000492421,0.00048341963,0.0005896796,0.0016490858],"category_scores_gemma":[0.0007187596,0.00017799513,0.00047126602,0.0022028636,0.00025900017,0.0007055942,0.00036127047,0.00050778297,0.00036894067],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008975947,0.00010002188,0.005670761,0.038957216,0.00022485574,0.0066032233,0.00031680454,0.0002002628,0.001566315,0.00051698374,0.013100344,0.9326535],"study_design_scores_gemma":[0.00009485315,0.00041143008,0.0508193,0.055088334,0.0017052423,0.23011403,0.0012361613,0.00030983405,0.0022404601,0.0013844365,0.6565077,0.0000882279],"about_ca_topic_score_codex":0.00089020643,"about_ca_topic_score_gemma":0.0024827714,"teacher_disagreement_score":0.0025250919,"about_ca_system_score_codex":0.00023565786,"about_ca_system_score_gemma":0.00059183274,"threshold_uncertainty_score":0.005516708},"labels":[],"label_agreement":null},{"id":"W2125952502","doi":"10.1177/1078155207080802","title":"Interaction between mercaptopurine and milk","year":2007,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mercaptopurine; Bioavailability; Medicine; Xanthine oxidase; Pharmacology; Purine; In vivo; Purine analogue; Theophylline; Biotechnology; Chemistry; Biochemistry; Enzyme; Biology","score_opus":0.06535646130096556,"score_gpt":0.4676410016685943,"score_spread":0.40228454036762873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125952502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92798424,0.056955084,0.002908492,0.0026701966,0.0004243241,0.00013323445,0.00021422826,0.00017629012,0.008533856],"genre_scores_gemma":[0.9798979,0.009644212,0.0022257725,0.000624501,0.0001319598,0.0000633223,0.00012301905,0.00002082943,0.007268421],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9994487,0.0002972759,0.000018618837,0.000049925624,0.000113874004,0.00007155329],"domain_scores_gemma":[0.9994012,0.00030361456,0.0001246533,0.000027020073,0.00007855903,0.00006504293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004020885,0.00025800444,0.0003320821,0.00025578245,0.00037264728,0.0005879074,0.00033808674,0.00068255427,0.0054075974],"category_scores_gemma":[0.002030126,0.00017857464,0.00043796896,0.00018619755,0.00012799048,0.0003356463,0.0005304089,0.00042780372,0.0006294802],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012578944,0.0017496512,0.086589836,0.0033885639,0.0012045304,0.009042472,0.0014526998,0.00082904985,0.52423835,0.0025378761,0.010150608,0.34623742],"study_design_scores_gemma":[0.00066754693,0.012119158,0.1318396,0.0005287106,0.0014668447,0.017525744,0.001372362,0.0048928945,0.6729169,0.002325711,0.15425354,0.00009096847],"about_ca_topic_score_codex":0.0013472082,"about_ca_topic_score_gemma":0.0009231036,"teacher_disagreement_score":0.0054075974,"about_ca_system_score_codex":0.00030759466,"about_ca_system_score_gemma":0.00033596068,"threshold_uncertainty_score":0.018090248},"labels":[],"label_agreement":null},{"id":"W2127016949","doi":"10.1191/1078155202jp098oa","title":"Updating a survey for medication error prevention","year":2002,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Medicine; Pharmacy; MEDLINE; Family medicine","score_opus":0.4440676569020101,"score_gpt":0.5651284326373278,"score_spread":0.1210607757353177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127016949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4908098,0.019750472,0.089710824,0.04081422,0.0046335817,0.17443421,0.06832389,0.0037570796,0.10776594],"genre_scores_gemma":[0.55230266,0.01274851,0.29039744,0.00971114,0.0012872153,0.08848786,0.034894068,0.00022400745,0.009947193],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.90220296,0.04798714,0.020951683,0.002087221,0.024780547,0.0019904827],"domain_scores_gemma":[0.74722946,0.07810461,0.028481975,0.013860146,0.1275489,0.004774885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08865349,0.00069270603,0.0013948407,0.011697661,0.0014564623,0.0014614544,0.0016962464,0.0013253386,0.0067397747],"category_scores_gemma":[0.16653346,0.00055512745,0.0012076884,0.011760312,0.0007554654,0.0028011561,0.0017669072,0.0012014334,0.00209818],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008936487,0.0015289568,0.21889229,0.011898168,0.00027965487,0.0002482657,0.007352636,0.0008447391,0.0022235045,0.0019765059,0.0824917,0.6713699],"study_design_scores_gemma":[0.0007549317,0.0036153807,0.7205702,0.008631916,0.0005295433,0.00041424128,0.011011582,0.0027335153,0.0030312883,0.0013189303,0.247225,0.00016348809],"about_ca_topic_score_codex":0.035909615,"about_ca_topic_score_gemma":0.04470982,"teacher_disagreement_score":0.08865349,"about_ca_system_score_codex":0.008109,"about_ca_system_score_gemma":0.025359422,"threshold_uncertainty_score":0.46885008},"labels":[],"label_agreement":null},{"id":"W2128690699","doi":"10.1177/1078155206069164","title":"Defining the clinical improvement in cancer drug therapy: implications for priority setting in healthcare","year":2006,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Consistency (knowledge bases); Health care; Intensive care medicine","score_opus":0.6336268699544115,"score_gpt":0.6600073452440877,"score_spread":0.02638047528967613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128690699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020973312,0.94791156,0.0048300093,0.04378303,0.0009889457,0.000037822178,0.000019309666,0.000013499333,0.0022060513],"genre_scores_gemma":[0.012246559,0.9690424,0.010815563,0.0055452595,0.0018609487,0.0001244498,0.000029508352,0.000009394515,0.00032595897],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9638543,0.024453133,0.002606307,0.0009214039,0.0075602354,0.00060469395],"domain_scores_gemma":[0.8695391,0.111178435,0.0065933587,0.0015971381,0.0095019275,0.001590072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06773412,0.0017973353,0.0049896645,0.01002319,0.0013689969,0.0078751305,0.0030828316,0.0069664605,0.00465238],"category_scores_gemma":[0.10977501,0.00079380476,0.001833374,0.013510187,0.009424477,0.015401136,0.0042001572,0.008592002,0.0011359248],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095481446,0.00013137769,0.000942822,0.017342284,0.0002951993,0.00013137994,0.0005076902,0.0034921186,0.00009866599,0.2503548,0.03464949,0.6919587],"study_design_scores_gemma":[0.00019492261,0.00024618895,0.0038522277,0.060288724,0.0003087704,0.00097056903,0.0017589004,0.0026640364,0.00023375015,0.6046167,0.3246921,0.0001731523],"about_ca_topic_score_codex":0.007693674,"about_ca_topic_score_gemma":0.008990454,"teacher_disagreement_score":0.06773412,"about_ca_system_score_codex":0.015671737,"about_ca_system_score_gemma":0.022453535,"threshold_uncertainty_score":0.35821658},"labels":[],"label_agreement":null},{"id":"W2128822306","doi":"10.1177/1078155213517127","title":"Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: The centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Ifosfamide; Pharmacy; Cyclophosphamide; Pharmacy technician; Methotrexate; Priming (agriculture); Mesna; Significant difference; Pharmacology; Chemotherapy; Internal medicine; Nursing","score_opus":0.08939353870294188,"score_gpt":0.48754432529429026,"score_spread":0.3981507865913484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128822306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943733,0.00052918424,0.0022236186,0.0006883113,0.00003853785,0.00020996263,0.000063404106,0.00007531369,0.0017985031],"genre_scores_gemma":[0.99287826,0.0003146267,0.0051566605,0.0003821204,0.000062795196,0.00012196094,0.00007325913,0.000009399408,0.0010009378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99217284,0.0050086863,0.00036276423,0.00040925114,0.0016023701,0.00044401045],"domain_scores_gemma":[0.9776408,0.011118473,0.0066148397,0.0011186765,0.0017886495,0.0017186287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004158099,0.00046839972,0.0003432012,0.0004675655,0.0004172913,0.0009710662,0.00061224296,0.0012692551,0.0044264044],"category_scores_gemma":[0.016856076,0.0002199064,0.0006684013,0.00031460737,0.0006255082,0.00066751865,0.0012352397,0.0006586748,0.00038780557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072790147,0.008971127,0.52996236,0.001843849,0.00052288466,0.0010610886,0.0032861452,0.0032247403,0.032125175,0.0004758502,0.002720763,0.408527],"study_design_scores_gemma":[0.00041632244,0.032869965,0.93115056,0.00029953112,0.00031385265,0.0015999273,0.004920588,0.0025726564,0.015927682,0.00023485727,0.009590071,0.00010393213],"about_ca_topic_score_codex":0.0010223648,"about_ca_topic_score_gemma":0.0010204955,"teacher_disagreement_score":0.0044264044,"about_ca_system_score_codex":0.0008684658,"about_ca_system_score_gemma":0.0015980577,"threshold_uncertainty_score":0.021990359},"labels":[],"label_agreement":null},{"id":"W2131280296","doi":"10.1177/1078155208096902","title":"Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration","year":2008,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Saline; Intrathecal; ThioTEPA; Anesthesia; Sterile water; Methotrexate; Ringer's solution; Surgery; Chemotherapy; Cyclophosphamide; Chemistry","score_opus":0.15626656441589343,"score_gpt":0.5113434548060312,"score_spread":0.35507689039013773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131280296","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6148833,0.37063503,0.0015041799,0.00047870187,0.000093425115,0.0003274789,0.004205831,0.000076653676,0.0077954526],"genre_scores_gemma":[0.84544724,0.14202318,0.008861761,0.00035715054,0.00008988612,0.00022610495,0.0023390877,0.000016352424,0.00063920784],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989128,0.0002961321,0.00031061735,0.00010452772,0.0003307037,0.000045244902],"domain_scores_gemma":[0.99511707,0.0016838703,0.0022232698,0.000064597254,0.0008093534,0.00010172242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015543271,0.00021793557,0.00055463926,0.00534055,0.00023894096,0.0004666792,0.0003712626,0.0003777418,0.0013116885],"category_scores_gemma":[0.0042478633,0.0001277364,0.0004834823,0.0050596762,0.00028338822,0.00062994706,0.00025121623,0.0001811488,0.0002259711],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004748406,0.0003760528,0.34008366,0.07675681,0.0012274274,0.00320122,0.0018185594,0.0006844131,0.09616426,0.0006219185,0.0046456857,0.46967155],"study_design_scores_gemma":[0.00038796716,0.009374415,0.70050716,0.0081413165,0.004009959,0.015630716,0.0041791624,0.00071502227,0.18369645,0.00041304124,0.07274142,0.00020334373],"about_ca_topic_score_codex":0.0014302589,"about_ca_topic_score_gemma":0.0028456391,"teacher_disagreement_score":0.00534055,"about_ca_system_score_codex":0.0005469014,"about_ca_system_score_gemma":0.0008028009,"threshold_uncertainty_score":0.008220136},"labels":[],"label_agreement":null},{"id":"W2132053614","doi":"10.1177/1078155212473000","title":"Intravenous chemotherapy preparation errors: Patient safety risks identified in a pan-Canadian exploratory study","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University of Alberta; Alberta Health Services; University Health Network","funders":"","keywords":"Medicine; Pharmacy; Patient safety; Intensive care medicine; Ambulatory; Cancer chemotherapy; Exploratory research; Adverse effect; Cancer; Medical emergency; Family medicine; Surgery; Internal medicine; Health care","score_opus":0.14805242021169487,"score_gpt":0.5126107606527117,"score_spread":0.36455834044101687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132053614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99495405,0.00022145307,0.00030896204,0.0006530374,0.000008655177,0.0004142424,0.0006801883,0.000010180226,0.0027491737],"genre_scores_gemma":[0.99767584,0.00035931103,0.0007489396,0.0004081628,0.000006500464,0.000096108175,0.0002481343,0.000004565364,0.00045228328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947141,0.0007538777,0.000375453,0.00048221904,0.002337919,0.0013364592],"domain_scores_gemma":[0.98449636,0.0018650314,0.0042998977,0.0006275843,0.006649071,0.0020620688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004529195,0.00057442853,0.00039510388,0.002892322,0.007587769,0.0020213816,0.0017362434,0.0008487995,0.0016970929],"category_scores_gemma":[0.01218335,0.00053378317,0.00062697794,0.00510697,0.002121943,0.0009538666,0.0031663568,0.0014326451,0.00014561188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022737272,0.0003818431,0.94524807,0.0002719767,0.000057576064,0.0007492084,0.035664644,0.00018249467,0.0004955896,0.00040871176,0.0018668197,0.014445689],"study_design_scores_gemma":[0.000019583416,0.0002714933,0.9419236,0.00011756394,0.000040973955,0.00037175766,0.05316833,0.0004121205,0.000248339,0.00010186874,0.0032746124,0.00004975417],"about_ca_topic_score_codex":0.97488344,"about_ca_topic_score_gemma":0.9849723,"teacher_disagreement_score":0.038543586,"about_ca_system_score_codex":0.038543586,"about_ca_system_score_gemma":0.08715591,"threshold_uncertainty_score":0.27965456},"labels":[],"label_agreement":null},{"id":"W2132076511","doi":"10.1177/1078155214540317","title":"Feasibility of using the Multinational Association of Supportive Care in Cancer Antiemesis Tool for assessment of chemotherapy-induced nausea and vomiting at the Tom Baker Cancer Centre","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Nausea and vomiting management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Nausea; Antiemetic; Chemotherapy-induced nausea and vomiting; Vomiting; Cancer; Anxiety; Chemotherapy; Intensive care medicine; Internal medicine; Quality of life (healthcare); Oncology; Physical therapy; Nursing; Psychiatry","score_opus":0.09027429011468012,"score_gpt":0.4988146104899062,"score_spread":0.4085403203752261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132076511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961714,0.00020484207,0.00014419753,0.0005927438,0.000019872794,0.0005359188,0.00024189203,0.00001694831,0.002072219],"genre_scores_gemma":[0.99831295,0.0001485055,0.0007920894,0.00013691136,0.000010194517,0.00030259692,0.00012517134,0.0000022080415,0.00016925897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966748,0.0019364676,0.00039770946,0.00014422362,0.00053282024,0.0003140053],"domain_scores_gemma":[0.9918628,0.002553263,0.003115922,0.00022073637,0.0011633927,0.0010839354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042619044,0.00018993407,0.0003092781,0.00056806614,0.0005486607,0.00076529954,0.0005324277,0.00044701746,0.0027324583],"category_scores_gemma":[0.015858738,0.00022562555,0.00039279312,0.00053398137,0.00026033208,0.00051963713,0.00078288873,0.0005919695,0.00040723445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002687417,0.00043656267,0.9739811,0.00012144031,0.000026232847,0.00015411268,0.0014901303,0.00009637075,0.00031717008,0.000021858328,0.0013911169,0.02169521],"study_design_scores_gemma":[0.000082172824,0.0025843156,0.9908846,0.00013851908,0.000028959237,0.00044418458,0.0032753039,0.0007793471,0.000248887,0.000017737037,0.001494863,0.000021108417],"about_ca_topic_score_codex":0.0057600476,"about_ca_topic_score_gemma":0.011027738,"teacher_disagreement_score":0.0057600476,"about_ca_system_score_codex":0.000625886,"about_ca_system_score_gemma":0.001797657,"threshold_uncertainty_score":0.022539437},"labels":[],"label_agreement":null},{"id":"W2136970657","doi":"10.1177/1078155214525369","title":"A comparison of toxicity and health care resource use between eribulin, capecitabine, gemcitabine, and vinorelbine in patients with metastatic breast cancer treated in a community oncology setting","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Eribulin; Metastatic breast cancer; Internal medicine; Gemcitabine; Vinorelbine; Neutropenia; Oncology; Breast cancer; Anemia; Capecitabine; Adverse effect; Cancer; Toxicity; Chemotherapy; Colorectal cancer","score_opus":0.06450904396762154,"score_gpt":0.4532250343000936,"score_spread":0.38871599033247206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136970657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99973947,0.00009690581,0.000007733343,0.0000134345955,8.4528955e-7,0.0000076302695,0.000060762286,3.9921036e-7,0.0000728292],"genre_scores_gemma":[0.9997023,0.000052530442,0.000023651688,0.000018707366,0.0000040112063,0.000012142089,0.00016093304,3.869438e-7,0.000025207555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993187,0.00029787686,0.00008197592,0.00010451835,0.00010878932,0.00008814734],"domain_scores_gemma":[0.9977502,0.0006650357,0.0010282872,0.00004020451,0.00012003435,0.0003962435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068474276,0.00019288075,0.00043406678,0.00064403197,0.000372453,0.0005309825,0.00028280012,0.0003398403,0.0011001141],"category_scores_gemma":[0.0033263303,0.00016877502,0.00050701085,0.0010875765,0.00022041817,0.00034335404,0.00035318665,0.0004037051,0.00007442389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031752086,0.00035326224,0.99280244,0.000028996312,0.00019163119,0.00010079135,0.00008580254,0.00016873887,0.00021243765,0.000009651837,0.00008298528,0.0027879684],"study_design_scores_gemma":[0.00022929473,0.0024321105,0.996099,0.00000952598,0.000070929775,0.00022816371,0.00024528048,0.00045506758,0.00008326376,0.00001724192,0.00012341574,0.0000066041953],"about_ca_topic_score_codex":0.004983045,"about_ca_topic_score_gemma":0.007087762,"teacher_disagreement_score":0.004983045,"about_ca_system_score_codex":0.0010501577,"about_ca_system_score_gemma":0.00051259005,"threshold_uncertainty_score":0.00990808},"labels":[],"label_agreement":null},{"id":"W2137664975","doi":"10.1177/1078155206073520","title":"Renal safety of 1-hour pamidronate infusion for breast cancer and multiple myeloma patients: comparison between clinical trials and population-based database","year":2006,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Bone health and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Zoledronic acid; Multiple myeloma; Breast cancer; Population; Clinical trial; Creatinine; Urology; Bisphosphonate; Internal medicine; Cancer; Surgery; Osteoporosis","score_opus":0.15569577953064376,"score_gpt":0.5284559983317456,"score_spread":0.3727602188011019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137664975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9085137,0.07307837,0.0029878921,0.0011352879,0.00019552962,0.0018118618,0.009243936,0.000060827533,0.0029726352],"genre_scores_gemma":[0.98958975,0.004918532,0.00080822455,0.00051546923,0.00009152024,0.0005536737,0.0033397486,0.0000133803815,0.00016964508],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.924639,0.05545002,0.00964703,0.0040813615,0.0055905855,0.0005919607],"domain_scores_gemma":[0.795426,0.13712917,0.05441281,0.0066848905,0.005077348,0.0012697476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.046862457,0.00054539385,0.0038317733,0.002003158,0.00023869734,0.002541446,0.0013844233,0.0017544366,0.0028541146],"category_scores_gemma":[0.12181223,0.000510959,0.00909795,0.0035163488,0.000603676,0.0013288492,0.0009565495,0.0010836192,0.00022735923],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45353168,0.0008591146,0.2839103,0.020203134,0.17929922,0.0003921672,0.00038426524,0.0071529318,0.0011808918,0.0009473225,0.002428609,0.04971043],"study_design_scores_gemma":[0.11301206,0.040354017,0.63163126,0.0043175477,0.17801076,0.0022623658,0.00047272595,0.016256174,0.0022536446,0.0027569619,0.0083169,0.000355668],"about_ca_topic_score_codex":0.0008537089,"about_ca_topic_score_gemma":0.0008202638,"teacher_disagreement_score":0.046862457,"about_ca_system_score_codex":0.001557608,"about_ca_system_score_gemma":0.0010847569,"threshold_uncertainty_score":0.24783528},"labels":[],"label_agreement":null},{"id":"W2138727105","doi":"10.1191/1078155201jp077oa","title":"Zoledronic acid versus pamidronate as palliative therapy in cancer patients: A Canadian time and motion analysis","year":2001,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Bone health and treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Novartis Pharmaceuticals Canada","keywords":"Zoledronic acid; Medicine; Bisphosphonate; Palliative care; Cancer; Outpatient clinic; Internal medicine; Osteoporosis; Nursing","score_opus":0.05877844720783541,"score_gpt":0.45060400744547263,"score_spread":0.3918255602376372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138727105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.903763,0.016461093,0.004147771,0.0048139333,0.00015357228,0.0013677551,0.030082636,0.00017526935,0.039035007],"genre_scores_gemma":[0.9757878,0.0050893985,0.0034200882,0.0005675558,0.000040893527,0.00020568472,0.009026829,0.00007051497,0.005791134],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99775666,0.00056433456,0.00008277026,0.0001913701,0.00085602864,0.00054887857],"domain_scores_gemma":[0.99469537,0.0020227334,0.00045213438,0.00011356807,0.0022817655,0.00043443518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002803032,0.0010650443,0.0014781562,0.0029086305,0.0012766114,0.0017561461,0.002033272,0.0007351983,0.0061021904],"category_scores_gemma":[0.009156786,0.00050530845,0.0038023277,0.0059953863,0.00048424306,0.00048046643,0.0007726479,0.0010057895,0.00024530914],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014109817,0.0010227776,0.2379702,0.0037241108,0.006013159,0.0008728489,0.00063932355,0.5140342,0.0015506492,0.02219177,0.06611648,0.1317546],"study_design_scores_gemma":[0.003316467,0.0020137941,0.37622562,0.00063117995,0.008231036,0.0004226822,0.0016945157,0.56210613,0.00087238714,0.0028173036,0.041255657,0.0004131779],"about_ca_topic_score_codex":0.9876359,"about_ca_topic_score_gemma":0.9849001,"teacher_disagreement_score":0.06261158,"about_ca_system_score_codex":0.06261158,"about_ca_system_score_gemma":0.049721625,"threshold_uncertainty_score":0.4542809},"labels":[],"label_agreement":null},{"id":"W2138894610","doi":"10.1177/1078155209337663","title":"Evaluation of creatinine-based formulas in dosing adjustment of cancer drugs other than carboplatin","year":2009,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Dosing; Renal function; Concordance; Carboplatin; Urology; Creatinine; Cancer; Population; Internal medicine; Chemotherapy; Cisplatin","score_opus":0.07709017014051144,"score_gpt":0.4697982283140929,"score_spread":0.39270805817358145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138894610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9549292,0.004961066,0.034543633,0.00032591907,0.00011330938,0.00052102533,0.0008690276,0.00044389922,0.0032929801],"genre_scores_gemma":[0.9758977,0.0004311006,0.022796454,0.000043603734,0.000027690883,0.00010084056,0.00056929764,0.00003978253,0.00009352111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9770337,0.011040764,0.0020559046,0.0009777657,0.008638418,0.000253407],"domain_scores_gemma":[0.9357434,0.031586096,0.015431844,0.0032044193,0.013478379,0.0005559277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02602491,0.0005666231,0.0008303528,0.0029683954,0.00032616543,0.0014173588,0.0010092652,0.00042849508,0.00054729875],"category_scores_gemma":[0.09760464,0.00026079515,0.0005723695,0.0030356436,0.00027427785,0.00064508186,0.0009866449,0.00063279935,0.00020801614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026100008,0.00017387938,0.8148499,0.00030285708,0.00060688646,0.00019356307,0.00036696417,0.011418818,0.002638448,0.000448709,0.0011378943,0.16525201],"study_design_scores_gemma":[0.0006282143,0.0054523707,0.7242657,0.00025344093,0.0011719889,0.003445837,0.0003450641,0.23346493,0.022209017,0.00069917546,0.007945669,0.00011856863],"about_ca_topic_score_codex":0.0029113034,"about_ca_topic_score_gemma":0.0024660162,"teacher_disagreement_score":0.02602491,"about_ca_system_score_codex":0.0013712732,"about_ca_system_score_gemma":0.0012551927,"threshold_uncertainty_score":0.13763452},"labels":[],"label_agreement":null},{"id":"W2139358417","doi":"10.1177/1078155208101960","title":"Examining the safety and efficacy of a chemotherapy dosing method in Allogeneic Stem Cell Transplant patients of extreme body size","year":2009,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Dosing; Chemotherapy; Regimen; Cyclophosphamide; Internal medicine; Surgery","score_opus":0.05740986971328053,"score_gpt":0.38088597773612665,"score_spread":0.3234761080228461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139358417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989058,0.00048759553,0.00024710182,0.000048891485,0.000008150727,0.000045686847,0.00004061171,0.000003371692,0.00021288311],"genre_scores_gemma":[0.9991197,0.00017856742,0.00039973643,0.000055235796,0.00002868644,0.00005261988,0.00010412439,0.0000013419321,0.000059973903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998882,0.000607285,0.0001249809,0.00010105194,0.000230856,0.000053740136],"domain_scores_gemma":[0.99270767,0.0030756253,0.0031507933,0.0003128142,0.00043708843,0.00031607834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023426206,0.00020396477,0.000388952,0.00037929814,0.00019787434,0.0002783962,0.00021452742,0.00027083888,0.00059820106],"category_scores_gemma":[0.00618336,0.00009096689,0.00044233337,0.00038241348,0.00030300661,0.0003284524,0.00023291765,0.00040910818,0.000120796525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02167958,0.001173528,0.91357446,0.000120510864,0.0002663829,0.00010782587,0.00011419536,0.0009953161,0.003071896,0.000055012126,0.00019450608,0.058646716],"study_design_scores_gemma":[0.0013717148,0.10860561,0.8779834,0.00006400971,0.00039843525,0.00084125414,0.00022736522,0.003879859,0.005243113,0.00012559808,0.001238081,0.000021593936],"about_ca_topic_score_codex":0.00021191326,"about_ca_topic_score_gemma":0.00029384534,"teacher_disagreement_score":0.0023426206,"about_ca_system_score_codex":0.00043618114,"about_ca_system_score_gemma":0.00036332518,"threshold_uncertainty_score":0.012389123},"labels":[],"label_agreement":null},{"id":"W2140450024","doi":"10.1177/1078155211412991","title":"A fatal case of <i>Pneumocystis jirovecii</i> pneumonia in a breast cancer patient receiving weekly paclitaxel and trastuzumab","year":2011,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pneumocystis jirovecii pneumonia detection and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; McMaster University; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Paclitaxel; Pneumocystis carinii; Trastuzumab; Dexamethasone; Internal medicine; Chemotherapy; Pneumonia; Breast cancer; Cancer; Surgery; Oncology; Gastroenterology; Pneumocystis jirovecii","score_opus":0.04043549870684363,"score_gpt":0.36265644267616093,"score_spread":0.3222209439693173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140450024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789779,0.0016498663,0.0021136908,0.0050282613,0.00038896673,0.00015746595,0.00018534977,0.00018247236,0.011316037],"genre_scores_gemma":[0.9958228,0.00045393745,0.00062593207,0.0015652033,0.000546839,0.000016683944,0.00008615118,0.00001962732,0.0008629439],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991315,0.00014947445,0.00009719348,0.00017929169,0.00011888968,0.00032369507],"domain_scores_gemma":[0.99768054,0.0006433512,0.00049197144,0.00020470603,0.0001551577,0.00082410825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004452704,0.0013514773,0.0010456458,0.0008939293,0.0042058113,0.001408851,0.0008783663,0.005530744,0.0012985279],"category_scores_gemma":[0.0033691574,0.0010601287,0.001198243,0.0005707249,0.00136663,0.0012879524,0.0012006984,0.0041323095,0.000605765],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012564442,0.00009895841,0.02089866,0.000025765823,0.000016892789,0.97512895,0.00036698565,0.00015222532,0.000925694,0.00025335525,0.0007222952,0.0012846267],"study_design_scores_gemma":[0.00004142067,0.0003412202,0.01278378,0.000029530596,0.000028830678,0.9834029,0.00025978166,0.00078446185,0.0010234312,0.00018989816,0.0010953803,0.00001922773],"about_ca_topic_score_codex":0.003505332,"about_ca_topic_score_gemma":0.0044975067,"teacher_disagreement_score":0.005530744,"about_ca_system_score_codex":0.0019120834,"about_ca_system_score_gemma":0.0008682867,"threshold_uncertainty_score":0.0138732195},"labels":[],"label_agreement":null},{"id":"W2144211082","doi":"10.1177/1078155213484786","title":"Templates of patient brochures for the preparation, administration and safe-handling of oral chemotherapy","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Dosing; Specialty; Drug administration; Drug; Pharmacology; Family medicine","score_opus":0.06774177070420548,"score_gpt":0.5035914161417157,"score_spread":0.43584964543751015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144211082","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19023961,0.00270758,0.5222553,0.014258193,0.0036755248,0.04164425,0.0040174965,0.027900131,0.19330192],"genre_scores_gemma":[0.09988304,0.0014500924,0.85013014,0.0016026287,0.00041446826,0.0063282633,0.002968478,0.0009886394,0.03623423],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9874139,0.006437613,0.0021483293,0.0007538174,0.002774741,0.00047165737],"domain_scores_gemma":[0.95081455,0.0198099,0.007274146,0.008665136,0.010038655,0.0033974475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015007867,0.0014535063,0.00060019107,0.0024615175,0.0015860858,0.0021551515,0.0025650884,0.0015488347,0.015495928],"category_scores_gemma":[0.0497673,0.0006015684,0.0009870026,0.0009511309,0.0009312269,0.0021832627,0.0032658037,0.0018645533,0.012462751],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051026244,0.0026581644,0.014371977,0.0014807998,0.00004327855,0.0017108064,0.01321751,0.0028847416,0.013231629,0.0054259836,0.16904779,0.775417],"study_design_scores_gemma":[0.00035678197,0.002230419,0.02961906,0.0032528166,0.00012375634,0.0055845873,0.007995502,0.008804375,0.030472992,0.008414834,0.90281445,0.00033050164],"about_ca_topic_score_codex":0.0009937836,"about_ca_topic_score_gemma":0.002252519,"teacher_disagreement_score":0.015495928,"about_ca_system_score_codex":0.0016536154,"about_ca_system_score_gemma":0.0068776486,"threshold_uncertainty_score":0.07937014},"labels":[],"label_agreement":null},{"id":"W2147340368","doi":"10.1177/1078155211431858","title":"Telepharmacy in a rural Alberta Community Cancer Network","year":2012,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; Alberta Health Services","funders":"","keywords":"Medicine; Telehealth; Pharmacy; Pharmacist; Certification; Pharmacy technician; Family medicine; Cancer; Medical emergency; Clinical pharmacy; Nursing; Telemedicine; Health care; Internal medicine","score_opus":0.07793116137621099,"score_gpt":0.47447789060052686,"score_spread":0.3965467292243159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147340368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98468655,0.00029607082,0.00029241477,0.0023056073,0.000040045597,0.00019031276,0.00018329693,0.0000564221,0.011949254],"genre_scores_gemma":[0.9890315,0.00042257324,0.0007450454,0.0010828107,0.000041385905,0.000083029736,0.0003191442,0.00001298671,0.008261597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926347,0.00013665005,0.000009845657,0.00006172354,0.00017491516,0.00035342897],"domain_scores_gemma":[0.9981407,0.0002001946,0.00013298575,0.00005276491,0.00027191074,0.0012013832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051873666,0.00017858249,0.00010539419,0.0004290465,0.004034014,0.001121655,0.0009845579,0.0005631346,0.0052513382],"category_scores_gemma":[0.0013957815,0.00024892547,0.000115057395,0.0009934447,0.00075193023,0.00032770552,0.0012275997,0.0006141692,0.00039400335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012470739,0.0031839514,0.7201395,0.00023427521,0.000055922355,0.022058047,0.012173683,0.0034530002,0.0036887627,0.0027763702,0.041827373,0.18916202],"study_design_scores_gemma":[0.00068853406,0.0027386073,0.84788895,0.0001521059,0.000096543044,0.009598717,0.046643786,0.0116219055,0.0011868709,0.0010940642,0.07821127,0.00007865139],"about_ca_topic_score_codex":0.67679,"about_ca_topic_score_gemma":0.85233,"teacher_disagreement_score":0.32321,"about_ca_system_score_codex":0.010594173,"about_ca_system_score_gemma":0.01867414,"threshold_uncertainty_score":0.6502269},"labels":[],"label_agreement":null},{"id":"W2148022235","doi":"10.1177/107815520000600201","title":"The cost of blood transfusions in cancer patients: a reanalysis of a Canadian economic evaluation","year":2000,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Blood transfusion and management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"Canadian Blood Services","keywords":"Medicine; Activity-based costing; Blood transfusion; Pharmacoeconomics; Cancer; Intensive care medicine; Intensive care unit; Anemia; Indirect costs; Emergency medicine; Cost driver; Unit cost; Blood supply; Medical emergency; Surgery; Internal medicine","score_opus":0.05225483039074251,"score_gpt":0.41695355061708533,"score_spread":0.3646987202263428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148022235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6143193,0.08956862,0.0058546956,0.011427908,0.0005249935,0.004012902,0.2349303,0.0002570824,0.039104164],"genre_scores_gemma":[0.9096357,0.025175352,0.0072435657,0.00093834085,0.00010132825,0.0012348664,0.051349193,0.00007156567,0.004250075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9905537,0.001805128,0.00064681954,0.0004397473,0.005696033,0.0008585973],"domain_scores_gemma":[0.9846246,0.0037762374,0.0011959464,0.00044515316,0.009488711,0.00046927013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006090697,0.0013187765,0.0021639862,0.011275851,0.001223535,0.0041800737,0.0017788877,0.00071451475,0.0020845693],"category_scores_gemma":[0.02816145,0.00078233756,0.006173618,0.024837501,0.0004939564,0.0007705824,0.0009333779,0.0014480257,0.00016779172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006127308,0.0005262804,0.3426879,0.016049735,0.029464854,0.0014856275,0.0011591952,0.2738939,0.0007645291,0.019899208,0.10852778,0.19941375],"study_design_scores_gemma":[0.0018551003,0.0005813382,0.7785746,0.0031769758,0.0132302,0.0006301253,0.0014272225,0.13657552,0.0006135238,0.003055351,0.059808034,0.0004719859],"about_ca_topic_score_codex":0.9768454,"about_ca_topic_score_gemma":0.9603501,"teacher_disagreement_score":0.89628625,"about_ca_system_score_codex":0.10371378,"about_ca_system_score_gemma":0.07098295,"threshold_uncertainty_score":0.7524997},"labels":[],"label_agreement":null},{"id":"W2148274830","doi":"10.1177/1078155213520261","title":"Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia","year":2014,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; Foothills Medical Centre","funders":"","keywords":"Nilotinib; Medicine; Dasatinib; Myeloid leukemia; Imatinib; Chronic myeloid leukaemia; Tyrosine-kinase inhibitor; Internal medicine; Imatinib mesylate; Pharmacology; Oncology; Cancer","score_opus":0.05700371716467508,"score_gpt":0.4052629115430166,"score_spread":0.3482591943783415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148274830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988789,0.00040973455,0.000028036764,0.000057960482,0.000005095488,0.000012375514,0.0002601873,0.0000018989637,0.00034572658],"genre_scores_gemma":[0.9995011,0.00018178679,0.000037906215,0.000044666183,0.000007467003,0.000009222804,0.00015427177,4.0582506e-7,0.000063172294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992569,0.00016116846,0.00016708471,0.00011070071,0.00021985588,0.00008421079],"domain_scores_gemma":[0.99826425,0.00027043917,0.0011554225,0.000048001675,0.00011565309,0.00014626488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006888165,0.00012572367,0.00033595445,0.0006195032,0.00034225624,0.00041395845,0.00019339842,0.00041301342,0.0012278669],"category_scores_gemma":[0.002886479,0.00018969589,0.00036687902,0.0009901904,0.000143348,0.00033328417,0.00023605074,0.0004770133,0.00010489448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003512251,0.000036945614,0.9983608,0.000011660151,0.000027488268,0.000024426758,0.000055359054,0.000009247836,0.000044611224,0.000004144424,0.000055089928,0.0013350886],"study_design_scores_gemma":[0.0000050875574,0.00009893824,0.99952173,0.000011590445,0.000015578811,0.00010778646,0.00008764113,0.00007053461,0.000015998186,0.000004605276,0.000059083624,0.0000013492144],"about_ca_topic_score_codex":0.004589204,"about_ca_topic_score_gemma":0.00586424,"teacher_disagreement_score":0.004589204,"about_ca_system_score_codex":0.0002615317,"about_ca_system_score_gemma":0.00025634642,"threshold_uncertainty_score":0.009124994},"labels":[],"label_agreement":null},{"id":"W2148493940","doi":"10.1177/1078155208098584","title":"Economic analysis of albumin-bound paclitaxel for the treatment of metastatic breast cancer","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; Princess Margaret Cancer Centre","funders":"","keywords":"Docetaxel; Medicine; Paclitaxel; Metastatic breast cancer; Oncology; Breast cancer; Internal medicine; Chemotherapy; Toxicity; Nab-paclitaxel; Cancer","score_opus":0.1128865310209775,"score_gpt":0.4903383100464727,"score_spread":0.3774517790254952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148493940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.820865,0.10485138,0.026645033,0.009858526,0.00031257866,0.003385664,0.003982654,0.00007077302,0.03002846],"genre_scores_gemma":[0.98478794,0.008463404,0.004235209,0.0004104942,0.00006700794,0.0005712907,0.00069230085,0.00001115991,0.00076119584],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9891885,0.009361255,0.00021624946,0.00014656053,0.0008103476,0.0002771074],"domain_scores_gemma":[0.9768289,0.020602217,0.0011825056,0.0001622806,0.0008073295,0.00041676033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014114517,0.00071808556,0.0013173097,0.0019282372,0.0002794469,0.0015057693,0.00074478023,0.00074103544,0.0036006267],"category_scores_gemma":[0.03855071,0.00030062094,0.0026353726,0.0020240652,0.00041639863,0.00076559355,0.00056089595,0.001217757,0.000114943236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04226703,0.0021369138,0.060267545,0.011499086,0.019787537,0.0009768433,0.00038357158,0.57595694,0.001132584,0.028532252,0.011513783,0.24554598],"study_design_scores_gemma":[0.009822994,0.01113572,0.06995782,0.004168041,0.020085819,0.0012408915,0.0011026527,0.80988216,0.0018799566,0.041368615,0.029129228,0.00022616521],"about_ca_topic_score_codex":0.014037811,"about_ca_topic_score_gemma":0.009400881,"teacher_disagreement_score":0.014114517,"about_ca_system_score_codex":0.008696207,"about_ca_system_score_gemma":0.005008416,"threshold_uncertainty_score":0.07464558},"labels":[],"label_agreement":null},{"id":"W2150180063","doi":"10.1191/1078155202jp095oa","title":"Standardization of body surface area calculations","year":2002,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Body surface area; Medicine; Pharmacy; Dosing; Standardization; Medical physics; Family medicine; Surgery; Pharmacology; Computer science","score_opus":0.15201721680733796,"score_gpt":0.5117210028426117,"score_spread":0.35970378603527375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150180063","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09011075,0.04950992,0.755183,0.004960107,0.0052239047,0.004817037,0.008958906,0.0061415047,0.07509482],"genre_scores_gemma":[0.2488507,0.015025969,0.71758336,0.0010811356,0.00088793645,0.0026076906,0.006876767,0.0013884247,0.0056980127],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9621954,0.01426972,0.007280354,0.002644071,0.013289309,0.00032113452],"domain_scores_gemma":[0.9512772,0.0138184,0.0059194593,0.008077234,0.020571867,0.00033583355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033459157,0.0012075182,0.0017148212,0.0070619495,0.000756106,0.0025563878,0.0028635347,0.0006816176,0.0031848592],"category_scores_gemma":[0.07661894,0.00055968907,0.0013714547,0.0054770038,0.0012096991,0.0017579752,0.0016060706,0.0013941693,0.0027624601],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036350853,0.00010170013,0.10126407,0.0022840006,0.0003491063,0.00015554414,0.00081281114,0.0039675445,0.0043482734,0.0113400025,0.035617806,0.83939564],"study_design_scores_gemma":[0.00020357374,0.0010064535,0.30097166,0.0048245364,0.00076950825,0.004032164,0.0012587139,0.03002893,0.02680011,0.01600819,0.613795,0.00030122825],"about_ca_topic_score_codex":0.0029583105,"about_ca_topic_score_gemma":0.0027321344,"teacher_disagreement_score":0.033459157,"about_ca_system_score_codex":0.0016125806,"about_ca_system_score_gemma":0.0024415303,"threshold_uncertainty_score":0.17695105},"labels":[],"label_agreement":null},{"id":"W2151289323","doi":"10.1177/1078155208088695","title":"Verification of imatinib cost-effectiveness in advanced gastrointestinal stromal tumor in British Columbia (VINCE-BC study)","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"BC Cancer Agency; Michael Smith Health Research BC","keywords":"Medicine; Imatinib; GiST; Stromal tumor; Imatinib mesylate; Internal medicine; Oncology; Stromal cell; General surgery; Intensive care medicine","score_opus":0.07987342428515348,"score_gpt":0.43006699291198847,"score_spread":0.350193568626835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151289323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95542973,0.024168702,0.0003858744,0.00089732604,0.000025222665,0.0007638846,0.011274026,0.000010373151,0.0070449496],"genre_scores_gemma":[0.99165666,0.0031632888,0.000523994,0.00018575852,0.0000113247,0.00019372854,0.0036403765,0.0000036535298,0.00062123634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859196,0.0006896712,0.00011187815,0.0001051782,0.00037883894,0.00012246979],"domain_scores_gemma":[0.9980205,0.0008393629,0.00044252494,0.00008903198,0.0004379976,0.00017052186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029060773,0.00024310256,0.0004702503,0.0008412801,0.0002335991,0.0008918947,0.0005161328,0.00033293708,0.0015625487],"category_scores_gemma":[0.0059197843,0.00015915377,0.00064245705,0.0013670718,0.00022199115,0.00019920213,0.00034195473,0.00032351946,0.00007801225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032805663,0.00048018937,0.74353343,0.0088409,0.011802316,0.0007106207,0.0003338319,0.015898747,0.0029938512,0.0023509646,0.014031099,0.16621844],"study_design_scores_gemma":[0.0052681128,0.0020896755,0.95937973,0.002120402,0.0062139938,0.00079397013,0.0003310355,0.006962622,0.0009207817,0.00048754681,0.015363963,0.000068197136],"about_ca_topic_score_codex":0.30192474,"about_ca_topic_score_gemma":0.43477964,"teacher_disagreement_score":0.6980753,"about_ca_system_score_codex":0.006591792,"about_ca_system_score_gemma":0.0050389217,"threshold_uncertainty_score":0.60033464},"labels":[],"label_agreement":null},{"id":"W2151481343","doi":"10.1191/1078155204jp135cr","title":"Quercetin/bromelain use associated with increased liver enzymes","year":2004,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pineapple and bromelain studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Medicine; Bromelain; Adverse effect; Alternative medicine; Intensive care medicine; Liver enzyme; Traditional medicine; Pharmacology; Internal medicine; Enzyme; Pathology","score_opus":0.03548960805135392,"score_gpt":0.3431028845520222,"score_spread":0.3076132765006683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151481343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99275744,0.0020230897,0.0006280684,0.0007929476,0.00003249789,0.00003771252,0.000043799555,0.000041128496,0.0036433227],"genre_scores_gemma":[0.99901295,0.00034251413,0.00011905664,0.00015156642,0.00003640311,0.000002199798,0.000018641555,0.0000021054213,0.0003145442],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996767,0.00008530584,0.000042060805,0.000059734128,0.00007571501,0.000060557108],"domain_scores_gemma":[0.9989562,0.0003785711,0.00037447404,0.000056456145,0.000066007065,0.000168305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022577512,0.00044674508,0.00038292838,0.00076688454,0.0005829567,0.0003314451,0.000263827,0.0009339801,0.0021077592],"category_scores_gemma":[0.0013697245,0.00026933145,0.00043779533,0.00044643835,0.0005469392,0.00038296543,0.00024998432,0.0010827462,0.00020156919],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012961252,0.00046546815,0.26060298,0.00019221523,0.000119775825,0.693855,0.00047603456,0.00017183064,0.027763084,0.00023748161,0.00067168643,0.014148245],"study_design_scores_gemma":[0.000081829356,0.00184294,0.27582955,0.00003264288,0.0001682039,0.7108964,0.000381242,0.0005202216,0.007988839,0.00021233037,0.0020181448,0.000027737915],"about_ca_topic_score_codex":0.002607857,"about_ca_topic_score_gemma":0.0026832295,"teacher_disagreement_score":0.002607857,"about_ca_system_score_codex":0.00040084487,"about_ca_system_score_gemma":0.00027689108,"threshold_uncertainty_score":0.00705117},"labels":[],"label_agreement":null},{"id":"W2151593637","doi":"10.1177/1078155211434852","title":"The oncology pharmacy in cancer care delivery in a resource-constrained setting in western Kenya","year":2012,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Eli Lilly and Company","keywords":"Medicine; Pharmacy; Multidisciplinary approach; Health care; Cancer; Resource (disambiguation); Oncology; Intensive care medicine; Family medicine; Nursing; Internal medicine; Economic growth","score_opus":0.09835412392973755,"score_gpt":0.5221202188851748,"score_spread":0.42376609495543727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151593637","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95560604,0.0024707455,0.00033572075,0.027563127,0.00014895955,0.00017395716,0.000023425164,0.000010730029,0.013667206],"genre_scores_gemma":[0.9860838,0.0037110953,0.00087399624,0.0046006804,0.000053810003,0.000046077035,0.000014078805,0.000011350396,0.0046049976],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9976574,0.0012865652,0.00008652698,0.00011283718,0.00019840329,0.00065820076],"domain_scores_gemma":[0.9960389,0.0006430612,0.00068723987,0.000048192025,0.00025204863,0.002330532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018050814,0.00025531172,0.0002117016,0.0003938982,0.014247384,0.003176097,0.00090953166,0.0018196054,0.005727446],"category_scores_gemma":[0.0037946845,0.00048399577,0.00014471258,0.0007296399,0.004251463,0.0029293573,0.0046424586,0.003015269,0.0004898807],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030427144,0.0018181679,0.14733624,0.0012328213,0.000032534022,0.044384602,0.6872796,0.00036041116,0.0057482403,0.011429256,0.01775322,0.08232062],"study_design_scores_gemma":[0.000062089086,0.00090199587,0.054152433,0.00083924615,0.000019650995,0.008957211,0.84723085,0.00024536342,0.00060028146,0.00087021163,0.086039014,0.00008167841],"about_ca_topic_score_codex":0.045482192,"about_ca_topic_score_gemma":0.15501076,"teacher_disagreement_score":0.045482192,"about_ca_system_score_codex":0.0063967104,"about_ca_system_score_gemma":0.01655198,"threshold_uncertainty_score":0.09043491},"labels":[],"label_agreement":null},{"id":"W2157527150","doi":"10.1177/1078155208097634","title":"Oncology medication safety: A 3D status report 2008","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Pharmacy; Family medicine; Vincristine; Best practice; Internal medicine; Chemotherapy","score_opus":0.1261452344844468,"score_gpt":0.5311838587467712,"score_spread":0.4050386242623244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157527150","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08198801,0.013367178,0.004929569,0.09385141,0.0154808685,0.0075942003,0.28844285,0.0031803707,0.49116558],"genre_scores_gemma":[0.17789106,0.036145184,0.01314196,0.038002163,0.0109274965,0.010028314,0.30262232,0.0005617748,0.41067967],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966569,0.00028741005,0.0004888501,0.00016832823,0.0021481672,0.00025023826],"domain_scores_gemma":[0.9903492,0.0009952482,0.0019740392,0.00036779596,0.00531034,0.0010034684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003669382,0.0005394223,0.0003652676,0.003826773,0.0007718777,0.002217936,0.00082896574,0.002018643,0.027400319],"category_scores_gemma":[0.0070466353,0.00035086434,0.00067226024,0.0032264919,0.000219687,0.0009850336,0.0013772761,0.0012373462,0.01877809],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013186483,0.0005522194,0.033062767,0.0007442456,0.000028179373,0.00016358997,0.00017780943,0.00013525815,0.00056942715,0.0004097899,0.83530015,0.12872463],"study_design_scores_gemma":[0.00007800808,0.00032814732,0.14214827,0.00077386736,0.000037282196,0.00029717255,0.00029723832,0.00031962484,0.00075836113,0.00014796543,0.8547877,0.000026249067],"about_ca_topic_score_codex":0.008887318,"about_ca_topic_score_gemma":0.00964978,"teacher_disagreement_score":0.027400319,"about_ca_system_score_codex":0.0019814095,"about_ca_system_score_gemma":0.0037671798,"threshold_uncertainty_score":0.09166318},"labels":[],"label_agreement":null},{"id":"W2158556490","doi":"10.1177/1078155206074045","title":"The oncology impact of highly active antiretroviral therapy","year":2007,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Hip and Knee Clinic; Alberta Cancer Foundation; University of Saskatchewan","funders":"","keywords":"Medicine; Chemotherapy; Incidence (geometry); Cancer; Internal medicine; Pharmacy; Population; Human immunodeficiency virus (HIV); Oncology; Antiretroviral therapy; Intensive care medicine; Viral load; Immunology; Family medicine; Environmental health","score_opus":0.04294212985874755,"score_gpt":0.4620958465046519,"score_spread":0.41915371664590434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158556490","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83999866,0.05943234,0.0005725144,0.018178543,0.00022586173,0.00012219633,0.0033791189,0.000026313613,0.07806433],"genre_scores_gemma":[0.98744535,0.008805356,0.00034816423,0.0010912857,0.00018946338,0.000010864408,0.0004898045,0.00000567481,0.0016139775],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981141,0.00079310837,0.000081414284,0.00005722281,0.0007788925,0.00017530429],"domain_scores_gemma":[0.9964018,0.0013015664,0.0012173365,0.00005894685,0.0005933424,0.00042703323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010044933,0.00015102062,0.00016254674,0.00046317143,0.00029943444,0.001202646,0.00029619253,0.0002375236,0.004500003],"category_scores_gemma":[0.0070395023,0.000067238594,0.0002527553,0.0010430908,0.00034482032,0.00036759602,0.0005366476,0.00046501975,0.0002422236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009173339,0.00051221816,0.74364775,0.00071018486,0.00050187146,0.0007017925,0.000156158,0.0037786437,0.0006786219,0.0030062762,0.008228085,0.23716098],"study_design_scores_gemma":[0.000048038644,0.0004314783,0.9744974,0.0002899553,0.00022772464,0.0008765232,0.0002235538,0.00092226855,0.00027489854,0.00062558264,0.0215745,0.000008213663],"about_ca_topic_score_codex":0.031870395,"about_ca_topic_score_gemma":0.06462352,"teacher_disagreement_score":0.031870395,"about_ca_system_score_codex":0.0028720568,"about_ca_system_score_gemma":0.0027964117,"threshold_uncertainty_score":0.06336975},"labels":[],"label_agreement":null},{"id":"W2158888632","doi":"10.1177/1078155206069163","title":"Acute reactions to chemotherapy agents","year":2006,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Medicine; Chemotherapy; Drug reaction; Cancer chemotherapy; Intensive care medicine; Hypersensitivity reaction; Pharmacology; Drug; Internal medicine","score_opus":0.29334632879909167,"score_gpt":0.6308276500863238,"score_spread":0.3374813212872321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158888632","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013052397,0.99157786,0.0005216019,0.00042422276,0.00031968005,0.000081057806,0.000060113325,0.00003883393,0.0056713386],"genre_scores_gemma":[0.011497416,0.98250383,0.00059886405,0.0011660072,0.00046576056,0.00007753284,0.00011371771,0.0000072308985,0.0035696207],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984982,0.00041226673,0.00023849057,0.00012542377,0.0005915682,0.00013398204],"domain_scores_gemma":[0.9978033,0.0008711438,0.00083677314,0.000056633722,0.0003412374,0.00009092208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009961881,0.001098483,0.0019359398,0.0011247713,0.00038428273,0.0009693663,0.0008034548,0.0012786442,0.0059603173],"category_scores_gemma":[0.0027586638,0.0003170188,0.0011804457,0.0013945723,0.0004719709,0.0008306203,0.00074939214,0.0014588847,0.0022370333],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029028443,0.00021513349,0.0022340526,0.024171807,0.0003230024,0.002275831,0.00015753032,0.0003194399,0.0044763456,0.0012857195,0.047400344,0.9168505],"study_design_scores_gemma":[0.0003004156,0.00088185375,0.01190287,0.014021945,0.0006221183,0.027145892,0.0002398779,0.00019505677,0.0053782603,0.0018581417,0.93740684,0.00004668304],"about_ca_topic_score_codex":0.00089576066,"about_ca_topic_score_gemma":0.0015652701,"teacher_disagreement_score":0.0059603173,"about_ca_system_score_codex":0.00049080426,"about_ca_system_score_gemma":0.00068770204,"threshold_uncertainty_score":0.019939244},"labels":[],"label_agreement":null},{"id":"W2159160631","doi":"10.1177/1078155213503591","title":"Administration of budesonide in children with graft-versus-host disease","year":2013,"lang":"en","type":"editorial","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Budesonide; Graft-versus-host disease; Host (biology); Administration (probate law); Disease; Internal medicine; Intensive care medicine; Corticosteroid","score_opus":0.0254638218905697,"score_gpt":0.3944965902531243,"score_spread":0.3690327683625546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159160631","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003576163,0.027484328,0.00031919987,0.06670215,0.9025568,0.000022437718,0.000065821325,0.00006108634,0.002430664],"genre_scores_gemma":[0.0027778803,0.015403452,0.00022962077,0.025773402,0.9527367,0.000021055206,0.000030360787,0.000021886099,0.0030056867],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972351,0.0006054419,0.00059283257,0.00026006947,0.0011205121,0.00018599414],"domain_scores_gemma":[0.9884327,0.006009463,0.0011025931,0.00021416071,0.0029768154,0.0012643064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042565325,0.002265267,0.0037273655,0.0018831885,0.0015887975,0.003680334,0.0027040127,0.012063238,0.0020861807],"category_scores_gemma":[0.018748023,0.00095291284,0.0022086557,0.0010910919,0.0016039875,0.0017962509,0.0005871117,0.017920148,0.0016303974],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022216648,0.000050840616,0.00031725093,0.0009435103,0.0001495184,0.0015547781,0.000032012493,0.00014298517,0.00018054171,0.00041392638,0.973724,0.022268487],"study_design_scores_gemma":[0.00043596988,0.00021069341,0.0029620572,0.0019551106,0.0006889121,0.004331797,0.00011099841,0.00072695577,0.00068452815,0.0006103632,0.9872292,0.000053392992],"about_ca_topic_score_codex":0.0031607733,"about_ca_topic_score_gemma":0.007318963,"teacher_disagreement_score":0.012063238,"about_ca_system_score_codex":0.0034946848,"about_ca_system_score_gemma":0.0027902646,"threshold_uncertainty_score":0.025355816},"labels":[],"label_agreement":null},{"id":"W2161866421","doi":"10.1177/1078155206072982","title":"Laboratory monitoring in oncology","year":2006,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Cardiotoxicity; Pharmacy; Intensive care medicine; Oncology; Cancer; Pharmacist; Internal medicine; MEDLINE; Cancer chemotherapy; Pharmacotherapy; Chemotherapy; Toxicity; Family medicine","score_opus":0.23903834207829994,"score_gpt":0.6166432076090078,"score_spread":0.3776048655307079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161866421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001546341,0.99801123,0.0001648577,0.00046218626,0.00014657239,0.000008308113,0.00000693924,0.00000978249,0.0010353912],"genre_scores_gemma":[0.0029952251,0.995119,0.00051138486,0.0004924615,0.000358843,0.000019738869,0.000023944882,0.0000019028313,0.00047758297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99826175,0.0006232344,0.00026918176,0.00017175007,0.00060736714,0.00006676176],"domain_scores_gemma":[0.99529546,0.0026365193,0.00092927075,0.000081144586,0.0009380389,0.0001195982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022286728,0.00102008,0.0016795109,0.0031123932,0.00028571073,0.0011430036,0.0009951115,0.0018717741,0.0041347435],"category_scores_gemma":[0.0056032063,0.00033270862,0.00069256016,0.003996142,0.0006546133,0.0016549306,0.00069990725,0.001560494,0.0019053139],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000755902,0.000094340816,0.0009387802,0.023278456,0.00010324706,0.00027727618,0.000093036164,0.0001388414,0.00046135596,0.0007358781,0.015970469,0.9578327],"study_design_scores_gemma":[0.00018367355,0.0005151929,0.015499741,0.053678893,0.00064218964,0.013286343,0.00046542723,0.00032734452,0.0015304165,0.0035797204,0.9102314,0.000059763457],"about_ca_topic_score_codex":0.0021086761,"about_ca_topic_score_gemma":0.0025897708,"teacher_disagreement_score":0.0041347435,"about_ca_system_score_codex":0.0009188123,"about_ca_system_score_gemma":0.0024885365,"threshold_uncertainty_score":0.013832092},"labels":[],"label_agreement":null},{"id":"W2164740567","doi":"10.1177/1078155213496675","title":"Hazards in determining whether a drug is hazardous","year":2013,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Hazardous waste; Formulary; Medicine; Scope (computer science); Risk analysis (engineering); Occupational safety and health; Environmental health; Pharmacology; Engineering; Computer science","score_opus":0.07286304680203594,"score_gpt":0.49734782216446694,"score_spread":0.424484775362431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164740567","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15689917,0.45255294,0.16558374,0.07627208,0.00841593,0.0035391978,0.0021277424,0.0003076193,0.13430174],"genre_scores_gemma":[0.69788563,0.123744614,0.14935824,0.017522158,0.0034544773,0.0014748276,0.00061001204,0.0000833753,0.005866728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9133464,0.041993257,0.019675782,0.0020638919,0.021864269,0.0010563689],"domain_scores_gemma":[0.7051594,0.2285056,0.029774329,0.0066087097,0.02872846,0.00122345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.069691055,0.00052271783,0.0007219177,0.008933263,0.001567647,0.0039539835,0.0014339677,0.0018306953,0.0024159614],"category_scores_gemma":[0.12724587,0.00060031353,0.0016694353,0.005480987,0.0048495294,0.00555187,0.0044201743,0.0027837192,0.0006043668],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072339416,0.0001817107,0.162219,0.019055868,0.0006657822,0.002292784,0.0093341945,0.0022446762,0.0052911225,0.078779094,0.011982554,0.7072298],"study_design_scores_gemma":[0.00014822932,0.0018014581,0.19190158,0.05602242,0.0024167886,0.011902568,0.020354588,0.0047415947,0.02173365,0.13794559,0.55062306,0.0004085057],"about_ca_topic_score_codex":0.004853567,"about_ca_topic_score_gemma":0.010638604,"teacher_disagreement_score":0.069691055,"about_ca_system_score_codex":0.003567233,"about_ca_system_score_gemma":0.007033066,"threshold_uncertainty_score":0.36856592},"labels":[],"label_agreement":null},{"id":"W2165391596","doi":"10.1191/1078155205jp165oa","title":"Management of extravasation of oxaliplatin","year":2005,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Sanofi","keywords":"Medicine; Oxaliplatin; Extravasation; Intensive care medicine; Pharmacology; Oncology; Internal medicine; Cancer; Colorectal cancer; Pathology","score_opus":0.13657433855565457,"score_gpt":0.5212253246911213,"score_spread":0.38465098613546667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165391596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007624075,0.9961267,0.000447146,0.0003648777,0.00015727701,0.000015058147,0.000010699874,0.000017975193,0.0020978325],"genre_scores_gemma":[0.005102871,0.992753,0.0006049243,0.00026102425,0.00015506468,0.000014511329,0.000026718357,0.0000030372553,0.0010788323],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997389,0.00006577345,0.00003864413,0.000028425267,0.00010735116,0.000020975174],"domain_scores_gemma":[0.9998004,0.000075750235,0.000053581833,0.000008517059,0.00004572471,0.000015927706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040503056,0.00067125034,0.0014316386,0.0022630512,0.00027868143,0.0005675415,0.0008457703,0.0008930247,0.002428987],"category_scores_gemma":[0.00070855906,0.00019688687,0.0005909005,0.0012874526,0.0003065793,0.0008076956,0.00047953645,0.0011880661,0.0013766912],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007946347,0.00010418356,0.0003434923,0.011537839,0.00012849527,0.0014956754,0.000060898237,0.00034881965,0.0018782304,0.00072638097,0.014422609,0.9688739],"study_design_scores_gemma":[0.0001332809,0.00043518635,0.005743049,0.009078067,0.00036777864,0.036477596,0.00021289964,0.0005732693,0.004682292,0.0022101093,0.94004434,0.000042084095],"about_ca_topic_score_codex":0.00085694116,"about_ca_topic_score_gemma":0.0017305228,"teacher_disagreement_score":0.002428987,"about_ca_system_score_codex":0.0005031224,"about_ca_system_score_gemma":0.0004715698,"threshold_uncertainty_score":0.008125722},"labels":[],"label_agreement":null},{"id":"W2166370227","doi":"10.1191/1078155205jp155oa","title":"Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature","year":2005,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"","keywords":"Medicine; Odds ratio; Meta-analysis; Confidence interval; CINAHL; MEDLINE; Cochrane Library; Cancer; Relative risk; Health care; Epidemiology; Internal medicine; Intensive care medicine; Psychological intervention; Psychiatry","score_opus":0.14696912199608408,"score_gpt":0.5418271636651654,"score_spread":0.3948580416690813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166370227","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006368185,0.9914751,0.0007405909,0.0003687762,0.00022351969,0.00031422373,0.00028480083,0.000019918938,0.00020482273],"genre_scores_gemma":[0.19371435,0.7985178,0.003389783,0.0012709892,0.0004362693,0.0018631978,0.0005696629,0.000023775521,0.00021416813],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96899563,0.019934941,0.0058247033,0.0020727008,0.002611438,0.0005604843],"domain_scores_gemma":[0.934567,0.05192647,0.008789474,0.0014268019,0.0027709662,0.0005191986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02668617,0.0032377432,0.021815656,0.009698923,0.00076360954,0.0035116037,0.0024093438,0.0038582217,0.0024629426],"category_scores_gemma":[0.09129674,0.0026281232,0.04304051,0.00954362,0.0011011977,0.0019675451,0.0016774334,0.0023065107,0.0002612653],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018565679,0.000028316044,0.0068593817,0.2556943,0.7249386,0.00017994356,0.000102020764,0.00037263663,0.000107472864,0.0001040252,0.00044121544,0.009315507],"study_design_scores_gemma":[0.0005809473,0.00025089143,0.004041205,0.020549303,0.973334,0.00014044666,0.000056210312,0.00012637289,0.00008096014,0.00015513417,0.0006661588,0.000018317376],"about_ca_topic_score_codex":0.008081175,"about_ca_topic_score_gemma":0.011675494,"teacher_disagreement_score":0.02668617,"about_ca_system_score_codex":0.003687937,"about_ca_system_score_gemma":0.0047578095,"threshold_uncertainty_score":0.1411317},"labels":[],"label_agreement":null},{"id":"W2167283073","doi":"10.1177/1078155208096904","title":"Evaluation of surface contamination in a hospital hematology—oncology pharmacy","year":2008,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Pharmacy; Hematology; Internal medicine; Contamination; Clinical Oncology; Oncology; Intensive care medicine; Cancer; Family medicine","score_opus":0.1750958365335434,"score_gpt":0.5471299552066452,"score_spread":0.37203411867310177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167283073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986185,0.000123476,0.00035252952,0.000030870797,0.0000029273979,0.000033977376,0.000071332106,0.00000974964,0.00075646985],"genre_scores_gemma":[0.9984432,0.00016328625,0.00079654565,0.000038464783,0.000009828056,0.000015992115,0.000108728214,0.0000050499343,0.00041881963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986609,0.00035623883,0.00009274161,0.00016599841,0.0005221955,0.00020195234],"domain_scores_gemma":[0.9978313,0.00034322156,0.0011483218,0.00008392513,0.00039889725,0.00019438492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005145219,0.00029830038,0.00024973633,0.00087433774,0.00067151646,0.0009289038,0.00043746157,0.00041370638,0.0019169782],"category_scores_gemma":[0.0022405963,0.00018869468,0.00024847494,0.00091234077,0.0006710207,0.00042241946,0.0011493027,0.00035211336,0.00032343587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062980485,0.00030016538,0.9517815,0.00016726217,0.000047108595,0.0017972469,0.0024035878,0.00024565464,0.022196148,0.00005286156,0.00017671798,0.020201925],"study_design_scores_gemma":[0.000008438178,0.002190239,0.9791565,0.000029476807,0.000029975341,0.0024669452,0.005382544,0.00025737713,0.008967258,0.00003525443,0.0014586465,0.000017410433],"about_ca_topic_score_codex":0.0035379922,"about_ca_topic_score_gemma":0.0035957494,"teacher_disagreement_score":0.0035379922,"about_ca_system_score_codex":0.00077275245,"about_ca_system_score_gemma":0.00087675167,"threshold_uncertainty_score":0.0070347786},"labels":[],"label_agreement":null},{"id":"W2168718641","doi":"10.1177/1078155206069161","title":"Re-evaluation of the cost effectiveness of temozolomide for malignant gliomas in British Columbia","year":2006,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"BC Cancer Agency","keywords":"Temozolomide; Medicine; Oncology; Glioblastoma; Glioma; Internal medicine; Intensive care medicine; Cancer research","score_opus":0.06406174344425247,"score_gpt":0.4230406319521479,"score_spread":0.35897888850789544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168718641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98556083,0.008216966,0.000118452735,0.0012294127,0.000024112202,0.000070297676,0.0013854967,0.000011312678,0.003383109],"genre_scores_gemma":[0.9955332,0.002439469,0.00020805359,0.00018898761,0.000016748108,0.00003114965,0.0007920367,0.0000050872923,0.00078531716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859375,0.00048576653,0.00013691474,0.00009004222,0.00051040517,0.00018305288],"domain_scores_gemma":[0.9963335,0.0011763608,0.0007958874,0.000104170955,0.0013521443,0.00023801255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018342983,0.00030388465,0.00060572027,0.0014624922,0.0003795139,0.0013099781,0.00081104477,0.00041249522,0.0014587999],"category_scores_gemma":[0.010318945,0.00018411415,0.0005589627,0.002310139,0.0002608474,0.0003350194,0.00044560796,0.00042406318,0.00009503526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009372752,0.00033150965,0.7915407,0.001703684,0.0020037533,0.00105413,0.00039132434,0.00858289,0.0014525749,0.0004771343,0.0052874475,0.17780223],"study_design_scores_gemma":[0.00052616524,0.00083752046,0.98366505,0.00057415,0.0011661752,0.0005665082,0.0006899654,0.006161071,0.0008956767,0.000085896165,0.0047915727,0.00004035936],"about_ca_topic_score_codex":0.7199814,"about_ca_topic_score_gemma":0.78205365,"teacher_disagreement_score":0.28001863,"about_ca_system_score_codex":0.016272377,"about_ca_system_score_gemma":0.009913992,"threshold_uncertainty_score":0.5633354},"labels":[],"label_agreement":null},{"id":"W2335967795","doi":"10.1177/1078155216637218","title":"Ibrutinib-associated tumor lysis syndrome in a patient with mantle cell lymphoma: A case report","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Mantle cell lymphoma; Ibrutinib; Tumor lysis syndrome; Medicine; Lymphoma; Cancer research; Oncology; Internal medicine; Pathology; Leukemia; Chemotherapy; Chronic lymphocytic leukemia","score_opus":0.023043965985297944,"score_gpt":0.3389743104693426,"score_spread":0.31593034448404467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335967795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713073,0.007559993,0.003938064,0.0060782237,0.0005753638,0.0002485076,0.00034430588,0.00032207495,0.009626249],"genre_scores_gemma":[0.9942948,0.0014403487,0.0011555582,0.0010858633,0.0006874101,0.000027936456,0.00010009582,0.000028158893,0.0011797461],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992649,0.00008047662,0.00008239317,0.00021501629,0.00010257261,0.0002546048],"domain_scores_gemma":[0.99861145,0.00029442686,0.0002846328,0.00010790233,0.00008933959,0.00061222573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034646908,0.002097088,0.0015744464,0.0026536905,0.002743576,0.0019653637,0.0017240463,0.0054442226,0.0020669724],"category_scores_gemma":[0.0024328295,0.0013298392,0.0017209321,0.0019375337,0.0017488286,0.002434639,0.001774501,0.0042957314,0.0010593387],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002461778,0.000046394853,0.0033572104,0.000020836369,0.000010115419,0.99498487,0.00012121862,0.00005150543,0.00040481557,0.00008633767,0.00022678931,0.00066529564],"study_design_scores_gemma":[0.000011977631,0.000066614615,0.0031862936,0.000010408341,0.000016747003,0.99579775,0.00009197158,0.00022642566,0.00023631466,0.00008166668,0.0002628498,0.000010998842],"about_ca_topic_score_codex":0.003242124,"about_ca_topic_score_gemma":0.0030337248,"teacher_disagreement_score":0.0054442226,"about_ca_system_score_codex":0.0017430577,"about_ca_system_score_gemma":0.00092993095,"threshold_uncertainty_score":0.012646854},"labels":[],"label_agreement":null},{"id":"W2339672514","doi":"10.1177/1078155216634180","title":"Evaluating the patient-perceived impact of clinical pharmacy services and proactive follow-up care in an ambulatory chemotherapy unit","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Pharmacist; Pharmacy; Clinical pharmacy; Ambulatory; Family medicine; Regimen; Patient satisfaction; Ambulatory care; Medication therapy management; Nursing; Pharmacy practice; Health care; Internal medicine","score_opus":0.3481103082943572,"score_gpt":0.6065087190202229,"score_spread":0.25839841072586567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339672514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834406,0.00016984539,0.000050713068,0.00033912013,0.000006232976,0.000035383073,0.00007826576,0.000004696258,0.0009717243],"genre_scores_gemma":[0.999485,0.0000773798,0.00018516995,0.00010326388,0.000008684954,0.000016863798,0.000048450995,0.0000010147791,0.000074107644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952356,0.0026682352,0.00046182814,0.00014420957,0.0010067198,0.0004833589],"domain_scores_gemma":[0.98416096,0.0058375476,0.005411029,0.00019874962,0.0014527604,0.002938942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034230133,0.00020014835,0.0002998129,0.00047249222,0.00047597245,0.0009571138,0.00028042344,0.00051555625,0.00273905],"category_scores_gemma":[0.019089153,0.00011826716,0.00065370434,0.00061166525,0.0003210574,0.0006746594,0.00075774704,0.0006878731,0.00017232377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068268017,0.0016438627,0.9570812,0.00018289473,0.00020625726,0.00019405887,0.0012177607,0.00041469108,0.00038100255,0.00005324916,0.0007275504,0.037214853],"study_design_scores_gemma":[0.00006888306,0.0050404556,0.9888948,0.000056427358,0.00010338285,0.00030306555,0.0033142038,0.0009900227,0.00029441796,0.000029842855,0.0008804823,0.000023972389],"about_ca_topic_score_codex":0.0023026417,"about_ca_topic_score_gemma":0.0037298326,"teacher_disagreement_score":0.0034230133,"about_ca_system_score_codex":0.00082557765,"about_ca_system_score_gemma":0.00096046634,"threshold_uncertainty_score":0.018102884},"labels":[],"label_agreement":null},{"id":"W2341523177","doi":"10.1177/1078155216631406","title":"Evaluation of a rapid hydration protocol: Safety and effectiveness","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Government of Canada; Department of National Defence","funders":"","keywords":"Medicine; Chemotherapy; Urine specific gravity; Urine; Staffing; Protocol (science); Cyclophosphamide; Ifosfamide; Adverse effect; Urology; Internal medicine; Cisplatin; Nursing; Pathology","score_opus":0.10518973022127787,"score_gpt":0.5030573286227796,"score_spread":0.39786759840150177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341523177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93436027,0.008453869,0.020971749,0.0016134036,0.00046520514,0.02379546,0.0011993651,0.00086216745,0.008278501],"genre_scores_gemma":[0.95253015,0.0025176953,0.031754028,0.00063482043,0.00028799538,0.01076632,0.00054584135,0.000069165784,0.00089393207],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9745557,0.014512999,0.0024526939,0.0011438438,0.0068880324,0.00044662037],"domain_scores_gemma":[0.9344276,0.03281108,0.017739177,0.0047021336,0.0076185493,0.0027014315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022917585,0.00076629536,0.0014532108,0.0010001032,0.00053508545,0.0011816111,0.0011328431,0.00086275616,0.0022325984],"category_scores_gemma":[0.069981955,0.00034355163,0.0009418547,0.0006718583,0.0006661507,0.001061935,0.00091719814,0.00087105273,0.00037173965],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06859863,0.011527068,0.06433842,0.003114844,0.00092074793,0.00030517118,0.0006322996,0.0053552114,0.0038892596,0.0004729605,0.0050735017,0.8357718],"study_design_scores_gemma":[0.04243767,0.46084222,0.35816956,0.0041802786,0.0031476615,0.0029471656,0.0017211908,0.052327093,0.031781074,0.0023401564,0.03961653,0.0004893633],"about_ca_topic_score_codex":0.0015384875,"about_ca_topic_score_gemma":0.0012865848,"teacher_disagreement_score":0.022917585,"about_ca_system_score_codex":0.0018202064,"about_ca_system_score_gemma":0.003906925,"threshold_uncertainty_score":0.12120122},"labels":[],"label_agreement":null},{"id":"W2341576176","doi":"10.1177/1078155216643860","title":"Pilot study of biological monitoring of four antineoplastic drugs among Canadian healthcare workers","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Pharmacy; Antineoplastic Drugs; Personal protective equipment; Health care; Family medicine; Internal medicine; Pharmacology","score_opus":0.20553509175868948,"score_gpt":0.49055970285928513,"score_spread":0.2850246111005956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2341576176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998939,0.000056536846,0.0001259717,0.000042200947,0.0000033440208,0.00021876376,0.00014012115,0.0000043962323,0.00046970928],"genre_scores_gemma":[0.99814653,0.00014234522,0.00070828636,0.00014927954,0.000008868452,0.0001230756,0.0001733707,0.0000016096341,0.0005464649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985103,0.0002579157,0.00006954569,0.00021409223,0.000576596,0.00037151587],"domain_scores_gemma":[0.99806637,0.00037052928,0.00031332477,0.00008335465,0.00071561226,0.0004508214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016985809,0.00055369246,0.0003257956,0.0007231037,0.0024820948,0.0004646994,0.00058758387,0.00057216495,0.0010942604],"category_scores_gemma":[0.0027132356,0.00038212232,0.00030481027,0.0007335026,0.0006072906,0.0002246692,0.000572766,0.00044184283,0.00018060139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045341175,0.0014803741,0.97817755,0.00009657188,0.000025813073,0.00037075626,0.004274937,0.00006220081,0.0043497607,0.00002642791,0.0002461221,0.010436056],"study_design_scores_gemma":[0.000048572103,0.0024556986,0.99323446,0.000012030399,0.000020318508,0.00019233205,0.0027505378,0.00016899109,0.0005579241,0.000009857581,0.00054035545,0.000008967926],"about_ca_topic_score_codex":0.66569436,"about_ca_topic_score_gemma":0.67854327,"teacher_disagreement_score":0.33430564,"about_ca_system_score_codex":0.004391454,"about_ca_system_score_gemma":0.0076651815,"threshold_uncertainty_score":0.6725489},"labels":[],"label_agreement":null},{"id":"W2345159752","doi":"10.1177/1078155215620920","title":"Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant","year":2015,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Alberta Health Services","funders":"","keywords":"Medicine; Mucositis; Cryotherapy; Multiple myeloma; Hematopoietic stem cell transplantation; Hematopoietic stem cell; Stem cell; Stomatitis; Plasma Cell Myeloma; Surgery; Internal medicine; Haematopoiesis; Transplantation; Chemotherapy","score_opus":0.10066832000404236,"score_gpt":0.42101859092038635,"score_spread":0.320350270916344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345159752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950277,0.004175285,0.00016219176,0.000054193668,0.000009773758,0.000033473545,0.000048188347,0.0000041326243,0.00048503643],"genre_scores_gemma":[0.9991456,0.0006117677,0.00011226561,0.00003431076,0.000015938691,0.000010929865,0.000030613923,5.9094793e-7,0.00003788847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996141,0.00013517271,0.00005675317,0.00004181178,0.00010422331,0.000047840396],"domain_scores_gemma":[0.9988953,0.00028112714,0.0006676543,0.000020409694,0.000047182395,0.0000883246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059361337,0.00012819447,0.00027772735,0.00044487478,0.00033399573,0.00029321233,0.00010591921,0.00019374615,0.0009134484],"category_scores_gemma":[0.0016951712,0.00007361934,0.00027576246,0.00047345497,0.00025244412,0.00019820573,0.00025318196,0.00021057022,0.00007005404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000548672,0.00010773814,0.97480464,0.00020524031,0.00006141311,0.00085257884,0.0001351999,0.00009664283,0.0016233994,0.000022796605,0.000157392,0.02138447],"study_design_scores_gemma":[0.000022582677,0.0014473818,0.9905934,0.000067219305,0.000094760166,0.0060006813,0.00025053916,0.000120770994,0.0008415727,0.000023443225,0.00053258694,0.0000051751776],"about_ca_topic_score_codex":0.00063911953,"about_ca_topic_score_gemma":0.0010843162,"teacher_disagreement_score":0.0009134484,"about_ca_system_score_codex":0.00027602655,"about_ca_system_score_gemma":0.00034976722,"threshold_uncertainty_score":0.0031393766},"labels":[],"label_agreement":null},{"id":"W2368261462","doi":"10.1177/1078155215627502","title":"Taxane-induced arthralgia and myalgia: A literature review","year":2016,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"myalgia; Taxane; Medicine; Docetaxel; Paclitaxel; Internal medicine; Chemotherapy; Oncology; Breast cancer; Cancer","score_opus":0.09835431357604807,"score_gpt":0.5213771832342611,"score_spread":0.423022869658213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2368261462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003032782,0.99914086,0.000028873248,0.00016053679,0.00007088394,0.00003119243,0.00005790501,0.0000026082578,0.00020374694],"genre_scores_gemma":[0.0020785828,0.99726,0.00012057618,0.00028115258,0.00009811294,0.000045986937,0.000056768145,0.0000011470191,0.000057612808],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976808,0.00049509143,0.0010676009,0.00020756618,0.00047126893,0.000077697885],"domain_scores_gemma":[0.9885306,0.007869993,0.002351984,0.000124377,0.000968461,0.00015460922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002400647,0.0009817474,0.003387128,0.011080523,0.0007340599,0.0016867138,0.0015203513,0.0016337819,0.0050698286],"category_scores_gemma":[0.010383957,0.00056996354,0.002739928,0.011982447,0.0007917126,0.0020992113,0.00093266217,0.0009188421,0.00045567236],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015711783,0.00005886123,0.0012626242,0.80994666,0.0011930646,0.00060118834,0.00027286884,0.00013063019,0.0002886005,0.0006327255,0.00894915,0.17650655],"study_design_scores_gemma":[0.00015779231,0.00034330285,0.01198599,0.83832544,0.017042544,0.0060569057,0.00067725434,0.00012925599,0.00034949716,0.001072262,0.123798326,0.0000615034],"about_ca_topic_score_codex":0.004112157,"about_ca_topic_score_gemma":0.009348469,"teacher_disagreement_score":0.011080523,"about_ca_system_score_codex":0.0019521446,"about_ca_system_score_gemma":0.00673944,"threshold_uncertainty_score":0.016960263},"labels":[],"label_agreement":null},{"id":"W2405394407","doi":"10.1177/1078155216650986","title":"Rationalizing the use of auxiliary label for oral oncology drugs","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"BC Cancer Agency","keywords":"Medicine; Formulary; Medical physics; Standardization; Agency (philosophy); Pharmacy; Package insert; Inclusion (mineral); Family medicine; Pharmacology; Computer science; Psychology","score_opus":0.3696067230437272,"score_gpt":0.5393909137530707,"score_spread":0.16978419070934347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405394407","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18600059,0.06298687,0.49983174,0.09333299,0.0035414535,0.06921869,0.0037433396,0.0036984812,0.07764585],"genre_scores_gemma":[0.17147958,0.0132530555,0.78960353,0.010318021,0.0005485007,0.009252102,0.0010892838,0.00031966437,0.004136305],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7633743,0.1483848,0.03314495,0.007926572,0.044936262,0.0022330987],"domain_scores_gemma":[0.6523301,0.16333811,0.060362995,0.020989824,0.099163726,0.0038152938],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.21047404,0.0015980441,0.002064743,0.012884824,0.0033432215,0.008361818,0.004836265,0.0032206774,0.0020380693],"category_scores_gemma":[0.29023433,0.0016214758,0.0020857966,0.0054872944,0.0044424813,0.0069924863,0.0075318054,0.004964327,0.0012471974],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079289096,0.00067850354,0.026083978,0.017755533,0.0004031082,0.00040868804,0.0152643,0.0031257928,0.009414933,0.01164767,0.023987751,0.89043695],"study_design_scores_gemma":[0.0010312184,0.006206358,0.087322414,0.06704871,0.00212419,0.00174394,0.025268197,0.015049356,0.055470787,0.042572737,0.69504607,0.001116113],"about_ca_topic_score_codex":0.010348907,"about_ca_topic_score_gemma":0.019160919,"teacher_disagreement_score":0.21047404,"about_ca_system_score_codex":0.011296948,"about_ca_system_score_gemma":0.05617226,"threshold_uncertainty_score":0.9736261},"labels":[],"label_agreement":null},{"id":"W2463802265","doi":"10.1177/1078155216656928","title":"Baxter elastomeric pumps: Feasibility of weight estimates","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Innovates; Alberta Health Services","funders":"","keywords":"Medicine; Pharmacy; Infusion pump; Anesthesia; Nursing","score_opus":0.0567887396634437,"score_gpt":0.4350797763739987,"score_spread":0.378291036710555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463802265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.625501,0.004934566,0.33636189,0.0034135315,0.00085020706,0.002202663,0.0016376999,0.0014693314,0.02362917],"genre_scores_gemma":[0.8745538,0.0007289327,0.12039745,0.0003438407,0.00019826002,0.00070753606,0.00032647318,0.00014998844,0.0025937906],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9802288,0.011096043,0.0013961538,0.0010590105,0.0059371036,0.0002828147],"domain_scores_gemma":[0.95931685,0.023332292,0.0061052945,0.0035272532,0.0073233075,0.00039500496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016534774,0.00058446854,0.00046470072,0.0009122325,0.00037499718,0.001674939,0.0010822295,0.00069272355,0.003829388],"category_scores_gemma":[0.06715542,0.00044278457,0.00039358178,0.0006934009,0.00055679615,0.0014192943,0.0011144616,0.0006568234,0.0011247414],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009798416,0.00068103167,0.2766929,0.0010532105,0.00024189556,0.0005965008,0.0016043575,0.0037504146,0.03633751,0.0021806634,0.0077554546,0.6593077],"study_design_scores_gemma":[0.0017104582,0.024224078,0.5946071,0.0013072324,0.0011735314,0.009971184,0.0029768187,0.13202484,0.1507372,0.0060458444,0.074833155,0.00038853608],"about_ca_topic_score_codex":0.00081251754,"about_ca_topic_score_gemma":0.0009189835,"teacher_disagreement_score":0.016534774,"about_ca_system_score_codex":0.00041614307,"about_ca_system_score_gemma":0.00055562664,"threshold_uncertainty_score":0.08744532},"labels":[],"label_agreement":null},{"id":"W2505248710","doi":"10.1177/1078155216660184","title":"Safe administration of docetaxel after weekly paclitaxel-induced acute pancreatitis","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Acute pancreatitis; Docetaxel; Carboplatin; Paclitaxel; Pancreatitis; Adverse effect; Chemotherapy; Pancreatic cancer; Internal medicine; Gastroenterology; Cancer; Cisplatin","score_opus":0.04567577280500804,"score_gpt":0.4385017096093566,"score_spread":0.3928259368043485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505248710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9569838,0.017936293,0.015632128,0.0016017604,0.0003453432,0.00024379377,0.00011700767,0.00038978836,0.0067500565],"genre_scores_gemma":[0.9948743,0.0018776543,0.001497664,0.00045241995,0.00011334676,0.000029439288,0.000075457276,0.000019617715,0.0010601238],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9997918,0.00006910576,0.000021492246,0.000024623621,0.00006336458,0.000029600804],"domain_scores_gemma":[0.99950445,0.00012301853,0.00018645437,0.00007717341,0.000040616367,0.00006820709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015570507,0.00018232019,0.0004556728,0.00019844552,0.000256739,0.00033306913,0.00018153629,0.00039238256,0.00042850204],"category_scores_gemma":[0.0013019162,0.00009845777,0.00031318975,0.00016075047,0.00017793455,0.00024749938,0.00023323434,0.0007871384,0.00025726165],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006832182,0.0029286218,0.09226934,0.0007097105,0.00040641744,0.10324724,0.0008523884,0.0023594676,0.110322595,0.0021483023,0.008287026,0.66963667],"study_design_scores_gemma":[0.0025451377,0.05230563,0.19028735,0.0007404541,0.0008035991,0.32453173,0.0005424713,0.014881549,0.23597664,0.0053840145,0.17185703,0.00014442272],"about_ca_topic_score_codex":0.00025897892,"about_ca_topic_score_gemma":0.00077363924,"teacher_disagreement_score":0.0004556728,"about_ca_system_score_codex":0.00022950409,"about_ca_system_score_gemma":0.00027744178,"threshold_uncertainty_score":0.001665175},"labels":[],"label_agreement":null},{"id":"W2507286557","doi":"10.1177/1078155216665245","title":"A rare case of blastic plasmacytoid dendritic cell neoplasm with deletion 7q.31, in the setting of heavy pre-treatment with alkylating chemotherapy","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Interleukin-3 receptor; Plasmacytoid dendritic cell; Neoplasm; Bone marrow; Pathology; Myeloid; Myeloid leukemia; Lymph node; Dermis; Leukemia; Chemotherapy; Dendritic cell; Cancer research; Immunology; Internal medicine; Immune system","score_opus":0.02534637620104926,"score_gpt":0.3832707602306541,"score_spread":0.35792438402960486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2507286557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835714,0.0032033192,0.001966952,0.0013364959,0.00014295135,0.00015514043,0.00020719474,0.00012288534,0.00929363],"genre_scores_gemma":[0.99695146,0.00078505103,0.0005974684,0.00031277427,0.00020677177,0.0000164524,0.0000707003,0.000012299058,0.0010470222],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996501,0.000032617027,0.00003491609,0.00010075047,0.00006274614,0.00011884299],"domain_scores_gemma":[0.9989404,0.00027296424,0.00026771193,0.000096416654,0.000069196016,0.00035337065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022714122,0.0007682011,0.0007245961,0.001194185,0.0019691132,0.00096684083,0.00068741635,0.0026311371,0.0017046364],"category_scores_gemma":[0.002014255,0.0005845975,0.0005066275,0.00096533226,0.0009784376,0.0011027362,0.0010110278,0.0019257364,0.000534646],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028975543,0.00001854668,0.006798356,0.000022712211,0.0000033860317,0.99103785,0.0000919158,0.000045917615,0.00091876014,0.000108972665,0.00014076111,0.0007839185],"study_design_scores_gemma":[0.000008697135,0.000036441976,0.003579911,0.0000054818306,0.0000068198347,0.9953402,0.00006568101,0.00011701616,0.000346825,0.00009449644,0.00039526095,0.0000030618746],"about_ca_topic_score_codex":0.0015359342,"about_ca_topic_score_gemma":0.0025113,"teacher_disagreement_score":0.0026311371,"about_ca_system_score_codex":0.0007542799,"about_ca_system_score_gemma":0.00073663983,"threshold_uncertainty_score":0.005702555},"labels":[],"label_agreement":null},{"id":"W2539944401","doi":"10.1177/1078155216676632","title":"Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 48 Canadian hospitals","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Ifosfamide; Methotrexate; Cyclophosphamide; Contamination; Antineoplastic Drugs; Chemotherapy; Emergency medicine; Internal medicine; Intensive care medicine; Pharmacology; Cisplatin","score_opus":0.032098385770829616,"score_gpt":0.4165334557517296,"score_spread":0.3844350699809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539944401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99814665,0.00013719712,0.00013494119,0.000043476313,0.0000045635347,0.00008497042,0.0007541896,0.000006478517,0.0006876929],"genre_scores_gemma":[0.99848384,0.00017223055,0.0003599606,0.000068834976,0.0000069968964,0.000031556752,0.0005448204,0.0000019783367,0.00032986482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812,0.0001868001,0.000099559664,0.000324007,0.0007587587,0.0005107915],"domain_scores_gemma":[0.99769324,0.0001718144,0.00061335944,0.00007447731,0.0010307665,0.0004163496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010187504,0.00041904647,0.0004025307,0.0015917715,0.002170996,0.001021914,0.00080580637,0.0004774004,0.0011465085],"category_scores_gemma":[0.0025318712,0.0003881786,0.00033018106,0.003110129,0.0008378078,0.00030134723,0.00079039414,0.00032766676,0.00013088857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008837845,0.000049401617,0.9932973,0.0000488467,0.000025584117,0.0001671404,0.0013288184,0.00006489244,0.00092712656,0.000026392796,0.0002202501,0.003755966],"study_design_scores_gemma":[0.0000031422865,0.000107978216,0.9971204,0.000012970533,0.000011862768,0.00011127849,0.0017387382,0.00010943935,0.00025368773,0.000004707334,0.0005190977,0.000006724123],"about_ca_topic_score_codex":0.90925586,"about_ca_topic_score_gemma":0.937684,"teacher_disagreement_score":0.09074414,"about_ca_system_score_codex":0.014099628,"about_ca_system_score_gemma":0.012970595,"threshold_uncertainty_score":0.18255705},"labels":[],"label_agreement":null},{"id":"W2546363677","doi":"10.1177/1078155216676631","title":"Adherence with capecitabine: A population-based analysis based on prescription refill data","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Medical prescription; Population; Family medicine; Emergency medicine; Intensive care medicine; Internal medicine; Pharmacology; Environmental health; Cancer; Colorectal cancer","score_opus":0.12305768815289346,"score_gpt":0.44592161540552244,"score_spread":0.32286392725262897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546363677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980673,0.00014272089,0.0007320737,0.000024947893,0.0000049841856,0.00003515604,0.00076038763,0.000015191843,0.00021722961],"genre_scores_gemma":[0.998599,0.000045577177,0.00041460025,0.000013905001,0.000008725692,0.00003271943,0.00082329265,0.000005354928,0.000056821988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995871,0.0018188689,0.0004256566,0.00093331246,0.00073000515,0.00022123707],"domain_scores_gemma":[0.9932666,0.0026191804,0.0022183876,0.000939499,0.000615442,0.00034096627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039125965,0.00032239748,0.0006096439,0.002935418,0.00036121297,0.0009208114,0.0005586719,0.00071769865,0.0011304143],"category_scores_gemma":[0.009588155,0.00033118294,0.001517286,0.0027663289,0.00032792677,0.0007116731,0.0007613095,0.00079347915,0.0002837456],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019198126,0.000053146545,0.9975752,0.0000128144375,0.0002678524,0.000040253548,0.00006218185,0.000102234764,0.00014984245,0.00000810546,0.000062822735,0.0014735436],"study_design_scores_gemma":[0.000012152039,0.00026743923,0.99805707,0.000004051253,0.00012512626,0.0001629102,0.00006871762,0.0010972905,0.00006294228,0.000016737842,0.00011851507,0.0000070256465],"about_ca_topic_score_codex":0.0052811834,"about_ca_topic_score_gemma":0.003847795,"teacher_disagreement_score":0.0052811834,"about_ca_system_score_codex":0.0004475901,"about_ca_system_score_gemma":0.00032414217,"threshold_uncertainty_score":0.02069205},"labels":[],"label_agreement":null},{"id":"W2550602224","doi":"10.1177/1078155216677854","title":"Development of a systematic approach to pharmaceutical industry’s patient assistance programs on accessing unfunded cancer drugs","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmacy and Medical Practices","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Health Canada","keywords":"Medicine; Pharmacist; Process (computing); Pharmacy; Family medicine; Computer science","score_opus":0.3718943334638246,"score_gpt":0.5608156648585646,"score_spread":0.18892133139474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550602224","genre_codex":"protocol","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058321293,0.017266179,0.29314607,0.03901121,0.002008011,0.5564739,0.0065334504,0.0030743629,0.024165587],"genre_scores_gemma":[0.056381386,0.0046210964,0.82826316,0.0023403454,0.00017894951,0.1047569,0.001759563,0.00011952139,0.0015791064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.5288589,0.32004747,0.08536142,0.013194063,0.048565447,0.0039727385],"domain_scores_gemma":[0.41268823,0.26035357,0.06469492,0.04907616,0.20185101,0.01133605],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.44278196,0.0022596933,0.0033513901,0.042956363,0.0062343245,0.008267703,0.0072824284,0.002905921,0.0033516244],"category_scores_gemma":[0.4454445,0.0023324569,0.004089285,0.022931812,0.004871061,0.0101743005,0.013914118,0.003926699,0.0014092315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003335927,0.001151212,0.021723114,0.05539076,0.00076878123,0.0009292797,0.07990668,0.0017305737,0.0026464046,0.0074942135,0.028488427,0.799437],"study_design_scores_gemma":[0.0027559053,0.003786166,0.06378772,0.2818141,0.0045258477,0.0017898607,0.14805195,0.013933635,0.013578923,0.031146461,0.43376583,0.0010636195],"about_ca_topic_score_codex":0.020512247,"about_ca_topic_score_gemma":0.06624561,"teacher_disagreement_score":0.44278196,"about_ca_system_score_codex":0.026928974,"about_ca_system_score_gemma":0.25971344,"threshold_uncertainty_score":0.68714905},"labels":[],"label_agreement":null},{"id":"W2553411963","doi":"10.1177/1078155216679028","title":"Prevention of carboplatin-induced hypersensitivity reactions in women with ovarian cancer","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Carboplatin; Ovarian cancer; Hypersensitivity reaction; Oncology; Internal medicine; Cancer; Dermatology; Gynecology; Pharmacology; Chemotherapy; Cisplatin","score_opus":0.06301764527040747,"score_gpt":0.4185180363633262,"score_spread":0.3555003910929187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553411963","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729062,0.022933383,0.00038190835,0.00077696465,0.000037730515,0.000111719666,0.0003565902,0.000034347537,0.0024613452],"genre_scores_gemma":[0.9965957,0.0026401298,0.0003413198,0.00013851275,0.000029774346,0.00002043839,0.00013537472,0.0000018633881,0.00009696659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971384,0.00011347864,0.000036936286,0.000034942233,0.00006481648,0.00003593499],"domain_scores_gemma":[0.998085,0.0005392789,0.0011028307,0.000053569544,0.00010250682,0.000116698844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045660223,0.0000809478,0.00024864462,0.00040743363,0.00014631922,0.00022260644,0.0001984565,0.00016810992,0.0008322694],"category_scores_gemma":[0.0041473582,0.00006918046,0.00018131486,0.0005620873,0.00012194622,0.0001515376,0.00021135106,0.00022687177,0.00006785199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045473973,0.000090715446,0.9328106,0.00034057457,0.000057445002,0.00024305486,0.00009055545,0.00015329715,0.0007021786,0.00003308111,0.00077897875,0.064244814],"study_design_scores_gemma":[0.00006177139,0.0007045528,0.9931161,0.00011814672,0.00007988415,0.0014820638,0.000107173946,0.0002696296,0.0007232679,0.00006036468,0.003273049,0.000004001513],"about_ca_topic_score_codex":0.0013248016,"about_ca_topic_score_gemma":0.0016063811,"teacher_disagreement_score":0.0013248016,"about_ca_system_score_codex":0.0002524232,"about_ca_system_score_gemma":0.00033534982,"threshold_uncertainty_score":0.0027841926},"labels":[],"label_agreement":null},{"id":"W2559612723","doi":"10.1177/1078155216681191","title":"Clinical effectiveness of bevacizumab in patients with recurrent brain tumours: A population-based evaluation","year":2016,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Bevacizumab; Temozolomide; Internal medicine; Population; Progression-free survival; Lomustine; Discontinuation; Surgery; Oncology; Chemotherapy; Cyclophosphamide; Vincristine","score_opus":0.05332702560261797,"score_gpt":0.48243508416870495,"score_spread":0.42910805856608697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559612723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99555236,0.0030522302,0.00009822922,0.000045315137,0.000006222557,0.00006434765,0.00071470137,0.000007105543,0.00045957998],"genre_scores_gemma":[0.99807334,0.0006298465,0.00009720265,0.000039618608,0.000030603707,0.00005185872,0.001025246,0.0000025339505,0.00004978024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997844,0.00074823154,0.00029564428,0.00044578314,0.00053258264,0.00013379264],"domain_scores_gemma":[0.9949987,0.0012200514,0.002532829,0.00014785108,0.00069736684,0.0004032008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025262223,0.00026855862,0.0010500071,0.0014998992,0.00026063435,0.0007415313,0.0004667528,0.0005126611,0.0007533151],"category_scores_gemma":[0.0059263594,0.00016953066,0.00094325654,0.0017519398,0.00030131187,0.00048233246,0.00028384224,0.0003731704,0.00016390406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019299586,0.000111954985,0.99081415,0.00009971128,0.0009635453,0.00009270204,0.000047517922,0.00015672177,0.00019598014,0.000009811921,0.00016327224,0.005414755],"study_design_scores_gemma":[0.0002339511,0.0016713289,0.9954299,0.000020297732,0.0008528026,0.000596664,0.00008331273,0.0003813425,0.000116314164,0.000022208094,0.00057802926,0.0000139959075],"about_ca_topic_score_codex":0.0029261755,"about_ca_topic_score_gemma":0.004572629,"teacher_disagreement_score":0.0029261755,"about_ca_system_score_codex":0.00086545723,"about_ca_system_score_gemma":0.00053275866,"threshold_uncertainty_score":0.013360083},"labels":[],"label_agreement":null},{"id":"W2577366119","doi":"10.1177/1078155216687153","title":"Baxter elastomeric pumps: Weighing as an alternative to visual inspection","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Calgary; University of Alberta; University of Ottawa","funders":"","keywords":"Medicine; Infusion pump; Preference; Dosing; Surgery; Anesthesia; Statistics; Mathematics; Internal medicine","score_opus":0.06497122907716572,"score_gpt":0.5163810874338346,"score_spread":0.45140985835666886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2577366119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79105246,0.020913858,0.14801736,0.0034446476,0.0016418331,0.0010910219,0.0012719122,0.0057927966,0.026774095],"genre_scores_gemma":[0.8522261,0.0041522156,0.13361,0.0011215891,0.0005558547,0.0005210902,0.0006963792,0.00037700788,0.006739824],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9932894,0.0027975505,0.0005924861,0.0006770198,0.0024407895,0.00020275393],"domain_scores_gemma":[0.9907122,0.0038613903,0.0029471822,0.000785278,0.0013675718,0.00032629317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004479711,0.00070355996,0.0006935248,0.0015781597,0.00030661587,0.001168463,0.00062773976,0.0005276629,0.005043846],"category_scores_gemma":[0.011541568,0.00035398453,0.0004073455,0.0013157693,0.0006749922,0.0013117103,0.0011345341,0.00060656545,0.0016969274],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061088395,0.00036216306,0.14071089,0.0011700499,0.00013569204,0.00057493366,0.0011159047,0.00058992655,0.09031961,0.0016704284,0.018210012,0.73903155],"study_design_scores_gemma":[0.0011659261,0.012531297,0.6441299,0.0011654092,0.0006291632,0.032624632,0.0021184764,0.019780789,0.17063414,0.0031943899,0.111362286,0.00066363066],"about_ca_topic_score_codex":0.00035650947,"about_ca_topic_score_gemma":0.00038800415,"teacher_disagreement_score":0.005043846,"about_ca_system_score_codex":0.00038522392,"about_ca_system_score_gemma":0.00027174703,"threshold_uncertainty_score":0.023691237},"labels":[],"label_agreement":null},{"id":"W2585427049","doi":"10.1177/1078155216689381","title":"A case report of enzalutamide administration in a dialysis-dependent patient with castration-resistant prostate cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Dialysis; Internal medicine; Urology; Population; Oncology; Cancer; Clinical trial; Androgen receptor","score_opus":0.0805586320688406,"score_gpt":0.4702348691241038,"score_spread":0.38967623705526316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585427049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9177407,0.020229327,0.011910046,0.017963309,0.0021239428,0.0004985709,0.0008092399,0.0006216821,0.0281032],"genre_scores_gemma":[0.9854628,0.0032796073,0.0027677177,0.0035271964,0.0020476738,0.00004718031,0.00015212833,0.000058002563,0.002657654],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992091,0.00011564814,0.00008248605,0.00025029908,0.000101418365,0.00024119836],"domain_scores_gemma":[0.99741757,0.0006985473,0.00045935926,0.00018493799,0.00016499078,0.0010746364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037159244,0.0021328744,0.0018858362,0.0028617515,0.0033735717,0.0025506455,0.0017213942,0.0076290104,0.0028047892],"category_scores_gemma":[0.0036597215,0.0012609613,0.0019534198,0.002067128,0.0018108066,0.0028619992,0.002027121,0.006882268,0.0010372541],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026551397,0.000040245293,0.0017231366,0.000018451312,0.000008627576,0.996765,0.00013693809,0.000060573475,0.00027085445,0.00011790828,0.00027690365,0.0005547329],"study_design_scores_gemma":[0.000011091902,0.000046192592,0.001145301,0.000016161124,0.000014128134,0.99767464,0.000111096495,0.00018231357,0.00020295534,0.00012920918,0.0004558185,0.000011072287],"about_ca_topic_score_codex":0.0050536958,"about_ca_topic_score_gemma":0.005088926,"teacher_disagreement_score":0.0076290104,"about_ca_system_score_codex":0.0020491164,"about_ca_system_score_gemma":0.0017868315,"threshold_uncertainty_score":0.014867485},"labels":[],"label_agreement":null},{"id":"W2589696207","doi":"10.1177/1078155217694493","title":"Stability of sodium bicarbonate injection 8.4% in syringes over a six-week period in refrigerated temperature","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Abbott Diagnostics","keywords":"Sodium bicarbonate; Medicine; Bicarbonate; Carbon dioxide; pH meter; Incubation period; Sodium; Incubation; Chromatography; Anesthesia; Chemistry; Biochemistry; Internal medicine","score_opus":0.05739433356511643,"score_gpt":0.4062935453483829,"score_spread":0.3488992117832665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589696207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939069,0.0014361143,0.003134407,0.00007689463,0.00006497259,0.00011724158,0.00048590096,0.00010060101,0.00067704933],"genre_scores_gemma":[0.99076885,0.0006191182,0.0065325038,0.000099691984,0.000027349124,0.00010926294,0.0006490779,0.000024751764,0.0011693223],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9990722,0.00018878261,0.00011077212,0.00018831583,0.000351904,0.00008801238],"domain_scores_gemma":[0.9982017,0.00024935257,0.0005877261,0.00015088859,0.0007079777,0.000102329504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012244945,0.00039617694,0.00040561226,0.00038098963,0.00034892245,0.0006527804,0.0005070758,0.00040124188,0.0013849535],"category_scores_gemma":[0.00200072,0.00019262069,0.00041284712,0.00045717863,0.00035548795,0.0004868625,0.0003204357,0.00033855377,0.0005402865],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016264422,0.00028522985,0.020835381,0.00024284374,0.00008624634,0.00023311022,0.0005940547,0.0003736777,0.9580594,0.00010217353,0.0003156906,0.017245783],"study_design_scores_gemma":[0.000036976162,0.005827793,0.056443382,0.00007277752,0.0001712721,0.00066290575,0.0005810026,0.002287509,0.9299888,0.00007634019,0.0037800688,0.00007115036],"about_ca_topic_score_codex":0.001099233,"about_ca_topic_score_gemma":0.0008164941,"teacher_disagreement_score":0.0013849535,"about_ca_system_score_codex":0.0003460114,"about_ca_system_score_gemma":0.00044831858,"threshold_uncertainty_score":0.0064758062},"labels":[],"label_agreement":null},{"id":"W2595991451","doi":"10.1177/1078155217698846","title":"Safe handling of monoclonal antibodies: Too large to be hazardous?","year":2017,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Monoclonal antibody; Medicine; Hazardous waste; Occupational exposure; Drug; Monoclonal; Immunology; Antibody; Pharmacology; Environmental health; Waste management","score_opus":0.4405719605430867,"score_gpt":0.6411255606374046,"score_spread":0.20055360009431783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595991451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013972928,0.99802434,0.00009560358,0.0008715907,0.00014111868,0.0000029343378,0.0000069145453,0.0000029582634,0.0007147725],"genre_scores_gemma":[0.001513936,0.99730766,0.00015334989,0.00045439886,0.00019391919,0.0000044173335,0.000011640434,0.0000011834275,0.00035952267],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999329,0.00017342123,0.00011544348,0.00007358827,0.00026535988,0.000043368],"domain_scores_gemma":[0.9984915,0.00096972217,0.00025932284,0.000035428013,0.00020467011,0.000039342518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011047254,0.00052115,0.0012243831,0.0016712953,0.00031804352,0.0012843461,0.00087819475,0.00185808,0.0037642869],"category_scores_gemma":[0.0022126336,0.00024759473,0.00070482737,0.0013275279,0.0011848091,0.002111584,0.00068566453,0.0016866471,0.0011385552],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006246854,0.00006791614,0.00040704355,0.04788631,0.00015685282,0.00050656206,0.00023495342,0.00019717835,0.0011548887,0.0072735325,0.022498127,0.9195542],"study_design_scores_gemma":[0.00001969253,0.00010728163,0.0010646402,0.018303363,0.00018071251,0.003980156,0.00030872558,0.00006424231,0.00078729907,0.004406488,0.97075474,0.000022638289],"about_ca_topic_score_codex":0.0014968108,"about_ca_topic_score_gemma":0.002498449,"teacher_disagreement_score":0.0037642869,"about_ca_system_score_codex":0.00058799115,"about_ca_system_score_gemma":0.0014784844,"threshold_uncertainty_score":0.012592852},"labels":[],"label_agreement":null},{"id":"W2600741732","doi":"10.1177/1078155217701293","title":"Clinical impact and management of fluconazole discontinuation on sirolimus levels in bone marrow transplant patients","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; Alberta Health Services","funders":"","keywords":"Sirolimus; Medicine; Fluconazole; Discontinuation; CYP3A4; Pharmacology; Internal medicine; Gastroenterology; Metabolism; Cytochrome P450; Antifungal","score_opus":0.09453958013113745,"score_gpt":0.47714750302053943,"score_spread":0.382607922889402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2600741732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99323314,0.0017277817,0.000059088015,0.0009347277,0.000020260588,0.000018393384,0.00004468747,0.0000064648502,0.003955509],"genre_scores_gemma":[0.99891126,0.0003970195,0.00006371198,0.00027808992,0.00004063208,0.000003340352,0.000060983002,0.0000015929081,0.00024343561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998031,0.000040325787,0.000019646248,0.000015605236,0.000051103274,0.000070158],"domain_scores_gemma":[0.9994777,0.000110654335,0.00015987072,0.000007955495,0.000057521193,0.00018628799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017742206,0.00014972728,0.00021843651,0.00022850928,0.00066836656,0.0005018773,0.00017163978,0.00045322132,0.0007869341],"category_scores_gemma":[0.0012314639,0.00007214349,0.00022941,0.0003890305,0.00022691092,0.00013309396,0.00014067221,0.0006771188,0.00008710497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053574936,0.00028952147,0.91571754,0.000043297277,0.000037654725,0.051143404,0.00046927246,0.00031068394,0.0022400925,0.00014599292,0.0012356191,0.027831161],"study_design_scores_gemma":[0.000050907038,0.0008641586,0.93184316,0.000059459235,0.00008638274,0.062148005,0.00066118,0.00053882535,0.0009768849,0.000078161036,0.0026777396,0.0000151968525],"about_ca_topic_score_codex":0.008410583,"about_ca_topic_score_gemma":0.016369777,"teacher_disagreement_score":0.008410583,"about_ca_system_score_codex":0.0011891758,"about_ca_system_score_gemma":0.0010395978,"threshold_uncertainty_score":0.016723216},"labels":[],"label_agreement":null},{"id":"W2602198097","doi":"10.1177/1078155217702214","title":"Incidence of late onset neutropenia associated with rituximab use in B cell lymphoma patients undergoing autologous stem cell transplantation","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Baker Hughes (Canada)","funders":"","keywords":"Medicine; Rituximab; Neutropenia; Autologous stem-cell transplantation; Transplantation; Febrile neutropenia; Internal medicine; Absolute neutrophil count; Lymphoma; Chemotherapy; Surgery; Hematopoietic stem cell transplantation; Incidence (geometry); Gastroenterology; Immunology","score_opus":0.047840597583751185,"score_gpt":0.3740233987825826,"score_spread":0.3261828011988314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2602198097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889165,0.00069424644,0.000073169445,0.000016533322,0.0000030189378,0.0000050951403,0.000042851058,0.0000031783113,0.00027028314],"genre_scores_gemma":[0.9996824,0.0001528679,0.000041826763,0.000020321788,0.000008493571,0.0000032916619,0.000058279147,0.0000010140361,0.000031530013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993755,0.00017993817,0.00012623197,0.00007861097,0.00014885793,0.00009082951],"domain_scores_gemma":[0.99660033,0.0005593084,0.0023006853,0.00009180655,0.00016427241,0.00028365784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005392318,0.00013773184,0.00032963723,0.0006453109,0.00024078424,0.00045612044,0.00020561944,0.0003001564,0.0007793312],"category_scores_gemma":[0.002183324,0.00014166845,0.00034394782,0.00069474336,0.00018689354,0.0002619257,0.0002476096,0.00044909725,0.00008805596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010988977,0.000029446097,0.9972362,0.000011450384,0.000019888648,0.00043559013,0.0000402017,0.000028412605,0.00021436193,0.000009311423,0.000040437215,0.0018248763],"study_design_scores_gemma":[0.000008330409,0.00032882445,0.99337375,0.00001937425,0.000042221152,0.005284202,0.00016981325,0.00022260922,0.0002733431,0.000017999537,0.00025331677,0.000006288327],"about_ca_topic_score_codex":0.00083610066,"about_ca_topic_score_gemma":0.0011699799,"teacher_disagreement_score":0.00083610066,"about_ca_system_score_codex":0.00026698038,"about_ca_system_score_gemma":0.00030552133,"threshold_uncertainty_score":0.0028517246},"labels":[],"label_agreement":null},{"id":"W2736583131","doi":"10.1177/1078155217718384","title":"Loperamide and cardiac events: Is high-dose use still safe for chemotherapy-induced diarrhea?","year":2017,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Loperamide; Medicine; Diarrhea; Chemotherapy; Dosing; Adverse effect; Anesthesia; Torsades de pointes; Incidence (geometry); QT interval; Internal medicine","score_opus":0.23018749822189583,"score_gpt":0.5265286030856199,"score_spread":0.29634110486372406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736583131","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010271396,0.99908566,0.000022015689,0.00043928184,0.00007028023,0.0000012008718,0.0000061201104,0.0000018869983,0.00027083958],"genre_scores_gemma":[0.001004415,0.9984149,0.00004439896,0.00026403094,0.00014398439,0.0000022799059,0.000011066498,6.3427575e-7,0.00011433854],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966073,0.000077089404,0.00008468003,0.00004290802,0.00011059747,0.000023926435],"domain_scores_gemma":[0.999067,0.0004998801,0.00019968506,0.000016382974,0.00017416774,0.00004288614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008210239,0.00043560273,0.0014022379,0.0014251426,0.00027370523,0.0010438265,0.00064444245,0.0012323675,0.0029322251],"category_scores_gemma":[0.0017773963,0.00021287822,0.0007383726,0.0016084503,0.0005282865,0.0013005468,0.00041448398,0.0013899945,0.0007635462],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009940057,0.0000450736,0.00059138896,0.027538348,0.00018335923,0.00029100775,0.00008456291,0.00013597126,0.0003733678,0.0018111557,0.022538606,0.9463078],"study_design_scores_gemma":[0.0000716242,0.00022447325,0.004396574,0.024612358,0.00062754087,0.005488977,0.0002322958,0.00012697454,0.00041523358,0.0025185177,0.96124905,0.000036382044],"about_ca_topic_score_codex":0.0015365104,"about_ca_topic_score_gemma":0.0030429966,"teacher_disagreement_score":0.0029322251,"about_ca_system_score_codex":0.0005320018,"about_ca_system_score_gemma":0.0013500063,"threshold_uncertainty_score":0.009809256},"labels":[],"label_agreement":null},{"id":"W2737770503","doi":"10.1177/1078155217718381","title":"Utilization of capecitabine plus oxaliplatin and 5-fluorouracil/folinic acid plus oxaliplatin in the adjuvant treatment of stage IIB and stage III colon cancer: A multi-centre, retrospective, chart review study","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency","keywords":"Oxaliplatin; Medicine; Folinic acid; FOLFOX; Capecitabine; Colorectal cancer; Fluorouracil; Tolerability; Regimen; Internal medicine; Stage (stratigraphy); Surgery; Cancer; Oncology; Gastroenterology; Adverse effect","score_opus":0.1493973258693315,"score_gpt":0.4807132871241634,"score_spread":0.33131596125483187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2737770503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99779946,0.000785714,0.000056147997,0.000017893872,0.0000021931965,0.00003282401,0.0009746384,0.0000037552295,0.00032734367],"genre_scores_gemma":[0.9981154,0.0006809223,0.00011538678,0.000022693286,0.000004482034,0.00003074005,0.0008759845,0.0000018965713,0.00015238668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991425,0.00018241751,0.00017429324,0.00014264823,0.00027590702,0.00008231396],"domain_scores_gemma":[0.99599314,0.0007813937,0.002279291,0.00010525622,0.00056022283,0.00028071058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005977073,0.00011297909,0.00025471798,0.0017231535,0.00031736988,0.0005324447,0.00021251803,0.00019393631,0.00070028956],"category_scores_gemma":[0.0025083309,0.00017521114,0.00025245303,0.0030295555,0.00021030617,0.0002181734,0.00020606615,0.00016574837,0.000106040374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013463764,0.000020670264,0.99644095,0.00009890259,0.00004474061,0.00017138515,0.00015107878,0.000034725163,0.00025540014,0.000008185003,0.00015647312,0.0024829393],"study_design_scores_gemma":[0.000007626039,0.00011163714,0.99855465,0.000024540319,0.000036170557,0.00040961956,0.00025621225,0.00007962954,0.00012144626,0.000002324582,0.00039209225,0.0000041219037],"about_ca_topic_score_codex":0.07017834,"about_ca_topic_score_gemma":0.11912902,"teacher_disagreement_score":0.07017834,"about_ca_system_score_codex":0.0015838313,"about_ca_system_score_gemma":0.0014786829,"threshold_uncertainty_score":0.13953972},"labels":[],"label_agreement":null},{"id":"W2739865956","doi":"10.1177/1078155217722047","title":"A deliberative framework to identify the need for real-life evidence building of new cancer drugs after interim funding decision","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Cancer Care Ontario","keywords":"Concordance; Interim; Medicine; Observational study; Interim analysis; Process management; Clinical trial; Management science; Political science; Business; Internal medicine; Engineering","score_opus":0.2165385595721144,"score_gpt":0.5102166603720768,"score_spread":0.29367810079996237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2739865956","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05302038,0.0024353308,0.7454999,0.11671913,0.0009886384,0.03276777,0.0008981203,0.00062399154,0.04704667],"genre_scores_gemma":[0.2486457,0.00073195924,0.72840965,0.00450613,0.00013995248,0.015502959,0.00047110565,0.00009316722,0.0014994255],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.43935314,0.5060698,0.024103206,0.0093105305,0.013947105,0.0072163017],"domain_scores_gemma":[0.38688546,0.52088827,0.018719273,0.019494655,0.0401433,0.013869008],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.46087292,0.003232082,0.0025012076,0.017239513,0.014963066,0.021440262,0.00779695,0.010512839,0.0053149625],"category_scores_gemma":[0.3944993,0.0021261729,0.005996614,0.006736998,0.03238099,0.025022797,0.028389934,0.011287361,0.0014288586],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006124332,0.00059305865,0.008783763,0.008393827,0.0004820765,0.0019323283,0.30425367,0.018710362,0.0020903754,0.46468082,0.021059938,0.16840726],"study_design_scores_gemma":[0.00048682286,0.0005252299,0.0028102181,0.014777667,0.0003140868,0.0007990833,0.14254421,0.022005819,0.002551043,0.66021407,0.15249632,0.00047537987],"about_ca_topic_score_codex":0.007874568,"about_ca_topic_score_gemma":0.00863336,"teacher_disagreement_score":0.46087292,"about_ca_system_score_codex":0.04932569,"about_ca_system_score_gemma":0.10537643,"threshold_uncertainty_score":0.6648397},"labels":[],"label_agreement":null},{"id":"W2747083578","doi":"10.1177/1078155217726160","title":"Survey of guidelines and current practices for safe handling of antineoplastic and other hazardous drugs used in 24 countries","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Clinical Oncological Society of Australia; National Institutes of Health; International Society of Oncology Pharmacy Practitioners","keywords":"Medicine; Antineoplastic Drugs; Hazardous waste; Pharmacology; Waste management","score_opus":0.3626607821254592,"score_gpt":0.5916071912413206,"score_spread":0.22894640911586134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747083578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98806715,0.0035774582,0.0005314697,0.0012358619,0.000034043347,0.00015057474,0.0011895237,0.00003371611,0.0051802592],"genre_scores_gemma":[0.9914029,0.004239162,0.0017663217,0.0008827862,0.000020985823,0.000114990464,0.0009975312,0.000011483567,0.00056376023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925102,0.003371023,0.001785778,0.00054738636,0.0013787721,0.0004069213],"domain_scores_gemma":[0.96257585,0.0098995855,0.016971007,0.0010664455,0.007551302,0.0019357868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063416134,0.00018598264,0.00034948208,0.0024136363,0.0005212218,0.0009959115,0.00056536106,0.0007497569,0.0013788732],"category_scores_gemma":[0.016272552,0.00033386966,0.00038954313,0.0036449772,0.0006394062,0.0009112508,0.00073375675,0.0004269797,0.00028871297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093041526,0.00012615342,0.93267906,0.0011186283,0.0001003646,0.00048024277,0.011289059,0.00033529015,0.0011021114,0.00025110194,0.0041802838,0.04824461],"study_design_scores_gemma":[0.000017687456,0.00046151358,0.9476833,0.0010014412,0.000043303102,0.00081292965,0.02296119,0.0003200331,0.0006135703,0.000074496806,0.02597191,0.00003855588],"about_ca_topic_score_codex":0.0076702503,"about_ca_topic_score_gemma":0.0051654885,"teacher_disagreement_score":0.0076702503,"about_ca_system_score_codex":0.0010814164,"about_ca_system_score_gemma":0.002181919,"threshold_uncertainty_score":0.033538043},"labels":[],"label_agreement":null},{"id":"W2747972503","doi":"10.1177/1078155217724595","title":"Effectiveness of adjuvant carboplatin-based chemotherapy compared to cisplatin in non-small cell lung cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Hôpital Saint-François d'Assise; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"","keywords":"Vinorelbine; Carboplatin; Medicine; Lung cancer; Cisplatin; Chemotherapy; Oncology; Internal medicine","score_opus":0.03448883472081306,"score_gpt":0.43717604190763587,"score_spread":0.4026872071868228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747972503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982811,0.001491142,0.000026829855,0.000018378214,0.0000056814324,0.000020369425,0.000030510548,0.0000014826783,0.00012443087],"genre_scores_gemma":[0.9995326,0.000252601,0.00003695171,0.000016846001,0.000007829667,0.0000109746325,0.000090565765,4.9346744e-7,0.000051146],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996799,0.00013982726,0.00003947855,0.000042676147,0.000057692716,0.000040523668],"domain_scores_gemma":[0.9991959,0.00031871177,0.00021341234,0.000027924892,0.000056199075,0.00018782828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006622343,0.00017358651,0.0005245776,0.00022634931,0.00016044757,0.00035307303,0.00022894613,0.00022599653,0.0007876648],"category_scores_gemma":[0.0013962142,0.0000962476,0.00047236722,0.00027525102,0.0002051825,0.00021754131,0.00017173521,0.00028296112,0.00006332804],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19209017,0.0032656284,0.6579712,0.00076963025,0.0013611527,0.00047723827,0.00020712499,0.0028422428,0.015338233,0.000075362834,0.00046188053,0.12514009],"study_design_scores_gemma":[0.004742012,0.07859176,0.90671444,0.00008215718,0.0011683713,0.00067541515,0.00013964242,0.0024759234,0.004113208,0.00006505928,0.0012141766,0.000017882414],"about_ca_topic_score_codex":0.002920606,"about_ca_topic_score_gemma":0.007685124,"teacher_disagreement_score":0.002920606,"about_ca_system_score_codex":0.0011265428,"about_ca_system_score_gemma":0.0007277188,"threshold_uncertainty_score":0.008173704},"labels":[],"label_agreement":null},{"id":"W2751383086","doi":"10.1177/1078155217727140","title":"Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness","year":2017,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Low molecular weight heparin; Randomized controlled trial; Clinical trial; Intensive care medicine; Adverse effect; Cancer; Venous thromboembolism; Vitamin K antagonist; Surgery; Heparin; Internal medicine; Warfarin; Thrombosis","score_opus":0.07988792753790282,"score_gpt":0.4762088049066638,"score_spread":0.396320877368761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2751383086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013731836,0.99734515,0.00012019474,0.00024878106,0.00005680977,0.00024293832,0.0003717844,0.000005780395,0.00023545018],"genre_scores_gemma":[0.021995537,0.97600025,0.0007154406,0.0005462613,0.00007036766,0.0003390803,0.00025967386,0.00000436616,0.00006906042],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99253196,0.0026491315,0.0029185445,0.00048168,0.0012282124,0.00019042248],"domain_scores_gemma":[0.9544963,0.03436815,0.0071966024,0.00048324227,0.0030971454,0.00035867977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009864517,0.0011722813,0.007805871,0.010631716,0.00046131862,0.0021124894,0.0016680078,0.0016403446,0.0035300127],"category_scores_gemma":[0.04280457,0.00075897196,0.008166999,0.009738334,0.00082261366,0.0017174254,0.0011180269,0.0010607444,0.00021181749],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038259834,0.00002252987,0.001092948,0.9507293,0.018002728,0.00007653981,0.00008949417,0.00013029152,0.00011250698,0.00023115995,0.000841549,0.028288212],"study_design_scores_gemma":[0.0006156333,0.00038917112,0.005768333,0.7918581,0.18915196,0.00034669292,0.00019241606,0.00017539675,0.00019978378,0.0004696973,0.010794516,0.000038342725],"about_ca_topic_score_codex":0.0071429787,"about_ca_topic_score_gemma":0.021862768,"teacher_disagreement_score":0.010631716,"about_ca_system_score_codex":0.0037194495,"about_ca_system_score_gemma":0.010643966,"threshold_uncertainty_score":0.052169204},"labels":[],"label_agreement":null},{"id":"W2757929633","doi":"10.1177/1078155217730130","title":"Durable complete remission following anti-EGFR antibodies in recurrent metastatic colorectal cancer","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Medicine; Discontinuation; Hypomagnesemia; Panitumumab; Cetuximab; Internal medicine; Adverse effect; Colorectal cancer; Cancer; Surgery; Oncology; Pediatrics","score_opus":0.11362827524337277,"score_gpt":0.4824869010611484,"score_spread":0.3688586258177756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2757929633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96222395,0.02013515,0.0043435353,0.002961572,0.000273153,0.000102300975,0.00023131512,0.0003757825,0.009353234],"genre_scores_gemma":[0.9951025,0.0016777721,0.00050514267,0.0007682452,0.00024087552,0.000012017456,0.00017868062,0.000024522602,0.0014899982],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.9996873,0.00003667073,0.000028615359,0.000059415856,0.00005186981,0.00013619298],"domain_scores_gemma":[0.9990074,0.00015701249,0.00041507272,0.00010583425,0.00006222932,0.00025243819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026559114,0.0004978803,0.0006867952,0.00052236,0.0008643348,0.0006144734,0.00048314044,0.0018436471,0.0012735971],"category_scores_gemma":[0.0015343283,0.00024800512,0.0006396625,0.00046371325,0.00040025433,0.0005832095,0.00062368275,0.0015195365,0.0006893592],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021156512,0.00007413119,0.025169283,0.00021054565,0.000037973306,0.9372564,0.00043843078,0.00023088284,0.0075301896,0.0002966407,0.0014885501,0.027055465],"study_design_scores_gemma":[0.000025450021,0.00021559444,0.012025948,0.000022235934,0.000043908654,0.98235863,0.000076974095,0.000289738,0.0013975324,0.00012203143,0.0034115266,0.000010382539],"about_ca_topic_score_codex":0.0013412513,"about_ca_topic_score_gemma":0.0028994197,"teacher_disagreement_score":0.0018436471,"about_ca_system_score_codex":0.0005095391,"about_ca_system_score_gemma":0.00036398665,"threshold_uncertainty_score":0.0042605996},"labels":[],"label_agreement":null},{"id":"W2761051584","doi":"10.1177/1078155217732400","title":"Optimizing patient education of oncology medications: A descriptive survey of pharmacist-provided patient education in Canada","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Nova Scotia; Nova Scotia Health Authority","funders":"Dalhousie University","keywords":"Medicine; Pharmacist; Pharmacy; Family medicine; Clinical pharmacy; Patient education; Descriptive statistics; Oncology nursing; Nursing; Oncology; Nurse education","score_opus":0.19454874108068795,"score_gpt":0.49677453778279024,"score_spread":0.30222579670210226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761051584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99650466,0.00017859977,0.000056353263,0.0003935929,0.0000031822306,0.00013289355,0.0011644503,0.0000063475286,0.0015598956],"genre_scores_gemma":[0.9982023,0.00032649326,0.00025788188,0.0002799132,0.000003275617,0.000050837665,0.00044792838,0.0000040420246,0.00042733736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967481,0.00036969487,0.0003616303,0.00023159703,0.0016141712,0.0006749043],"domain_scores_gemma":[0.98940176,0.0014524542,0.00268419,0.00014887888,0.0041880216,0.0021247515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015873006,0.000155329,0.00033469123,0.001465595,0.002612685,0.0014163441,0.00075587194,0.00047502384,0.0013814843],"category_scores_gemma":[0.008042666,0.00034469002,0.0003250132,0.0039720396,0.0008757263,0.0005611901,0.0011305425,0.000764978,0.00013683461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077340286,0.00016335475,0.978856,0.00011878611,0.000027917029,0.00013428307,0.009292885,0.000083299405,0.00021717984,0.00006396845,0.0009997011,0.009965367],"study_design_scores_gemma":[0.000008057042,0.000104783176,0.9853078,0.000040749,0.000008792083,0.00008344297,0.012272529,0.00024490312,0.00011623498,0.000008339996,0.0017906665,0.00001368193],"about_ca_topic_score_codex":0.95179284,"about_ca_topic_score_gemma":0.97098464,"teacher_disagreement_score":0.048207164,"about_ca_system_score_codex":0.028287677,"about_ca_system_score_gemma":0.044850826,"threshold_uncertainty_score":0.20524246},"labels":[],"label_agreement":null},{"id":"W2774074342","doi":"10.1177/1078155217743311","title":"A “chamber of errors” adaptation to assess pharmaceutical assistants’ knowledge in chemotherapy preparation","year":2017,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Pharmacist; Listing (finance); Pharmaceutical care; Medical education; Nursing","score_opus":0.3870703681985413,"score_gpt":0.5860764264337797,"score_spread":0.19900605823523837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2774074342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95119894,0.00052629045,0.016807713,0.0006698001,0.00025810784,0.0056813573,0.002036363,0.0005268177,0.022294616],"genre_scores_gemma":[0.92409194,0.00082233426,0.05656399,0.00058142364,0.00011453038,0.0075134044,0.002115139,0.00012603174,0.00807123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9908635,0.0027863407,0.0018938725,0.0005701029,0.0030494537,0.0008367098],"domain_scores_gemma":[0.95557445,0.016599018,0.010908547,0.0033332915,0.010299073,0.0032856327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066714967,0.000854993,0.00078106683,0.0023695673,0.0014760541,0.0016766821,0.0011167268,0.0012051131,0.006662636],"category_scores_gemma":[0.027583545,0.00055458955,0.0022267522,0.0014784912,0.0011541371,0.0014536454,0.0027035512,0.0014493226,0.0012856176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002347307,0.0038565537,0.70331335,0.0025242644,0.0005018182,0.0004784836,0.010822664,0.0024753804,0.008183782,0.001634563,0.022307027,0.24155486],"study_design_scores_gemma":[0.0002554609,0.004274028,0.9420928,0.00044640191,0.0002495065,0.00065196044,0.0053297696,0.005406991,0.007500802,0.0008682155,0.032676168,0.00024799607],"about_ca_topic_score_codex":0.007118173,"about_ca_topic_score_gemma":0.013372369,"teacher_disagreement_score":0.007118173,"about_ca_system_score_codex":0.0026452318,"about_ca_system_score_gemma":0.003582205,"threshold_uncertainty_score":0.03528273},"labels":[],"label_agreement":null},{"id":"W2782528556","doi":"10.1177/1078155217748735","title":"Approach to initiating QT-prolonging oncology drugs in the ambulatory setting","year":2018,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; QT interval; Torsades de pointes; Intensive care medicine; Ambulatory; Drug; Internal medicine; Cancer; Oncology; Pharmacology","score_opus":0.08855229204534298,"score_gpt":0.4709454513604985,"score_spread":0.3823931593151555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782528556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047058004,0.9839543,0.00233739,0.006392748,0.00052432757,0.000105849365,0.000063244675,0.00004833504,0.0061032297],"genre_scores_gemma":[0.0043580215,0.98518974,0.005399928,0.003013457,0.0005907812,0.000086949556,0.00007652976,0.0000068852883,0.0012778167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99916196,0.00023949954,0.00020417568,0.000101633166,0.00025547456,0.00003722651],"domain_scores_gemma":[0.99864227,0.00072186155,0.0002073442,0.00003647003,0.00032208415,0.00006984169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016482625,0.00063485507,0.00087049184,0.0016575198,0.0003650476,0.0012585362,0.0009493862,0.0015658843,0.003408881],"category_scores_gemma":[0.003476874,0.0002593622,0.0010235319,0.00081243314,0.0005057469,0.0015699645,0.00069838576,0.0039382363,0.001974553],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009091143,0.00022204217,0.0008828678,0.017695863,0.00010685191,0.00066130614,0.00025024824,0.00038081335,0.00111123,0.0061768442,0.03316452,0.93925655],"study_design_scores_gemma":[0.00009428743,0.0002514677,0.003323173,0.021959031,0.0003002338,0.006488298,0.00023285479,0.00029538636,0.0010496489,0.0051303245,0.9608322,0.000043129126],"about_ca_topic_score_codex":0.0019056149,"about_ca_topic_score_gemma":0.004221812,"teacher_disagreement_score":0.003408881,"about_ca_system_score_codex":0.0007921744,"about_ca_system_score_gemma":0.0028117718,"threshold_uncertainty_score":0.011403859},"labels":[],"label_agreement":null},{"id":"W2789266762","doi":"10.1177/1078155218760704","title":"ClotAssist: A program to treat cancer-associated thrombosis in an outpatient pharmacy setting","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thornhill Medical (Canada); University of Alberta","funders":"","keywords":"Medicine; Emergency department; Deep vein; Pharmacy; Cancer; Thrombosis; Venous thrombosis; Pharmacist; Patient education; Pulmonary embolism; Patient satisfaction; Intensive care medicine; Outpatient clinic; Emergency medicine; Internal medicine; Surgery; Nursing","score_opus":0.08972178726377769,"score_gpt":0.49879988555861304,"score_spread":0.4090780982948353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789266762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926916,0.00017612438,0.0008371793,0.0005820658,0.000046807065,0.0016191131,0.00017449645,0.00017464478,0.003697957],"genre_scores_gemma":[0.98143643,0.0005900962,0.009337481,0.0010752536,0.00016051643,0.0016184937,0.00039299403,0.000022002487,0.005366707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996996,0.00009930157,0.000016698274,0.000040489544,0.00006972274,0.000074219824],"domain_scores_gemma":[0.9986589,0.00013265884,0.0001413539,0.000049055554,0.000077488505,0.000940566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045554645,0.00018077402,0.00019441177,0.00029974832,0.0009180134,0.00039213581,0.0004460721,0.00037787974,0.006424081],"category_scores_gemma":[0.001889786,0.00013371676,0.00026730818,0.00021478634,0.00013854627,0.00026636766,0.00070453825,0.0006954999,0.0006758686],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048700515,0.10344389,0.10707394,0.00047370634,0.00014611908,0.0016090516,0.0016298594,0.0006426194,0.013026882,0.0003454342,0.016631056,0.75010735],"study_design_scores_gemma":[0.016418463,0.20303129,0.69550246,0.00021533384,0.00028675425,0.0058418782,0.002046161,0.0050350344,0.007790898,0.0004489471,0.06328112,0.00010173658],"about_ca_topic_score_codex":0.0018235025,"about_ca_topic_score_gemma":0.0057989354,"teacher_disagreement_score":0.006424081,"about_ca_system_score_codex":0.00042130673,"about_ca_system_score_gemma":0.002609717,"threshold_uncertainty_score":0.021490633},"labels":[],"label_agreement":null},{"id":"W2789751197","doi":"10.1177/1078155217752076","title":"Implementation of additional prescribing authorization among oncology pharmacists in Alberta","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"","keywords":"Medicine; Prior authorization; Family medicine; Pharmacy; Descriptive statistics; Medical prescription; Pharmacist; Ambulatory care; Ambulatory; Nursing; Health care; Internal medicine","score_opus":0.15210245188081975,"score_gpt":0.5274901880963858,"score_spread":0.3753877362155661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789751197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991336,0.00069269154,0.00010244618,0.0012876968,0.000014226437,0.000051138137,0.0001737855,0.000014019588,0.0063280766],"genre_scores_gemma":[0.9971367,0.0008273007,0.000334489,0.00043992998,0.000012860654,0.000013508244,0.00012872968,0.0000024163805,0.0011039901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988065,0.00011984463,0.00004019211,0.000086489614,0.0006545142,0.00029241038],"domain_scores_gemma":[0.9970078,0.00044277633,0.0010501931,0.000054498294,0.0005928297,0.0008518961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076679315,0.000078820216,0.00011134581,0.0005431315,0.0011401974,0.0008084302,0.000618901,0.00029458757,0.0018750597],"category_scores_gemma":[0.0033197573,0.00012993316,0.00014161809,0.0010392739,0.00039860557,0.00025203457,0.00072755414,0.00038678214,0.0000924481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014305732,0.0001701296,0.92632055,0.00015073665,0.00003077021,0.0010954331,0.0030211,0.0003403325,0.0014265917,0.00018397605,0.0023183487,0.064798914],"study_design_scores_gemma":[0.000016766526,0.00011288231,0.9904218,0.000058604084,0.000011187036,0.0006579042,0.0032483393,0.0003039863,0.0001614482,0.000032912467,0.0049658846,0.000008228979],"about_ca_topic_score_codex":0.728595,"about_ca_topic_score_gemma":0.8926652,"teacher_disagreement_score":0.27140498,"about_ca_system_score_codex":0.008867834,"about_ca_system_score_gemma":0.027648488,"threshold_uncertainty_score":0.5460067},"labels":[],"label_agreement":null},{"id":"W2791012194","doi":"10.1177/1078155217752534","title":"Integration of clinical pharmacists into an ambulatory, pediatric hematology/oncology/transplant clinic","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services; Alberta Children's Hospital","funders":"","keywords":"Medicine; Pharmacist; Clinical pharmacy; Pharmacy; Outpatient clinic; Ambulatory; Internal medicine; Hematology; Family medicine; Oncology; Intensive care medicine","score_opus":0.3215229400368311,"score_gpt":0.6011754592993891,"score_spread":0.279652519262558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791012194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900221,0.00038693045,0.0010518541,0.0012056686,0.000030177727,0.00032422523,0.0001577916,0.00006994338,0.0067511895],"genre_scores_gemma":[0.99243706,0.00044059515,0.0053374465,0.0005254479,0.00005617711,0.000113528724,0.00015728883,0.000009870779,0.0009225165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667585,0.0011963958,0.0002373942,0.00035871187,0.0009155832,0.00061608676],"domain_scores_gemma":[0.99270177,0.0010233859,0.0020302285,0.00025027874,0.0008980897,0.0030962783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001647813,0.00019305738,0.00015154094,0.0007292955,0.0015549466,0.0011390396,0.0006848198,0.0004970874,0.002676335],"category_scores_gemma":[0.0076928143,0.00021962794,0.00020558377,0.0005537555,0.00035426154,0.0005900782,0.0014607613,0.0007810597,0.00033860284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003816286,0.0030503182,0.77586275,0.00025539997,0.000077484954,0.0042194645,0.005820463,0.00079300225,0.0040799594,0.00028124507,0.0038401503,0.20133807],"study_design_scores_gemma":[0.000119119024,0.0046832175,0.9540863,0.00019436942,0.000067754016,0.010135043,0.008208391,0.0020452654,0.0024564506,0.00012454481,0.017837524,0.000042000152],"about_ca_topic_score_codex":0.009358555,"about_ca_topic_score_gemma":0.029990422,"teacher_disagreement_score":0.009358555,"about_ca_system_score_codex":0.0020925696,"about_ca_system_score_gemma":0.008119615,"threshold_uncertainty_score":0.018608153},"labels":[],"label_agreement":null},{"id":"W2800852263","doi":"10.1177/1078155218771461","title":"A case–control study analyzing mannitol dosing for prevention of cisplatin-induced acute nephrotoxicity","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; Princess Margaret Cancer Centre","funders":"University Health Network","keywords":"Nephrotoxicity; Medicine; Renal function; Urology; Dosing; Cisplatin; Mannitol; Odds ratio; Internal medicine; Toxicity; Chemotherapy; Chemistry","score_opus":0.07868815350006637,"score_gpt":0.4609149688159561,"score_spread":0.38222681531588976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800852263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989058,0.00046890663,0.00018207921,0.000025994566,0.000014772155,0.00005459319,0.000095775664,0.0000034789598,0.00024861653],"genre_scores_gemma":[0.99945873,0.00010419996,0.00017356801,0.000026499536,0.000022163542,0.000031067666,0.00010529078,0.0000015678079,0.000076796045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974572,0.00095835124,0.00026675218,0.00076917314,0.0003498296,0.00019870541],"domain_scores_gemma":[0.99555135,0.0015327948,0.0014051303,0.0005055196,0.00049602485,0.00050910685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023656108,0.0005425236,0.0006258532,0.0013780685,0.00095420604,0.0009419224,0.00077145343,0.0010802081,0.0019044101],"category_scores_gemma":[0.0072949217,0.0008944529,0.00062956,0.00147622,0.00063452206,0.00050516205,0.00043721142,0.0007205173,0.00018527132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012560413,0.00038400188,0.9948808,0.00004086215,0.00026412582,0.0009383942,0.00017812042,0.00003556312,0.00053847505,0.000053276297,0.000151361,0.00127901],"study_design_scores_gemma":[0.00033866556,0.001933431,0.99326104,0.000021028483,0.00033519676,0.002405628,0.00023897839,0.0006198681,0.00018239267,0.000053587104,0.00059350743,0.000016677724],"about_ca_topic_score_codex":0.004021743,"about_ca_topic_score_gemma":0.003405989,"teacher_disagreement_score":0.004021743,"about_ca_system_score_codex":0.0006120382,"about_ca_system_score_gemma":0.00052882935,"threshold_uncertainty_score":0.012510657},"labels":[],"label_agreement":null},{"id":"W2801969419","doi":"10.1177/1078155218773862","title":"Surface contamination with ten antineoplastic drugs in 83 Canadian centers","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institut de recherche Robert-Sauvé en santé et en sécurité du travail; Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Antineoplastic Drugs; Docetaxel; Pharmacy; Contamination; Ifosfamide; Vinorelbine; Cabazitaxel; Cytarabine; Internal medicine; Cancer; Pharmacology; Family medicine; Chemotherapy; Prostate cancer","score_opus":0.046898613899876714,"score_gpt":0.4504586978067135,"score_spread":0.4035600839068368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801969419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951638,0.0009908037,0.00041254875,0.00011393928,0.000007968544,0.00009368242,0.0012006129,0.00002501785,0.001991586],"genre_scores_gemma":[0.99616027,0.0008718798,0.0011692503,0.0001222099,0.000005786293,0.000017105483,0.0007941354,0.000008560498,0.00085074344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974814,0.00014009466,0.00008618167,0.00035292452,0.0015083748,0.0004310779],"domain_scores_gemma":[0.99855644,0.000112920556,0.00038440048,0.000050158967,0.0007300826,0.00016603265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000666723,0.00045338747,0.00035680647,0.0014508636,0.0020139548,0.0013511678,0.00085082103,0.00041702148,0.0014709983],"category_scores_gemma":[0.0015947403,0.00031047547,0.0002993151,0.0028604784,0.0008136092,0.00021321054,0.00071867055,0.00034492076,0.00019118961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019774468,0.00007779708,0.96233845,0.00024272867,0.000055554225,0.0003416588,0.0012252916,0.00018380048,0.004320189,0.000080392645,0.0008679724,0.030068342],"study_design_scores_gemma":[0.0000061431483,0.0001302701,0.9908246,0.000041489177,0.000046877027,0.00043371634,0.0016273679,0.0003120285,0.0030092935,0.000019737403,0.003533744,0.000014722852],"about_ca_topic_score_codex":0.86646605,"about_ca_topic_score_gemma":0.89347535,"teacher_disagreement_score":0.13353395,"about_ca_system_score_codex":0.01086358,"about_ca_system_score_gemma":0.013188287,"threshold_uncertainty_score":0.2686407},"labels":[],"label_agreement":null},{"id":"W2803561168","doi":"10.1177/1078155218774871","title":"Capecitabine-induced myopericarditis – A case report and review of literature","year":2018,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Capecitabine; Medicine; Myopericarditis; Oxaliplatin; Discontinuation; Internal medicine; Cardiotoxicity; Exemestane; Oncology; Surgery; Colorectal cancer; Chemotherapy; Cancer; Pericarditis; Tamoxifen; Breast cancer","score_opus":0.10637401030030615,"score_gpt":0.501616162044704,"score_spread":0.3952421517443979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803561168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033189435,0.9948001,0.00013323795,0.00034253643,0.00025583818,0.00001160791,0.000028343089,0.00001001602,0.0010993173],"genre_scores_gemma":[0.027688436,0.9697361,0.00043154423,0.0005841829,0.00092944544,0.000014470031,0.00007146042,0.0000051422257,0.0005392359],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.99954623,0.000063774496,0.00016925164,0.000081263446,0.00009332239,0.000046165256],"domain_scores_gemma":[0.99904114,0.00041438983,0.0003530132,0.00003174959,0.0000950075,0.00006467157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003773959,0.0009676348,0.0010672087,0.0048910514,0.00064459175,0.0011973269,0.0010574567,0.0016954037,0.0024149846],"category_scores_gemma":[0.0012899708,0.00037130702,0.000671915,0.0038302813,0.00076664187,0.0015637632,0.0006930055,0.00090127625,0.000650765],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018098908,0.00030391852,0.013555644,0.07878519,0.00061778695,0.41306716,0.0015877828,0.0006410198,0.0051688054,0.002620118,0.03909644,0.44437504],"study_design_scores_gemma":[0.00003655066,0.00014081011,0.0077975825,0.014863323,0.000618434,0.82124895,0.0010948486,0.00018434973,0.0008490571,0.0013013012,0.15181156,0.00005333164],"about_ca_topic_score_codex":0.0010513258,"about_ca_topic_score_gemma":0.0019232038,"teacher_disagreement_score":0.0048910514,"about_ca_system_score_codex":0.00039384075,"about_ca_system_score_gemma":0.001173753,"threshold_uncertainty_score":0.008078873},"labels":[],"label_agreement":null},{"id":"W2809872660","doi":"10.1177/1078155218784716","title":"Real world evidence: Abiraterone use post-docetaxel in metastatic castrate-resistant prostate cancer","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Docetaxel; Medicine; Abiraterone; Prostate cancer; Context (archaeology); Oncology; Pharmacy; Abiraterone acetate; Internal medicine; Clinical trial; Chemotherapy; Cancer; Family medicine; Androgen deprivation therapy","score_opus":0.1885419126451846,"score_gpt":0.5200089429495252,"score_spread":0.33146703030434055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809872660","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3172902,0.596347,0.0017274441,0.03270557,0.0015176934,0.0007791307,0.01208673,0.00007241331,0.037473876],"genre_scores_gemma":[0.93046093,0.05970352,0.0012906402,0.0040513673,0.0012508251,0.000100090016,0.0023758505,0.00001355848,0.00075321447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.976306,0.014808512,0.0028242548,0.0010864491,0.004585884,0.00038878174],"domain_scores_gemma":[0.8564967,0.08039952,0.04766018,0.0035531092,0.010156425,0.0017341195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01578442,0.00025692192,0.0007565684,0.0009300134,0.00037172795,0.0031774384,0.000853168,0.0009392698,0.007509202],"category_scores_gemma":[0.08735108,0.00021096409,0.0010656279,0.0024474754,0.0009790014,0.000978103,0.00070191553,0.0012813623,0.00050701684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026084207,0.0005838784,0.45895326,0.05176886,0.021047276,0.00055316836,0.00084242347,0.0014858501,0.00068614,0.0029840227,0.020548519,0.41446233],"study_design_scores_gemma":[0.012316828,0.010634729,0.77622026,0.03650715,0.03318769,0.001935191,0.0020535947,0.0015671189,0.0011110948,0.0028681417,0.12144407,0.00015416267],"about_ca_topic_score_codex":0.00995558,"about_ca_topic_score_gemma":0.02925942,"teacher_disagreement_score":0.01578442,"about_ca_system_score_codex":0.0021878653,"about_ca_system_score_gemma":0.004394564,"threshold_uncertainty_score":0.08347702},"labels":[],"label_agreement":null},{"id":"W2809947581","doi":"10.1177/1078155218783238","title":"The use of sacubitril/valsartan in anthracycline-induced cardiomyopathy: A mini case series","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Sacubitril, Valsartan; Medicine; Valsartan; Anthracycline; Cardiomyopathy; Sacubitril; Internal medicine; Heart failure; Cardiology; Pharmacology; Cancer; Blood pressure","score_opus":0.12280379569286283,"score_gpt":0.4354991659880195,"score_spread":0.3126953702951567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809947581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877104,0.0058817803,0.0013490185,0.00094923005,0.00019678158,0.00014788704,0.00011205509,0.000049800074,0.003603017],"genre_scores_gemma":[0.9953177,0.0022669141,0.0005291662,0.00051435054,0.00046376724,0.000030088808,0.00013590281,0.000018864754,0.0007233245],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99918514,0.00008936227,0.00013596678,0.00019482938,0.00013810808,0.00025654718],"domain_scores_gemma":[0.9980508,0.00037809202,0.00063207245,0.00013838732,0.00012981541,0.0006707548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040041466,0.0017013436,0.00086310477,0.0025068389,0.0021884774,0.0013704749,0.0013416545,0.0036848844,0.0025775272],"category_scores_gemma":[0.0019834314,0.0009873501,0.001212597,0.0012186901,0.0016745692,0.0014104634,0.0017468301,0.0017227599,0.00096875505],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006734296,0.00016007404,0.04083022,0.000066297776,0.000039051276,0.9541301,0.00047165432,0.00006080136,0.0008395803,0.00012145015,0.00039870993,0.0028146943],"study_design_scores_gemma":[0.000008959068,0.00009989811,0.0130751515,0.000022249716,0.000023807374,0.9857707,0.00026360794,0.00010404208,0.0002006646,0.00004495938,0.0003722722,0.000013648249],"about_ca_topic_score_codex":0.0014914015,"about_ca_topic_score_gemma":0.0022186688,"teacher_disagreement_score":0.0036848844,"about_ca_system_score_codex":0.0010293076,"about_ca_system_score_gemma":0.00078847137,"threshold_uncertainty_score":0.008622646},"labels":[],"label_agreement":null},{"id":"W2810807790","doi":"10.1177/1078155218784760","title":"Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Temozolomide; Bevacizumab; Solitary fibrous tumor; Regimen; Progression-free survival; Population; Surgery; Internal medicine; Oncology; Chemotherapy","score_opus":0.04501833263111176,"score_gpt":0.41924313128775564,"score_spread":0.3742247986566439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810807790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99919385,0.00038127814,0.00006746332,0.000016904414,0.0000017423985,0.000014310351,0.00014332308,0.0000032165713,0.00017789294],"genre_scores_gemma":[0.99967563,0.00006924972,0.00003624564,0.000009219314,0.000004557072,0.000011620566,0.00016990624,0.0000013145673,0.000022246864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997773,0.0008810052,0.00023678025,0.0003970327,0.0005611228,0.00015095805],"domain_scores_gemma":[0.99609864,0.0011140502,0.0020436693,0.00016346852,0.00028307794,0.00029705066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027676814,0.000194875,0.00074607204,0.0008708967,0.00023289458,0.00062598946,0.00037909116,0.00039328527,0.00073851197],"category_scores_gemma":[0.0059111924,0.00018696627,0.0010403587,0.0010495665,0.0003361821,0.00038849714,0.00043524368,0.00038984703,0.00012695887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014766455,0.00008981535,0.99425656,0.00003246159,0.0006062568,0.00010700681,0.00007122265,0.00017957736,0.00038811722,0.000014138046,0.00007899772,0.0026991453],"study_design_scores_gemma":[0.00014008577,0.0015403272,0.99594384,0.000007757168,0.00041938992,0.0007252603,0.000108591616,0.0006352217,0.00016773923,0.000025520492,0.00027694006,0.000009188034],"about_ca_topic_score_codex":0.002104983,"about_ca_topic_score_gemma":0.0022556162,"teacher_disagreement_score":0.0027676814,"about_ca_system_score_codex":0.00080375496,"about_ca_system_score_gemma":0.00048354888,"threshold_uncertainty_score":0.014637053},"labels":[],"label_agreement":null},{"id":"W2887065191","doi":"10.1177/1078155218790801","title":"Patient monitoring programs in oncology pharmacy practice: A survey of oncology pharmacists in Atlantic Canada","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Augmentium Pharma Consulting (Canada); Dr. H. Bliss Murphy Cancer Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Respondent; Pharmacy; Staffing; Family medicine; Pharmacist; Gynecologic oncology; Pharmacy technician; Oncology; Nursing","score_opus":0.19264057973995066,"score_gpt":0.4929369162646226,"score_spread":0.3002963365246719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887065191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968731,0.00023183515,0.00005165557,0.0007608432,0.0000057929306,0.00009321575,0.00063721475,0.0000049444716,0.001341448],"genre_scores_gemma":[0.9984043,0.00038120584,0.00014821714,0.00037440547,0.000005706914,0.000031728112,0.00025059955,0.00000270101,0.00040112052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969193,0.00036733184,0.00026130505,0.00022565766,0.0013866145,0.0008397242],"domain_scores_gemma":[0.9908015,0.00090515666,0.0026577334,0.0001342769,0.0024993883,0.0030018857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015172736,0.00017887696,0.000275646,0.000982473,0.0019813445,0.0012495766,0.00096150866,0.0006448851,0.0016080881],"category_scores_gemma":[0.005066746,0.00035624887,0.00027316247,0.0030430472,0.0008981824,0.0005143029,0.0011392426,0.0008048157,0.00021990034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004835912,0.00009468356,0.9887227,0.00006150087,0.000013418128,0.00013190683,0.003837375,0.000044290573,0.00021373827,0.00003057077,0.0008091318,0.0059923716],"study_design_scores_gemma":[0.000005789351,0.00007275305,0.9915868,0.00003061223,0.000004482439,0.00007473932,0.006763255,0.00018251884,0.000045782792,0.0000056178646,0.0012207424,0.000006901149],"about_ca_topic_score_codex":0.9298479,"about_ca_topic_score_gemma":0.9535761,"teacher_disagreement_score":0.070152104,"about_ca_system_score_codex":0.015041655,"about_ca_system_score_gemma":0.023982095,"threshold_uncertainty_score":0.14113045},"labels":[],"label_agreement":null},{"id":"W2888297957","doi":"10.1177/1078155218792985","title":"Evaluation of laboratory disturbance risk when adding low-dose cotrimoxazole for PJP prophylaxis to regimens of high-grade glioma patients taking RAAS inhibitors","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Renin–angiotensin system; Internal medicine; Aldosterone; Endocrinology; Urology; Blood pressure","score_opus":0.04978829066442618,"score_gpt":0.4044276425102027,"score_spread":0.3546393518457765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888297957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766624,0.0013479241,0.00018100941,0.00008149355,0.000013781603,0.00002811042,0.00015159987,0.0000073914644,0.000522408],"genre_scores_gemma":[0.9992798,0.0003052612,0.00020193648,0.00003251148,0.000012089617,0.0000105738545,0.00010774516,0.0000012435771,0.000048880793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993279,0.0001832086,0.00013141002,0.00009500613,0.0001729038,0.000089669324],"domain_scores_gemma":[0.9974126,0.00055372,0.0014334721,0.00005887243,0.0002795536,0.00026184059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006467698,0.00017684612,0.00048430747,0.0006544362,0.00028488954,0.00052741735,0.0002266629,0.00020343026,0.0007096434],"category_scores_gemma":[0.003487366,0.00012206874,0.00047715698,0.0008499099,0.00016471703,0.0003615387,0.00019432114,0.0004114982,0.00008439958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038472674,0.000035736135,0.99538285,0.000028419283,0.000041785395,0.00014514934,0.000029999374,0.000033624437,0.00018918916,0.000008321791,0.00006638289,0.0036538304],"study_design_scores_gemma":[0.000017888748,0.0008262989,0.9968984,0.000023946146,0.00013018257,0.0008649271,0.00013820274,0.00037738812,0.00037659664,0.000022217177,0.00031890642,0.0000050212857],"about_ca_topic_score_codex":0.0018391974,"about_ca_topic_score_gemma":0.002826372,"teacher_disagreement_score":0.0018391974,"about_ca_system_score_codex":0.0004438408,"about_ca_system_score_gemma":0.0005851235,"threshold_uncertainty_score":0.003657043},"labels":[],"label_agreement":null},{"id":"W2892317516","doi":"10.1177/1078155218796182","title":"Developing recommendations for the safe handling of oral anti-cancer drugs in community pharmacies: A pan-Canadian consensus approach","year":2018,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; St. John’s Health Sciences Centre; Neighbourhood Pharmacy Association of Canada; Ministère de la Santé et des Services Sociaux (Québec); Canadian Pharmacists Association; Cancer Care Ontario; University of Toronto","funders":"Association des pharmaciens du Canada","keywords":"Medicine; Pharmacy; Delphi method; Grey literature; Delphi; Medical education; Relevance (law); Family medicine; MEDLINE; Political science; Computer science","score_opus":0.5862096122925438,"score_gpt":0.5982760421431328,"score_spread":0.012066429850589033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892317516","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056262113,0.056464564,0.33899367,0.37215787,0.008515759,0.06983239,0.005757871,0.0014396242,0.090576105],"genre_scores_gemma":[0.1788516,0.020054586,0.7666914,0.010985293,0.00028096978,0.014915861,0.0022414722,0.00019877525,0.005780003],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.77146125,0.11722784,0.044131875,0.008084169,0.049235903,0.009859058],"domain_scores_gemma":[0.6610129,0.0905011,0.015926082,0.0070273373,0.20663303,0.01889949],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.25100723,0.002857125,0.0034520256,0.022347037,0.010863395,0.013405034,0.012397251,0.0091043925,0.0053970674],"category_scores_gemma":[0.26325765,0.002254877,0.006185713,0.014725176,0.0076363534,0.009884297,0.015481952,0.01200571,0.001782266],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004081392,0.0007216008,0.01794239,0.061026275,0.0014128265,0.0036808783,0.14374062,0.009209075,0.0048180753,0.053232353,0.1470159,0.5567919],"study_design_scores_gemma":[0.0005493604,0.0005309554,0.024006968,0.13786818,0.0017175907,0.0015176815,0.14793299,0.014571874,0.0035895554,0.061180737,0.60531086,0.001223167],"about_ca_topic_score_codex":0.37081572,"about_ca_topic_score_gemma":0.38623598,"teacher_disagreement_score":0.9156459,"about_ca_system_score_codex":0.084354095,"about_ca_system_score_gemma":0.35143504,"threshold_uncertainty_score":0.92364144},"labels":[],"label_agreement":null},{"id":"W2896528559","doi":"10.1177/1078155218804293","title":"Risk of pulmonary toxicity of bleomycin and filgrastim","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; The Quebec Population Health Research Network; Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec; Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"","keywords":"Medicine; Filgrastim; Pulmonary toxicity; Bleomycin; Internal medicine; Toxicity; Odds ratio; Etoposide; Concomitant; Lung cancer; Chemotherapy; Surgery; Oncology; Gastroenterology; Neutropenia","score_opus":0.03659143879223954,"score_gpt":0.41773289620522913,"score_spread":0.3811414574129896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896528559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928992,0.004429362,0.0013948536,0.00014078106,0.000033583558,0.000033009903,0.00032056856,0.000011338239,0.0007372272],"genre_scores_gemma":[0.99907887,0.00027114528,0.00032042337,0.000031880078,0.00003160638,0.000009914735,0.00010982489,0.000002713931,0.0001436466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970546,0.0014675688,0.0002721329,0.0006431907,0.0004227918,0.00013965249],"domain_scores_gemma":[0.9922009,0.0029522511,0.00364675,0.00065628486,0.00025898422,0.0002847661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003146045,0.0002799565,0.0006329387,0.0006735762,0.0001638703,0.00071499735,0.0004208768,0.0005948707,0.0017821506],"category_scores_gemma":[0.00905002,0.00023596003,0.0016834041,0.00047499416,0.00026198942,0.00033897138,0.00040925737,0.00060435646,0.00015213496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003807736,0.00009116643,0.9826901,0.00013487358,0.0027982367,0.00020400935,0.000044181423,0.00034445495,0.0012513414,0.00016417723,0.000120746874,0.008349026],"study_design_scores_gemma":[0.00015867803,0.001748855,0.9889522,0.000038076516,0.0020384293,0.0019250086,0.000111465844,0.002787752,0.0009996113,0.00036627418,0.00085253397,0.000021169684],"about_ca_topic_score_codex":0.00058865757,"about_ca_topic_score_gemma":0.00046563297,"teacher_disagreement_score":0.003146045,"about_ca_system_score_codex":0.00021834447,"about_ca_system_score_gemma":0.00019352845,"threshold_uncertainty_score":0.01663804},"labels":[],"label_agreement":null},{"id":"W2898849184","doi":"10.1177/1078155218808354","title":"Centralized preparation of chemotherapy for remote administration","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Pharmacy; Service delivery framework; Service (business); Operations management; Nursing; Business; Engineering; Marketing","score_opus":0.1134769843646694,"score_gpt":0.5759547935993498,"score_spread":0.46247780923468035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898849184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44850236,0.008793849,0.26272342,0.013954826,0.0012620349,0.0101661775,0.001427149,0.006344669,0.24682553],"genre_scores_gemma":[0.8273513,0.0032948584,0.111647844,0.0016947618,0.0005150706,0.0010407105,0.0010063559,0.00052638585,0.052922755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953768,0.0016723824,0.00023816757,0.00069917546,0.0014793818,0.0005339961],"domain_scores_gemma":[0.9904516,0.002011382,0.0017344521,0.0027200074,0.0017132025,0.0013693782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040494255,0.0003320859,0.0005581415,0.00088356604,0.002044484,0.0021792504,0.0021180967,0.000590191,0.029590271],"category_scores_gemma":[0.00825277,0.00046986248,0.00079409184,0.0011541558,0.0017480031,0.0012771526,0.0047978368,0.002058626,0.0057103373],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019757275,0.001562985,0.0158341,0.0021903582,0.00008839763,0.0016846466,0.0037639947,0.008146975,0.055053793,0.018790714,0.030152066,0.8607564],"study_design_scores_gemma":[0.0019581341,0.012488987,0.12358754,0.0017024857,0.00022653161,0.008758854,0.0043527517,0.01759491,0.08684309,0.015735554,0.726384,0.0003671536],"about_ca_topic_score_codex":0.014040419,"about_ca_topic_score_gemma":0.026100347,"teacher_disagreement_score":0.029590271,"about_ca_system_score_codex":0.0059424946,"about_ca_system_score_gemma":0.015830949,"threshold_uncertainty_score":0.09898937},"labels":[],"label_agreement":null},{"id":"W2901645458","doi":"10.1177/1078155218812945","title":"A case of severe, irreversible hypocalcemia after one dose of pamidronate administered for hypercalcemia of malignancy","year":2018,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Bone health and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Bisphosphonate; Malignancy; vitamin D deficiency; Incidence (geometry); Vitamin D and neurology; Cancer; Internal medicine; Osteoporosis; Gastroenterology; Surgery","score_opus":0.10198953141690957,"score_gpt":0.4462119020234829,"score_spread":0.3442223706065733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901645458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93199766,0.017385317,0.009626213,0.010549536,0.000946524,0.0003594838,0.0003666299,0.0004268664,0.028341897],"genre_scores_gemma":[0.98960567,0.0027018145,0.0017752661,0.0023815206,0.0007281367,0.00003512723,0.000083696475,0.000035128403,0.0026536698],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9992341,0.0001336233,0.00009275511,0.00015645,0.00012993127,0.00025305257],"domain_scores_gemma":[0.9982323,0.0004632976,0.00059059623,0.00016681568,0.00011160101,0.00043539738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031537347,0.0013271953,0.0010481956,0.0017934956,0.0021790795,0.001394848,0.0011824055,0.0044425447,0.0020342807],"category_scores_gemma":[0.0034623211,0.0009463527,0.0015012573,0.0014609047,0.0011994684,0.0021914577,0.0016145187,0.004077894,0.0005736541],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040482566,0.000055062006,0.0046328097,0.000038086182,0.00001043029,0.9920195,0.00024144271,0.000083302504,0.0006958268,0.00022026336,0.0004469009,0.001515935],"study_design_scores_gemma":[0.000007664358,0.000051043775,0.0014104724,0.000009419439,0.000009714859,0.99701464,0.00008083807,0.00011780382,0.00032335662,0.000114536764,0.0008536302,0.0000068994123],"about_ca_topic_score_codex":0.002244354,"about_ca_topic_score_gemma":0.0031620641,"teacher_disagreement_score":0.0044425447,"about_ca_system_score_codex":0.0011393445,"about_ca_system_score_gemma":0.0010720382,"threshold_uncertainty_score":0.008266568},"labels":[],"label_agreement":null},{"id":"W2913849805","doi":"10.1177/1078155219828806","title":"Relative bioavailability of an extemporaneously prepared aprepitant oral suspension in healthy adults","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Nausea and vomiting management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Pediatric Oncology Group; University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"Garron Family Cancer Centre; Hospital for Sick Children; Pediatric Oncology Group of Ontario","keywords":"Aprepitant; Bioavailability; Bioequivalence; Capsule; Medicine; Pharmacokinetics; Nausea; Pharmacology; Vomiting; Crossover study; Chemotherapy-induced nausea and vomiting; Cmax; Anesthesia; Antiemetic; Placebo; Pathology","score_opus":0.0467665615634192,"score_gpt":0.4289969711107242,"score_spread":0.38223040954730503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913849805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720484,0.0015814413,0.00058855134,0.00003356842,0.00002266934,0.00012646645,0.00011753595,0.00001535427,0.00030944106],"genre_scores_gemma":[0.99823356,0.00034731772,0.0007955981,0.000085076754,0.000032395932,0.00007583737,0.00018554366,0.000003638146,0.00024104191],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99926084,0.0002757056,0.000078362136,0.00016561302,0.00018388947,0.00003549743],"domain_scores_gemma":[0.99900144,0.00032335398,0.00038349465,0.0000634061,0.00012383828,0.00010449334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017451547,0.00034611401,0.0005229586,0.00021088848,0.00016902915,0.00032477162,0.00017482533,0.0004717287,0.0011972693],"category_scores_gemma":[0.0024044584,0.00018516748,0.0002983254,0.0001475423,0.00028730487,0.0002775516,0.00020882214,0.00044006226,0.00031520694],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2963793,0.00990941,0.22418223,0.00131328,0.0015458356,0.0011897531,0.0008023014,0.0012931724,0.3052737,0.00022155132,0.0011358584,0.15675361],"study_design_scores_gemma":[0.008820382,0.51128536,0.4089245,0.00007316612,0.0009596368,0.0027854703,0.00029432063,0.0027329496,0.060743768,0.00013954713,0.0031939351,0.000046918438],"about_ca_topic_score_codex":0.00032561706,"about_ca_topic_score_gemma":0.00022377603,"teacher_disagreement_score":0.0017451547,"about_ca_system_score_codex":0.00019731912,"about_ca_system_score_gemma":0.00025027597,"threshold_uncertainty_score":0.009229362},"labels":[],"label_agreement":null},{"id":"W2925036534","doi":"10.1177/1078155219837333","title":"Survival outcomes associated with different sunitinib dosing regimens in metastatic renal cell carcinoma","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Dosing; Medicine; Sunitinib; Renal cell carcinoma; Discontinuation; Internal medicine; Surgery","score_opus":0.07079760148535519,"score_gpt":0.37716953225057115,"score_spread":0.30637193076521596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925036534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810565,0.0012170157,0.00006775814,0.000036014644,0.000005020314,0.000011336802,0.00029556334,0.0000031195507,0.00025842706],"genre_scores_gemma":[0.9992387,0.00021177415,0.000036981455,0.000015062525,0.000010934136,0.000008509832,0.0004364536,0.0000013010682,0.000040228453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865156,0.00045157748,0.00017955319,0.00022645283,0.00034089168,0.0001500721],"domain_scores_gemma":[0.9949372,0.0017492264,0.0025070626,0.00012207741,0.0003317029,0.0003526855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017146122,0.0001594854,0.00044286012,0.00059362414,0.00022882914,0.0004760553,0.00022762448,0.00031826977,0.00090090366],"category_scores_gemma":[0.0047444566,0.00008832776,0.0007486352,0.0007793085,0.00028304235,0.0004738268,0.00042268532,0.0005360314,0.000095545205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010183103,0.00023786996,0.9644201,0.00017676894,0.00068434485,0.00021367124,0.000110464935,0.0011522457,0.0011415194,0.000043369935,0.00031943398,0.021317152],"study_design_scores_gemma":[0.00012577567,0.0026728548,0.9950112,0.000020243271,0.00024271145,0.0004403323,0.000079053236,0.00064680964,0.00043846085,0.00006659401,0.00024583723,0.000010097316],"about_ca_topic_score_codex":0.00085840723,"about_ca_topic_score_gemma":0.0016769032,"teacher_disagreement_score":0.0017146122,"about_ca_system_score_codex":0.0010151303,"about_ca_system_score_gemma":0.00034714388,"threshold_uncertainty_score":0.009067893},"labels":[],"label_agreement":null},{"id":"W2934475215","doi":"10.1177/1078155219839458","title":"Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"Ipsen Biopharmaceuticals","keywords":"Medicine; Lanreotide; Octreotide; Neuroendocrine tumors; Observational study; Internal medicine; Neuroendocrine carcinoma; Oncology; Somatostatin; Gastroenterology; Growth hormone; Acromegaly; Carcinoma; Hormone","score_opus":0.0331734117751259,"score_gpt":0.3898444417554972,"score_spread":0.3566710299803713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2934475215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983677,0.00038920168,0.00046244,0.0000357574,0.000011703303,0.000097879965,0.00043322422,0.0000037801444,0.00019828985],"genre_scores_gemma":[0.9985348,0.00014030575,0.00042099415,0.000037374655,0.00002135419,0.00013482422,0.0006154827,0.000002731546,0.00009227329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963276,0.0019792023,0.00047537105,0.00047962496,0.0005215441,0.00021668227],"domain_scores_gemma":[0.98535836,0.005856579,0.006538635,0.0005361718,0.00082501216,0.000885227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038919435,0.00026676132,0.00098055,0.0009787696,0.00043295286,0.0006109719,0.00053026056,0.00043351782,0.0013368821],"category_scores_gemma":[0.009357861,0.00023735766,0.0021296872,0.0013053188,0.0003104669,0.0006063406,0.0007924217,0.0006272165,0.00014546879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017813466,0.0008167453,0.9704514,0.000169055,0.0016177135,0.000063686,0.0004099225,0.00043885672,0.0004325701,0.00007074856,0.00023468409,0.007481137],"study_design_scores_gemma":[0.0011135952,0.020229246,0.97009224,0.000049883034,0.0015399347,0.00024785567,0.0013254168,0.0036864604,0.00046288315,0.00009797456,0.0011120309,0.00004251766],"about_ca_topic_score_codex":0.003281732,"about_ca_topic_score_gemma":0.004024343,"teacher_disagreement_score":0.0038919435,"about_ca_system_score_codex":0.00095957046,"about_ca_system_score_gemma":0.0009548468,"threshold_uncertainty_score":0.020582795},"labels":[],"label_agreement":null},{"id":"W2937090821","doi":"10.1177/1078155219842329","title":"Impact of the introduction of novel hormonal agents on metastatic castration-resistant prostate cancer treatment choice","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"Réseau de cancérologie Rossy","keywords":"Medicine; Docetaxel; Enzalutamide; Prostate cancer; Internal medicine; Cohort; Abiraterone acetate; Oncology; Medical prescription; Cancer; Hormonal therapy; Androgen deprivation therapy; Pharmacology","score_opus":0.11467175331138577,"score_gpt":0.49921140993396806,"score_spread":0.38453965662258227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937090821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98732424,0.004604865,0.00012815962,0.0026429924,0.000040102354,0.000031615815,0.0012385177,0.000010934482,0.00397844],"genre_scores_gemma":[0.9984983,0.00060274196,0.000057513735,0.00018888086,0.00002343787,0.000004500015,0.00025481425,0.000003177469,0.0003665791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988361,0.0003759558,0.00007556684,0.00014886557,0.00029392494,0.00026961343],"domain_scores_gemma":[0.9918094,0.0020172275,0.0036747444,0.00017793805,0.0009334511,0.001387209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013091586,0.00012586161,0.0002522822,0.00034055984,0.0004972597,0.0010465666,0.0004998258,0.0003775922,0.0041843415],"category_scores_gemma":[0.008110377,0.00009685534,0.00067319983,0.00076995743,0.00032830215,0.00042415675,0.00033426966,0.0006865106,0.00018428819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041673065,0.000069146765,0.9863193,0.000039759103,0.00010332051,0.000122444,0.000067191046,0.00037949783,0.00012771247,0.00010344908,0.00066307845,0.011588548],"study_design_scores_gemma":[0.000017370698,0.000112140115,0.9977404,0.000041811723,0.000057295834,0.00014429222,0.00016036055,0.00047374895,0.00006587928,0.000024845098,0.001155939,0.0000059023987],"about_ca_topic_score_codex":0.4142282,"about_ca_topic_score_gemma":0.5371583,"teacher_disagreement_score":0.4142282,"about_ca_system_score_codex":0.006553145,"about_ca_system_score_gemma":0.0072380863,"threshold_uncertainty_score":0.82363427},"labels":[],"label_agreement":null},{"id":"W2940319705","doi":"10.1177/1078155219843675","title":"Optimizing patient education of oncology medications: A quantitative analysis of the patient perspective","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aberdeen Regional Hospital; Nova Scotia Health Authority","funders":"","keywords":"Medicine; Pharmacist; Family medicine; Patient education; Internal medicine; Oncology; Nursing; Pharmacy","score_opus":0.07104078666103733,"score_gpt":0.47626981778101385,"score_spread":0.40522903111997655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940319705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802655,0.00007975337,0.00014485401,0.00029855722,0.0000061384,0.000059918566,0.00029114287,0.0000025406405,0.0010903812],"genre_scores_gemma":[0.99888355,0.00011559777,0.00034067297,0.000120364064,0.000004685028,0.00007955207,0.00018411793,0.0000021223414,0.00026934175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99680966,0.0015982494,0.00027586098,0.00017182538,0.0007290557,0.0004153773],"domain_scores_gemma":[0.98493886,0.0082318215,0.0031885288,0.00028479524,0.0023449294,0.001011165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051751565,0.00016522796,0.00030992128,0.0013208581,0.0011754782,0.0015858043,0.00035977626,0.0003684498,0.0017954945],"category_scores_gemma":[0.018117033,0.00018576944,0.00042062375,0.0012450017,0.0008437531,0.00081406947,0.0016785741,0.0007494811,0.00013206867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030142945,0.00018886608,0.7875334,0.0004043142,0.000097210475,0.00035926222,0.18185815,0.00012772605,0.0009217612,0.0004225748,0.0019137944,0.025871564],"study_design_scores_gemma":[0.000021482321,0.0003189173,0.66589046,0.00019736022,0.00004181749,0.0002983895,0.3279578,0.00048279922,0.00028255774,0.00013930711,0.0043348684,0.0000341867],"about_ca_topic_score_codex":0.008440214,"about_ca_topic_score_gemma":0.014755395,"teacher_disagreement_score":0.008440214,"about_ca_system_score_codex":0.0026750255,"about_ca_system_score_gemma":0.0024943063,"threshold_uncertainty_score":0.027369201},"labels":[],"label_agreement":null},{"id":"W2946596565","doi":"10.1177/1078155219846952","title":"Concomitant use of capecitabine and proton pump inhibitors – Is it safe?","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Richmond Hospital","funders":"Association Canadienne de Pharmacie en Oncologie","keywords":"Capecitabine; Medicine; Rabeprazole; Proton-pump inhibitor; Drug; Pharmacology; Seriousness; Concomitant; Oncology; Internal medicine; Drug interaction; Intensive care medicine; Cancer; Colorectal cancer","score_opus":0.0597436009393854,"score_gpt":0.40288855315836125,"score_spread":0.34314495221897584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946596565","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3052876,0.555251,0.0066098603,0.11307726,0.0021031098,0.00016147298,0.00060109096,0.00006651411,0.01684212],"genre_scores_gemma":[0.84402573,0.1323542,0.0044451472,0.013751422,0.003968279,0.00008189709,0.0003155465,0.000030319445,0.0010273544],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995717,0.0017747855,0.0007455242,0.0004321663,0.0011756889,0.00015482736],"domain_scores_gemma":[0.95720637,0.022036606,0.015687473,0.0012038704,0.0025751728,0.0012905337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048587364,0.00028270035,0.0015620072,0.0005387009,0.000629437,0.0015266713,0.00051439926,0.0020409818,0.0040642507],"category_scores_gemma":[0.035688445,0.00021010335,0.0012529548,0.00086478906,0.0015892348,0.0019625458,0.0006084554,0.0018201839,0.0006322571],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006800978,0.00053785776,0.2886123,0.008518481,0.002314554,0.0065009706,0.00063396833,0.00059750606,0.0029501237,0.00431659,0.011709952,0.6665068],"study_design_scores_gemma":[0.0020450382,0.016894333,0.53549284,0.035808265,0.006128878,0.08534486,0.0050786007,0.0033616596,0.008055213,0.04606135,0.25540128,0.00032766702],"about_ca_topic_score_codex":0.0007535341,"about_ca_topic_score_gemma":0.0015537603,"teacher_disagreement_score":0.0048587364,"about_ca_system_score_codex":0.00074960815,"about_ca_system_score_gemma":0.0015625093,"threshold_uncertainty_score":0.025695741},"labels":[],"label_agreement":null},{"id":"W2948116664","doi":"10.1177/1078155219850299","title":"Adherence to human epidermal growth factor receptor-2 testing and adjuvant trastuzumab treatment guidelines in Ontario","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Ontario Institute for Cancer Research; Public Health Ontario; Institute for Clinical Evaluative Sciences; Alberta Bone and Joint Health Institute; University of Calgary; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network; University of Toronto; Sunnybrook Health Science Centre; Hospital for Sick Children; Cancer Care Ontario; McMaster University; St. Joseph’s Healthcare Hamilton; Canadian Centre for Applied Research in Cancer Control","funders":"Ontario Institute for Cancer Research; Ontario Ministry of Health and Long-Term Care","keywords":"Trastuzumab; Medicine; Oncology; Internal medicine; Breast cancer; Cancer; Epidermal growth factor receptor; Immunohistochemistry; Gynecology","score_opus":0.31022023476033067,"score_gpt":0.5294626497073359,"score_spread":0.21924241494700525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2948116664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947465,0.00045283925,0.00009396967,0.00064840744,0.000011909523,0.0000449246,0.0017091767,0.000007284979,0.0022849303],"genre_scores_gemma":[0.99838614,0.00027794953,0.00009139547,0.00009249169,0.0000069544294,0.000020129892,0.0005974783,0.0000028599366,0.0005246481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837,0.00015198051,0.0001410911,0.00019683522,0.0006410908,0.00049906166],"domain_scores_gemma":[0.99425405,0.00041269083,0.0026679586,0.00014833579,0.0015444214,0.0009726036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007034678,0.00017843592,0.00024936348,0.0007291753,0.0013658922,0.00081469887,0.00082165207,0.0002783195,0.0016357594],"category_scores_gemma":[0.0051832474,0.00031642092,0.0004069748,0.0023576904,0.00055479154,0.00031822425,0.0008325331,0.00032943903,0.00010461259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004103654,0.000018133604,0.99557143,0.00002431476,0.000022877726,0.000086497465,0.0005608186,0.00008165832,0.000104332685,0.000051997587,0.0006443905,0.0027924601],"study_design_scores_gemma":[0.000007107385,0.000013978617,0.9987417,0.000014850716,0.00000920257,0.00003795755,0.00031836098,0.00014390849,0.00002521253,0.000009937236,0.0006738657,0.0000038652793],"about_ca_topic_score_codex":0.9832722,"about_ca_topic_score_gemma":0.9862109,"teacher_disagreement_score":0.9832722,"about_ca_system_score_codex":0.021844374,"about_ca_system_score_gemma":0.030315818,"threshold_uncertainty_score":0.15849274},"labels":[],"label_agreement":null},{"id":"W2964960971","doi":"10.1177/1078155219862040","title":"Comparison between two premedication regimens of dexamethasone before a pemetrexed-based chemotherapy: A single-center experience study","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut universitaire de cardiologie et de pneumologie de Québec; Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec","funders":"","keywords":"Medicine; Dexamethasone; Pemetrexed; Regimen; Premedication; Chemotherapy; Internal medicine; Chemotherapy regimen; Single Center; Surgery; Anesthesia; Oncology; Cisplatin","score_opus":0.08138048394853586,"score_gpt":0.5062292627131044,"score_spread":0.42484877876456856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964960971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987821,0.0004887982,0.00016904935,0.0000136931085,0.000018362729,0.0003673234,0.000021598711,0.0000027176206,0.00013648983],"genre_scores_gemma":[0.99746895,0.00083158,0.0009936047,0.0000711837,0.000090262074,0.0002793983,0.00010592271,0.0000031436277,0.00015605068],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9970048,0.0018540764,0.00030772816,0.00030301482,0.00034629757,0.00018402787],"domain_scores_gemma":[0.99551183,0.0019060235,0.0008639275,0.00043690993,0.00040602832,0.00087524235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038644334,0.0006582713,0.0017231709,0.00048233842,0.0005325815,0.00062209263,0.0006765556,0.0005989738,0.0014994993],"category_scores_gemma":[0.0051963786,0.0003446752,0.0013569716,0.0004967594,0.00063142186,0.00074186205,0.00039609385,0.0010391452,0.00026536206],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32787964,0.39238757,0.061278533,0.0019443661,0.0027419461,0.0008058221,0.0022590745,0.0022938119,0.02356122,0.0002873399,0.00059736735,0.18396336],"study_design_scores_gemma":[0.016701601,0.95889443,0.021536674,0.000028018267,0.00036286435,0.00017610293,0.00020909589,0.00044342753,0.0012031955,0.000022947777,0.00040219852,0.000019416275],"about_ca_topic_score_codex":0.00082716433,"about_ca_topic_score_gemma":0.001513942,"teacher_disagreement_score":0.0038644334,"about_ca_system_score_codex":0.00082037604,"about_ca_system_score_gemma":0.001095902,"threshold_uncertainty_score":0.02043736},"labels":[],"label_agreement":null},{"id":"W2966864262","doi":"10.1177/1078155219865931","title":"Evaluation of decontamination strategies for cyclophosphamide","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medical Device Sterilization and Disinfection","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Human decontamination; Cyclophosphamide; Intensive care medicine; Internal medicine; Chemotherapy; Pathology","score_opus":0.05720562013633591,"score_gpt":0.4325025211999046,"score_spread":0.3752969010635687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2966864262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376136,0.0037601027,0.0012730118,0.00003853879,0.000018833352,0.00016583779,0.00006866476,0.000021352345,0.00089244166],"genre_scores_gemma":[0.99175644,0.003090972,0.004164029,0.00004693861,0.000011949881,0.00007304381,0.00014457256,0.000008412203,0.0007036691],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99951315,0.00011558783,0.00003677616,0.00009811925,0.00017528502,0.00006106259],"domain_scores_gemma":[0.99964356,0.000080481484,0.000119867545,0.000029796272,0.00009042608,0.000035806304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034272528,0.0005387774,0.00037716408,0.00036866256,0.00017421313,0.0004580921,0.00037721082,0.0003900959,0.0010055193],"category_scores_gemma":[0.0008129048,0.00012960921,0.00022486529,0.00021081812,0.00023588717,0.00030973254,0.00027044822,0.00023779098,0.00018296542],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025241864,0.0008316262,0.003755518,0.0008654445,0.00005206956,0.00009713468,0.000081310216,0.0008328862,0.94457895,0.00006591758,0.00007108457,0.046243984],"study_design_scores_gemma":[0.000120855664,0.04895609,0.019702129,0.00016155628,0.00021475229,0.0004818577,0.00023248579,0.0020805357,0.9244843,0.000078837526,0.0034655083,0.000020933858],"about_ca_topic_score_codex":0.0009651226,"about_ca_topic_score_gemma":0.0012438507,"teacher_disagreement_score":0.0010055193,"about_ca_system_score_codex":0.0002975182,"about_ca_system_score_gemma":0.00043244244,"threshold_uncertainty_score":0.0033638477},"labels":[],"label_agreement":null},{"id":"W2968062006","doi":"10.1177/1078155219864406","title":"Implementation of an online chemotherapy checking training module enhances scope of practice and ensures competency","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Simulation-Based Education in Healthcare","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"Alberta Cancer Foundation","keywords":"Scope (computer science); Task (project management); Medicine; Alertness; Variety (cybernetics); Training (meteorology); Computer science; Medical education; Artificial intelligence; Programming language","score_opus":0.10795893989070637,"score_gpt":0.5284234198532434,"score_spread":0.420464479962537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968062006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6706978,0.00028949446,0.1826028,0.0064819455,0.0010044173,0.024414955,0.0014707485,0.01588521,0.097152576],"genre_scores_gemma":[0.34609804,0.0005982032,0.579344,0.0017921546,0.00031802256,0.012512829,0.0013639079,0.0004952445,0.057477526],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998615,0.00049073825,0.00013826894,0.00015010669,0.0003895148,0.00021637348],"domain_scores_gemma":[0.99235255,0.0032122198,0.0006670391,0.0008126079,0.001334897,0.0016206785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030449661,0.00059116294,0.000521967,0.0008856429,0.00045171112,0.00072783534,0.0009946555,0.00078526477,0.026451172],"category_scores_gemma":[0.00861963,0.00040955536,0.00062379247,0.000357102,0.00019969068,0.00076208066,0.001521778,0.0009979402,0.010490462],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052576076,0.021253021,0.011738347,0.00064828555,0.000024945519,0.00027286645,0.0013188814,0.0022643546,0.017380806,0.0007006464,0.027331624,0.91654056],"study_design_scores_gemma":[0.002448086,0.036108773,0.29692465,0.0023184114,0.00017844062,0.0040312717,0.0021171148,0.035390962,0.07245744,0.005044576,0.54233253,0.0006477537],"about_ca_topic_score_codex":0.00028642558,"about_ca_topic_score_gemma":0.0008727687,"teacher_disagreement_score":0.026451172,"about_ca_system_score_codex":0.00049804617,"about_ca_system_score_gemma":0.0022347206,"threshold_uncertainty_score":0.08848798},"labels":[],"label_agreement":null},{"id":"W2969810241","doi":"10.1177/1078155219868525","title":"External contamination of antineoplastic drug containers from a Canadian wholesaler","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Docetaxel; Ifosfamide; Vinorelbine; Vial; Drug packaging; Antineoplastic Drugs; Contamination; Medicine; Irinotecan; Paclitaxel; Camptothecin; Pharmacology; Chemotherapy; Surgery; Chromatography; Internal medicine; Cancer; Chemistry; Cisplatin","score_opus":0.034623440308504776,"score_gpt":0.43802260050283515,"score_spread":0.40339916019433036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969810241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339855,0.0008346259,0.0008601366,0.00013231518,0.00001289976,0.00016074885,0.0012190713,0.000032036674,0.0033495363],"genre_scores_gemma":[0.99389064,0.0009849976,0.0015473216,0.0002786042,0.000006872352,0.000027680473,0.0009078264,0.000015756674,0.0023402872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982223,0.00008717989,0.000079451354,0.00029868382,0.0010924432,0.00021993341],"domain_scores_gemma":[0.99832124,0.00009535953,0.00059879955,0.000064119435,0.00081187347,0.00010856698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006383501,0.00048626884,0.00023988554,0.0007724086,0.0016933259,0.0014088462,0.0006583921,0.00039031057,0.0024690973],"category_scores_gemma":[0.0010080242,0.00028957883,0.00031521503,0.0014261813,0.0008897857,0.0003970047,0.0006234177,0.00034487294,0.0004175866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002349871,0.00008721173,0.95991224,0.00023570219,0.00005691778,0.0010515976,0.0021770813,0.00010364138,0.016072314,0.000109270724,0.0010073227,0.018951649],"study_design_scores_gemma":[0.000005326214,0.0002288431,0.9786693,0.000093402174,0.000056576668,0.0014517258,0.0029736487,0.00021040237,0.009601322,0.000030429359,0.006658632,0.000020450458],"about_ca_topic_score_codex":0.72229433,"about_ca_topic_score_gemma":0.7243507,"teacher_disagreement_score":0.27770567,"about_ca_system_score_codex":0.006858391,"about_ca_system_score_gemma":0.0069802497,"threshold_uncertainty_score":0.5586822},"labels":[],"label_agreement":null},{"id":"W2978048836","doi":"10.1177/1078155219876683","title":"Voriconazole prophylaxis in leukemic patients: A retrospective single-center study","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"","keywords":"Voriconazole; Medicine; Posaconazole; Internal medicine; Incidence (geometry); Fluconazole; Retrospective cohort study; Myeloid leukemia; Acute leukemia; Leukemia; Surgery; Antifungal; Dermatology","score_opus":0.028973254345573834,"score_gpt":0.3749430525480026,"score_spread":0.34596979820242874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978048836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988661,0.00050622935,0.000118246215,0.00002238305,0.000004071738,0.000033163178,0.00018924926,0.0000031777147,0.00025747324],"genre_scores_gemma":[0.9993375,0.00024066774,0.00010450915,0.000034423123,0.000010054289,0.000020154685,0.00022199427,0.0000017638432,0.000028898903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986094,0.0003464772,0.0002527948,0.0003442658,0.0003233153,0.00012363796],"domain_scores_gemma":[0.99658895,0.00054190855,0.0020102398,0.00027071702,0.00030649794,0.00028169237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011059842,0.00026980927,0.00059533014,0.0008116377,0.0005953864,0.00074816844,0.00038931036,0.00032689577,0.0016881686],"category_scores_gemma":[0.0032255538,0.00040320778,0.00038763057,0.0016248062,0.00038039696,0.00058487727,0.00043695164,0.00045415573,0.00028260713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111470516,0.000036312733,0.9988972,0.000018854633,0.00003413453,0.00010571192,0.000055589673,0.000010298856,0.00008702619,0.0000129927785,0.00004865877,0.0005816147],"study_design_scores_gemma":[0.00009300077,0.0009212575,0.9942469,0.000051322837,0.0001647759,0.0026477668,0.00064122357,0.0002547916,0.00019005495,0.00004376824,0.00073347864,0.000011849288],"about_ca_topic_score_codex":0.0024154878,"about_ca_topic_score_gemma":0.0029555834,"teacher_disagreement_score":0.0024154878,"about_ca_system_score_codex":0.00046695623,"about_ca_system_score_gemma":0.00072889216,"threshold_uncertainty_score":0.0058490634},"labels":[],"label_agreement":null},{"id":"W2994312780","doi":"10.1177/1078155219890659","title":"Toxic epidermal necrolysis associated with pembrolizumab","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de l'Outaouais; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Toxic epidermal necrolysis; Pembrolizumab; Medicine; Rash; Erythroderma; Dermatology; Maculopapular rash; Skin biopsy; Paraneoplastic pemphigus; Pathology; Biopsy; Cancer; Internal medicine; Immunology; Immunotherapy; Antibody","score_opus":0.03781405407038124,"score_gpt":0.38944784365116236,"score_spread":0.3516337895807811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994312780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91317576,0.051160846,0.005929998,0.0008152461,0.00026117833,0.00020381833,0.0002369702,0.0005093498,0.027706806],"genre_scores_gemma":[0.9932587,0.0044161472,0.00046135185,0.00027251217,0.00012080194,0.000015615311,0.00011788444,0.0000122604915,0.0013247161],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99966097,0.0000581124,0.000053254054,0.000041423187,0.00007920269,0.00010700663],"domain_scores_gemma":[0.9994804,0.00011647191,0.00023159805,0.000056715504,0.000048112066,0.00006662623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021399098,0.0006311975,0.0004207685,0.0007393362,0.00046506876,0.00045190062,0.0002828357,0.0008364984,0.0027662222],"category_scores_gemma":[0.0011391198,0.00026607676,0.0004361568,0.0005321185,0.00041208765,0.00046326924,0.00045867127,0.00083567336,0.00073504867],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024165293,0.00009299196,0.037777573,0.00065187673,0.00009586857,0.9171981,0.00024633098,0.00019828108,0.012251737,0.00031081715,0.0014031737,0.029531635],"study_design_scores_gemma":[0.000017211201,0.00007542642,0.012675855,0.00008519533,0.000053512536,0.98093855,0.00007872611,0.00019328564,0.0022240083,0.00014436197,0.0035083236,0.0000054466414],"about_ca_topic_score_codex":0.00075205776,"about_ca_topic_score_gemma":0.000801002,"teacher_disagreement_score":0.0027662222,"about_ca_system_score_codex":0.0002743686,"about_ca_system_score_gemma":0.00028090188,"threshold_uncertainty_score":0.009253919},"labels":[],"label_agreement":null},{"id":"W2996559717","doi":"10.1177/1078155219892666","title":"Integration of a nausea and vomiting assessment tool into antineoplastic management of pediatric oncology patients","year":2019,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Nausea and vomiting management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; Alberta Health Services","funders":"","keywords":"Nausea; Vomiting; Medicine; Chemotherapy; Quality of life (healthcare); Psychological intervention; Intensive care medicine; Internal medicine; Nursing","score_opus":0.02966264793266361,"score_gpt":0.423860209679362,"score_spread":0.3941975617466984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996559717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98036397,0.001262285,0.002128443,0.001908894,0.00007017967,0.0020508692,0.0012473363,0.0002827774,0.010685156],"genre_scores_gemma":[0.9726093,0.0012468122,0.022012817,0.00056572596,0.000059975937,0.0012299846,0.0013779036,0.00002752269,0.0008700624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968273,0.0015584511,0.0004096059,0.00013990456,0.00078919163,0.0002755088],"domain_scores_gemma":[0.99083626,0.0029422883,0.002850272,0.00026765332,0.0016201076,0.0014834814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003598959,0.0002563254,0.00039247258,0.0012161961,0.00037834654,0.00083446264,0.0007448349,0.00029338626,0.0018676973],"category_scores_gemma":[0.015849734,0.00018422636,0.00044368705,0.0013561163,0.00025476754,0.00055077695,0.0012404077,0.0006460256,0.0002808529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028061235,0.0007857951,0.712826,0.00044092876,0.0000623399,0.0006413573,0.0020440829,0.0005838082,0.00063804345,0.00013543347,0.00876364,0.272798],"study_design_scores_gemma":[0.000083373976,0.001237546,0.9822527,0.00033178856,0.00004894633,0.0009811071,0.0017496381,0.0016635652,0.000680611,0.00009350507,0.010840479,0.000036613685],"about_ca_topic_score_codex":0.014909248,"about_ca_topic_score_gemma":0.035670355,"teacher_disagreement_score":0.014909248,"about_ca_system_score_codex":0.0021019173,"about_ca_system_score_gemma":0.0045234906,"threshold_uncertainty_score":0.029644907},"labels":[],"label_agreement":null},{"id":"W3005534920","doi":"10.1177/1078155220904147","title":"Very high-dose methylprednisolone for treatment of nivolumab-induced limbic encephalitis: A case report","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Nivolumab; Limbic encephalitis; Prednisone; Adverse effect; Methylprednisolone; Encephalitis; Weakness; Cancer; Internal medicine; Anesthesia; Surgery; Immunotherapy; Immunology","score_opus":0.1220786963557368,"score_gpt":0.446066123515647,"score_spread":0.3239874271599102,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005534920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9193657,0.026800284,0.0096722,0.013533647,0.0018196383,0.0006641085,0.0005060836,0.0006206951,0.027017612],"genre_scores_gemma":[0.98932344,0.0032187772,0.0019933174,0.0018222705,0.0015545355,0.00005268255,0.000100314384,0.000039395927,0.0018953911],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99892163,0.0001368307,0.00011771473,0.00025627585,0.00017788383,0.0003896539],"domain_scores_gemma":[0.998659,0.00030376832,0.0003060034,0.00013201118,0.00009453696,0.00050472276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048804365,0.0028039385,0.0016956289,0.0033487584,0.0037586405,0.002321428,0.0016819951,0.0092612505,0.0025725865],"category_scores_gemma":[0.00227215,0.0015579439,0.0023013318,0.001859394,0.0019754395,0.0030910994,0.0016771244,0.005242404,0.0011060617],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015938273,0.00003092164,0.0011532579,0.000021874408,0.000007873916,0.9976815,0.000066964545,0.00003354989,0.00023560283,0.00006732211,0.00018184738,0.00050337915],"study_design_scores_gemma":[0.000008547153,0.000034012646,0.0008272786,0.000013972292,0.000009673359,0.9984164,0.00005084246,0.00014330377,0.00016219965,0.00005459585,0.00027318788,0.0000060433626],"about_ca_topic_score_codex":0.0034416954,"about_ca_topic_score_gemma":0.0044394056,"teacher_disagreement_score":0.0092612505,"about_ca_system_score_codex":0.0024537572,"about_ca_system_score_gemma":0.0017811677,"threshold_uncertainty_score":0.017803371},"labels":[],"label_agreement":null},{"id":"W3009614921","doi":"10.1177/1078155220907650","title":"Managing chemotherapy-related toxicities in the community setting: A survey of pharmacists in Ontario","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Cancer Care Ontario; University of Toronto","funders":"","keywords":"Medicine; Pharmacy; Family medicine; Socioeconomic status; Pharmaceutical care; Cancer; Pharmacy practice; Nursing; Internal medicine; Population; Environmental health","score_opus":0.2134095114127702,"score_gpt":0.49789875927577887,"score_spread":0.28448924786300867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009614921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99662554,0.00016880778,0.00004707307,0.000736114,0.000004564238,0.00011023601,0.0003187316,0.0000031871334,0.0019858216],"genre_scores_gemma":[0.99817634,0.0005076893,0.00013385802,0.0003937752,0.0000066681177,0.00003877814,0.00017673508,0.0000018043581,0.00056437904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988728,0.00014955267,0.00007493792,0.00009057005,0.00053613895,0.00027595332],"domain_scores_gemma":[0.99744666,0.00021217397,0.0008903995,0.000037121976,0.0006109558,0.00080278266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006654242,0.00013533044,0.00017490903,0.0004769567,0.0016374657,0.0007220656,0.00043974924,0.0004051076,0.0022179687],"category_scores_gemma":[0.002667699,0.0002772144,0.00019552455,0.0012830519,0.00046143166,0.00047169116,0.00079044275,0.0004196555,0.00018521339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060330774,0.00015313689,0.9751267,0.0001453917,0.00002303223,0.00067917095,0.009365278,0.00005120514,0.0008163034,0.000034313667,0.001769437,0.011775728],"study_design_scores_gemma":[0.000012070701,0.00011366686,0.9880769,0.00003677,0.000005614886,0.00023073044,0.008820824,0.00010850296,0.000041282132,0.000010281267,0.0025371395,0.0000062016484],"about_ca_topic_score_codex":0.71404797,"about_ca_topic_score_gemma":0.8683487,"teacher_disagreement_score":0.28595203,"about_ca_system_score_codex":0.006024118,"about_ca_system_score_gemma":0.0109317275,"threshold_uncertainty_score":0.5752721},"labels":[],"label_agreement":null},{"id":"W3010072035","doi":"10.1177/1078155220907125","title":"Cross-sectional evaluation of surface contamination with 9 antineoplastic drugs in 93 Canadian healthcare centers: 2019 results","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Docetaxel; Antineoplastic Drugs; Cyclophosphamide; Pharmacy; Vinorelbine; Gemcitabine; Internal medicine; Outpatient clinic; Cabazitaxel; Oncology; Cancer; Pharmacology; Chemotherapy; Family medicine","score_opus":0.1376602587389043,"score_gpt":0.5074619643237185,"score_spread":0.3698017055848142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010072035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98576343,0.0009074511,0.0005621259,0.00013378063,0.0000131327215,0.00024326294,0.0092602,0.000030185834,0.0030863415],"genre_scores_gemma":[0.99441046,0.00049046864,0.0011721699,0.00012565442,0.000007547343,0.000060825703,0.0027502263,0.000007866563,0.00097479625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974809,0.00014438367,0.00012624016,0.00042536878,0.0012516433,0.0005713742],"domain_scores_gemma":[0.99743396,0.000120978846,0.00046275774,0.00005641012,0.001601688,0.00032429668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010314068,0.00065592787,0.0003927748,0.0022191764,0.0020405524,0.0011866948,0.0010665734,0.00046600707,0.0016444527],"category_scores_gemma":[0.0018344189,0.00047394127,0.0005572599,0.0044055684,0.0007153187,0.0002930262,0.0010025238,0.00033197072,0.0002348815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066391156,0.00002131255,0.9930697,0.000079766774,0.000056738798,0.00007327779,0.0005247074,0.00010340913,0.00068731455,0.000023401277,0.0005921878,0.004701826],"study_design_scores_gemma":[0.0000014720823,0.000033262066,0.9979017,0.000014102242,0.000017481936,0.000056082674,0.0008324741,0.00011578775,0.0002191851,0.0000038764747,0.0007987861,0.0000058058354],"about_ca_topic_score_codex":0.9614941,"about_ca_topic_score_gemma":0.9779574,"teacher_disagreement_score":0.03850591,"about_ca_system_score_codex":0.01678686,"about_ca_system_score_gemma":0.015098594,"threshold_uncertainty_score":0.12179774},"labels":[],"label_agreement":null},{"id":"W3010156616","doi":"10.1177/1078155220907129","title":"Quantification of healthcare workers’ exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de Santé Publique du Québec; Centre intégré de santé et de services sociaux de la Montérégie-Centre; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Université de Montréal; Santé Montérégie; Centre Intégré de Santé et de Services Sociaux des Laurentides; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Urine; Ifosfamide; Cyclophosphamide; Health care; Methotrexate; Internal medicine; Chemotherapy; Etoposide","score_opus":0.17944044003681844,"score_gpt":0.4720080280671828,"score_spread":0.2925675880303643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010156616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990595,0.00011694609,0.00040761713,0.0000098211785,0.0000023777027,0.00007934634,0.000108707594,0.0000034845195,0.00021220172],"genre_scores_gemma":[0.9984225,0.00010541962,0.0008967156,0.000039613613,0.000007991923,0.000083296174,0.00014774114,0.000001638394,0.00029518304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992374,0.0002184838,0.00007640433,0.00017047582,0.00022311237,0.00007415128],"domain_scores_gemma":[0.99836534,0.00042540015,0.00054292777,0.00009707525,0.00043223728,0.00013702187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009768575,0.00035406149,0.00023293188,0.00047278818,0.0005123832,0.00035993406,0.0003004092,0.00040250883,0.0008588974],"category_scores_gemma":[0.0017418856,0.00020326972,0.000245929,0.00032069275,0.00040687513,0.0002647076,0.0002661643,0.00018103915,0.00019697512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084413175,0.0010192884,0.96751547,0.00012693806,0.00005490144,0.00023336572,0.0014358493,0.00006891571,0.01877771,0.000010213516,0.00009093672,0.009822417],"study_design_scores_gemma":[0.000022256932,0.0068402644,0.9852697,0.00001523836,0.000039961473,0.00068437844,0.0015144928,0.00015442804,0.005052632,0.000012952797,0.0003833103,0.000010311301],"about_ca_topic_score_codex":0.0068219034,"about_ca_topic_score_gemma":0.00882918,"teacher_disagreement_score":0.0068219034,"about_ca_system_score_codex":0.00033813991,"about_ca_system_score_gemma":0.0005330632,"threshold_uncertainty_score":0.013564408},"labels":[],"label_agreement":null},{"id":"W3010753547","doi":"10.1177/1078155220910252","title":"Safety of trastuzumab after trastuzumab emtansine-induced nodular regenerative hyperplasia: A case report","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Trastuzumab emtansine; Trastuzumab; Nodular regenerative hyperplasia; Internal medicine; Breast cancer; Oncology; Cirrhosis; Surgery; Gastroenterology; Cancer; Portal hypertension","score_opus":0.10711538175138427,"score_gpt":0.4658162816026355,"score_spread":0.3587008998512512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010753547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615892,0.016068364,0.00502873,0.005122546,0.0005485983,0.00019267257,0.00019833758,0.00024605435,0.01100557],"genre_scores_gemma":[0.9938362,0.0016275718,0.0006586617,0.0009878069,0.0006629555,0.000028034892,0.00011743499,0.000024337609,0.0020568776],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9991559,0.00014066829,0.000098366705,0.00019741122,0.0001597781,0.0002479466],"domain_scores_gemma":[0.9970228,0.0009970013,0.00076225144,0.00037441516,0.00018994397,0.0006535873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006001659,0.0011552991,0.0011015041,0.0014394377,0.0015831951,0.0015959532,0.0010199444,0.004642463,0.0018262689],"category_scores_gemma":[0.0033252824,0.0006081559,0.001388799,0.0008195723,0.0012581587,0.0016234244,0.0011965972,0.0029196064,0.000874754],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059667636,0.00004622218,0.0048680156,0.000026906522,0.000014234521,0.9922909,0.00010664178,0.000064984975,0.0006055703,0.00013875576,0.00021181509,0.0015663209],"study_design_scores_gemma":[0.000018178062,0.000091251786,0.0022423714,0.000010053153,0.000015619053,0.9959965,0.00005209262,0.00027128754,0.00054753973,0.00010341838,0.0006448685,0.000006829071],"about_ca_topic_score_codex":0.00095373846,"about_ca_topic_score_gemma":0.00087835867,"teacher_disagreement_score":0.004642463,"about_ca_system_score_codex":0.0012608003,"about_ca_system_score_gemma":0.00081707555,"threshold_uncertainty_score":0.009147823},"labels":[],"label_agreement":null},{"id":"W3011063999","doi":"10.1177/1078155220908948","title":"Safety of two-hour intermittent intravenous infusions of tacrolimus in the allogeneic hematopoietic stem cell transplantation unit","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Tacrolimus; Nephrotoxicity; Discontinuation; Neurotoxicity; Transplantation; Adverse effect; Hematopoietic stem cell transplantation; Population; Anesthesia; Internal medicine; Toxicity; Gastroenterology; Urology","score_opus":0.0579723187395441,"score_gpt":0.3729555157035169,"score_spread":0.3149831969639728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011063999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99687696,0.001407495,0.0005765627,0.00007376583,0.000011513019,0.000029354109,0.00010529147,0.000016372946,0.0009026982],"genre_scores_gemma":[0.99884844,0.0005147314,0.0002806109,0.00008033759,0.00002819171,0.000017251235,0.00013913495,0.000004438307,0.0000868591],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837863,0.0005152833,0.00030366625,0.00012247001,0.0006091605,0.00007086926],"domain_scores_gemma":[0.99215513,0.0018302823,0.0044302004,0.00036966882,0.00081812637,0.00039663684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001458191,0.00013282061,0.0004676792,0.0003440216,0.00025027647,0.00055896613,0.00022882935,0.0001903556,0.00042934637],"category_scores_gemma":[0.006427235,0.00007647692,0.00023507439,0.00048816626,0.00025007347,0.00025662716,0.00018124987,0.00040734606,0.00013275503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001477831,0.00021709122,0.91709274,0.00014803869,0.000073004114,0.0013086308,0.00031090147,0.00035543466,0.0034891434,0.000065364555,0.0004457359,0.075016156],"study_design_scores_gemma":[0.00006866067,0.0085678715,0.9740724,0.00013106462,0.0001402129,0.007581967,0.00033481803,0.0011005667,0.005874427,0.00006569741,0.0020447592,0.00001764351],"about_ca_topic_score_codex":0.00059294497,"about_ca_topic_score_gemma":0.00052523875,"teacher_disagreement_score":0.001458191,"about_ca_system_score_codex":0.0003634012,"about_ca_system_score_gemma":0.0004950405,"threshold_uncertainty_score":0.007711768},"labels":[],"label_agreement":null},{"id":"W3014032731","doi":"10.1177/1078155220914349","title":"Stability of extemporaneously compounded temozolomide 10 mg/mL suspensions in Oral Mix SF® in glass and plastic bottles and plastic syringes","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Temozolomide; Medicine; Citric acid; Chromatography; Surgery; Chemistry; Food science; Chemotherapy","score_opus":0.1395919372264321,"score_gpt":0.45628747861382074,"score_spread":0.31669554138738865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014032731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993687,0.0016180055,0.0031414647,0.00003821684,0.00003288985,0.000091385176,0.0004607495,0.00007080474,0.0008593686],"genre_scores_gemma":[0.98731506,0.0011789872,0.008539065,0.00003395083,0.000015550406,0.00015112292,0.0007621837,0.000035583522,0.0019684571],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99954504,0.00009291778,0.000052679043,0.00012568153,0.00015101013,0.000032705044],"domain_scores_gemma":[0.9995134,0.000118986616,0.00015490185,0.000049854436,0.00013054545,0.00003228412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007523258,0.00045351003,0.00029946413,0.0002724072,0.00022228449,0.00037361876,0.00026500484,0.00026826435,0.00186645],"category_scores_gemma":[0.0011678471,0.0001876798,0.00024237238,0.00031216134,0.0003132955,0.00035852668,0.00024446484,0.00038927514,0.00041370123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013770183,0.00008358539,0.002889167,0.000112935064,0.000040572882,0.00008282743,0.00024179267,0.00023800433,0.985091,0.00006180953,0.00011552034,0.009665729],"study_design_scores_gemma":[0.000053714775,0.0038654045,0.01904304,0.000039542705,0.00013098723,0.00038161527,0.00016372468,0.0013129333,0.9721734,0.00004568493,0.002757145,0.000032984983],"about_ca_topic_score_codex":0.0012287316,"about_ca_topic_score_gemma":0.0012756689,"teacher_disagreement_score":0.00186645,"about_ca_system_score_codex":0.0004279126,"about_ca_system_score_gemma":0.00043344157,"threshold_uncertainty_score":0.006243944},"labels":[],"label_agreement":null},{"id":"W3015742209","doi":"10.1177/1078155219897959","title":"Proceedings of the biosimilars workshop at the International Symposium on Oncology Pharmacy Practice 2019","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Medicine; Pharmacy; Formulary; Product (mathematics); Pharmacology; Family medicine; Internal medicine","score_opus":0.0693095778245597,"score_gpt":0.4139647923595849,"score_spread":0.3446552145350252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015742209","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012019668,0.037336893,0.004337316,0.43327484,0.3736727,0.0006946936,0.0009670646,0.00035497997,0.13734196],"genre_scores_gemma":[0.09303732,0.040148355,0.007201763,0.08800651,0.15423207,0.0012896502,0.002543939,0.00063922507,0.61290115],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995453,0.0016498215,0.00021255735,0.0005218355,0.0014555583,0.0007072132],"domain_scores_gemma":[0.99200225,0.0009771344,0.00033651906,0.00013559306,0.0018776078,0.004670797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008893625,0.0013870569,0.00069708575,0.001249635,0.0030663568,0.0056303237,0.0014851833,0.0061482526,0.059390992],"category_scores_gemma":[0.00937061,0.00050465454,0.0012253772,0.00072698237,0.0012571106,0.0027017351,0.0064619407,0.008211732,0.015844164],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001685322,0.0002101237,0.00035727842,0.00033066212,0.000018564595,0.00048677518,0.00082567363,0.00016619998,0.0008835502,0.0021347401,0.9403143,0.0541036],"study_design_scores_gemma":[0.000032566208,0.00008518554,0.00094919605,0.0003299016,0.000008159507,0.0001990682,0.00061018654,0.00009253083,0.00026736487,0.0011622187,0.99624676,0.000016965572],"about_ca_topic_score_codex":0.0020411517,"about_ca_topic_score_gemma":0.006287295,"teacher_disagreement_score":0.059390992,"about_ca_system_score_codex":0.004091249,"about_ca_system_score_gemma":0.009234897,"threshold_uncertainty_score":0.19868267},"labels":[],"label_agreement":null},{"id":"W3015995016","doi":"10.1177/1078155219893441","title":"International Society of Oncology Pharmacy Practitioners global position on the use of biosimilars in cancer treatment and supportive care","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Biosimilar; Medicine; Pharmacy; Pharmacovigilance; Health care; Position statement; Product (mathematics); Pharmacy practice; Family medicine; Pharmacology; Adverse effect; Internal medicine","score_opus":0.15815005056833825,"score_gpt":0.4658848871336269,"score_spread":0.30773483656528866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015995016","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015319705,0.030287461,0.0023625472,0.806565,0.08449854,0.00029019325,0.00026285092,0.00015680063,0.07404467],"genre_scores_gemma":[0.048150603,0.09150337,0.01972572,0.5104218,0.12355437,0.00078331534,0.0012453699,0.00060231454,0.20401312],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9663282,0.0065069334,0.0027881612,0.0025483486,0.0175138,0.0043145414],"domain_scores_gemma":[0.9242804,0.011018938,0.010619921,0.0027096802,0.024036562,0.027334416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036011294,0.0018752533,0.0015725977,0.002921849,0.004237253,0.011915264,0.0029164571,0.023149902,0.013071843],"category_scores_gemma":[0.033004668,0.00087285315,0.001609794,0.0040268227,0.005122526,0.0060419096,0.008244091,0.022275284,0.009189308],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006269674,0.00015379752,0.0008445338,0.0005389831,0.000027543152,0.00024597923,0.00053013535,0.0003056681,0.0008808704,0.015050556,0.87928885,0.10207034],"study_design_scores_gemma":[0.00003682502,0.000094116825,0.0010093098,0.00092765986,0.000017196317,0.0003120431,0.00022443109,0.00012845622,0.00029026344,0.0036987348,0.9932371,0.000023962497],"about_ca_topic_score_codex":0.004829291,"about_ca_topic_score_gemma":0.0078083747,"teacher_disagreement_score":0.036011294,"about_ca_system_score_codex":0.006196642,"about_ca_system_score_gemma":0.058538042,"threshold_uncertainty_score":0.19044822},"labels":[],"label_agreement":null},{"id":"W3017304434","doi":"10.1177/1078155220915769","title":"Oral sodium bicarbonate protocol for high-dose methotrexate urine alkalinization: A pediatric experience","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital; University of Alberta; Stollery Children's Hospital; Alberta Health Services","funders":"","keywords":"Medicine; Sodium bicarbonate; Methotrexate; Urine; Bicarbonate; Pharmacology; Internal medicine","score_opus":0.11547888598136673,"score_gpt":0.4798205246155273,"score_spread":0.3643416386341606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017304434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97429854,0.009880419,0.004999521,0.0021081555,0.00019136931,0.00057540834,0.0002313152,0.00010312038,0.007612131],"genre_scores_gemma":[0.9779468,0.010409121,0.008553858,0.0013130439,0.00018060002,0.00016775262,0.00034258462,0.00004794944,0.0010382318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936897,0.00021874733,0.00008155661,0.00008980618,0.00013549444,0.00010540027],"domain_scores_gemma":[0.99899644,0.00017540691,0.00019706787,0.00007345358,0.00013703946,0.00042049045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009251209,0.00040220734,0.00034921628,0.0002814866,0.0006032102,0.00064463966,0.00048093745,0.0004909098,0.0012045456],"category_scores_gemma":[0.0024562972,0.00019796494,0.00030200614,0.0008001198,0.000658565,0.0004533203,0.0006141795,0.000998852,0.00031728396],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016829993,0.0042425776,0.54607743,0.0010737883,0.0002256393,0.082590364,0.0044363285,0.0017016861,0.01063399,0.0017040174,0.013679,0.33195218],"study_design_scores_gemma":[0.0007599811,0.021325137,0.54285526,0.0009699365,0.00044377355,0.30909646,0.005779143,0.0035491071,0.013352326,0.0011287588,0.100577675,0.00016238222],"about_ca_topic_score_codex":0.004992627,"about_ca_topic_score_gemma":0.011831102,"teacher_disagreement_score":0.004992627,"about_ca_system_score_codex":0.0015999479,"about_ca_system_score_gemma":0.0021757828,"threshold_uncertainty_score":0.011608541},"labels":[],"label_agreement":null},{"id":"W3024661543","doi":"10.1177/1078155220927450","title":"Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Pharmacy; Pandemic; Coronavirus disease 2019 (COVID-19); Health care; Pharmacy practice; Adverse effect; Pharmaceutical care; Family medicine; Global health; Oncology; Intensive care medicine; Nursing; Public health; Internal medicine; Infectious disease (medical specialty); Disease","score_opus":0.31796318706339144,"score_gpt":0.6090012370732517,"score_spread":0.29103805000986027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024661543","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009521137,0.005291529,0.0010630022,0.9652057,0.0031874573,0.00003768623,0.00020561283,0.00003859086,0.015449313],"genre_scores_gemma":[0.27824298,0.025995793,0.0033148634,0.6755631,0.009866171,0.00007600211,0.00038008447,0.00014105086,0.0064200424],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9897037,0.005087158,0.0007072836,0.00071396126,0.0023411475,0.0014467407],"domain_scores_gemma":[0.96769494,0.014293298,0.0046007647,0.0012005399,0.0068614664,0.0053489543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009520934,0.00033603594,0.0004956212,0.0007315947,0.003328845,0.0071859625,0.0010150055,0.006071767,0.007749048],"category_scores_gemma":[0.038175404,0.00021102726,0.0008761178,0.0013033728,0.0044486057,0.006108342,0.006249436,0.01036913,0.00088037725],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011423599,0.00013395977,0.0334548,0.0014434139,0.0001476682,0.0027579805,0.011623452,0.0009897428,0.00073995517,0.06622165,0.72747016,0.15490305],"study_design_scores_gemma":[0.000038385024,0.0001868026,0.015221498,0.0021220576,0.000053226708,0.0012595481,0.015773477,0.0006652644,0.0005998928,0.027478658,0.9364932,0.00010805152],"about_ca_topic_score_codex":0.015277935,"about_ca_topic_score_gemma":0.036011543,"teacher_disagreement_score":0.015277935,"about_ca_system_score_codex":0.006023639,"about_ca_system_score_gemma":0.017271543,"threshold_uncertainty_score":0.050352097},"labels":[],"label_agreement":null},{"id":"W3033377324","doi":"10.1177/1078155220929415","title":"Opioid rotation from transdermal fentanyl to continuous subcutaneous hydromorphone in a cachectic patient: A case report and review of the literature","year":2020,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Hydromorphone; Medicine; Transdermal; Fentanyl; Anesthesia; Opioid; Morphine; Pharmacology; Internal medicine","score_opus":0.0346936673618775,"score_gpt":0.39066156994830475,"score_spread":0.35596790258642724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033377324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11683384,0.8585973,0.004521008,0.005413966,0.0018202183,0.00018969714,0.0002671895,0.00019550945,0.012161319],"genre_scores_gemma":[0.43680242,0.54393953,0.0040800576,0.005226634,0.0058045913,0.000087978,0.00036351767,0.00007897549,0.0036162098],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99929214,0.00009111265,0.00020380889,0.000149301,0.00014649749,0.000117034804],"domain_scores_gemma":[0.99890924,0.00039403822,0.00042711565,0.00004357298,0.00009133694,0.0001346514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037561957,0.0016224972,0.0015315389,0.003949166,0.0012933316,0.0018174328,0.0016412367,0.003412208,0.0021103786],"category_scores_gemma":[0.0017537777,0.00076688995,0.0011201351,0.004354432,0.0017121849,0.0026844686,0.0010122288,0.0021241766,0.0012249051],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025109099,0.00006827808,0.005165156,0.0018503194,0.00006438358,0.9680722,0.00049343496,0.00015920858,0.00083858066,0.00035321745,0.0037981824,0.019111864],"study_design_scores_gemma":[0.0000048889983,0.000023592924,0.0018732594,0.00047401167,0.000051048755,0.99074125,0.00042476883,0.000100361525,0.00015166991,0.00016675833,0.0059718825,0.000016500151],"about_ca_topic_score_codex":0.0019105859,"about_ca_topic_score_gemma":0.0033032058,"teacher_disagreement_score":0.003949166,"about_ca_system_score_codex":0.00094748405,"about_ca_system_score_gemma":0.001017216,"threshold_uncertainty_score":0.0070599914},"labels":[],"label_agreement":null},{"id":"W3034836530","doi":"10.1177/1078155220929756","title":"A real-world data approach to determine the optimal dosing strategy for pembrolizumab","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Dosing; Vial; Medicine; Lung cancer; Pharmacy; Pembrolizumab; Cost sharing; Cancer; Emergency medicine; Internal medicine; Nursing; Immunotherapy","score_opus":0.422417440482586,"score_gpt":0.5594710717550829,"score_spread":0.13705363127249692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034836530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6885277,0.0028488217,0.1545127,0.009001807,0.00018754783,0.0038512629,0.11327983,0.0010624164,0.026727952],"genre_scores_gemma":[0.8988606,0.0005596632,0.07734633,0.00032671122,0.00004669145,0.00083783,0.021358483,0.000053219363,0.0006104229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99245036,0.004026233,0.0009077099,0.0011453084,0.001196951,0.00027356157],"domain_scores_gemma":[0.96525294,0.019904405,0.005985463,0.0022814325,0.0060395165,0.00053625996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01155603,0.0006811643,0.000691164,0.004157065,0.0005078125,0.0033656014,0.0013110772,0.001169484,0.003360018],"category_scores_gemma":[0.04562218,0.00051833014,0.0009765672,0.0056601902,0.00055385235,0.002062615,0.0009539229,0.0011015057,0.0006932334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016183924,0.0011015033,0.4855706,0.0018784283,0.0011842247,0.00052029593,0.000660006,0.33508715,0.0023604988,0.015315595,0.016030207,0.13867314],"study_design_scores_gemma":[0.0003030764,0.0012018125,0.17423205,0.00059025,0.00040045212,0.0004987254,0.0025283783,0.7722132,0.0028501549,0.012915828,0.03213251,0.00013350701],"about_ca_topic_score_codex":0.024022967,"about_ca_topic_score_gemma":0.018861137,"teacher_disagreement_score":0.024022967,"about_ca_system_score_codex":0.0041069738,"about_ca_system_score_gemma":0.0031623545,"threshold_uncertainty_score":0.061114848},"labels":[],"label_agreement":null},{"id":"W3035248893","doi":"10.1177/1078155220929754","title":"Educational needs of oncology pharmacists: A survey by the International Society of Oncology Pharmacy Practitioners","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Pharmacy; Medicine; Internal medicine; Oncology; Pharmacy practice; Family medicine; Descriptive statistics; Medical education","score_opus":0.2493643759119361,"score_gpt":0.5229458394202,"score_spread":0.2735814635082639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035248893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944007,0.0004188765,0.000095185256,0.0021533011,0.000021616454,0.00008489237,0.0005532451,0.00000491968,0.0022673055],"genre_scores_gemma":[0.9959002,0.0012723157,0.00041096334,0.0011485834,0.000037148537,0.00014687907,0.00042638902,0.000004398607,0.0006530272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802244,0.00055384665,0.00025026422,0.00015668843,0.0006702143,0.00034659205],"domain_scores_gemma":[0.9932105,0.0013065625,0.0027167003,0.00011029983,0.0011984236,0.001457504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029369644,0.00012745996,0.00025921484,0.001067496,0.0006888096,0.00090267666,0.00030133114,0.00086724275,0.001834893],"category_scores_gemma":[0.010384766,0.00023249765,0.00031427672,0.0015118287,0.0002631495,0.0014400643,0.0013087398,0.00096428575,0.00038784198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035821824,0.00022534239,0.97065645,0.0001570622,0.000024995503,0.00035649465,0.010331479,0.000053640782,0.0003577009,0.00005298153,0.0031793679,0.014568602],"study_design_scores_gemma":[0.0000103052325,0.0002640167,0.9608472,0.00017844512,0.000012395893,0.0009347216,0.030661294,0.00016714807,0.00009265578,0.000030840034,0.006789381,0.000011711508],"about_ca_topic_score_codex":0.004616316,"about_ca_topic_score_gemma":0.0064993105,"teacher_disagreement_score":0.004616316,"about_ca_system_score_codex":0.00076348835,"about_ca_system_score_gemma":0.0017803252,"threshold_uncertainty_score":0.015532315},"labels":[],"label_agreement":null},{"id":"W3038008047","doi":"10.1177/1078155220934163","title":"Tolerability of pemetrexed and oxaliplatin in the treatment of stage III colon cancer during raltitrexed shortage","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Oxaliplatin; Medicine; Tolerability; Pemetrexed; Raltitrexed; Colorectal cancer; Internal medicine; Oncology; Regimen; Adverse effect; Discontinuation; Capecitabine; Chemotherapy; Cancer; Cisplatin","score_opus":0.095645687261969,"score_gpt":0.44555424946895417,"score_spread":0.3499085622069852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038008047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897831,0.006705451,0.00072983967,0.00031030536,0.000025430832,0.000052324696,0.00005434736,0.000013944477,0.0023251516],"genre_scores_gemma":[0.9985447,0.0008074547,0.00017290759,0.00013635565,0.00001942335,0.000008121497,0.0000405109,0.0000032917872,0.00026724345],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99983203,0.00007022798,0.000023576451,0.0000151135255,0.00003761604,0.00002138389],"domain_scores_gemma":[0.9995529,0.00014644743,0.00017664595,0.00001992212,0.000044330987,0.000059756127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037653197,0.00009756791,0.00031679793,0.00008214132,0.00016249948,0.00023381056,0.00010003357,0.00018415276,0.00059316144],"category_scores_gemma":[0.0013834784,0.00006354358,0.0003006129,0.00013954769,0.00009668057,0.00022586704,0.000119517514,0.00040835753,0.00010258646],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022459758,0.002572138,0.32004514,0.0024011873,0.0009771147,0.075441256,0.0030992164,0.0048017404,0.18285523,0.00064185297,0.0037607842,0.38094455],"study_design_scores_gemma":[0.001146328,0.09121655,0.6111567,0.0003941914,0.0012447725,0.18064606,0.0019620957,0.006511346,0.06551766,0.00050411094,0.039612,0.0000881892],"about_ca_topic_score_codex":0.000653929,"about_ca_topic_score_gemma":0.0011893507,"teacher_disagreement_score":0.000653929,"about_ca_system_score_codex":0.00027623583,"about_ca_system_score_gemma":0.00018667697,"threshold_uncertainty_score":0.0020042658},"labels":[],"label_agreement":null},{"id":"W3046818137","doi":"10.1177/1078155220945374","title":"Off-label infusion of biosimilar bevacizumab: A provincial experience","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Bevacizumab; Biosimilar; Medicine; Pharmacology; Surgery; Internal medicine; Chemotherapy","score_opus":0.09157931705200487,"score_gpt":0.4237562736411736,"score_spread":0.3321769565891687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046818137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838816,0.0026392492,0.002641543,0.0013940274,0.00007149328,0.00021526476,0.00020079527,0.000055386467,0.008900572],"genre_scores_gemma":[0.9895566,0.003269126,0.002022984,0.0011747055,0.00006905332,0.000040620223,0.0004503817,0.00006544998,0.0033511543],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99872273,0.0004287786,0.00007058707,0.000114147566,0.0004734567,0.00019024605],"domain_scores_gemma":[0.99659085,0.00070354925,0.0004886071,0.00035062732,0.00074077887,0.0011255897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017590172,0.00026541675,0.00034558217,0.00020315929,0.0010526181,0.0011882896,0.00057012984,0.000526781,0.002006501],"category_scores_gemma":[0.00768855,0.0002190338,0.0003725949,0.0007564671,0.0007056241,0.00053396967,0.00068301073,0.0019945153,0.0006445137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01466678,0.029136458,0.17868781,0.0007349091,0.00047441042,0.01756725,0.016089214,0.0027609076,0.046050113,0.002723972,0.015403534,0.6757046],"study_design_scores_gemma":[0.009976807,0.13651873,0.4351148,0.00069216115,0.001222062,0.1125947,0.009929361,0.016228423,0.055246342,0.0031479008,0.21893965,0.0003890439],"about_ca_topic_score_codex":0.030335661,"about_ca_topic_score_gemma":0.041380655,"teacher_disagreement_score":0.030335661,"about_ca_system_score_codex":0.003326561,"about_ca_system_score_gemma":0.0044558886,"threshold_uncertainty_score":0.060318172},"labels":[],"label_agreement":null},{"id":"W3080500936","doi":"10.1177/1078155220950412","title":"Clinical pharmacy services in an ambulatory oncology clinic: Patient perception and satisfaction","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Horizon Health Network","funders":"","keywords":"Medicine; Pharmacist; Pharmacy; Ambulatory; Family medicine; Clinical pharmacy; Patient satisfaction; Ambulatory care; Nursing; Health care; Internal medicine","score_opus":0.2740545123783654,"score_gpt":0.5610473654386364,"score_spread":0.286992853060271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080500936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99783415,0.00026963183,0.00006732182,0.00037668349,0.0000053429535,0.000015915935,0.00010113876,0.0000052619644,0.0013246373],"genre_scores_gemma":[0.99959475,0.000105784835,0.00007001979,0.000099328274,0.000006886633,0.00000693774,0.000034197506,9.1838234e-7,0.00008120495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978241,0.0010894994,0.00019178462,0.00010819063,0.0005494839,0.00023712208],"domain_scores_gemma":[0.99223644,0.002690887,0.0028580246,0.00007971747,0.00065114006,0.0014838453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002034148,0.000091808804,0.000284939,0.00047221076,0.0005729186,0.0011985935,0.00020461009,0.000395588,0.0044116103],"category_scores_gemma":[0.008139955,0.000098818215,0.00026204588,0.00080666796,0.0003599514,0.0004918404,0.0006519647,0.00051835383,0.00024038284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025634607,0.00032019863,0.969112,0.00013653222,0.000071135124,0.00032120943,0.0054062638,0.00007609475,0.00037453006,0.00006294083,0.0012217049,0.022641083],"study_design_scores_gemma":[0.000030123809,0.0010717746,0.984915,0.000049803693,0.000033694236,0.0010825093,0.010705969,0.00034340683,0.00011595353,0.000059205708,0.0015785841,0.000013877429],"about_ca_topic_score_codex":0.0020732423,"about_ca_topic_score_gemma":0.0020083112,"teacher_disagreement_score":0.0044116103,"about_ca_system_score_codex":0.000490028,"about_ca_system_score_gemma":0.0006055289,"threshold_uncertainty_score":0.014758289},"labels":[],"label_agreement":null},{"id":"W3081239366","doi":"10.1177/1078155220951845","title":"Evaluating genomic biomarkers associated with resistance or sensitivity to chemotherapy in patients with advanced breast and colorectal cancer","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Capecitabine; Oncology; Internal medicine; Colorectal cancer; Breast cancer; Oxaliplatin; Population; Irinotecan; Bevacizumab; Cohort; Cancer; Chemotherapy","score_opus":0.023036834099459485,"score_gpt":0.36349604843974925,"score_spread":0.34045921434028975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081239366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99822146,0.00048254695,0.00012215029,0.000036164383,0.0000023894274,0.000010322224,0.00081062916,0.000005137513,0.000309204],"genre_scores_gemma":[0.9988048,0.00013839258,0.00026449095,0.00002651877,0.0000056647036,0.000013194252,0.0006583955,0.0000014963733,0.000086983455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997042,0.000068498506,0.00003342801,0.00008946422,0.00005878386,0.000045727375],"domain_scores_gemma":[0.99920374,0.00013823056,0.0004637593,0.000041305844,0.00007388358,0.000079148354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033464242,0.00013307619,0.00028813878,0.001033648,0.0001936058,0.00045130376,0.00017543015,0.0002442745,0.00083930034],"category_scores_gemma":[0.0012134117,0.00011924431,0.00020519267,0.0013817567,0.00017634097,0.00017594393,0.0003009573,0.00018960185,0.00013847138],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014284399,0.000009101758,0.9966748,0.000013834257,0.0000272771,0.00003801191,0.000016212645,0.00008317218,0.0007370917,0.0000093202125,0.00008011332,0.0021682465],"study_design_scores_gemma":[0.000004742786,0.000051851737,0.99888164,0.0000029734501,0.00002126423,0.00027593074,0.000036368103,0.00014954314,0.00031341208,0.000013936474,0.00024687167,0.0000016326729],"about_ca_topic_score_codex":0.0020824594,"about_ca_topic_score_gemma":0.0027403333,"teacher_disagreement_score":0.0020824594,"about_ca_system_score_codex":0.00031549015,"about_ca_system_score_gemma":0.00021999197,"threshold_uncertainty_score":0.004140675},"labels":[],"label_agreement":null},{"id":"W3090557829","doi":"10.1177/1078155220960823","title":"Assessment of Canadian patient education material for oncology pharmaceutics","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Health Literacy and Information Accessibility","field":"Health Professions","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Readability; Medicine; Health literacy; Reading (process); Comprehension; Index (typography); Patient education; Health care; Literacy; Medical education; Family medicine; Oncology; Medical physics; Psychology; Pedagogy; World Wide Web","score_opus":0.210418510204725,"score_gpt":0.6111942620725934,"score_spread":0.4007757518678684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090557829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88620806,0.0015330279,0.001098212,0.0020815106,0.000095283634,0.00097278046,0.01765008,0.00029049075,0.0900706],"genre_scores_gemma":[0.9802358,0.0011424612,0.0038133613,0.00034712127,0.00003209886,0.00015662552,0.0055946712,0.0000256955,0.008652001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981205,0.0001434066,0.00013417631,0.000071354894,0.0013925582,0.00013785886],"domain_scores_gemma":[0.9893271,0.0018620023,0.0020118908,0.00018575831,0.005560089,0.001053104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016699162,0.00024036517,0.00021124611,0.002823508,0.0009288317,0.0009496762,0.00064605055,0.00025493253,0.014877536],"category_scores_gemma":[0.017872326,0.00009896212,0.00039269956,0.0021509882,0.0002805938,0.00043365877,0.00067914324,0.00042996978,0.00097976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003782405,0.00026833627,0.7550764,0.0010008999,0.00008641533,0.00040362103,0.0036610595,0.00048253292,0.0012522924,0.00037243043,0.03109527,0.20592253],"study_design_scores_gemma":[0.000013382411,0.00016845755,0.968832,0.00018741019,0.000034711997,0.0002726906,0.0016293222,0.00043344422,0.0006201203,0.00004976391,0.027738255,0.000020378437],"about_ca_topic_score_codex":0.5258032,"about_ca_topic_score_gemma":0.6064897,"teacher_disagreement_score":0.4741968,"about_ca_system_score_codex":0.008801419,"about_ca_system_score_gemma":0.011523119,"threshold_uncertainty_score":0.9539789},"labels":[],"label_agreement":null},{"id":"W3092092024","doi":"10.1177/1078155220962192","title":"Impact of dose-capping chemotherapy in concurrent chemoradiotherapy in rectal cancer patients","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Innovates - Health Solutions","keywords":"Medicine; Colorectal cancer; Toxicity; Chemotherapy; Internal medicine; Odds ratio; Chemoradiotherapy; Gastroenterology; Urology; Cancer; Body surface area; Surgery","score_opus":0.07881382300837912,"score_gpt":0.4776368017900626,"score_spread":0.3988229787816835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092092024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964126,0.0025466909,0.00019258441,0.00009658113,0.0000150262995,0.000016828415,0.00009506999,0.000006905564,0.00061765424],"genre_scores_gemma":[0.99934465,0.00030924327,0.00016932306,0.000039601182,0.000015598944,0.000005147558,0.0000615764,0.0000018182056,0.000052955464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946994,0.0002357732,0.00005795575,0.00006437976,0.00011564303,0.000056348406],"domain_scores_gemma":[0.9980564,0.00056978245,0.0009387855,0.00010572422,0.00008730925,0.00024199754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005043648,0.0001689979,0.00026596946,0.00022767202,0.00017525477,0.00048848323,0.00021459414,0.00017870257,0.0008329708],"category_scores_gemma":[0.003424635,0.00009898174,0.0004453594,0.00050499494,0.0002662973,0.0002913334,0.00031719415,0.0002638338,0.000065098524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040171705,0.00023890556,0.91058254,0.0002467684,0.0004922599,0.0008403964,0.00009568438,0.0018319021,0.0035594448,0.00005683473,0.000366894,0.07767125],"study_design_scores_gemma":[0.0000647759,0.0033800458,0.9898958,0.000059418977,0.00021818583,0.002166114,0.00007874303,0.0012265225,0.001313541,0.00006521872,0.0015201577,0.000011472103],"about_ca_topic_score_codex":0.00098824,"about_ca_topic_score_gemma":0.002106158,"teacher_disagreement_score":0.00098824,"about_ca_system_score_codex":0.00042260095,"about_ca_system_score_gemma":0.00033322157,"threshold_uncertainty_score":0.0030661821},"labels":[],"label_agreement":null},{"id":"W3092126151","doi":"10.1177/1078155220963550","title":"An exploration of mercaptopurine/methotrexate tolerance during maintenance therapy in children with acute lymphoblastic leukemia","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Mercaptopurine; Maintenance therapy; Methotrexate; Lymphoblastic Leukemia; Internal medicine; Leukemia; Pediatrics; Chemotherapy","score_opus":0.05078809239460636,"score_gpt":0.3882808544407327,"score_spread":0.3374927620461263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092126151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99817693,0.0012809982,0.00009028884,0.000059277674,0.0000018199579,0.000007425205,0.000055822875,0.0000033727104,0.00032419173],"genre_scores_gemma":[0.999316,0.00041963652,0.00014688668,0.000023481794,0.000004420948,0.000005861716,0.00004823825,0.0000011600836,0.000034326757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992501,0.00028873666,0.0001125357,0.000058234058,0.00022104706,0.00006918249],"domain_scores_gemma":[0.99613166,0.0014847221,0.0018716488,0.00009371524,0.00024951034,0.00016887642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010631811,0.00011084411,0.00018884876,0.0007534372,0.00023941394,0.00038472316,0.00026848592,0.00024611127,0.00055744074],"category_scores_gemma":[0.004767967,0.00010447452,0.00018796744,0.000951163,0.00026213934,0.00048846996,0.00018205233,0.0003483023,0.00005675562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001399988,0.000021284726,0.99203616,0.000042708012,0.0000106394955,0.0006036204,0.00030990882,0.000029983115,0.00029548872,0.000017659966,0.000040291052,0.0064522764],"study_design_scores_gemma":[0.000008257872,0.00059365603,0.98978174,0.000036230726,0.0000447304,0.007328741,0.0007739478,0.00013683614,0.00054120825,0.000035144636,0.00071555196,0.000004095138],"about_ca_topic_score_codex":0.002213878,"about_ca_topic_score_gemma":0.0019772265,"teacher_disagreement_score":0.002213878,"about_ca_system_score_codex":0.00056326314,"about_ca_system_score_gemma":0.0006060237,"threshold_uncertainty_score":0.0056227446},"labels":[],"label_agreement":null},{"id":"W3092974696","doi":"10.1177/1078155220964247","title":"Medication reconciliation in ambulatory oncology new patient clinics","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Ambulatory; Pharmacist; Flexibility (engineering); Medical emergency; Patient safety; Health care; Ambulatory care; Family medicine; Pharmacy; Internal medicine","score_opus":0.2883116566109833,"score_gpt":0.5292934698727221,"score_spread":0.2409818132617388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3092974696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97919446,0.00094974675,0.0034151939,0.0031261402,0.00014163146,0.0040827924,0.00043162523,0.0004986512,0.008159852],"genre_scores_gemma":[0.96406645,0.0008876699,0.030142218,0.0012507795,0.00017570794,0.0016227307,0.00033805586,0.00005973774,0.0014567277],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9758588,0.016077608,0.001954214,0.0011374163,0.0038722544,0.0010997895],"domain_scores_gemma":[0.93870586,0.023404092,0.014156208,0.006148602,0.009480859,0.00810434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023888012,0.00024965825,0.00058129936,0.0011280414,0.0031831465,0.0021663308,0.001666135,0.0009645632,0.004826015],"category_scores_gemma":[0.058523927,0.00047086793,0.00064138585,0.0011034643,0.0007741163,0.0016140506,0.0026521184,0.0017448979,0.0007768187],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003647394,0.016117178,0.18520501,0.0022234346,0.00022652466,0.0030262987,0.027872363,0.0025761465,0.007358985,0.0011557562,0.022119759,0.7284712],"study_design_scores_gemma":[0.003555801,0.05643958,0.7522691,0.002903532,0.00031275937,0.0073889256,0.027708007,0.011267045,0.017268566,0.0018450482,0.118499495,0.0005421693],"about_ca_topic_score_codex":0.003325728,"about_ca_topic_score_gemma":0.010435869,"teacher_disagreement_score":0.023888012,"about_ca_system_score_codex":0.0039519314,"about_ca_system_score_gemma":0.011021957,"threshold_uncertainty_score":0.12633336},"labels":[],"label_agreement":null},{"id":"W3094894289","doi":"10.1177/1078155220969797","title":"Risks of hepatitis C virus reactivation in a real-life population of oncology patients treated in an academic center","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hepatitis C virus research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Hepatitis C virus; Population; Hepatocellular carcinoma; Gastroenterology; Entecavir; Chemotherapy; Hepatitis C; Decompensation; Immunology; Hepatitis B virus; Virus; Lamivudine","score_opus":0.26556071281829735,"score_gpt":0.5367321290823053,"score_spread":0.2711714162640079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094894289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99944586,0.00015539325,0.00005192241,0.000069433954,0.000003448191,0.000006451475,0.00009852023,0.0000015612794,0.00016744941],"genre_scores_gemma":[0.9996636,0.000104547646,0.000035390596,0.00003102855,0.000015190549,0.000006575717,0.00011367375,9.068247e-7,0.00002925088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990864,0.00029658375,0.00010075503,0.0001848812,0.00014068911,0.00019077797],"domain_scores_gemma":[0.99653816,0.0007205251,0.0015904515,0.000111547466,0.00022432457,0.00081506855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008547666,0.00023264534,0.00038378357,0.0010386894,0.0007904393,0.0011299644,0.00034164172,0.0005168392,0.0017653275],"category_scores_gemma":[0.0038627652,0.00023589616,0.0002577453,0.0012523129,0.0004700683,0.00080356235,0.0007646107,0.0005817378,0.00024587862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038463008,0.000032295982,0.99897337,0.0000046191562,0.000008836509,0.00011397691,0.0000827289,0.000031084168,0.00003543605,0.000009240836,0.000045174995,0.00062472007],"study_design_scores_gemma":[0.0000069080525,0.0002464658,0.997054,0.000009359555,0.00001344551,0.00097061857,0.0010970454,0.00035683502,0.00003862789,0.000032343676,0.00016752824,0.0000069577663],"about_ca_topic_score_codex":0.0034484726,"about_ca_topic_score_gemma":0.0024314553,"teacher_disagreement_score":0.0034484726,"about_ca_system_score_codex":0.00067564455,"about_ca_system_score_gemma":0.00064118596,"threshold_uncertainty_score":0.006856799},"labels":[],"label_agreement":null},{"id":"W3095755590","doi":"10.1177/1078155220968613","title":"Actual body weight dosing of temozolomide and overall survival in patients with glioblastoma","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health; Alberta Health Services; Fraser Health","funders":"","keywords":"Temozolomide; Medicine; Body surface area; Dosing; Toxicity; Clinical endpoint; Glioblastoma; Phases of clinical research; Internal medicine; Dacarbazine; Body weight; Chemotherapy; Oncology; Clinical trial","score_opus":0.024541129886818922,"score_gpt":0.3406331577519476,"score_spread":0.31609202786512863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3095755590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876535,0.0006325856,0.000041349074,0.000031687505,0.0000023802734,0.0000060322577,0.00020576874,0.0000041838416,0.00031063904],"genre_scores_gemma":[0.99954295,0.00013316533,0.000044762382,0.000012146454,0.000002370967,0.0000028422419,0.00021010793,8.2909185e-7,0.000050920557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998338,0.000026621969,0.000019797582,0.000024370285,0.00007087232,0.000024418418],"domain_scores_gemma":[0.999012,0.0001102789,0.0006790565,0.00002043477,0.00009659383,0.00008166522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030378674,0.00008541033,0.00015384833,0.00040933365,0.00013309612,0.00026344042,0.00015488516,0.00012842608,0.0005666113],"category_scores_gemma":[0.0012841895,0.000069661,0.00011967935,0.00064621685,0.00014295542,0.00015343066,0.0001503082,0.00024361185,0.000071705086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041708996,0.000025127523,0.9954465,0.000016103822,0.000025549478,0.000050121344,0.000025967025,0.00011175092,0.0003056346,0.000006083146,0.00008449065,0.0034854955],"study_design_scores_gemma":[0.0000064064748,0.0002266034,0.99919456,0.0000037577913,0.000019825722,0.00013794102,0.0000261487,0.00010078535,0.00012222774,0.0000066682264,0.00015340578,0.0000015929405],"about_ca_topic_score_codex":0.0082645565,"about_ca_topic_score_gemma":0.0122991055,"teacher_disagreement_score":0.0082645565,"about_ca_system_score_codex":0.00077692984,"about_ca_system_score_gemma":0.00040704096,"threshold_uncertainty_score":0.016432881},"labels":[],"label_agreement":null},{"id":"W3097320822","doi":"10.1177/1078155220967738","title":"A multicenter review of infusion-related reactions to daratumumab for relapsed multiple myeloma in the real world setting","year":2020,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Daratumumab; Medicine; Multiple myeloma; Internal medicine; Oncology","score_opus":0.12117873050926282,"score_gpt":0.5053502990464438,"score_spread":0.384171568537181,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3097320822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019502953,0.9966271,0.0000769238,0.00036671635,0.00018115883,0.00007692453,0.00024983546,0.000008435477,0.00046270236],"genre_scores_gemma":[0.014943623,0.982831,0.00058425794,0.00064807595,0.00027685412,0.00012644373,0.00041557217,0.000006232206,0.00016793524],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99301744,0.002121084,0.0030200954,0.00046599898,0.0012415162,0.00013384571],"domain_scores_gemma":[0.96343774,0.015903475,0.013845547,0.0005745382,0.0056959,0.0005427221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007518515,0.0006536034,0.0024187174,0.012105802,0.00044290125,0.0015355092,0.001314449,0.0010356634,0.0023688392],"category_scores_gemma":[0.019323269,0.00040402287,0.0020778775,0.013081277,0.00052074704,0.0015260202,0.0006858994,0.0005840985,0.00039962487],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008508172,0.00011908865,0.0100445505,0.4941691,0.0036239044,0.0015132325,0.00082108896,0.00022291398,0.0017750589,0.00064421864,0.029838352,0.45637766],"study_design_scores_gemma":[0.00037666474,0.0019138579,0.08585274,0.46581256,0.021794789,0.014836574,0.0014713301,0.00023351006,0.0013769456,0.00036366205,0.4058557,0.000111604575],"about_ca_topic_score_codex":0.0016034205,"about_ca_topic_score_gemma":0.0045061787,"teacher_disagreement_score":0.012105802,"about_ca_system_score_codex":0.0019727442,"about_ca_system_score_gemma":0.004763706,"threshold_uncertainty_score":0.0397622},"labels":[],"label_agreement":null},{"id":"W3105095529","doi":"10.1177/1078155220974085","title":"A retrospective review of the real-world experience of the Pegfilgrastim biosimilar (Lapelga®) to the reference biologic (Neulasta®)","year":2020,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Pegfilgrastim; Medicine; Biosimilar; Febrile neutropenia; Filgrastim; Retrospective cohort study; Internal medicine; Neutropenia; Adverse effect; Incidence (geometry); Surgery; Oncology; Chemotherapy","score_opus":0.15253540125523035,"score_gpt":0.5035109893388551,"score_spread":0.3509755880836247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105095529","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787582,0.016795529,0.00047364528,0.00014196165,0.000022172213,0.0002770548,0.0021762804,0.000010833424,0.0013442525],"genre_scores_gemma":[0.9912212,0.006054739,0.00047023984,0.0002620121,0.000040988205,0.000142872,0.0015311333,0.000010436398,0.0002664099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960951,0.0013030297,0.00088757434,0.0007511949,0.0007536986,0.00020936041],"domain_scores_gemma":[0.98140097,0.0050204825,0.010621476,0.0008927208,0.0015482693,0.00051614095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030594117,0.00024607818,0.0006109806,0.0017715286,0.00028940634,0.0007611267,0.00055174745,0.00039777238,0.0017104555],"category_scores_gemma":[0.009938727,0.0003793806,0.0006235588,0.0028746745,0.00057561044,0.00045393629,0.00047348725,0.0002985744,0.00035088006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009239396,0.00014975703,0.9678065,0.0018541618,0.00039837998,0.003275071,0.00093520794,0.0002097331,0.00066363113,0.00021428824,0.0019633744,0.021605916],"study_design_scores_gemma":[0.00014027963,0.0015356317,0.9629069,0.001148514,0.00072823785,0.015389848,0.0024026178,0.00034112312,0.00092787785,0.00009287334,0.0143430345,0.000043069434],"about_ca_topic_score_codex":0.0030467848,"about_ca_topic_score_gemma":0.0027887963,"teacher_disagreement_score":0.0030594117,"about_ca_system_score_codex":0.0014005944,"about_ca_system_score_gemma":0.00156126,"threshold_uncertainty_score":0.01617992},"labels":[],"label_agreement":null},{"id":"W3112230402","doi":"10.1177/1078155220978446","title":"Accurate determination of glomerular filtration rate in adults for carboplatin dosing: Moving beyond Cockcroft and Gault","year":2020,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cégep de l'Outaouais; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Carboplatin; Dosing; Medicine; Renal function; Extrapolation; Urology; Intensive care medicine; Internal medicine; Oncology; Chemotherapy; Cisplatin; Statistics; Mathematics","score_opus":0.06847210940845423,"score_gpt":0.44502727345405246,"score_spread":0.37655516404559825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112230402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015518471,0.9983254,0.00030782388,0.00058850995,0.00012820838,0.000006998949,0.000035888635,0.0000050453527,0.00044698245],"genre_scores_gemma":[0.002967361,0.9951148,0.00092137913,0.0005299297,0.00019322708,0.00001681546,0.000069994225,0.000004117337,0.00018234245],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809617,0.00062711036,0.00041723912,0.00023308386,0.00058126193,0.000045194636],"domain_scores_gemma":[0.99614966,0.0024847607,0.000504269,0.00009804914,0.0007237255,0.00003960229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035316148,0.0005371041,0.0018830507,0.0022891392,0.00014283675,0.0012108883,0.0009932644,0.0010284112,0.0018780374],"category_scores_gemma":[0.007684567,0.0002549454,0.0014934608,0.0023854054,0.0005102732,0.0017097301,0.0005901148,0.0019802954,0.00071263785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013630248,0.000029565037,0.00093477673,0.03868407,0.0005939738,0.00007572663,0.000081273116,0.00041131847,0.0004086328,0.004069574,0.011638824,0.94293594],"study_design_scores_gemma":[0.00010914663,0.0004156342,0.008511445,0.056999836,0.0017232825,0.0021186783,0.00019271504,0.0006676293,0.0014420655,0.005610192,0.9221245,0.00008489508],"about_ca_topic_score_codex":0.0021851063,"about_ca_topic_score_gemma":0.0024486084,"teacher_disagreement_score":0.0035316148,"about_ca_system_score_codex":0.00072567625,"about_ca_system_score_gemma":0.0019670688,"threshold_uncertainty_score":0.018677235},"labels":[],"label_agreement":null},{"id":"W3112738960","doi":"10.1177/1078155220979047","title":"Blinatumomab use in pediatric ALL: Taking a BiTE out of preparation, administration and toxicity challenges","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Blinatumomab; Medicine; Food and drug administration; Toxicity; Pharmacy; Minimal residual disease; Pharmacology; Monoclonal antibody; CD19; Oncology; Intensive care medicine; Immunology; Antibody; Internal medicine; Family medicine; Leukemia","score_opus":0.23883833877160415,"score_gpt":0.4993435177847658,"score_spread":0.26050517901316167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112738960","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13678235,0.61649436,0.037707154,0.17216827,0.0021621448,0.0003659258,0.00025450162,0.0005982084,0.033467073],"genre_scores_gemma":[0.58673275,0.33234704,0.039043754,0.03136687,0.003734443,0.00034461048,0.00019636417,0.00027360895,0.0059606554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852705,0.00066383975,0.00018622639,0.00011108893,0.00040400287,0.00010786996],"domain_scores_gemma":[0.99737775,0.0010835552,0.00080447877,0.00012184747,0.00034289615,0.00026951905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026579797,0.00023986357,0.00074468367,0.0003492739,0.0006710632,0.0016184134,0.0005199282,0.0011168491,0.0018292965],"category_scores_gemma":[0.005190326,0.00017891586,0.00051262596,0.0003864587,0.0008269858,0.0017628293,0.0010884524,0.0032136007,0.0006554405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045579876,0.00031265465,0.013882504,0.0023320357,0.000090091184,0.0041355663,0.0011729756,0.0006681107,0.008593442,0.0060426965,0.026131887,0.9361822],"study_design_scores_gemma":[0.0002499792,0.0039605186,0.02666714,0.0056390185,0.00031321964,0.047470465,0.0032711804,0.0018756177,0.02673896,0.01298406,0.87074405,0.00008579042],"about_ca_topic_score_codex":0.0009491167,"about_ca_topic_score_gemma":0.0023605174,"teacher_disagreement_score":0.0026579797,"about_ca_system_score_codex":0.0009139956,"about_ca_system_score_gemma":0.0018063963,"threshold_uncertainty_score":0.014056921},"labels":[],"label_agreement":null},{"id":"W3115308691","doi":"10.1177/1078155220980051","title":"Results of a pre-implementation analysis of Ethiopia’s National Pediatric Cancer Registry","year":2020,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Cancer registry; Documentation; Workflow; Cancer; Pediatric cancer; Family medicine; Database","score_opus":0.15330059917364128,"score_gpt":0.5543706569300876,"score_spread":0.40107005775644633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115308691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98291785,0.000117994554,0.002502696,0.0013800621,0.000055041906,0.0029794842,0.0030521266,0.000099978366,0.006894821],"genre_scores_gemma":[0.96958727,0.00046719567,0.020231236,0.00082047493,0.000037950278,0.0023649754,0.0034505455,0.00007491395,0.0029655797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96512467,0.017337162,0.004517434,0.0017800349,0.008353294,0.002887399],"domain_scores_gemma":[0.88608354,0.03727418,0.011730786,0.0053232126,0.05465125,0.00493703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.051271047,0.00050064834,0.0005466356,0.0030906147,0.0015920663,0.0038543215,0.0012780834,0.00048919197,0.0014882521],"category_scores_gemma":[0.07169018,0.0006417426,0.00094893906,0.0041822502,0.0007051653,0.0019214072,0.0024651191,0.0015705709,0.000523922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010315065,0.003006945,0.79239535,0.0012978826,0.00023168435,0.0009196438,0.038697414,0.003156998,0.0022938591,0.0014117036,0.0075028343,0.1480542],"study_design_scores_gemma":[0.00011317535,0.0032389648,0.8852184,0.000797652,0.00024046161,0.00039524917,0.072164774,0.0038864873,0.006127647,0.00026156858,0.027406253,0.00014942397],"about_ca_topic_score_codex":0.03041384,"about_ca_topic_score_gemma":0.036786553,"teacher_disagreement_score":0.051271047,"about_ca_system_score_codex":0.008968706,"about_ca_system_score_gemma":0.01578305,"threshold_uncertainty_score":0.27115047},"labels":[],"label_agreement":null},{"id":"W3123927868","doi":"10.1177/1078155220984252","title":"Safety and efficacy analysis of pembrolizumab dosing patterns in patients with advanced melanoma and non-small cell lung cancer","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Pembrolizumab; Internal medicine; Adverse effect; Lung cancer; Oncology; Melanoma; Dosing; Cancer; Clinical endpoint; Ipilimumab; Area under the curve; Retrospective cohort study; Immunotherapy; Clinical trial","score_opus":0.013520859069533205,"score_gpt":0.34912054884712973,"score_spread":0.3355996897775965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123927868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988919,0.0005080522,0.00023458482,0.000027203996,0.0000031660327,0.000009503947,0.00011222704,0.000004372422,0.00020899116],"genre_scores_gemma":[0.9996183,0.00004935997,0.00012519631,0.000018323903,0.0000063305424,0.0000041722474,0.0001494234,0.0000016958099,0.000027192176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985709,0.00051581033,0.00021318957,0.00029513487,0.0003510376,0.00005391793],"domain_scores_gemma":[0.9939318,0.0018531097,0.003289761,0.00036509105,0.0003594948,0.00020079673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017586724,0.0001811329,0.00042760963,0.00041433942,0.00016080981,0.00037366236,0.00021152606,0.00029234783,0.00047312968],"category_scores_gemma":[0.0068473695,0.00015512001,0.00042524564,0.00052474963,0.00017461674,0.00038887994,0.00017184792,0.00040386675,0.00013837556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015338154,0.00005360226,0.98897785,0.000022754424,0.00022612484,0.00008204357,0.00003283184,0.00044030332,0.0011323664,0.0000113711985,0.000048845082,0.007438177],"study_design_scores_gemma":[0.000051271305,0.0011963171,0.99567455,0.0000061056753,0.00007581969,0.0006604568,0.00002800186,0.0015199222,0.0004923165,0.000034442844,0.00025549982,0.000005160308],"about_ca_topic_score_codex":0.0003271508,"about_ca_topic_score_gemma":0.0003911714,"teacher_disagreement_score":0.0017586724,"about_ca_system_score_codex":0.00036214892,"about_ca_system_score_gemma":0.00019281013,"threshold_uncertainty_score":0.009300888},"labels":[],"label_agreement":null},{"id":"W3128155601","doi":"10.1177/1078155221991202","title":"Development of a process map for the delivery of virtual clinical pharmacy services at Odette Cancer Centre during the COVID-19 pandemic","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thunder Bay Regional Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Pharmacy; Medicine; Workflow; Pandemic; Clinical pharmacy; Telemedicine; Medical emergency; Coronavirus disease 2019 (COVID-19); Family medicine; Health care; Internal medicine; Disease","score_opus":0.1941331107015844,"score_gpt":0.555415230940486,"score_spread":0.36128212023890155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128155601","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40476617,0.0007845628,0.44258976,0.0044148564,0.0004547106,0.0072504277,0.027594604,0.020308066,0.09183686],"genre_scores_gemma":[0.41725743,0.00072792347,0.5653677,0.00009059569,0.000028126407,0.002024365,0.008686489,0.0004300128,0.0053873593],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9987907,0.00039568197,0.0001038862,0.00015391577,0.00040722694,0.00014864573],"domain_scores_gemma":[0.9956018,0.0021054724,0.0004535853,0.00034338757,0.0011793462,0.0003163258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022320494,0.0007381017,0.00031010393,0.005420338,0.0014321948,0.0036301215,0.00094023405,0.00087261864,0.007617666],"category_scores_gemma":[0.007501896,0.00046726764,0.0008300522,0.004142416,0.00041206507,0.0025294735,0.0016171002,0.00086304604,0.0013166725],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009439616,0.0015865124,0.09888115,0.002607183,0.00017853866,0.0021430228,0.01806978,0.16961186,0.0115151405,0.034039967,0.0362109,0.62421197],"study_design_scores_gemma":[0.00029757596,0.0010425054,0.10227618,0.0017379606,0.00019856662,0.0007687913,0.019666228,0.61542654,0.019381693,0.016286228,0.22246905,0.00044876314],"about_ca_topic_score_codex":0.046705186,"about_ca_topic_score_gemma":0.050837245,"teacher_disagreement_score":0.046705186,"about_ca_system_score_codex":0.0033315273,"about_ca_system_score_gemma":0.008186837,"threshold_uncertainty_score":0.09286666},"labels":[],"label_agreement":null},{"id":"W3128521569","doi":"10.1177/1078155221992103","title":"Surface contamination with nine antineoplastic drugs in 109 canadian centers; 10 years of a monitoring program","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Contamination; Docetaxel; Antineoplastic Drugs; Cabazitaxel; Drug packaging; Body surface area; Adverse effect; Cyclophosphamide; Ifosfamide; Biological safety; Toxicology; Internal medicine; Pharmacology; Cancer; Chemotherapy","score_opus":0.053062162136837086,"score_gpt":0.45872665097134774,"score_spread":0.4056644888345107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128521569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960801,0.00022698568,0.00024500792,0.0001026873,0.0000069832213,0.00016909715,0.0016719543,0.000029452714,0.0014677334],"genre_scores_gemma":[0.9952205,0.00029234248,0.001214264,0.00016079213,0.00000946147,0.00006591682,0.0015592966,0.000007851318,0.0014696385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687105,0.00020335117,0.00008509288,0.0005475511,0.0011427802,0.0011502481],"domain_scores_gemma":[0.99705964,0.0001471372,0.00066367636,0.00012159158,0.0013993698,0.00060851505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012327565,0.0007803574,0.00038696855,0.001665036,0.0027187981,0.0012951024,0.0015222491,0.0006804091,0.0011615665],"category_scores_gemma":[0.0020294103,0.0008000775,0.00036842594,0.0029801046,0.0011663535,0.0003825334,0.0012614777,0.00049270596,0.0003376593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001226173,0.000120545585,0.9865762,0.000046174755,0.000021156115,0.00013372314,0.0009784224,0.00012983395,0.0010377567,0.000018733665,0.00062803144,0.0101868],"study_design_scores_gemma":[0.000005489501,0.00012666507,0.9971028,0.000012737499,0.000014205613,0.00005969123,0.0009036858,0.00023602555,0.00041248606,0.0000047250755,0.0011121081,0.000009342676],"about_ca_topic_score_codex":0.9504672,"about_ca_topic_score_gemma":0.95619106,"teacher_disagreement_score":0.04953277,"about_ca_system_score_codex":0.019726558,"about_ca_system_score_gemma":0.024423817,"threshold_uncertainty_score":0.1431269},"labels":[],"label_agreement":null},{"id":"W3139398038","doi":"10.1177/10781552211004705","title":"Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Ambulatory; Risk assessment; Cancer; Pharmacist; Pharmacy; Intensive care medicine; Venous thromboembolism; Framingham Risk Score; Guideline; Clinical trial; Emergency medicine; Internal medicine; Thrombosis; Family medicine; Pathology","score_opus":0.031344573049732226,"score_gpt":0.45946471313867665,"score_spread":0.42812014008894445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3139398038","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23667112,0.5035167,0.058929835,0.14329477,0.0013912692,0.018934708,0.002337861,0.0004583211,0.03446544],"genre_scores_gemma":[0.6569034,0.13411269,0.18390764,0.015119275,0.00087264314,0.0070057083,0.0012760875,0.0000288519,0.00077367696],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9659298,0.021628484,0.0042625824,0.0013992894,0.0063506723,0.0004292314],"domain_scores_gemma":[0.9380882,0.03769096,0.010530624,0.0010121461,0.01138266,0.0012954994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03179191,0.00044786604,0.0011296102,0.0025541733,0.0006275692,0.0027206605,0.0017304677,0.0014375622,0.0006330461],"category_scores_gemma":[0.08005886,0.00037264428,0.0014754379,0.002192342,0.00086902326,0.0018981899,0.0013924834,0.0019371731,0.00018392183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015171261,0.0015557862,0.1501673,0.04770294,0.0019545313,0.0009246029,0.0020276625,0.004166616,0.0014929487,0.0069794715,0.013277492,0.76823354],"study_design_scores_gemma":[0.0060449312,0.020263564,0.4872234,0.23785493,0.017099217,0.0048349397,0.0075054956,0.035994656,0.0063483356,0.013604372,0.16228595,0.00094028615],"about_ca_topic_score_codex":0.010291889,"about_ca_topic_score_gemma":0.025696797,"teacher_disagreement_score":0.03179191,"about_ca_system_score_codex":0.0038573383,"about_ca_system_score_gemma":0.017017704,"threshold_uncertainty_score":0.16813368},"labels":[],"label_agreement":null},{"id":"W3159791832","doi":"10.1177/10781552211007535","title":"Education strategy for the implementation of oncology biosimilars essential for operational and patient safety in Alberta, Canada","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; Alberta Cancer Foundation","funders":"","keywords":"Biosimilar; Medicine; Pharmacy; Harm; Patient safety; Oncology; Internal medicine; Family medicine; Health care","score_opus":0.0369520180908905,"score_gpt":0.4361260698854512,"score_spread":0.3991740517945607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3159791832","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17439793,0.007167296,0.019473178,0.6161209,0.005319784,0.011829617,0.0018115343,0.0023579085,0.16152182],"genre_scores_gemma":[0.56585115,0.0059319464,0.072503,0.19558774,0.0011429976,0.002287966,0.0020727264,0.00017498956,0.1544475],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99126786,0.0009621651,0.00030600736,0.0002714666,0.0039772387,0.0032153297],"domain_scores_gemma":[0.9627537,0.0016249612,0.0013560768,0.00030367175,0.014037991,0.019923558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01152256,0.0005933769,0.00029366414,0.0023789012,0.007144822,0.003910852,0.003265212,0.0049795024,0.008294775],"category_scores_gemma":[0.0112278955,0.0005868101,0.0007115391,0.0011945821,0.0015476311,0.0011026222,0.0040213396,0.0045905504,0.0008567309],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005644538,0.0036642419,0.054809634,0.0011923105,0.00009113493,0.0038489173,0.006061709,0.005524359,0.010700392,0.022270802,0.49053842,0.40073362],"study_design_scores_gemma":[0.00048474758,0.001184839,0.16005644,0.0010488468,0.00009264671,0.0006660857,0.0070941616,0.0044897627,0.003644699,0.001978437,0.8190671,0.00019217105],"about_ca_topic_score_codex":0.938643,"about_ca_topic_score_gemma":0.96802217,"teacher_disagreement_score":0.098077156,"about_ca_system_score_codex":0.098077156,"about_ca_system_score_gemma":0.5697491,"threshold_uncertainty_score":0.7116029},"labels":[],"label_agreement":null},{"id":"W3160148357","doi":"10.1177/10781552211010928","title":"Closed-system transfer device use with oncology biologics: A survey of Canadian healthcare practitioners","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); University of Toronto","funders":"","keywords":"Medicine; Health care; Healthcare system; Family medicine","score_opus":0.25366092318314876,"score_gpt":0.5006360324424663,"score_spread":0.2469751092593176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160148357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844413,0.002241908,0.00022528751,0.004704557,0.000025143461,0.00013393747,0.0015054452,0.000019043699,0.0067034145],"genre_scores_gemma":[0.9942473,0.0024482901,0.00050177926,0.0015736452,0.000009759249,0.000034533943,0.0003622139,0.000009105249,0.00081331737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99455476,0.0005984159,0.00043809964,0.00046075424,0.003136489,0.0008114249],"domain_scores_gemma":[0.98486716,0.0025574842,0.004376769,0.00027042662,0.004799478,0.003128628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003167299,0.00020544052,0.00033643746,0.0017976682,0.0030441235,0.0018612489,0.0012968626,0.00075510156,0.003147542],"category_scores_gemma":[0.013605449,0.000421318,0.0003775553,0.0046149446,0.0015012616,0.0010624263,0.0015399313,0.0009871047,0.00026282153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000721468,0.00010061119,0.9264789,0.00055762,0.000041244195,0.0003313157,0.03388643,0.00009422163,0.00040483449,0.0002715236,0.007237453,0.030523669],"study_design_scores_gemma":[0.000011815745,0.00013194542,0.9326249,0.00045126834,0.000029775176,0.00043012615,0.054217495,0.00028550837,0.00014332103,0.0000539787,0.011580873,0.000039055434],"about_ca_topic_score_codex":0.9615979,"about_ca_topic_score_gemma":0.9684844,"teacher_disagreement_score":0.03840208,"about_ca_system_score_codex":0.025985403,"about_ca_system_score_gemma":0.0401622,"threshold_uncertainty_score":0.1885382},"labels":[],"label_agreement":null},{"id":"W3160237041","doi":"10.1177/10781552211013878","title":"Bendamustine-induced nephrogenic diabetes insipidus – A case report","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-related skin toxicity","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Bendamustine; Salvage therapy; Etoposide; Diabetes insipidus; Nephrogenic diabetes insipidus; Rituximab; Chemoimmunotherapy; Surgery; Internal medicine; Oncology; Chemotherapy; Lymphoma","score_opus":0.05946062220933491,"score_gpt":0.4267024205602352,"score_spread":0.3672417983509003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160237041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92303634,0.045857158,0.0055182856,0.006542364,0.0010934598,0.00030538626,0.00049221626,0.0003700873,0.016784677],"genre_scores_gemma":[0.98692024,0.007580402,0.0012773314,0.0011343872,0.0013934099,0.000027829661,0.00011861057,0.00002650045,0.001521227],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993118,0.000068417765,0.00010424368,0.0001853737,0.00011905093,0.00021116162],"domain_scores_gemma":[0.99850744,0.00041789538,0.00042597004,0.0001201903,0.000080548096,0.0004478765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037102218,0.0018849013,0.0010782486,0.0028841812,0.0020503902,0.0018103214,0.0013982514,0.0044818376,0.0028968882],"category_scores_gemma":[0.0017280186,0.001065961,0.001129224,0.0023940702,0.0018099328,0.0023944357,0.001755592,0.0031344946,0.00078298984],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000100805,0.000018007077,0.001872472,0.00004088552,0.0000114381055,0.9964386,0.00006865679,0.000035727804,0.00029844316,0.0000796037,0.00017561877,0.00095040974],"study_design_scores_gemma":[0.0000041531453,0.000012799986,0.000822263,0.0000130132275,0.00000900485,0.99849916,0.0000479223,0.000051074945,0.00014134451,0.000060043178,0.0003346689,0.0000046454024],"about_ca_topic_score_codex":0.0019376517,"about_ca_topic_score_gemma":0.0024122267,"teacher_disagreement_score":0.0044818376,"about_ca_system_score_codex":0.0013092278,"about_ca_system_score_gemma":0.00094163354,"threshold_uncertainty_score":0.009691},"labels":[],"label_agreement":null},{"id":"W3165284022","doi":"10.1177/10781552211017199","title":"International Society of Oncology Pharmacy Practitioners (ISOPP) position statement: Role of the oncology pharmacy team in cancer care","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Pharmacy; Specialty; Health care; Clinical pharmacy; Pharmacy practice; Certification; Oncology; Position statement; Internal medicine; Hospital pharmacy; Family medicine; Nursing; Management","score_opus":0.0796815553989943,"score_gpt":0.5282888441346095,"score_spread":0.44860728873561523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165284022","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014204658,0.009391168,0.0020959296,0.87417156,0.063035496,0.00029829118,0.00026556032,0.00008219312,0.04923925],"genre_scores_gemma":[0.05850795,0.03542579,0.023315642,0.6595498,0.07246034,0.0008988075,0.0009838359,0.0002497589,0.14860812],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97837937,0.003792765,0.002386489,0.0015043346,0.01053581,0.003401152],"domain_scores_gemma":[0.936159,0.010836026,0.006819751,0.0014533104,0.021450788,0.023281112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024708683,0.0011492649,0.0008732295,0.001696353,0.006064988,0.007976093,0.0034906687,0.02529054,0.006701314],"category_scores_gemma":[0.03492358,0.0007816513,0.0013434022,0.0019874705,0.0035724265,0.0038633086,0.006706721,0.023736415,0.005762254],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032797358,0.00014060231,0.0013577569,0.00033793616,0.000018002242,0.00023318654,0.00041457513,0.00020693413,0.00038095214,0.0135209095,0.93220955,0.051146757],"study_design_scores_gemma":[0.000042130083,0.00011070335,0.0021572916,0.0010929854,0.000025489247,0.00035321593,0.00041323353,0.00022439343,0.00042828752,0.0033952107,0.99171996,0.000037126978],"about_ca_topic_score_codex":0.012093337,"about_ca_topic_score_gemma":0.029362077,"teacher_disagreement_score":0.02529054,"about_ca_system_score_codex":0.0055911154,"about_ca_system_score_gemma":0.06355475,"threshold_uncertainty_score":0.13067359},"labels":[],"label_agreement":null},{"id":"W3165558536","doi":"10.1177/10781552211019116","title":"Oncology boot camp: A preparatory curriculum for advanced pharmacy practice experience students","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Boot camp; Medicine; Pharmacy; Curriculum; Intervention (counseling); Oncology; Medical education; Internal medicine; Pharmacy practice; Family medicine; Nursing; Psychology; Pedagogy","score_opus":0.15549518125223413,"score_gpt":0.577359489756687,"score_spread":0.4218643085044529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165558536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888919,0.00024326002,0.001104113,0.0005323238,0.00014939382,0.001667471,0.00020404453,0.00013062287,0.007076935],"genre_scores_gemma":[0.9744252,0.00074420875,0.011424463,0.0007286913,0.0002706532,0.0025102654,0.0006772425,0.000020148651,0.009199108],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9994037,0.000088735396,0.00002551919,0.00007173221,0.00017724712,0.00023307627],"domain_scores_gemma":[0.99664694,0.00015480418,0.00028554365,0.00009278205,0.00021000126,0.002609895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011054656,0.00054513605,0.00036351295,0.0004858081,0.0013684201,0.0008436169,0.0012863906,0.000529893,0.016548706],"category_scores_gemma":[0.0013940352,0.00031709103,0.00036621492,0.0003177662,0.00040680222,0.00042952283,0.0026439994,0.0010716573,0.0027274457],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032416084,0.0870046,0.19290175,0.001733489,0.000050480674,0.001680416,0.0051867883,0.0016139058,0.026673919,0.00092819624,0.024762306,0.65422255],"study_design_scores_gemma":[0.00084644265,0.059655353,0.8487227,0.0005187106,0.00005258467,0.001932204,0.0072405706,0.0011738895,0.0113525875,0.000846833,0.06757466,0.000083421066],"about_ca_topic_score_codex":0.00077788957,"about_ca_topic_score_gemma":0.0037788583,"teacher_disagreement_score":0.016548706,"about_ca_system_score_codex":0.0010370782,"about_ca_system_score_gemma":0.005077083,"threshold_uncertainty_score":0.055360913},"labels":[],"label_agreement":null},{"id":"W3168852790","doi":"10.1177/10781552211024723","title":"Preventing drug vial wastage and reducing expenditure associated with injectable cancer drugs: International oncology pharmacy survey","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Vial; Pharmacy; Medicine; Economic shortage; Legislation; Government (linguistics); Family medicine","score_opus":0.08597447481179106,"score_gpt":0.5003286322502933,"score_spread":0.4143541574385023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168852790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905281,0.0005235327,0.00037534974,0.0019891006,0.000012690925,0.00024051941,0.0015309786,0.000022835782,0.004777048],"genre_scores_gemma":[0.9949575,0.0011684202,0.0008444045,0.00090775365,0.000024134015,0.00014224595,0.0012482614,0.0000073416495,0.00069986837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790514,0.0008514407,0.00031676266,0.000116903466,0.00049023185,0.00031945598],"domain_scores_gemma":[0.9911942,0.0013281128,0.004934914,0.00019005885,0.0011446613,0.0012081313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034385172,0.00015386271,0.00018359908,0.0011226016,0.00024067522,0.0006028294,0.00038471067,0.00043616554,0.0019100504],"category_scores_gemma":[0.009060914,0.00017321302,0.0003040571,0.0017559095,0.00022439093,0.0010070335,0.00089042867,0.00060503365,0.00025797443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008173251,0.00023979122,0.9679051,0.00024334657,0.000040283994,0.00006760268,0.0009159248,0.00021849986,0.00022725786,0.000071075614,0.002495524,0.027493872],"study_design_scores_gemma":[0.0000069807816,0.00028427585,0.9945648,0.000054458727,0.000014143992,0.0000855945,0.0015012373,0.000205825,0.00013803449,0.000011533229,0.0031270643,0.0000060742755],"about_ca_topic_score_codex":0.008117057,"about_ca_topic_score_gemma":0.007596661,"teacher_disagreement_score":0.008117057,"about_ca_system_score_codex":0.00093435164,"about_ca_system_score_gemma":0.0016618345,"threshold_uncertainty_score":0.01818484},"labels":[],"label_agreement":null},{"id":"W3199660051","doi":"10.1177/10781552211034473","title":"Defining cytotoxic drugs – you know it when you see it?","year":2021,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Antineoplastic Drugs; Medicine; Confusion; Cytotoxic T cell; Drug; Cancer chemotherapy; Intensive care medicine; Pharmacology; Risk analysis (engineering); Chemotherapy; Surgery; Biology","score_opus":0.15725876243317632,"score_gpt":0.5466091430940703,"score_spread":0.38935038066089395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199660051","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020175002,0.99168724,0.00037512725,0.0037589562,0.0006947682,0.00001526704,0.000037882193,0.0000070000406,0.0032219924],"genre_scores_gemma":[0.0021126922,0.9931252,0.000530049,0.002398959,0.00043373017,0.000015253207,0.000049611208,0.0000035450814,0.0013309813],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989215,0.00037285994,0.00016347154,0.00011110176,0.0003776795,0.00005332648],"domain_scores_gemma":[0.99814165,0.0010285705,0.0002613185,0.000047177018,0.00046387996,0.000057391735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011704124,0.0005555122,0.0010286327,0.0024970982,0.00046569135,0.0018653016,0.00076402293,0.001537049,0.0048349844],"category_scores_gemma":[0.0036049199,0.00022550834,0.00066119124,0.0024135467,0.0012070903,0.0034809622,0.0009023241,0.0022075924,0.0019891625],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057228764,0.000052952495,0.00066081417,0.04417088,0.00012816736,0.00023366854,0.0005401482,0.00015427885,0.0009784566,0.018362492,0.06154511,0.87311584],"study_design_scores_gemma":[0.00001041651,0.000041859246,0.00084252487,0.018526236,0.00008804271,0.0012434084,0.0003586816,0.000049799528,0.00033220428,0.0043460433,0.97414464,0.0000160244],"about_ca_topic_score_codex":0.0031546673,"about_ca_topic_score_gemma":0.0049350853,"teacher_disagreement_score":0.0048349844,"about_ca_system_score_codex":0.0010154577,"about_ca_system_score_gemma":0.0027217437,"threshold_uncertainty_score":0.016174614},"labels":[],"label_agreement":null},{"id":"W3202818939","doi":"10.1177/10781552211040176","title":"Barriers and facilitators for the safe handling of antineoplastic drugs","year":2021,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Government of Canada; Simon Fraser University; Government of Prince Edward Island; University of Calgary; University of British Columbia; World Wildlife Fund Canada; Alberta Health Services","funders":"WorkSafeBC","keywords":"Antineoplastic Drugs; Medicine; Patient safety; Work (physics); Nursing; Health care; Pharmacology; Political science","score_opus":0.14212217737960584,"score_gpt":0.5553594440900238,"score_spread":0.41323726671041794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202818939","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54258287,0.3032727,0.012860494,0.07787703,0.000810499,0.0012791571,0.00086808647,0.00016367869,0.060285483],"genre_scores_gemma":[0.85861564,0.1276955,0.007062509,0.003561526,0.00009122741,0.00064362056,0.00020412108,0.000028719396,0.0020971892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9828772,0.009303111,0.0021581966,0.000770795,0.0035709825,0.0013197737],"domain_scores_gemma":[0.91954863,0.06352611,0.009300627,0.0007990688,0.0058603324,0.00096527155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016328176,0.00036752402,0.0006264222,0.0017996955,0.0017728589,0.002802807,0.0012623678,0.0013951927,0.0030921646],"category_scores_gemma":[0.0504692,0.00046523323,0.0014038606,0.0018392559,0.001860789,0.00321755,0.002368321,0.0014902664,0.00022576285],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004567637,0.00036453837,0.1050483,0.14598775,0.0014325054,0.0036809486,0.17689061,0.0021906747,0.0053040828,0.046545897,0.017837098,0.49426085],"study_design_scores_gemma":[0.00012320829,0.00054583116,0.11572085,0.15328997,0.0026477238,0.0028383022,0.24852851,0.00091140415,0.0061817956,0.013624976,0.45537066,0.00021674208],"about_ca_topic_score_codex":0.012097147,"about_ca_topic_score_gemma":0.020489823,"teacher_disagreement_score":0.016328176,"about_ca_system_score_codex":0.0035528655,"about_ca_system_score_gemma":0.018149529,"threshold_uncertainty_score":0.08635265},"labels":[],"label_agreement":null},{"id":"W3203264829","doi":"10.1177/10781552211038031","title":"Case report: Proton pump inhibitor drug-related problem in pancreatic cancer patient unmasks pancreatic enzyme insufficiency","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Palliative care; Gemcitabine; Proton-pump inhibitor; Cancer; Intensive care medicine; Pancreatic cancer; Internal medicine; Nursing","score_opus":0.03216640220981898,"score_gpt":0.37754402234664647,"score_spread":0.3453776201368275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203264829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9021872,0.03376419,0.008154772,0.022083042,0.0020336527,0.00047324493,0.0007484916,0.00061321224,0.029942257],"genre_scores_gemma":[0.9823142,0.0057532643,0.0030247378,0.0034370741,0.0025603282,0.00006192925,0.00020558252,0.000060388542,0.002582423],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9987495,0.0001684288,0.00015396814,0.00034733373,0.000195488,0.000385261],"domain_scores_gemma":[0.9974674,0.00069725834,0.0007058644,0.00016455243,0.00016665067,0.0007982474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004783381,0.0026673423,0.0019369178,0.0035320546,0.003848656,0.0030237339,0.0016211832,0.007963351,0.003697143],"category_scores_gemma":[0.0043279296,0.0015023183,0.0018005925,0.0029483486,0.0020166738,0.005644814,0.0027435212,0.0076416023,0.0012382776],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015684984,0.000026459213,0.0028608933,0.000027204076,0.0000056699164,0.9955918,0.00012144732,0.00004270433,0.00013389219,0.0001047174,0.00035773515,0.0007117867],"study_design_scores_gemma":[0.000005070702,0.000018981968,0.00081023754,0.000017304012,0.000005443349,0.99834454,0.00012294373,0.00009453676,0.00009091415,0.00010688559,0.0003775521,0.0000055339015],"about_ca_topic_score_codex":0.0024713883,"about_ca_topic_score_gemma":0.0027621435,"teacher_disagreement_score":0.007963351,"about_ca_system_score_codex":0.0021168855,"about_ca_system_score_gemma":0.0016678823,"threshold_uncertainty_score":0.015359163},"labels":[],"label_agreement":null},{"id":"W3203377226","doi":"10.1177/10781552211041680","title":"A randomized controlled trial to assess the influence of a picture-based antiemetic medication calendar on medication-taking behavior in adults receiving chemotherapy","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Western University; London Health Sciences Centre; University of Waterloo","funders":"","keywords":"Medicine; Antiemetic; Randomized controlled trial; Chemotherapy; Emergency medicine; Intensive care medicine; Pediatrics; Internal medicine","score_opus":0.11864104330982754,"score_gpt":0.496285031150853,"score_spread":0.37764398784102543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203377226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.938686,0.010646564,0.002025787,0.0015708947,0.0031100542,0.037857607,0.0021770583,0.000322747,0.0036033264],"genre_scores_gemma":[0.92784184,0.004975208,0.007953366,0.001992128,0.0011618336,0.051905077,0.0008980005,0.000028024284,0.0032445742],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99690056,0.0018821991,0.0003863228,0.00040497136,0.00023551048,0.00019042268],"domain_scores_gemma":[0.99477804,0.0026759226,0.0012003753,0.00026150458,0.0002705771,0.0008135537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003397261,0.0013695047,0.0038546512,0.0006492739,0.0007219697,0.0011096738,0.00096047594,0.0025518117,0.012980475],"category_scores_gemma":[0.0083495695,0.0007525636,0.0021003396,0.0007097583,0.0010920553,0.0012972017,0.00064474565,0.0027777636,0.00081054866],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98251295,0.006543305,0.0003684897,0.0012420415,0.00076658704,0.000021821239,0.000036463458,0.0000867301,0.00038730787,0.000075603915,0.00032004702,0.0076386533],"study_design_scores_gemma":[0.9690822,0.02958662,0.00063730567,0.000051741135,0.0002745694,0.0000059806925,0.00001063794,0.000099678015,0.00005424193,0.000046081437,0.00014622364,0.000004537859],"about_ca_topic_score_codex":0.0016523282,"about_ca_topic_score_gemma":0.0026219583,"teacher_disagreement_score":0.012980475,"about_ca_system_score_codex":0.00070105004,"about_ca_system_score_gemma":0.002060348,"threshold_uncertainty_score":0.04342395},"labels":[],"label_agreement":null},{"id":"W3203670468","doi":"10.1177/10781552211038677","title":"Use of <i>nab</i> -paclitaxel and gemcitabine in pancreatic cancer without granulocyte colony-stimulating factor: A multicenter real-world experience","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"Alberta Cancer Foundation; Celgene","keywords":"Medicine; Gemcitabine; Neutropenia; Pancreatic cancer; Internal medicine; Progression-free survival; Granulocyte colony-stimulating factor; Oncology; Cancer; Surgery; Chemotherapy","score_opus":0.1481114958646065,"score_gpt":0.4937965166833536,"score_spread":0.3456850208187471,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3203670468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628085,0.0019677177,0.0001390867,0.000488806,0.00001332175,0.00006786829,0.00011157708,0.000006953591,0.00092376827],"genre_scores_gemma":[0.9973611,0.00164819,0.00029448562,0.0002812138,0.000065274675,0.000053996864,0.00021275999,0.0000047107387,0.00007818222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773335,0.0013701017,0.00031190124,0.00020840127,0.00022617645,0.00014998618],"domain_scores_gemma":[0.9946532,0.0017513892,0.0023747196,0.0003125783,0.0002884716,0.00061959133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034085421,0.00019587985,0.00035933647,0.0003042969,0.0005680851,0.001104916,0.0005850211,0.0006086543,0.0007231347],"category_scores_gemma":[0.0072041657,0.00022050228,0.0004890346,0.0008122633,0.00061043527,0.00067868124,0.0005944901,0.0007725444,0.00018832137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010299302,0.004242205,0.9012843,0.00034495853,0.00037826932,0.004399199,0.0021215556,0.00082645495,0.002391055,0.0002899332,0.0024408526,0.07098195],"study_design_scores_gemma":[0.005244858,0.054854415,0.88527346,0.00040784443,0.00079132366,0.025621455,0.0042022155,0.0024833586,0.0039418153,0.00028324747,0.016782314,0.00011364782],"about_ca_topic_score_codex":0.0019819273,"about_ca_topic_score_gemma":0.0022319283,"teacher_disagreement_score":0.0034085421,"about_ca_system_score_codex":0.0017588005,"about_ca_system_score_gemma":0.0010667996,"threshold_uncertainty_score":0.018026292},"labels":[],"label_agreement":null},{"id":"W3204094393","doi":"10.1177/10781552211043525","title":"Evaluation of a patient self-medication program in allogeneic hematopoietic stem cell transplantation","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Pharmacist; Hematopoietic stem cell transplantation; Medication adherence; Adverse effect; Patient satisfaction; Physical therapy; Transplantation; Pharmacy; Emergency medicine; Internal medicine; Family medicine; Nursing","score_opus":0.08769869127573136,"score_gpt":0.44874665385146856,"score_spread":0.3610479625757372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204094393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975273,0.00013335652,0.00015674323,0.00017093733,0.000016153544,0.00050829095,0.00006627704,0.000014235455,0.0014067977],"genre_scores_gemma":[0.9974481,0.00014612719,0.0011856887,0.000120423654,0.000017745,0.0005373242,0.0001470493,0.0000016683682,0.0003959239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975458,0.0013725328,0.00023757014,0.000091468195,0.0005798145,0.00017282162],"domain_scores_gemma":[0.99728024,0.0005820285,0.0007303939,0.00008892759,0.0004698629,0.0008484863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037072403,0.00019643627,0.00032542,0.00030218068,0.0004243776,0.00052636815,0.00029189416,0.00031180738,0.0016667537],"category_scores_gemma":[0.0055167014,0.00008537548,0.00049779203,0.00024462387,0.00018030991,0.00034030282,0.0005741863,0.0005013967,0.00022858163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027044397,0.018395478,0.72051793,0.00035819178,0.00016608022,0.00020649844,0.0015964828,0.00049188634,0.0012004222,0.00015252882,0.0016199558,0.2525901],"study_design_scores_gemma":[0.0006073325,0.05233492,0.93804604,0.00016884696,0.0001466067,0.000319794,0.0014940613,0.0015256386,0.0018412125,0.00012346853,0.0033708115,0.000021177113],"about_ca_topic_score_codex":0.00060549285,"about_ca_topic_score_gemma":0.0009711254,"teacher_disagreement_score":0.0037072403,"about_ca_system_score_codex":0.0004774589,"about_ca_system_score_gemma":0.0013454086,"threshold_uncertainty_score":0.019605994},"labels":[],"label_agreement":null},{"id":"W3209911848","doi":"10.1177/10781552211048892","title":"Impact of coronavirus of 2019 on the delivery of pharmacy services to patients with cancer: An international survey of oncology pharmacy practitioners","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Alberta Health Services","funders":"","keywords":"Medicine; Pharmacy; Pandemic; Family medicine; Workforce; Personal protective equipment; Pharmacist; Nursing; Coronavirus disease 2019 (COVID-19); Internal medicine","score_opus":0.1597021314677648,"score_gpt":0.5447627895809734,"score_spread":0.38506065811320855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209911848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725276,0.00034673588,0.000047350004,0.00049988827,0.000009015265,0.000035875182,0.0006567321,0.0000028252618,0.0011487078],"genre_scores_gemma":[0.9985103,0.0004017033,0.000062211766,0.00033044125,0.000016183716,0.000025575571,0.0004080868,0.0000016142106,0.000243879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990288,0.00026458863,0.00016789736,0.000118203236,0.00022529952,0.00019517358],"domain_scores_gemma":[0.9962249,0.0004023801,0.002308514,0.00009243884,0.00036614318,0.00060565054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013874803,0.00015064697,0.00013620417,0.00070468895,0.00035918184,0.00057422795,0.0002601108,0.00060604996,0.0019816991],"category_scores_gemma":[0.0034668122,0.00021438942,0.00043312437,0.000971909,0.0002610245,0.0008022487,0.00097499316,0.0006313499,0.00027311247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020386928,0.000051561787,0.9967235,0.000023983765,0.000017613624,0.00003197815,0.0005207198,0.000018554545,0.000117377866,0.000009135145,0.00032926438,0.002135951],"study_design_scores_gemma":[0.000002042272,0.000097254444,0.99789596,0.00002142009,0.0000051684583,0.00012459717,0.0013517549,0.00003833138,0.0000249919,0.0000033260844,0.00043318118,0.0000020366256],"about_ca_topic_score_codex":0.00729824,"about_ca_topic_score_gemma":0.008003305,"teacher_disagreement_score":0.00729824,"about_ca_system_score_codex":0.00048620626,"about_ca_system_score_gemma":0.0005606672,"threshold_uncertainty_score":0.014511526},"labels":[],"label_agreement":null},{"id":"W3213957885","doi":"10.1177/10781552211053253","title":"Application of the Failure Mode and Effects Analysis (FMEA) to identify vulnerabilities and opportunities for improvement prior to implementing a computerized prescription order entry (CPOE) system in a university hospital oncology clinic","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Electronic Health Records Systems","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Eli Lilly Canada; Amgen Canada; Novartis Pharmaceuticals Canada; Astellas Pharma Canada; Merck Canada; AstraZeneca Canada; F. Hoffmann-La Roche; Takeda Pharmaceuticals North America; Celgene; Bristol-Myers Squibb Canada; Seattle Genetics; Gilead Sciences","keywords":"Medicine; Medical prescription; Order entry; Computerized physician order entry; Failure mode and effects analysis; Medical emergency; Emergency medicine; Intensive care medicine; Nursing; Health care; Reliability engineering","score_opus":0.07289850436393183,"score_gpt":0.4934987644334726,"score_spread":0.42060026006954077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213957885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9024923,0.00035289407,0.09166195,0.00030923964,0.000035079636,0.0015282872,0.00055100117,0.0004174502,0.0026518079],"genre_scores_gemma":[0.92922044,0.00010143784,0.069523476,0.00006026569,0.000011257412,0.0005934865,0.00016067126,0.000021996992,0.00030697347],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9917352,0.0051336195,0.00051852706,0.00071472296,0.0016597455,0.00023813776],"domain_scores_gemma":[0.917762,0.07092824,0.005658234,0.0017582452,0.0034394576,0.00045379307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017206922,0.0010083037,0.0007130346,0.0059430744,0.0007493151,0.001129961,0.00066321203,0.0007202712,0.0021104228],"category_scores_gemma":[0.04292984,0.0003534241,0.002014576,0.0015900377,0.0005650166,0.0010629527,0.0009383614,0.0006946966,0.00013442553],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016572812,0.0016155159,0.6677501,0.0011500148,0.0014778598,0.0005749526,0.005243442,0.020607457,0.006655008,0.0020298485,0.0010769238,0.29016155],"study_design_scores_gemma":[0.00020314303,0.009294786,0.80976534,0.0005915237,0.0010588095,0.00081282726,0.0037793051,0.15990977,0.008129988,0.0039335024,0.0023262994,0.00019469806],"about_ca_topic_score_codex":0.0057747085,"about_ca_topic_score_gemma":0.005248039,"teacher_disagreement_score":0.017206922,"about_ca_system_score_codex":0.0019725112,"about_ca_system_score_gemma":0.003109922,"threshold_uncertainty_score":0.09099996},"labels":[],"label_agreement":null},{"id":"W3216845069","doi":"10.1177/10781552211061133","title":"Evaluation and clinical impact of a pharmacist-led, interdisciplinary service focusing on education, monitoring and toxicity management of immune checkpoint inhibitors","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Saint John Regional Hospital; Horizon Health Network; Moncton Hospital","funders":"Association Canadienne de Pharmacie en Oncologie","keywords":"Medicine; Ipilimumab; Discontinuation; Pharmacist; Adverse effect; Cohort; Hazard ratio; Immune checkpoint; Internal medicine; Retrospective cohort study; Oncology; Emergency medicine; Pharmacy; Cancer; Confidence interval; Immunotherapy; Family medicine","score_opus":0.09540476578122901,"score_gpt":0.5345291494025659,"score_spread":0.4391243836213369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216845069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960877,0.00043240964,0.00014724996,0.0006731309,0.000026462521,0.0005428836,0.00019388285,0.000015985377,0.0018802788],"genre_scores_gemma":[0.9978917,0.00041234004,0.0007083629,0.0003359556,0.00005803605,0.00026582132,0.00013156902,0.000002721674,0.00019340406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960359,0.001921467,0.00036324965,0.00041622657,0.0006431994,0.00062008057],"domain_scores_gemma":[0.9886856,0.0024253887,0.0038290936,0.00034798175,0.0010162125,0.0036957376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032885205,0.0002496166,0.00030129004,0.00070423546,0.00066249917,0.001038882,0.0005867377,0.0005884478,0.002304474],"category_scores_gemma":[0.011860607,0.00023280355,0.0005198578,0.0006125882,0.0003297048,0.0007100418,0.001435565,0.00060878776,0.00022541913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045252386,0.007144474,0.84814304,0.00044829113,0.00024329718,0.00038725507,0.00063723617,0.0009793709,0.0006358788,0.00017017275,0.0018763804,0.13480939],"study_design_scores_gemma":[0.0013301057,0.016535543,0.97657084,0.00034576375,0.00015890144,0.0003921706,0.0013405225,0.0013998271,0.000314783,0.000103283135,0.0014854316,0.000022743081],"about_ca_topic_score_codex":0.0094941035,"about_ca_topic_score_gemma":0.016556982,"teacher_disagreement_score":0.0094941035,"about_ca_system_score_codex":0.0035777227,"about_ca_system_score_gemma":0.008303295,"threshold_uncertainty_score":0.0259583},"labels":[],"label_agreement":null},{"id":"W3217493071","doi":"10.1177/10781552211055405","title":"Asparaginase activity monitoring and management of asparaginase hypersensitivity reactions in Canada","year":2021,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Asparaginase; Medicine; Guideline; Intensive care medicine; Economic shortage; Pediatrics; Internal medicine; Lymphoblastic Leukemia; Leukemia; Pathology","score_opus":0.052131353991888514,"score_gpt":0.40391779820269563,"score_spread":0.3517864442108071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217493071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84545934,0.023459237,0.0012063539,0.061798397,0.00020105686,0.0007236394,0.0075342525,0.00016460345,0.0594531],"genre_scores_gemma":[0.9764598,0.0118475575,0.0018616581,0.0051472792,0.000039114762,0.00007859449,0.001186743,0.000019284926,0.0033599976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978764,0.00028747672,0.00017336414,0.00014055718,0.00094911986,0.0005730646],"domain_scores_gemma":[0.98936266,0.00094256335,0.0018290653,0.0001041177,0.0038108,0.0039508427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011671259,0.00014554594,0.00018257627,0.0010143704,0.0018376925,0.0013917284,0.0009763393,0.00033109108,0.002827419],"category_scores_gemma":[0.0073227854,0.0001720258,0.00021997602,0.0030500814,0.00079101464,0.00046348787,0.0008946306,0.0007125652,0.00018171623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119151504,0.00021487029,0.83395314,0.00072013075,0.000052818268,0.0005556096,0.0025107278,0.0006553124,0.00045833964,0.0014375828,0.03532606,0.12399628],"study_design_scores_gemma":[0.000035845984,0.00012007721,0.9531477,0.00061214005,0.000031550753,0.0005190094,0.0043829004,0.00083167275,0.00032777496,0.00022681714,0.039734278,0.000030149213],"about_ca_topic_score_codex":0.98795193,"about_ca_topic_score_gemma":0.99060667,"teacher_disagreement_score":0.052391686,"about_ca_system_score_codex":0.052391686,"about_ca_system_score_gemma":0.13287938,"threshold_uncertainty_score":0.38013005},"labels":[],"label_agreement":null},{"id":"W4205535522","doi":"10.1177/10781552211072877","title":"Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 122 centers","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Docetaxel; Antineoplastic Drugs; Vinorelbine; Contamination; Therapeutic drug monitoring; Cyclophosphamide; Paclitaxel; Pharmacology; Internal medicine; Drug; Chemotherapy","score_opus":0.042896651219423244,"score_gpt":0.43967635355610424,"score_spread":0.396779702336681,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205535522","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9431678,0.0025547757,0.0043550115,0.0010529881,0.000050371396,0.0009467878,0.030799054,0.00034584198,0.016727384],"genre_scores_gemma":[0.96889704,0.0014512393,0.009624761,0.0002774476,0.000024023724,0.0002077109,0.012124086,0.00003358258,0.0073601156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972752,0.00020130683,0.00008480099,0.0003543343,0.0017229345,0.00036147406],"domain_scores_gemma":[0.9950289,0.00014346326,0.0006287498,0.00010171884,0.003705577,0.0003915973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011914172,0.0005457503,0.00027549153,0.0026929101,0.0014608025,0.0008595805,0.0011907025,0.00031910714,0.0021292241],"category_scores_gemma":[0.0020252764,0.00027439318,0.0002837075,0.0033796658,0.0003368693,0.0001683995,0.0006169457,0.00024139592,0.0003534477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016858258,0.00008391404,0.92495894,0.00036122746,0.00005940581,0.00013295533,0.0007870356,0.0006694981,0.0079828845,0.00020006203,0.0075109713,0.05708453],"study_design_scores_gemma":[0.000006246929,0.00009087403,0.98598933,0.000039509607,0.000016929542,0.00007145401,0.0003890161,0.00056536874,0.0021046845,0.000016705122,0.0106984135,0.00001141951],"about_ca_topic_score_codex":0.9335561,"about_ca_topic_score_gemma":0.9374406,"teacher_disagreement_score":0.06644392,"about_ca_system_score_codex":0.016448038,"about_ca_system_score_gemma":0.024400966,"threshold_uncertainty_score":0.13367039},"labels":[],"label_agreement":null},{"id":"W4205891771","doi":"10.1177/10781552211073470","title":"Role of clinical pharmacist in the palliative care of adults and elderly patients with cancer: A scoping review","year":2022,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacist; Psychological intervention; MEDLINE; Palliative care; Family medicine; Clinical pharmacy; Data extraction; Scopus; Ambulatory; Nursing; Pharmacy; Internal medicine","score_opus":0.3675907298714855,"score_gpt":0.616885904520953,"score_spread":0.24929517464946754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205891771","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00068447326,0.99715877,0.00019631856,0.0006266973,0.00023174661,0.00034452268,0.0001556838,0.0000056761705,0.00059619057],"genre_scores_gemma":[0.005484425,0.99218106,0.00072486256,0.0005064122,0.0001882708,0.0006502511,0.00015450311,0.000004453109,0.00010577768],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98241985,0.005993585,0.0074444725,0.000985907,0.0027186973,0.00043752734],"domain_scores_gemma":[0.9167683,0.06379076,0.011313986,0.0009814427,0.00649931,0.0006461731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019177178,0.001736278,0.005191567,0.02374078,0.0015302786,0.005063788,0.002499734,0.0042169634,0.0043031294],"category_scores_gemma":[0.0780949,0.0013855003,0.0051443046,0.018984092,0.0014970503,0.005504976,0.0029018193,0.001796381,0.00061909034],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009556565,0.0000333139,0.00082371157,0.8925047,0.0013253005,0.00015153343,0.0008015136,0.000108590706,0.0001319785,0.0007360677,0.002842782,0.10044486],"study_design_scores_gemma":[0.000022967823,0.00006288411,0.0009531009,0.97544265,0.004534479,0.00021143953,0.0005270641,0.00004198648,0.000062529376,0.00023566604,0.017892346,0.000012744335],"about_ca_topic_score_codex":0.005918123,"about_ca_topic_score_gemma":0.011898103,"teacher_disagreement_score":0.02374078,"about_ca_system_score_codex":0.004120484,"about_ca_system_score_gemma":0.021637307,"threshold_uncertainty_score":0.101419866},"labels":[],"label_agreement":null},{"id":"W4206137847","doi":"10.1177/10781552211073673","title":"Biomarkers of everolimus efficacy in breast cancer therapy","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Essar Steel Algoma (Canada); Sault Area Hospital","funders":"","keywords":"Everolimus; Medicine; Breast cancer; Oncology; Internal medicine; Biomarker; PTEN; PI3K/AKT/mTOR pathway; Predictive marker; Cancer; Hormonal therapy; Signal transduction","score_opus":0.035185080806225365,"score_gpt":0.40571748754187237,"score_spread":0.370532406735647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206137847","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05054855,0.90613663,0.0051362594,0.007271619,0.0007520289,0.0004079915,0.015849298,0.00016686629,0.01373082],"genre_scores_gemma":[0.64900255,0.31492677,0.016736163,0.0035101725,0.0016980481,0.0007969562,0.010790876,0.000046559562,0.0024918793],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9950028,0.0020081392,0.0011142688,0.00038240722,0.0014034823,0.000088931134],"domain_scores_gemma":[0.9737995,0.015857311,0.0074705877,0.00028778138,0.0022952415,0.00028953247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057617784,0.0004879606,0.0015076143,0.005767157,0.00024463155,0.002457688,0.0005374433,0.0007596637,0.0034425033],"category_scores_gemma":[0.022359548,0.00015587635,0.0010760619,0.008091242,0.00044979563,0.0012786996,0.0005478068,0.0007435782,0.00082967815],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028359548,0.0003165334,0.20967712,0.0585425,0.004131984,0.00067007396,0.00036574632,0.0025040414,0.0038270766,0.005474188,0.02620356,0.68545115],"study_design_scores_gemma":[0.00078899955,0.0034721442,0.47606143,0.05373938,0.01326994,0.0058270986,0.0011269845,0.0075222915,0.016574115,0.016804863,0.4044691,0.0003436574],"about_ca_topic_score_codex":0.0007841472,"about_ca_topic_score_gemma":0.0010368046,"teacher_disagreement_score":0.005767157,"about_ca_system_score_codex":0.0007938944,"about_ca_system_score_gemma":0.0014527943,"threshold_uncertainty_score":0.030471504},"labels":[],"label_agreement":null},{"id":"W4213004141","doi":"10.1177/10781552221078207","title":"Evaluation of a pediatric pre-chemotherapy rapid hydration protocol: A quality assurance project","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Children's Hospital","funders":"","keywords":"Medicine; Ifosfamide; Chemotherapy; Methotrexate; Urine; Nephrotoxicity; Cyclophosphamide; Ambulatory; Protocol (science); Cisplatin; Internal medicine; Toxicity","score_opus":0.1480628172170722,"score_gpt":0.5164670749098501,"score_spread":0.3684042576927779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213004141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44330597,0.113682985,0.107055895,0.04057225,0.0020924925,0.22625338,0.006170158,0.004239383,0.05662748],"genre_scores_gemma":[0.60653967,0.04617301,0.28413084,0.006125333,0.0006373437,0.04531139,0.005348417,0.0002416165,0.005492295],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9363641,0.032722514,0.0075182146,0.0016052783,0.02053103,0.0012589548],"domain_scores_gemma":[0.81976193,0.030714417,0.046830703,0.0075895004,0.086430304,0.008673137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0942194,0.00063802075,0.00084339385,0.0023980937,0.0014942012,0.0025040444,0.0039985892,0.00070582447,0.0012127553],"category_scores_gemma":[0.09742824,0.0006051349,0.0009592783,0.0024205775,0.0009928638,0.0013120763,0.0019689025,0.0012817248,0.00035405357],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012294241,0.0018987383,0.07573349,0.012796595,0.00048753404,0.00028547793,0.0030568265,0.0027643507,0.004134425,0.0015928475,0.021983815,0.8740364],"study_design_scores_gemma":[0.0023246459,0.018480599,0.60096097,0.032579236,0.0018899308,0.0011710936,0.004722102,0.0072132843,0.022489097,0.0009862258,0.30684364,0.00033920584],"about_ca_topic_score_codex":0.038966652,"about_ca_topic_score_gemma":0.06630392,"teacher_disagreement_score":0.0942194,"about_ca_system_score_codex":0.013311363,"about_ca_system_score_gemma":0.07387697,"threshold_uncertainty_score":0.49828577},"labels":[],"label_agreement":null},{"id":"W4221038733","doi":"10.1177/10781552221084616","title":"Real-world incidence of venetoclax toxicities in British Columbia","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Methemoglobinemia and Tumor Lysis Syndrome","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Medicine; Neutropenia; Incidence (geometry); Internal medicine; Clinical trial; Toxicity; Oncology; Chronic lymphocytic leukemia; Pediatrics; Leukemia","score_opus":0.03711518437483042,"score_gpt":0.3877993800557443,"score_spread":0.3506841956809139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221038733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877008,0.0014793675,0.00015334411,0.0005546157,0.0000135052815,0.000061189385,0.005652896,0.000036082703,0.0043480946],"genre_scores_gemma":[0.99558866,0.000969431,0.00024056014,0.00025535235,0.000006333661,0.000031116055,0.0021743102,0.000009348279,0.0007249695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992274,0.000100981095,0.000097148135,0.00010798783,0.00034118225,0.00012526008],"domain_scores_gemma":[0.9963399,0.00042488222,0.0012533936,0.000114706214,0.0013253313,0.0005417426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051053206,0.000158398,0.00017651929,0.0013189506,0.0008834229,0.0010672509,0.0006462569,0.0003021879,0.0027858035],"category_scores_gemma":[0.002347229,0.00016754551,0.00012980202,0.0026435934,0.00039138252,0.00019222312,0.0004830638,0.00048089595,0.00026255805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000831406,0.00003266927,0.9857227,0.000100109355,0.0000313523,0.0003619231,0.00024894334,0.00018158105,0.00039091072,0.00006108513,0.0024967385,0.010288754],"study_design_scores_gemma":[0.000012219872,0.00004688105,0.99392974,0.00010519495,0.000019621757,0.0007633782,0.0010331227,0.00038844356,0.00026432567,0.00003283288,0.0033893061,0.000014967274],"about_ca_topic_score_codex":0.8313446,"about_ca_topic_score_gemma":0.8884753,"teacher_disagreement_score":0.1686554,"about_ca_system_score_codex":0.009408402,"about_ca_system_score_gemma":0.006698328,"threshold_uncertainty_score":0.33929724},"labels":[],"label_agreement":null},{"id":"W4224230859","doi":"10.1177/10781552221089667","title":"Pharmacists’ practices and views regarding management of sexual health in patients with cancer","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer survivorship and care","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Family medicine; Cancer; Nursing; Internal medicine","score_opus":0.09509897474524641,"score_gpt":0.4605347049710721,"score_spread":0.36543573022582565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224230859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289423,0.0008213651,0.00011060309,0.0026481543,0.000017740089,0.000031914806,0.00010417474,0.0000041730223,0.0033675707],"genre_scores_gemma":[0.99820197,0.00091949146,0.0001547749,0.00045926607,0.000011450995,0.000013782285,0.000038589507,0.0000010476867,0.00019965168],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99776435,0.0010186719,0.00024823443,0.00011262232,0.00061453384,0.00024148714],"domain_scores_gemma":[0.9880774,0.0043476187,0.004817516,0.0002102395,0.0011572231,0.0013899317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002324958,0.000081863334,0.00020932949,0.0003948695,0.0009802347,0.001237826,0.0002817927,0.0006045843,0.0021233219],"category_scores_gemma":[0.019100321,0.00018461971,0.0002916869,0.0005964604,0.00051807205,0.0010833751,0.0009422353,0.000900965,0.00016445838],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012509248,0.0002080762,0.9065427,0.00035734024,0.00009275601,0.00062879076,0.038445603,0.00019141732,0.0005783424,0.00013837355,0.0019940978,0.050697368],"study_design_scores_gemma":[0.000057893078,0.0009407488,0.8472104,0.000842756,0.000111433794,0.004292018,0.13364364,0.0007212022,0.0004354633,0.00022595612,0.011456645,0.00006190194],"about_ca_topic_score_codex":0.01356497,"about_ca_topic_score_gemma":0.022363968,"teacher_disagreement_score":0.01356497,"about_ca_system_score_codex":0.00082176796,"about_ca_system_score_gemma":0.0031723224,"threshold_uncertainty_score":0.026972055},"labels":[],"label_agreement":null},{"id":"W4226254150","doi":"10.1177/10781552221090199","title":"International society of oncology pharmacy practitioners (ISOPP) position statement: The role of oncology pharmacy practitioners in immunotherapy treatment with immune checkpoint inhibitors for malignant conditions","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Cancer Care Ontario; CancerCare Manitoba","funders":"","keywords":"Medicine; Pharmacy; Oncology nursing; Pharmacy practice; Oncology; Clinical pharmacy; Internal medicine; Immunotherapy; Position statement; Immune checkpoint; Cancer; Family medicine; Nursing; Nurse education","score_opus":0.03706517425586087,"score_gpt":0.4121058449302516,"score_spread":0.37504067067439073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4226254150","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015713056,0.012087173,0.0018152195,0.918637,0.0408841,0.00031510092,0.00030487508,0.0000691151,0.024316164],"genre_scores_gemma":[0.057226688,0.066850856,0.028958643,0.71601367,0.051153764,0.0011311447,0.0013569142,0.00018625207,0.07712213],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9787877,0.005175878,0.0026450902,0.0011600832,0.008912889,0.003318389],"domain_scores_gemma":[0.91878235,0.01658499,0.007753641,0.0015134765,0.027739933,0.027625639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02855612,0.0011027419,0.0009503668,0.0019158653,0.0052871914,0.007407409,0.0029194676,0.019468017,0.006967879],"category_scores_gemma":[0.043567754,0.00072769326,0.0018548303,0.0020542997,0.0027627978,0.004077443,0.00744697,0.025341863,0.00484981],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050794974,0.0002144256,0.0022243375,0.00070489326,0.000037444468,0.0003053217,0.000660075,0.00022572906,0.00041643615,0.008622678,0.90045834,0.086079404],"study_design_scores_gemma":[0.00007167298,0.00015685258,0.0031245714,0.0020343922,0.000047444017,0.00041593815,0.0006600668,0.00019116602,0.00042419723,0.0026581497,0.990166,0.000049522147],"about_ca_topic_score_codex":0.01334083,"about_ca_topic_score_gemma":0.032399066,"teacher_disagreement_score":0.02855612,"about_ca_system_score_codex":0.0061950474,"about_ca_system_score_gemma":0.0778073,"threshold_uncertainty_score":0.151021},"labels":[],"label_agreement":null},{"id":"W4238227307","doi":"10.1191/1078155205jp152oa","title":"Antineoplastic agent workplace contamination study: the Alberta Cancer Board Pharmacy perspective","year":2005,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Medicine; Pharmacy; Antineoplastic Drugs; Perspective (graphical); Cancer; Contamination; Cancer drugs; Family medicine; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.09123418649140072,"score_gpt":0.5188351417491699,"score_spread":0.4276009552577692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238227307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99342406,0.0007311888,0.0002895069,0.00074476673,0.000018953118,0.0003464666,0.00016454565,0.000009861777,0.0042706276],"genre_scores_gemma":[0.99612564,0.00062033185,0.00070365315,0.00061567326,0.000029935305,0.00006812487,0.0002038223,0.000003550384,0.0016293194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99598515,0.0009122356,0.000070334456,0.0002372772,0.0021144617,0.0006806598],"domain_scores_gemma":[0.995886,0.00045842413,0.00067125243,0.00010096941,0.001773536,0.0011098405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021242728,0.0003467496,0.00025121073,0.0012097032,0.0025032072,0.0013626569,0.0011630324,0.0006797872,0.0019992667],"category_scores_gemma":[0.0028860606,0.00037181142,0.00022714795,0.0017421418,0.0010333576,0.0003744772,0.0009823097,0.00075379445,0.00016294415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012615271,0.002315925,0.9425773,0.00030346663,0.00007645476,0.0024660958,0.004647815,0.00030422845,0.005664912,0.00044379968,0.0019714427,0.037967063],"study_design_scores_gemma":[0.00013184584,0.0021385523,0.98162466,0.000046563633,0.00004396209,0.00072483235,0.008270747,0.00031497743,0.0011790233,0.000063492414,0.005438665,0.00002263242],"about_ca_topic_score_codex":0.75344056,"about_ca_topic_score_gemma":0.8527108,"teacher_disagreement_score":0.24655944,"about_ca_system_score_codex":0.017135607,"about_ca_system_score_gemma":0.030533804,"threshold_uncertainty_score":0.49602294},"labels":[],"label_agreement":null},{"id":"W4282017708","doi":"10.1177/10781552221104422","title":"Toxicity analysis of busulfan pharmacokinetic therapeutic dose monitoring","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inimex Pharmaceuticals (Canada)","funders":"","keywords":"Busulfan; Medicine; Pharmacokinetics; Therapeutic drug monitoring; Therapeutic index; Toxicity; Drug; Pharmacology; Therapeutic effect; Cyclophosphamide; Internal medicine; Chemotherapy","score_opus":0.07412746311896341,"score_gpt":0.4379495859559921,"score_spread":0.3638221228370287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282017708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867763,0.0036249815,0.0060374546,0.000058685255,0.000015723668,0.00047620974,0.0011961651,0.000073738694,0.0017407039],"genre_scores_gemma":[0.9946367,0.0007505816,0.002893666,0.000040354775,0.000021061987,0.00022852184,0.0010483298,0.000018794351,0.00036196082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968815,0.001270316,0.00044819567,0.0002671464,0.0010121092,0.00012077919],"domain_scores_gemma":[0.9930742,0.0018059213,0.0030342585,0.00041661673,0.0014814812,0.00018747932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002989726,0.0002739974,0.0007141447,0.0009105908,0.00017434025,0.0004280348,0.00031951323,0.00017040777,0.0007776068],"category_scores_gemma":[0.0060773324,0.00009071568,0.00097468344,0.0012385921,0.00022044338,0.00035364807,0.00025651586,0.00033459582,0.00011306316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010383896,0.00073174044,0.830273,0.0007080428,0.00086050096,0.0004388199,0.00016712799,0.0054505593,0.015837178,0.00035407796,0.0005756869,0.13421942],"study_design_scores_gemma":[0.00025819844,0.024199504,0.9206851,0.00009934492,0.0014639451,0.0019607674,0.00009534848,0.013199566,0.032767564,0.0004135635,0.0048090327,0.00004804969],"about_ca_topic_score_codex":0.00058026036,"about_ca_topic_score_gemma":0.0006298162,"teacher_disagreement_score":0.002989726,"about_ca_system_score_codex":0.0008269815,"about_ca_system_score_gemma":0.00066622405,"threshold_uncertainty_score":0.015811384},"labels":[],"label_agreement":null},{"id":"W4282018015","doi":"10.1177/10781552221102884","title":"Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacy","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; AMT Die Casting (Canada)","funders":"Pfizer","keywords":"Medicine; Discontinuation; Fulvestrant; Internal medicine; Pharmacy; Breast cancer; Oncology; Palbociclib; Letrozole; Cancer; Metastatic breast cancer; Tamoxifen; Family medicine","score_opus":0.05411267099891534,"score_gpt":0.42878351827453065,"score_spread":0.3746708472756153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282018015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986255,0.00018898312,0.00009529585,0.00019300457,0.0000031768857,0.000044537006,0.00023189036,0.0000043392743,0.0006132895],"genre_scores_gemma":[0.9996056,0.0000626521,0.00012316598,0.00004123388,0.000004622547,0.000013236224,0.00011407885,8.6254244e-7,0.000034605713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974644,0.0011955589,0.00024076458,0.00030401524,0.000606501,0.00018865128],"domain_scores_gemma":[0.99369377,0.00087788835,0.0041493354,0.0001801699,0.00047027814,0.00062854064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019265494,0.00008686599,0.00019656836,0.00061522727,0.00046378313,0.0009122103,0.00033025158,0.0002635329,0.0008331338],"category_scores_gemma":[0.006875981,0.00014238487,0.00021245565,0.00144058,0.00029099695,0.00048944895,0.0006665785,0.00031208992,0.00008735235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007746065,0.00008788415,0.9951062,0.000015037127,0.000017882354,0.000036567777,0.00017033683,0.00005062926,0.00008825926,0.000015339354,0.0001290726,0.0042053307],"study_design_scores_gemma":[0.000013367564,0.00020674187,0.9985856,0.000009893785,0.000009912637,0.00012802832,0.00034111826,0.00031436884,0.000055256412,0.000014541314,0.00031827358,0.0000027607107],"about_ca_topic_score_codex":0.009548723,"about_ca_topic_score_gemma":0.016535122,"teacher_disagreement_score":0.009548723,"about_ca_system_score_codex":0.0013765102,"about_ca_system_score_gemma":0.0017511843,"threshold_uncertainty_score":0.018986285},"labels":[],"label_agreement":null},{"id":"W4289838535","doi":"10.1177/10781552221118535","title":"Developing wipe sampling strategy guidance for assessing environmental contamination of antineoplastic drugs","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of British Columbia","funders":"Alberta Health Services","keywords":"Medicine; Antineoplastic Drugs; Percentile; Sampling (signal processing); Pharmacy; Contamination; Environmental health; Statistics; Pharmacology; Family medicine; Computer science; Telecommunications","score_opus":0.15113008029559152,"score_gpt":0.5187497198166111,"score_spread":0.3676196395210196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289838535","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55287486,0.00045680688,0.42470455,0.0015431958,0.00008211596,0.0021607827,0.0023673992,0.0012564723,0.014553798],"genre_scores_gemma":[0.80443984,0.00022331913,0.19258419,0.00017439696,0.0000066374,0.0008051231,0.0007604771,0.000049277874,0.0009567647],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99775106,0.001248946,0.00010594558,0.0001669749,0.00050969975,0.00021734474],"domain_scores_gemma":[0.99324787,0.004172507,0.0006418843,0.0003503468,0.0014376004,0.00014991457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060932892,0.000765269,0.00065833906,0.0009096256,0.0005509744,0.0012015061,0.0012895494,0.0010392537,0.0017883043],"category_scores_gemma":[0.016140647,0.000644742,0.0005882599,0.00057531864,0.00040820145,0.0012256526,0.0008475411,0.0007904898,0.0003058903],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009236779,0.00019418952,0.018672496,0.0001283229,0.000035339388,0.00005970046,0.000082752245,0.9538944,0.0026533778,0.0023277742,0.0011782818,0.020681089],"study_design_scores_gemma":[0.00008555383,0.0003158214,0.004627021,0.000050441155,0.000021479646,0.000028374094,0.00019005997,0.9869827,0.0036601268,0.002156494,0.0018543544,0.000027527329],"about_ca_topic_score_codex":0.030259307,"about_ca_topic_score_gemma":0.03428577,"teacher_disagreement_score":0.030259307,"about_ca_system_score_codex":0.0019018466,"about_ca_system_score_gemma":0.004519003,"threshold_uncertainty_score":0.06016636},"labels":[],"label_agreement":null},{"id":"W4292870479","doi":"10.1177/10781552221122005","title":"Ocular toxicity following carboplatin chemotherapy for neuroendocrine tumour of the bladder","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Drug-Induced Ocular Toxicity","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Carboplatin; Medicine; Chemotherapy; Cisplatin; Toxicity; Blurred vision; Etoposide; Surgery; Oncology; Internal medicine","score_opus":0.039022091257262415,"score_gpt":0.3936813237783743,"score_spread":0.35465923252111187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292870479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95308834,0.020887954,0.004483847,0.0022443652,0.000269058,0.00020175586,0.00013828378,0.00029525082,0.018391069],"genre_scores_gemma":[0.9945938,0.0023425973,0.00050003274,0.000625071,0.00017292044,0.000016252281,0.000059663867,0.000018938194,0.0016707401],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99944943,0.00009381769,0.000068864494,0.000062982195,0.000170171,0.00015480186],"domain_scores_gemma":[0.9982174,0.0005443137,0.0007280919,0.0001404053,0.00012974661,0.0002400056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003014202,0.0006214023,0.00066415005,0.0012546841,0.0010852612,0.0009484085,0.0005227565,0.0016263849,0.0016734056],"category_scores_gemma":[0.0024532287,0.0003546145,0.0007851031,0.0012122385,0.0008387004,0.0009999445,0.0008778166,0.002056889,0.00037218112],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008588335,0.000030743824,0.010413241,0.00010483153,0.000018387394,0.98075897,0.00014901455,0.00012946299,0.0024213688,0.00014652211,0.00034308012,0.005398494],"study_design_scores_gemma":[0.000022345299,0.00017981867,0.009334618,0.00003918545,0.000029742818,0.9851532,0.00012648384,0.0004162745,0.0025527996,0.00016431115,0.0019707843,0.0000104201],"about_ca_topic_score_codex":0.0021533926,"about_ca_topic_score_gemma":0.0033859292,"teacher_disagreement_score":0.0021533926,"about_ca_system_score_codex":0.0015230508,"about_ca_system_score_gemma":0.0008083023,"threshold_uncertainty_score":0.011050522},"labels":[],"label_agreement":null},{"id":"W4293213938","doi":"10.1177/10781552221122057","title":"Elevated transaminases and development of cardiomyopathy in a 32-year-old woman with metastatic breast cancer after treatment with ribociclib followed by palbociclib","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"","keywords":"Palbociclib; Medicine; Discontinuation; Metastatic breast cancer; Breast cancer; Internal medicine; Cardiomyopathy; Heart failure; Adverse effect; Cancer; Oncology","score_opus":0.024529496821787684,"score_gpt":0.3570514982484372,"score_spread":0.3325220014266495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293213938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898371,0.0028303969,0.00076879305,0.0023627367,0.00017364525,0.00009665552,0.00012421377,0.00006739378,0.0037389628],"genre_scores_gemma":[0.99793696,0.00067830033,0.00022271238,0.0005001442,0.00015337234,0.000009281993,0.000051285777,0.0000061651867,0.00044186256],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996933,0.000041341922,0.00003529794,0.00008209076,0.0000472208,0.00010079335],"domain_scores_gemma":[0.9992211,0.00013872517,0.00022230652,0.00003505094,0.00005616765,0.00032665476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027048276,0.0008707888,0.00069602765,0.0011367947,0.0015571105,0.00061377516,0.00050116924,0.0021400037,0.0012754312],"category_scores_gemma":[0.0013894406,0.000665945,0.0007362457,0.0008095479,0.0006900356,0.00100927,0.00062792376,0.0022525953,0.00037039386],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011659168,0.000079067926,0.03957656,0.000027376269,0.0000144905625,0.9573301,0.00029144986,0.00005799117,0.0012303308,0.00004942587,0.00029206788,0.00093453156],"study_design_scores_gemma":[0.000020627785,0.00040397877,0.05025281,0.00003076305,0.000027540156,0.9476322,0.00035967593,0.0002838801,0.00040006795,0.0000739011,0.00049720105,0.000017321983],"about_ca_topic_score_codex":0.002274828,"about_ca_topic_score_gemma":0.003726211,"teacher_disagreement_score":0.002274828,"about_ca_system_score_codex":0.0009124924,"about_ca_system_score_gemma":0.000586459,"threshold_uncertainty_score":0.006620586},"labels":[],"label_agreement":null},{"id":"W4294843065","doi":"10.1177/10781552221103551","title":"Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"Janssen Research and Development","keywords":"Daratumumab; Medicine; Lenalidomide; Adverse effect; Multiple myeloma; Internal medicine; Expanded access; Oncology","score_opus":0.03477357326497679,"score_gpt":0.37979663970437233,"score_spread":0.3450230664393955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294843065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403834,0.0030196044,0.00021554355,0.0002535329,0.000016334734,0.000022431426,0.00010743708,0.00002754874,0.0022990631],"genre_scores_gemma":[0.99897563,0.000389158,0.00014585022,0.00018526062,0.0000133087515,0.0000049761484,0.00008440552,0.0000020149914,0.00019934982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995202,0.00014758344,0.000050013165,0.00007603889,0.00014922589,0.00005698179],"domain_scores_gemma":[0.9987286,0.0002822654,0.0007271446,0.00006342107,0.00008369993,0.00011492323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006304227,0.00014026716,0.0002734929,0.00014613809,0.0003182182,0.00052689173,0.0001237181,0.00023386051,0.0018883538],"category_scores_gemma":[0.0018977816,0.000081374405,0.00022587525,0.00034175446,0.00017950794,0.00020802785,0.0002213058,0.00048078553,0.00027429746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004394214,0.0007619785,0.7366157,0.00019224372,0.00033024847,0.0005350145,0.00032802692,0.00034512382,0.010664305,0.00008141198,0.0019071084,0.24384457],"study_design_scores_gemma":[0.0006346639,0.012836284,0.9577599,0.00012063536,0.00030694497,0.0077547436,0.0004370261,0.0010241808,0.0066396547,0.00029304903,0.012172654,0.000020247571],"about_ca_topic_score_codex":0.00038557444,"about_ca_topic_score_gemma":0.0007791251,"teacher_disagreement_score":0.0018883538,"about_ca_system_score_codex":0.00021934665,"about_ca_system_score_gemma":0.00026046866,"threshold_uncertainty_score":0.0063171983},"labels":[],"label_agreement":null},{"id":"W4296041784","doi":"10.1177/10781552221112603","title":"Oral oncolytic monitoring pilot with patient-reported outcomes and adherence assessments","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacist; Adverse effect; Internal medicine; Pharmacy; Emergency medicine; Intensive care medicine; Family medicine","score_opus":0.17346339030429375,"score_gpt":0.4920311052374802,"score_spread":0.3185677149331865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296041784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99026847,0.0001510094,0.0007964116,0.00020815601,0.000026275005,0.0034684925,0.0016671397,0.00008520379,0.0033287194],"genre_scores_gemma":[0.9833966,0.00021423196,0.005989762,0.00017596614,0.00007357408,0.005890927,0.0019387183,0.00001631689,0.0023037784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979206,0.0008701622,0.00030994264,0.00023837917,0.00044341382,0.00021764805],"domain_scores_gemma":[0.9953826,0.00079382386,0.0015192258,0.00033504155,0.0011486576,0.00082071614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031234943,0.00039589038,0.0005517764,0.00063622755,0.00061382045,0.0006277717,0.0003693394,0.0003744012,0.0050630965],"category_scores_gemma":[0.0039920546,0.00021440412,0.0006399509,0.00053791713,0.00018906947,0.00035328648,0.00092769513,0.0007593966,0.0009164403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011892301,0.021184089,0.76170677,0.00043488387,0.00023386863,0.00076007866,0.0020307878,0.000692414,0.004744891,0.00016930074,0.0054696104,0.19068106],"study_design_scores_gemma":[0.0018585452,0.050643247,0.93146265,0.0001062567,0.00023193377,0.000843496,0.0005421984,0.0017711901,0.004376872,0.00015381213,0.007954208,0.000055609657],"about_ca_topic_score_codex":0.0016391777,"about_ca_topic_score_gemma":0.0018837318,"teacher_disagreement_score":0.0050630965,"about_ca_system_score_codex":0.0005333455,"about_ca_system_score_gemma":0.0010244342,"threshold_uncertainty_score":0.016937733},"labels":[],"label_agreement":null},{"id":"W4308959566","doi":"10.1177/10781552221135121","title":"Safe handling of hazardous drugs","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lakeridge Health; McMaster University; Cancer Care Ontario; Southlake Regional Health Center; Regional Municipality of Durham; University of Toronto; Kingston Health Sciences Centre","funders":"","keywords":"Guideline; Medicine; Accidental; Hazardous waste; Health care; Pharmacy; Medical emergency; Family medicine","score_opus":0.08298654180514832,"score_gpt":0.5078588193423224,"score_spread":0.42487227753717405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308959566","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006960028,0.46419114,0.05296851,0.28203985,0.012659607,0.0073201745,0.0038882722,0.0011537287,0.16881877],"genre_scores_gemma":[0.06727433,0.6076197,0.17135571,0.12672077,0.0037258237,0.0057308604,0.0038590932,0.0002088331,0.013504925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.96082264,0.014811679,0.010099604,0.001217044,0.012169396,0.00087969075],"domain_scores_gemma":[0.9455008,0.025079068,0.009364939,0.0022770076,0.01657927,0.0011990002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020014826,0.0014169505,0.0020875053,0.0044000107,0.001459,0.0034642974,0.0047941385,0.008111105,0.005873758],"category_scores_gemma":[0.06910113,0.0010085016,0.0039634956,0.0020456247,0.0027650872,0.004030858,0.0035506918,0.006279146,0.0041529275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011716637,0.0003134165,0.0027909388,0.10344982,0.0005632042,0.00088631327,0.0017857902,0.0014474594,0.0014479262,0.014135133,0.32403338,0.54902947],"study_design_scores_gemma":[0.00015710991,0.00021458474,0.0033956203,0.18932396,0.0005890571,0.0013738498,0.0005289298,0.00040995696,0.0010649732,0.007993998,0.79484785,0.000100228564],"about_ca_topic_score_codex":0.010810059,"about_ca_topic_score_gemma":0.018362198,"teacher_disagreement_score":0.020014826,"about_ca_system_score_codex":0.0028135693,"about_ca_system_score_gemma":0.019385234,"threshold_uncertainty_score":0.10584974},"labels":[],"label_agreement":null},{"id":"W4312018881","doi":"10.1177/10781552221145667","title":"Exploration of current pharmacy practice in cardio-oncology: Experiences &amp; perspectives","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo; Alberta Pharmacists Association; Alberta Health Services","funders":"","keywords":"Medicine; Cardiotoxicity; Pharmacy; Oncology; Pharmacy practice; Family medicine; Clinical pharmacy; Nursing; Internal medicine","score_opus":0.13177719943355853,"score_gpt":0.48809345303582236,"score_spread":0.3563162536022638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312018881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92190367,0.0057622436,0.0006259773,0.03849718,0.00029756117,0.00010252651,0.00015093594,0.000022830684,0.03263711],"genre_scores_gemma":[0.9894935,0.004405358,0.00035065765,0.003191473,0.00006823406,0.000039085553,0.00004581988,0.000009914935,0.0023960578],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99260384,0.0032459057,0.00020334455,0.0003095068,0.0016066966,0.0020308397],"domain_scores_gemma":[0.9869725,0.0045447554,0.0014157458,0.00018285528,0.0020328427,0.004851268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005365265,0.00024277899,0.00036871317,0.0011147966,0.010869996,0.0073793614,0.0014652126,0.0018739115,0.0029449821],"category_scores_gemma":[0.011477017,0.0003934685,0.00034852582,0.002136698,0.0072188247,0.0047851126,0.0060587768,0.003419295,0.00029263564],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032145508,0.000116957206,0.018028155,0.0003588987,0.000010485721,0.0020761227,0.9523085,0.00003517615,0.00026221355,0.0016647974,0.004313365,0.020793295],"study_design_scores_gemma":[0.0000045507277,0.000042199907,0.008259064,0.0002773129,0.000004519044,0.0011183089,0.95934284,0.000032942324,0.00007297139,0.00018308232,0.030645384,0.000016920423],"about_ca_topic_score_codex":0.14289074,"about_ca_topic_score_gemma":0.24717647,"teacher_disagreement_score":0.14289074,"about_ca_system_score_codex":0.011145539,"about_ca_system_score_gemma":0.02609997,"threshold_uncertainty_score":0.28411806},"labels":[],"label_agreement":null},{"id":"W4312095782","doi":"10.1177/10781552221146801","title":"Etoposide hypersensitivity reactions associated with in-line filter use: A retrospective cohort study at CHU de Québec-Université Laval","year":2022,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval","funders":"Fondation CHU de Québec; Université Laval","keywords":"Medicine; Retrospective cohort study; Incidence (geometry); Etoposide; Cohort; Medical record; Population; Cumulative incidence; Surgery; Internal medicine; Chemotherapy","score_opus":0.04226150017374332,"score_gpt":0.35635523560713916,"score_spread":0.31409373543339586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312095782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975535,0.0005699828,0.00011044458,0.00006482313,0.0000066342873,0.000061014573,0.0010749991,0.000007048053,0.0005514792],"genre_scores_gemma":[0.99879515,0.00027835555,0.0001001331,0.00008418433,0.000008387007,0.000026947422,0.0004912799,0.0000032806272,0.00021223967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992054,0.00008027798,0.00006175022,0.00023072537,0.00020428603,0.0002176321],"domain_scores_gemma":[0.9980811,0.00020641564,0.0008561804,0.00011273921,0.00040738654,0.0003362473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056804233,0.00032261116,0.0005382118,0.0010118821,0.0009271482,0.00083646725,0.00069226156,0.00042826275,0.0025073874],"category_scores_gemma":[0.0012922519,0.00031796622,0.00042309068,0.0018602845,0.00045346442,0.00038980096,0.00040133964,0.0004973232,0.0001939844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005480374,0.000019815745,0.9982451,0.000018797922,0.00003293209,0.00019355932,0.00011568044,0.000029429204,0.00018102222,0.000017600923,0.0002171078,0.0008742359],"study_design_scores_gemma":[0.0000073153287,0.000105607935,0.9980574,0.000027940707,0.000028141189,0.0005363137,0.0003058602,0.0001682848,0.0000642558,0.000006944228,0.0006854658,0.000006481226],"about_ca_topic_score_codex":0.5420528,"about_ca_topic_score_gemma":0.5831028,"teacher_disagreement_score":0.4579472,"about_ca_system_score_codex":0.004899232,"about_ca_system_score_gemma":0.0044333925,"threshold_uncertainty_score":0.92128825},"labels":[],"label_agreement":null},{"id":"W4312200106","doi":"10.1177/10781552221147500","title":"An overview of the role of selpercatinib and pralsetinib in RET-fusion-positive non-small cell lung cancer (NSCLC)","year":2022,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Medicine; Tolerability; Lung cancer; Internal medicine; Context (archaeology); Oncology; Adverse effect; Clinical trial; Neutropenia; non-small cell lung cancer (NSCLC); Intensive care medicine; Toxicity","score_opus":0.08405027830177551,"score_gpt":0.5071884258990789,"score_spread":0.42313814759730334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312200106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022994293,0.9982407,0.00009338886,0.0004159411,0.00009424752,0.000011224317,0.00005477946,0.0000063369025,0.0008534358],"genre_scores_gemma":[0.0012760195,0.99750817,0.00028601725,0.0003485994,0.00014462616,0.000018034796,0.00010305296,0.0000016180901,0.00031386348],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995956,0.000092349386,0.00012269792,0.0000612649,0.00009704492,0.000031120264],"domain_scores_gemma":[0.99924004,0.00041180378,0.00013994059,0.000012773447,0.00015213256,0.00004326232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011181553,0.00065156934,0.0014542132,0.0042927037,0.0002705243,0.0010269153,0.00070555415,0.0009814982,0.0032412552],"category_scores_gemma":[0.0013169866,0.0002993622,0.0016266411,0.0036368298,0.00022817968,0.0014165823,0.000533144,0.0011384137,0.0008679087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034617173,0.000078539175,0.00068379176,0.090679444,0.0004935738,0.00033290024,0.00015523998,0.00042996783,0.0016364951,0.0025064475,0.027203625,0.8754539],"study_design_scores_gemma":[0.000095704345,0.0006298802,0.00411625,0.04823912,0.002019407,0.0025627913,0.00018055063,0.00028601757,0.0005919277,0.0019946767,0.9392375,0.0000462792],"about_ca_topic_score_codex":0.0017478731,"about_ca_topic_score_gemma":0.0037314934,"teacher_disagreement_score":0.0042927037,"about_ca_system_score_codex":0.0009445291,"about_ca_system_score_gemma":0.0017488961,"threshold_uncertainty_score":0.010843039},"labels":[],"label_agreement":null},{"id":"W4323809563","doi":"10.1177/10781552231160678","title":"The role of the pharmacist in the hospital discharge of cancer patients: an integrative review","year":2023,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacist; MEDLINE; Medical prescription; Family medicine; Hospital discharge; Pharmaceutical care; Clinical pharmacy; Multidisciplinary approach; Pharmacotherapy; Cancer; Pharmacy; Nursing; Intensive care medicine; Internal medicine","score_opus":0.19189831728090095,"score_gpt":0.5697733033055442,"score_spread":0.37787498602464326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323809563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000892026,0.9984518,0.00003667393,0.00027259873,0.000060789793,0.000024067296,0.000032694894,0.0000016468326,0.00022774737],"genre_scores_gemma":[0.010106052,0.9892464,0.00021371854,0.0002173522,0.00008361887,0.000050609855,0.000039505612,0.0000010906278,0.000041714626],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99716944,0.0011422395,0.0008337308,0.00023991166,0.00051447866,0.00010019393],"domain_scores_gemma":[0.98111343,0.014543518,0.0029915671,0.00014113379,0.000999979,0.00021040287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032011485,0.00064800505,0.002033758,0.009035944,0.0005573257,0.002387449,0.0011023817,0.0015684434,0.0021101336],"category_scores_gemma":[0.01572244,0.00039002896,0.002411691,0.0088654915,0.00064198213,0.0021472382,0.001021801,0.00088155956,0.0001756737],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017463915,0.00007591837,0.0037005995,0.7626613,0.002875811,0.00037653223,0.0011211857,0.00012615511,0.00015527305,0.0007645775,0.0030808095,0.22488724],"study_design_scores_gemma":[0.000117606935,0.00034646338,0.018322442,0.8919489,0.02007006,0.0020866378,0.0024258539,0.00015046661,0.000207204,0.0007692118,0.0635005,0.00005468099],"about_ca_topic_score_codex":0.0047043697,"about_ca_topic_score_gemma":0.009351825,"teacher_disagreement_score":0.009035944,"about_ca_system_score_codex":0.0017553312,"about_ca_system_score_gemma":0.0066641313,"threshold_uncertainty_score":0.016929448},"labels":[],"label_agreement":null},{"id":"W4323812920","doi":"10.1177/10781552231162012","title":"Prescribing practices of oncology pharmacists working in ambulatory cancer centers in Alberta","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Cancer Foundation; University of Alberta; Alberta Children's Hospital","funders":"Alberta Health Services","keywords":"Medicine; Medical prescription; Interquartile range; Ambulatory; Pharmacist; Family medicine; Emergency medicine; Pharmacy; Internal medicine; Nursing","score_opus":0.30627243002902105,"score_gpt":0.5438910268885448,"score_spread":0.2376185968595238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323812920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821234,0.000223147,0.00005336979,0.00012365813,0.000001914661,0.00002017195,0.00035561205,0.0000057715833,0.0010041347],"genre_scores_gemma":[0.9987035,0.0002938394,0.00020470028,0.00008897106,0.000005286552,0.000008566105,0.00026020364,0.0000015856208,0.0004333815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992225,0.000077346725,0.000052317595,0.00009289745,0.00040596412,0.00014894134],"domain_scores_gemma":[0.9980123,0.00022040909,0.000994282,0.000039764374,0.00034534975,0.0003879026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039107483,0.00013604463,0.00013408142,0.00086320343,0.000801771,0.0006045633,0.00051609194,0.00024979658,0.001109141],"category_scores_gemma":[0.0022738553,0.00016503932,0.00012509633,0.0013845955,0.00028462702,0.00025499743,0.00041541358,0.00025781954,0.00014476945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030506018,0.000043715772,0.9927899,0.00001907169,0.000012333435,0.00009401561,0.0007999036,0.000075177704,0.00020399611,0.00001105679,0.00031973585,0.0056004403],"study_design_scores_gemma":[0.000003640813,0.000050927403,0.9980684,0.000013342368,0.0000046778,0.00013077498,0.0010761927,0.00015783127,0.00005168383,0.000004943701,0.00043467645,0.0000030117237],"about_ca_topic_score_codex":0.66008735,"about_ca_topic_score_gemma":0.8089688,"teacher_disagreement_score":0.33991265,"about_ca_system_score_codex":0.0049275397,"about_ca_system_score_gemma":0.0052905576,"threshold_uncertainty_score":0.68382895},"labels":[],"label_agreement":null},{"id":"W4362657402","doi":"10.1177/10781552231167329","title":"Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 124 centers","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Docetaxel; Gemcitabine; Antineoplastic Drugs; Cyclophosphamide; Internal medicine; Cancer; Pharmacology; Chemotherapy","score_opus":0.05560200019666819,"score_gpt":0.4623512739777416,"score_spread":0.40674927378107345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362657402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700586,0.0013141617,0.0027669242,0.000544473,0.000037730173,0.00083236623,0.01632279,0.00025834152,0.007864547],"genre_scores_gemma":[0.9816576,0.0008724146,0.0067662215,0.00018757813,0.000023434757,0.00023860409,0.00718706,0.000023622637,0.0030434527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99693453,0.00025726442,0.00014644892,0.00046044437,0.0017534284,0.00044787984],"domain_scores_gemma":[0.9927539,0.00030297338,0.0013272566,0.00021399006,0.0047059273,0.0006959399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015654347,0.0005342878,0.00031544923,0.0029538302,0.0013286251,0.00076756335,0.0014433889,0.00030444286,0.001499685],"category_scores_gemma":[0.0032590013,0.00029845684,0.00034059572,0.0038554461,0.00037071566,0.00023802258,0.00078249647,0.0002674637,0.00025864603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014484389,0.00008110312,0.9457732,0.00022974449,0.00004350711,0.000117268966,0.00096021284,0.00042175376,0.0030871308,0.00011567007,0.0041268086,0.044898797],"study_design_scores_gemma":[0.0000052921478,0.00009616693,0.9927451,0.000030832653,0.000011056301,0.00007190621,0.00042400704,0.0004655918,0.0010546311,0.000012775154,0.0050714416,0.000011114138],"about_ca_topic_score_codex":0.9191043,"about_ca_topic_score_gemma":0.8953381,"teacher_disagreement_score":0.9836635,"about_ca_system_score_codex":0.01633651,"about_ca_system_score_gemma":0.023445593,"threshold_uncertainty_score":0.16274422},"labels":[],"label_agreement":null},{"id":"W4378952203","doi":"10.1177/10781552231179190","title":"Implementation and evaluation of a shared care model between oncologists and pharmacists for breast cancer patients at a Canadian regional ambulatory cancer centre","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacist; Ambulatory; Family medicine; Breast cancer; Medical prescription; Cancer; Pharmaceutical care; Ambulatory care; Pharmacy; Internal medicine; Health care; Nursing","score_opus":0.13863132179766358,"score_gpt":0.5167725657152309,"score_spread":0.3781412439175673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378952203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98384374,0.00023985101,0.0019023195,0.0034998371,0.00008754275,0.005549693,0.00026040795,0.00018655174,0.0044301385],"genre_scores_gemma":[0.97659475,0.00029834444,0.018155474,0.0010415935,0.000052222113,0.002117536,0.00029307744,0.00001847187,0.0014284966],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.985225,0.006268834,0.0005624727,0.001171054,0.0031266026,0.0036460205],"domain_scores_gemma":[0.9771313,0.002619846,0.0015224877,0.0010962491,0.005642321,0.01198784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013150553,0.0007830701,0.0004920888,0.0006427795,0.00644097,0.0022645753,0.0045014704,0.0017071505,0.004195216],"category_scores_gemma":[0.020657668,0.00062583917,0.001076553,0.0007783953,0.0015213615,0.0013560312,0.005165317,0.0017130679,0.00039962356],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012768986,0.06939389,0.20940827,0.0024166405,0.00068212015,0.0032372721,0.03319895,0.012252353,0.0050571207,0.0015011588,0.019835869,0.6302474],"study_design_scores_gemma":[0.024961444,0.12153631,0.6617214,0.0016010617,0.0012261106,0.0014435,0.07411544,0.051532086,0.0043751835,0.0012556334,0.05550679,0.0007249519],"about_ca_topic_score_codex":0.6129478,"about_ca_topic_score_gemma":0.7864985,"teacher_disagreement_score":0.6129478,"about_ca_system_score_codex":0.037380077,"about_ca_system_score_gemma":0.14288749,"threshold_uncertainty_score":0.7786632},"labels":[],"label_agreement":null},{"id":"W4383872302","doi":"10.1177/10781552231188309","title":"Pilot study evaluating feasibility and utility of pharmacist-driven oral antineoplastic agent monitoring program","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacist; Pharmacy; Psychological intervention; Adverse effect; Patient satisfaction; Clinical pharmacy; Patient safety; Medication therapy management; Health care; Medical emergency; Emergency medicine; Family medicine; Nursing; Internal medicine","score_opus":0.5216673933825094,"score_gpt":0.5890936689976283,"score_spread":0.06742627561511882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383872302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931352,0.000027747863,0.00062338455,0.00008397617,0.000018354933,0.0053758714,0.00015624893,0.000030457952,0.0005487001],"genre_scores_gemma":[0.98654443,0.00006376087,0.0057212687,0.00026947388,0.000055104498,0.00666501,0.00028473246,0.000008235236,0.00038800505],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9926191,0.004949017,0.00043447287,0.0005100336,0.00073243043,0.0007549023],"domain_scores_gemma":[0.9875789,0.004716485,0.0015197212,0.0010145428,0.0022164977,0.0029538423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01136007,0.00073642784,0.0005134644,0.0004802281,0.0010637707,0.0007893904,0.0009748497,0.0009421473,0.0038228636],"category_scores_gemma":[0.01113216,0.00046912718,0.00070894073,0.0003751751,0.00067177,0.00090086466,0.00073931005,0.0015127253,0.00070723175],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058829144,0.5230674,0.3010673,0.0005685515,0.0004100017,0.0006651951,0.0028221025,0.0013650362,0.0090655545,0.00022649528,0.0014637155,0.100449495],"study_design_scores_gemma":[0.018731019,0.8131143,0.16113356,0.000050997303,0.00017069491,0.00021276454,0.0009759273,0.0020248303,0.0023844207,0.000056293447,0.0011144067,0.00003077316],"about_ca_topic_score_codex":0.00243458,"about_ca_topic_score_gemma":0.0026681481,"teacher_disagreement_score":0.01136007,"about_ca_system_score_codex":0.0011687686,"about_ca_system_score_gemma":0.0042615035,"threshold_uncertainty_score":0.0600785},"labels":[],"label_agreement":null},{"id":"W4384818836","doi":"10.1177/10781552231188320","title":"Initial assessment of multi-compound antineoplastic drug surface contamination in Argentinean healthcare centers: Insights into occupational exposures in South America","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Fondo para la Investigación Científica y Tecnológica","keywords":"Antineoplastic Drugs; Contamination; Medicine; Drug; Toxicology; Environmental health; Pharmacology","score_opus":0.12636622964018557,"score_gpt":0.5322894968150766,"score_spread":0.4059232671748911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384818836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833435,0.0003178414,0.00017565428,0.000053550535,0.0000014936488,0.000027743314,0.00017639477,0.0000036861945,0.00090922596],"genre_scores_gemma":[0.9988412,0.00033806698,0.00035090698,0.000049209404,0.0000035978462,0.000016767712,0.00012840121,0.000002129392,0.0002697928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997061,0.00007195312,0.000019686126,0.00006806508,0.000060419687,0.00007381921],"domain_scores_gemma":[0.99934715,0.00010989378,0.00026845664,0.000024470673,0.00016238957,0.00008764839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043969724,0.00046333086,0.00019442844,0.0010801726,0.0005762582,0.00065209216,0.00022735161,0.00033561798,0.0013616476],"category_scores_gemma":[0.000682195,0.00020744234,0.00017895937,0.00079500227,0.0003863609,0.00023396712,0.0007087293,0.000190545,0.0001331272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013234264,0.000039540613,0.98170483,0.00008130998,0.000016439697,0.00026627487,0.0018683221,0.00006204869,0.008131511,0.000026205855,0.00013972464,0.0075313784],"study_design_scores_gemma":[0.0000017016622,0.00010183937,0.996415,0.000019328432,0.000009453458,0.0001650085,0.0019487769,0.0000807967,0.00051545515,0.00000784227,0.00073215825,0.0000026281064],"about_ca_topic_score_codex":0.028497072,"about_ca_topic_score_gemma":0.03590608,"teacher_disagreement_score":0.028497072,"about_ca_system_score_codex":0.000920957,"about_ca_system_score_gemma":0.00063809764,"threshold_uncertainty_score":0.05666238},"labels":[],"label_agreement":null},{"id":"W4385330812","doi":"10.1177/10781552231189695","title":"Single center evaluation on the use of conditionally ordered low molecular weight heparins in malignant hematology patients with venous thromboembolism","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Concordance; Internal medicine; Hematology; Venous thromboembolism; Low molecular weight heparin; Cancer; Pediatrics; Heparin; Thrombosis","score_opus":0.07901018509527911,"score_gpt":0.36657191374363096,"score_spread":0.28756172864835183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385330812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991924,0.000079669386,0.000053824962,0.00002951095,0.0000030165568,0.000050548206,0.00028478238,0.000004345097,0.00030198903],"genre_scores_gemma":[0.9993862,0.000046380614,0.00012163622,0.000021699361,0.00000657982,0.000025827849,0.00035794472,9.391657e-7,0.00003289408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745506,0.00080767844,0.00056654494,0.00036218492,0.00057764025,0.00023085599],"domain_scores_gemma":[0.98538554,0.0031472708,0.008158726,0.00052454567,0.0017556603,0.0010282929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002096322,0.00019836909,0.00035047266,0.0009702834,0.00042490283,0.00062492787,0.0004205237,0.00032508696,0.00090397766],"category_scores_gemma":[0.010056683,0.00021721984,0.00035316846,0.0011362723,0.00031581393,0.0005368264,0.0005974843,0.00037198924,0.00017901654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001479448,0.000042277206,0.99858284,0.000009074064,0.000011592188,0.000030599767,0.000055449993,0.000017858207,0.000052779928,0.0000055325413,0.00004914645,0.0009948352],"study_design_scores_gemma":[0.000017560265,0.00057934655,0.9985727,0.000009223028,0.000020321622,0.00017754974,0.0001816706,0.00021219623,0.00011648649,0.0000052919577,0.00010399645,0.0000035450814],"about_ca_topic_score_codex":0.0044963066,"about_ca_topic_score_gemma":0.005371906,"teacher_disagreement_score":0.0044963066,"about_ca_system_score_codex":0.00080628495,"about_ca_system_score_gemma":0.0009279171,"threshold_uncertainty_score":0.011086583},"labels":[],"label_agreement":null},{"id":"W4386346756","doi":"10.1177/10781552231199048","title":"Utilization and toxicity patterns of 2-weekly (Q2W) versus 4-weekly (Q4W) nivolumab for treatment of adjuvant and metastatic melanoma at BC cancer","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Dosing; Medicine; Incidence (geometry); Nivolumab; Adverse effect; Cancer; Internal medicine; Immunotherapy","score_opus":0.16286691192930697,"score_gpt":0.46567016003911027,"score_spread":0.3028032481098033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386346756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99908113,0.00029953266,0.00015284253,0.00002404054,0.0000025699894,0.000021915794,0.00010970267,0.0000054818124,0.0003027411],"genre_scores_gemma":[0.9993637,0.000097588934,0.00012730497,0.000026454447,0.0000033783213,0.000019146924,0.00015484366,0.0000032499875,0.00020439773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993185,0.00022654422,0.00008723078,0.00014331046,0.00015186978,0.00007262725],"domain_scores_gemma":[0.9976782,0.0004887425,0.0013455687,0.00008408024,0.00025028767,0.00015311806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096465513,0.00011911294,0.00023958016,0.0003212797,0.00012963059,0.00031949067,0.0001884261,0.00022636766,0.00096335873],"category_scores_gemma":[0.0029199228,0.000093224575,0.00037978406,0.0004352798,0.00011656556,0.00029628433,0.00016073207,0.00027900285,0.00014395562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010591996,0.0012388927,0.8634489,0.00022126749,0.0003359593,0.00032908464,0.00031692805,0.002324833,0.016920147,0.00015217255,0.0005902526,0.10352957],"study_design_scores_gemma":[0.00020851319,0.01282046,0.97745514,0.000029377363,0.0001665905,0.0007345724,0.00017084728,0.002441016,0.0044696704,0.00011476151,0.0013732476,0.000015881289],"about_ca_topic_score_codex":0.0012296746,"about_ca_topic_score_gemma":0.0015816708,"teacher_disagreement_score":0.9987703,"about_ca_system_score_codex":0.00062061806,"about_ca_system_score_gemma":0.00037119698,"threshold_uncertainty_score":0.0051016808},"labels":[],"label_agreement":null},{"id":"W4387001864","doi":"10.1177/10781552231200169","title":"Managing opioids and mitigating opioid risks in patients with cancer: An environmental scan of the attitudes, confidence, and practices of ambulatory, community and hospital pharmacists practicing in Canada","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Beatrice Hunter Cancer Research Institute; Nova Scotia Health Authority; Centre for Addiction and Mental Health; University of Toronto; University Health Network; Sinai Health System","funders":"","keywords":"Medicine; Ambulatory; Opioid; Confidence interval; Family medicine; Emergency medicine; Medical emergency; Intensive care medicine; Internal medicine","score_opus":0.03970063577060555,"score_gpt":0.3882419813998531,"score_spread":0.34854134562924755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387001864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99581605,0.00042443976,0.00008521337,0.000932728,0.0000040823693,0.000051774452,0.000665939,0.0000072041366,0.0020126202],"genre_scores_gemma":[0.9980679,0.0008076169,0.00020143225,0.00027538065,0.000004395537,0.000025573945,0.00023800343,0.0000039415468,0.00037573112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981122,0.0002634258,0.00011449218,0.0001422079,0.0008463696,0.00052141753],"domain_scores_gemma":[0.9948242,0.0012831887,0.00093872345,0.00010125613,0.002252456,0.0006002195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094478566,0.00012640478,0.00024696358,0.0015566472,0.0041756122,0.0018192718,0.0005937039,0.0003120105,0.001598515],"category_scores_gemma":[0.0044586924,0.00027959453,0.00023635813,0.004754787,0.0017211576,0.00076386787,0.0016147324,0.000585261,0.000111552625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007368126,0.000102994054,0.8864955,0.00032998918,0.000030142275,0.000504655,0.078770675,0.00010683318,0.0005432949,0.00019120342,0.0017479275,0.031103248],"study_design_scores_gemma":[0.0000036248694,0.000081713835,0.9008657,0.00014291718,0.00001227073,0.00022961358,0.094692804,0.00013884027,0.00015903867,0.000038391536,0.0036155994,0.000019549176],"about_ca_topic_score_codex":0.939596,"about_ca_topic_score_gemma":0.96725947,"teacher_disagreement_score":0.060404003,"about_ca_system_score_codex":0.015354763,"about_ca_system_score_gemma":0.03873364,"threshold_uncertainty_score":0.12151939},"labels":[],"label_agreement":null},{"id":"W4388975236","doi":"10.1177/10781552231216101","title":"National survey of safe handling of hazardous drugs in hospital settings: Use of an innovative approach","year":2023,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal; Université Laval; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Hazardous waste; Pharmacy; Environmental health; Health care; Hygiene; Medical emergency; Family medicine","score_opus":0.1727510979722796,"score_gpt":0.5090317187183417,"score_spread":0.33628062074606213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388975236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98932236,0.00018715241,0.00025246223,0.00046666202,0.00001217439,0.00020611027,0.006998075,0.000017661863,0.0025373779],"genre_scores_gemma":[0.9941994,0.0003194602,0.0005614296,0.00037261267,0.000011514696,0.00019346495,0.003574381,0.000003738214,0.0007641259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983076,0.00036775952,0.00027561522,0.00014978711,0.00069172867,0.00020754908],"domain_scores_gemma":[0.9936243,0.00064420473,0.0027846647,0.0002013854,0.0019637719,0.00078169233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017238912,0.00018432474,0.00018019527,0.0011203175,0.00039364933,0.00039815882,0.00044965264,0.0003954334,0.0020378288],"category_scores_gemma":[0.0043836352,0.00019474943,0.00022168866,0.0020049708,0.0002985778,0.00037559753,0.0005304615,0.00043324806,0.000454557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003695432,0.000065608976,0.9941955,0.00008466063,0.00001363812,0.000025875792,0.0003605921,0.00005536217,0.0002925309,0.000010894837,0.0011321084,0.0037263043],"study_design_scores_gemma":[0.0000020554285,0.000036163605,0.9989961,0.000019005209,0.0000013874962,0.000017014792,0.0003586772,0.00005254853,0.000028758708,0.0000023213154,0.0004833921,0.0000026319206],"about_ca_topic_score_codex":0.24116533,"about_ca_topic_score_gemma":0.24087766,"teacher_disagreement_score":0.24116533,"about_ca_system_score_codex":0.0025151311,"about_ca_system_score_gemma":0.0031992367,"threshold_uncertainty_score":0.47952318},"labels":[],"label_agreement":null},{"id":"W4392365446","doi":"10.1177/10781552241233489","title":"Palonosetron in pediatric patients: A single-center, retrospective evaluation of policy and clinical practice guideline discordance","year":2024,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Nausea and vomiting management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Pediatric Oncology Group; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Palonosetron; Medicine; Chemotherapy-induced nausea and vomiting; Antiemetic; Nausea; Chemotherapy; Vomiting; Oncology; Internal medicine; Anesthesia","score_opus":0.09609602017322073,"score_gpt":0.5257986027666897,"score_spread":0.42970258259346894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392365446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99808264,0.0006669209,0.00009120098,0.000048294776,0.0000039794736,0.00008643682,0.0006426307,0.0000030921258,0.00037473574],"genre_scores_gemma":[0.998716,0.00034124238,0.0001995814,0.00005655437,0.0000073466476,0.000090622874,0.0005539391,0.0000041393364,0.00003054708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99282503,0.0021072885,0.0016291955,0.0011468809,0.0016821916,0.00060946436],"domain_scores_gemma":[0.9617142,0.00827565,0.024729423,0.0014601124,0.00289561,0.0009249838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057471613,0.00026205488,0.0005991132,0.0029127237,0.00064670085,0.0013315774,0.00070596376,0.00049307646,0.001301313],"category_scores_gemma":[0.02028697,0.0006068164,0.0004366916,0.005754959,0.00078586093,0.001031768,0.0011423979,0.0007525392,0.00020087542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050151575,0.000021346112,0.998475,0.00003186296,0.000019421552,0.000094376504,0.00038087615,0.000013326881,0.000025034344,0.000016166885,0.00006757765,0.0008048175],"study_design_scores_gemma":[0.000018034778,0.00025311706,0.99484044,0.00010221676,0.00005494302,0.0011924456,0.0023829022,0.00019976689,0.00013066146,0.000015800457,0.0008008283,0.000008782612],"about_ca_topic_score_codex":0.00737329,"about_ca_topic_score_gemma":0.00707176,"teacher_disagreement_score":0.00737329,"about_ca_system_score_codex":0.0019864861,"about_ca_system_score_gemma":0.0024237633,"threshold_uncertainty_score":0.030394197},"labels":[],"label_agreement":null},{"id":"W4393988990","doi":"10.1177/10781552241243042","title":"The relationship between immune-related adverse events during ipilimumab monotherapy and survival outcomes among melanoma patients: A systematic review","year":2024,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Ipilimumab; Medicine; Adverse effect; Internal medicine; Discontinuation; Oncology; Hazard ratio; Incidence (geometry); Melanoma; Clinical trial; Confounding; Cancer; Immunotherapy; Confidence interval","score_opus":0.07369751300540853,"score_gpt":0.44483823801374756,"score_spread":0.37114072500833906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393988990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027146318,0.99578637,0.00014513508,0.00018409049,0.00006456363,0.00023887052,0.0006583537,0.0000078880485,0.00020020336],"genre_scores_gemma":[0.04377204,0.95362574,0.0006280471,0.00056128134,0.00008907436,0.00067283557,0.00050170126,0.000008179814,0.00014106391],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9930052,0.0021557051,0.003089867,0.0005694541,0.0009810821,0.00019873468],"domain_scores_gemma":[0.96312004,0.026541958,0.0073678074,0.00045579832,0.0022456734,0.00026884617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064174365,0.0011525375,0.0070313048,0.009643894,0.00050140196,0.0022609818,0.0014151576,0.0013988514,0.0032448252],"category_scores_gemma":[0.03468382,0.000842762,0.007919237,0.010407951,0.00074724393,0.0016207619,0.0012442613,0.0009507069,0.00020425103],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018806457,0.000011773803,0.0018417652,0.966299,0.016256258,0.000086759006,0.00014167998,0.00009026526,0.00010709069,0.000095882104,0.0005870019,0.014294338],"study_design_scores_gemma":[0.00027813754,0.00028760082,0.012232149,0.77206194,0.20204192,0.0005462042,0.0003171271,0.00013636015,0.00021695423,0.00029305433,0.011538077,0.000050442388],"about_ca_topic_score_codex":0.007669895,"about_ca_topic_score_gemma":0.021808686,"teacher_disagreement_score":0.009643894,"about_ca_system_score_codex":0.0027202996,"about_ca_system_score_gemma":0.0074181873,"threshold_uncertainty_score":0.033939064},"labels":[],"label_agreement":null},{"id":"W4396778056","doi":"10.1177/10781552241238198","title":"Review of drug-drug interactions in patients with prostate cancer","year":2024,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Polypharmacy; Prostate cancer; Drug; Cancer drugs; Cancer; Drug-drug interaction; Intensive care medicine; Pharmacology; Oncology; Internal medicine","score_opus":0.1037906823693015,"score_gpt":0.5476061643329013,"score_spread":0.4438154819635998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396778056","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021854928,0.9990127,0.00004805187,0.000164057,0.00007101897,0.000020302172,0.000112186244,0.0000042887305,0.00034886593],"genre_scores_gemma":[0.0026604093,0.99650025,0.00020832979,0.0002921509,0.00008741888,0.000025179468,0.00011306253,0.0000016204946,0.000111596535],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969428,0.0009133462,0.0010480937,0.0002551898,0.0007588691,0.00008174905],"domain_scores_gemma":[0.9914172,0.0060551018,0.0016472656,0.000076331315,0.00071080006,0.000093299204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017819232,0.0008818472,0.002915183,0.005919161,0.00039967804,0.0013480984,0.0010320201,0.0010441645,0.00536178],"category_scores_gemma":[0.008228382,0.00038608478,0.0028739776,0.007720546,0.00033488558,0.0012831074,0.00065122073,0.00088807696,0.00045143388],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017407857,0.000049978473,0.0014994701,0.56310445,0.0031337205,0.0005198287,0.00020195614,0.00033299602,0.00027535623,0.000665527,0.019901827,0.41014078],"study_design_scores_gemma":[0.00014360013,0.00047554803,0.016268557,0.45340562,0.015758624,0.006631975,0.00037341003,0.00028861137,0.0004921117,0.0010824046,0.5049967,0.000082707156],"about_ca_topic_score_codex":0.0047365194,"about_ca_topic_score_gemma":0.009439651,"teacher_disagreement_score":0.005919161,"about_ca_system_score_codex":0.0014167663,"about_ca_system_score_gemma":0.003759128,"threshold_uncertainty_score":0.017936885},"labels":[],"label_agreement":null},{"id":"W4400983376","doi":"10.1177/10781552241262248","title":"Hypokalemia, hypomagnesemia, and hyponatremia are associated with acute kidney injury in patients treated with cisplatin","year":2024,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Hypomagnesemia; Hypokalemia; Medicine; Hyponatremia; Acute kidney injury; Cisplatin; Internal medicine; Diabetes mellitus; Tolvaptan; Gastroenterology; Endocrinology; Chemotherapy; Magnesium","score_opus":0.01600358763426598,"score_gpt":0.3375553216395489,"score_spread":0.3215517340052829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400983376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990426,0.00033038732,0.00016311865,0.000068610876,0.00000699582,0.0000082951055,0.00010386673,0.000004837611,0.00027112197],"genre_scores_gemma":[0.99963987,0.000113022594,0.00007114364,0.000022664657,0.000012698282,0.000005003926,0.000096867334,0.0000010169738,0.00003765008],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991289,0.00022760402,0.00013026944,0.00013272074,0.00024126087,0.00013916726],"domain_scores_gemma":[0.9964037,0.00073969347,0.0020764188,0.00015130542,0.00020190579,0.00042695136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005905795,0.00018936084,0.00048324847,0.0006536757,0.000501906,0.00073157554,0.00030362027,0.000455665,0.0019201236],"category_scores_gemma":[0.0050724032,0.0002979312,0.00048597183,0.0011446517,0.00033253673,0.0004956387,0.00047172734,0.0006802356,0.00015969372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001193951,0.000014676824,0.99884784,0.00000633397,0.000025568974,0.00008581535,0.00001699451,0.00003473277,0.0001229077,0.00000852946,0.000040775023,0.0006763713],"study_design_scores_gemma":[0.000014349587,0.00012390409,0.9972357,0.000010344614,0.0000515086,0.00139683,0.0000955448,0.0006714388,0.00009712441,0.00006059676,0.00023765511,0.000004979999],"about_ca_topic_score_codex":0.0018757934,"about_ca_topic_score_gemma":0.0019089408,"teacher_disagreement_score":0.0019201236,"about_ca_system_score_codex":0.00024989806,"about_ca_system_score_gemma":0.00053862925,"threshold_uncertainty_score":0.0064234734},"labels":[],"label_agreement":null},{"id":"W4401392027","doi":"10.1177/10781552241269722","title":"Assessing the impact of aprepitant on response to dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP)","year":2024,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Nausea and vomiting management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; Alberta Health Services","funders":"","keywords":"Aprepitant; Medicine; Etoposide; Oncology; Internal medicine; Cyclophosphamide; Antiemetic; Nausea; Chemotherapy","score_opus":0.06942844549734552,"score_gpt":0.5093144953916011,"score_spread":0.4398860498942556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401392027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971842,0.0014845831,0.00013556205,0.00007756876,0.000009080039,0.000049493443,0.00030871044,0.000005408192,0.0007455047],"genre_scores_gemma":[0.9992424,0.00020148455,0.000109538254,0.0000420053,0.000011757259,0.000013932257,0.00027362414,0.0000014592993,0.000103790066],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99821174,0.0006210992,0.0002160416,0.00017238899,0.00058957003,0.00018906847],"domain_scores_gemma":[0.99287415,0.0029028011,0.0025756126,0.00016231523,0.0008758661,0.0006092337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029831466,0.00016080904,0.00044430117,0.00049702416,0.00015822018,0.00041896178,0.00036209438,0.00019332833,0.000838364],"category_scores_gemma":[0.0061258464,0.00008849047,0.00050884526,0.0006241516,0.0002452025,0.00029655788,0.00023351095,0.000411926,0.000118420176],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034487364,0.000105155494,0.9801824,0.00006736051,0.00020389707,0.00006365625,0.000045461366,0.00028929583,0.00068160356,0.000016176995,0.00017426476,0.014722041],"study_design_scores_gemma":[0.000047231864,0.0021066857,0.9960433,0.00001237358,0.00013472942,0.0001726316,0.0000607005,0.00045360517,0.00049561134,0.00001237358,0.0004569798,0.0000037546813],"about_ca_topic_score_codex":0.0052602985,"about_ca_topic_score_gemma":0.009563856,"teacher_disagreement_score":0.0052602985,"about_ca_system_score_codex":0.0011774673,"about_ca_system_score_gemma":0.000706059,"threshold_uncertainty_score":0.015776634},"labels":[],"label_agreement":null},{"id":"W4401890998","doi":"10.1177/10781552241276530","title":"Assessment of chemical contamination by cancer drugs during use of the RIVA <sup>TM</sup> compounding robot: A pilot study","year":2024,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Compounding; Contamination; Medicine; Toxicology; Environmental science; Pharmacology; Biology","score_opus":0.12154416299849577,"score_gpt":0.5185561525477776,"score_spread":0.39701198954928185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401890998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951233,0.00022729227,0.003534986,0.000023138395,0.000007647441,0.00027210405,0.00018869176,0.000039536444,0.00058329216],"genre_scores_gemma":[0.9886636,0.0003911297,0.0086686015,0.000061516206,0.000016622836,0.00017705037,0.00032951016,0.000026443737,0.0016656161],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99872154,0.00026501023,0.00007232357,0.00025757766,0.0005799769,0.000103682556],"domain_scores_gemma":[0.9986745,0.000252731,0.00055496965,0.00010153264,0.0003459626,0.00007031793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069963216,0.0007052732,0.000499893,0.00070100266,0.00045038963,0.00064173434,0.0004458831,0.00065301376,0.0012986251],"category_scores_gemma":[0.001073968,0.00023765204,0.0006443427,0.000390318,0.0005603288,0.00028941216,0.00050045486,0.00030781876,0.00042664036],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027415366,0.001600112,0.33393693,0.00087165285,0.00018405305,0.0020483113,0.0019023458,0.0020020972,0.59262115,0.00012670645,0.00047884957,0.06148624],"study_design_scores_gemma":[0.000073604875,0.032144155,0.50441164,0.00010583013,0.000454292,0.005371407,0.001947213,0.0060225306,0.44362378,0.00016373215,0.0055689956,0.00011280986],"about_ca_topic_score_codex":0.004280214,"about_ca_topic_score_gemma":0.0043918695,"teacher_disagreement_score":0.004280214,"about_ca_system_score_codex":0.00048291,"about_ca_system_score_gemma":0.000777496,"threshold_uncertainty_score":0.00851059},"labels":[],"label_agreement":null},{"id":"W4402650936","doi":"10.1177/10781552241284528","title":"Evaluation of voriconazole therapeutic drug monitoring in malignant hematology patients","year":2024,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Voriconazole; Medicine; Therapeutic drug monitoring; Internal medicine; Neutropenia; Adverse effect; Clinical endpoint; Chemotherapy; Clinical trial; Pharmacokinetics; Dermatology","score_opus":0.09446946036107214,"score_gpt":0.47140486505762913,"score_spread":0.376935404696557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402650936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138546,0.005506275,0.0003466884,0.00034293212,0.0000120109125,0.000049124796,0.00028277998,0.000018686382,0.0020560108],"genre_scores_gemma":[0.9983182,0.0009854544,0.00038184697,0.00007153877,0.000018462975,0.000013235703,0.0001281191,0.0000014405668,0.00008171184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872357,0.00052940194,0.00021522428,0.00010138493,0.00032572454,0.000104619],"domain_scores_gemma":[0.99466574,0.0015117733,0.0028097094,0.00008772854,0.00057816587,0.00034688791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013381897,0.00012322525,0.00029203863,0.0008800673,0.00027914945,0.0007534157,0.00031228366,0.00020286931,0.0009601996],"category_scores_gemma":[0.0043987427,0.00009854485,0.00016691089,0.0010229455,0.0002663082,0.00034489526,0.00027066696,0.00026072853,0.00014523277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018963218,0.000030214269,0.9840045,0.000075055614,0.000012576697,0.00042415725,0.00012464629,0.00005942973,0.0005366274,0.000023798873,0.00023128084,0.014287935],"study_design_scores_gemma":[0.000020143936,0.00078005926,0.98962456,0.00011139195,0.000041167612,0.0045102,0.0005020075,0.00069505,0.00173724,0.00005249984,0.001918093,0.0000075810694],"about_ca_topic_score_codex":0.0014407968,"about_ca_topic_score_gemma":0.001642474,"teacher_disagreement_score":0.0014407968,"about_ca_system_score_codex":0.0005179156,"about_ca_system_score_gemma":0.00052801915,"threshold_uncertainty_score":0.007077098},"labels":[],"label_agreement":null},{"id":"W4405247699","doi":"10.1177/10781552241304638","title":"An assessment of seven closed system transfer devices in accordance with the 2015 NIOSH vapor containment performance protocol","year":2024,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; BD","keywords":"Protocol (science); Compounding; Spectrum analyzer; Isopropyl alcohol; Medicine; Computer science; Chemistry; Telecommunications","score_opus":0.061425612386984074,"score_gpt":0.5479265178218267,"score_spread":0.4865009054348426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405247699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710485,0.0004552933,0.022222579,0.00009960138,0.000072061914,0.0024714086,0.00076592364,0.00035162817,0.0025130021],"genre_scores_gemma":[0.9260749,0.00044973765,0.06335662,0.00027409475,0.00003923881,0.002038769,0.0022812427,0.00014166516,0.0053437143],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9929622,0.0014630297,0.0007830186,0.0010401137,0.003468218,0.0002834194],"domain_scores_gemma":[0.99515533,0.000884285,0.0010215229,0.00053623295,0.0021977113,0.0002049691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048880884,0.0009237424,0.00045691093,0.00061481696,0.00072352623,0.0010520979,0.0012734897,0.0007609711,0.002864172],"category_scores_gemma":[0.007397658,0.00040083742,0.00064679823,0.00038482618,0.00078340736,0.0011379898,0.0014975893,0.0005824044,0.0010467302],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063142953,0.0032874055,0.06134756,0.0014956696,0.00016390317,0.00027176453,0.0019396839,0.003273462,0.794833,0.0005404992,0.0022897406,0.12424293],"study_design_scores_gemma":[0.00028142778,0.07356861,0.16255626,0.00026771508,0.0004329835,0.0012611467,0.0016232487,0.010065901,0.72547835,0.00036998698,0.023858018,0.00023630596],"about_ca_topic_score_codex":0.0020900588,"about_ca_topic_score_gemma":0.003016945,"teacher_disagreement_score":0.0048880884,"about_ca_system_score_codex":0.0009163438,"about_ca_system_score_gemma":0.0012880918,"threshold_uncertainty_score":0.025851011},"labels":[],"label_agreement":null},{"id":"W4405249277","doi":"10.1177/10781552241300517","title":"Hospital pharmacists’ perceived competence in providing care to oncology patients – (HoPP-CoP2)","year":2024,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Alexandra Hospital; University of British Columbia; Alberta Health Services; Foothills Medical Centre","funders":"","keywords":"Medicine; Competence (human resources); Likert scale; Psychological intervention; Family medicine; Nursing; Oncology; Internal medicine; Psychology","score_opus":0.10078368443882381,"score_gpt":0.49695682027557814,"score_spread":0.39617313583675434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405249277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99459654,0.00017127655,0.00015786667,0.00058519485,0.00002081525,0.00008090168,0.00026397835,0.000008262649,0.0041151913],"genre_scores_gemma":[0.99867296,0.00008015299,0.00031237124,0.00014147566,0.000009084918,0.000029065195,0.00017589124,0.0000018404716,0.00057727046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972905,0.0008162851,0.0003360441,0.00013997062,0.00094518444,0.00047199655],"domain_scores_gemma":[0.9869824,0.0030777012,0.00457418,0.0004151423,0.002278381,0.0026721903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035456393,0.00015351115,0.0002331183,0.00042230473,0.00045392243,0.0011885382,0.00032484223,0.00036680928,0.0069692056],"category_scores_gemma":[0.016581448,0.00014456363,0.00041484332,0.00027110006,0.00033250058,0.00058487203,0.0011414461,0.0006586871,0.00057331903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014299733,0.00037201602,0.97252715,0.00011972946,0.0001396294,0.00008929329,0.0010506697,0.00016905184,0.0003620254,0.00007772265,0.0018636491,0.023086092],"study_design_scores_gemma":[0.000024383857,0.00033791314,0.99573046,0.000049871695,0.000020389862,0.00026279845,0.0013550852,0.00028524408,0.00020516188,0.000059682854,0.0016593321,0.000009630919],"about_ca_topic_score_codex":0.0064149685,"about_ca_topic_score_gemma":0.01138909,"teacher_disagreement_score":0.0069692056,"about_ca_system_score_codex":0.001054589,"about_ca_system_score_gemma":0.0022091665,"threshold_uncertainty_score":0.023314357},"labels":[],"label_agreement":null},{"id":"W4405953371","doi":"10.1177/10781552241296516","title":"Pharmacist interventions in optimising opioid medication therapy in pain management for palliative care patients: A systematic review","year":2024,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Pain Management and Opioid Use","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Palliative care; Pharmacist; PsycINFO; Psychological intervention; MEDLINE; Opioid; Pain medicine; Systematic review; Medication therapy management; Pain management; Intensive care medicine; Family medicine; Pharmacy; Nursing; Physical therapy; Psychiatry; Internal medicine; Anesthesiology","score_opus":0.19040569478577227,"score_gpt":0.5321862582065203,"score_spread":0.34178056342074803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405953371","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012323979,0.99768436,0.00009708576,0.00020482104,0.00008802105,0.0002977081,0.00011313267,0.000008419506,0.0002740244],"genre_scores_gemma":[0.015945993,0.9821561,0.0007010672,0.00041942322,0.000081627135,0.00052242185,0.00008091316,0.0000038026533,0.00008861842],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.993634,0.0028405292,0.0017739168,0.00038859487,0.0011953966,0.00016758418],"domain_scores_gemma":[0.9794591,0.015466079,0.0033398448,0.00019131208,0.001288204,0.00025541347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005855351,0.0012355937,0.0065017003,0.0052300994,0.00060892175,0.0021845356,0.0014988768,0.002066109,0.004620018],"category_scores_gemma":[0.026985563,0.000844374,0.007848611,0.005180546,0.0005307508,0.0018171639,0.0010824507,0.0013730185,0.00031288655],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003480314,0.000056566547,0.00041681802,0.939006,0.0074115642,0.00006845871,0.00014159064,0.00008680823,0.00009095611,0.00010881153,0.00079215324,0.051472243],"study_design_scores_gemma":[0.0010152602,0.0006770219,0.0044386294,0.89506537,0.082842216,0.00033438444,0.00029785951,0.00015294246,0.0002150927,0.00021619891,0.014702851,0.000042272386],"about_ca_topic_score_codex":0.0050397967,"about_ca_topic_score_gemma":0.018291637,"teacher_disagreement_score":0.0065017003,"about_ca_system_score_codex":0.0027329465,"about_ca_system_score_gemma":0.008818338,"threshold_uncertainty_score":0.030966401},"labels":[],"label_agreement":null},{"id":"W4406127406","doi":"10.1177/10781552241306741","title":"Analysis of real-world safety, tolerability, and cost efficiency of Sub-Cutaneous administration of Daratumumab in Manitoba","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Daratumumab; Medicine; Tolerability; Retrospective cohort study; Toxicity; Subcutaneous injection; Internal medicine; Emergency medicine; Oncology; Surgery; Multiple myeloma; Adverse effect","score_opus":0.054436104547021545,"score_gpt":0.45732928911255444,"score_spread":0.4028931845655329,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406127406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979347,0.00054913183,0.00026746103,0.000028677485,0.000003372548,0.00014501317,0.00043433212,0.0000134648835,0.00062392745],"genre_scores_gemma":[0.9977209,0.0005222408,0.00050464063,0.00005387671,0.0000063339535,0.0000934915,0.00058705296,0.000008373745,0.000503133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990375,0.00040301387,0.000054990745,0.00012660971,0.00025780147,0.0001199849],"domain_scores_gemma":[0.9974903,0.00073520397,0.0007055939,0.00018679445,0.000678224,0.00020385583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017030354,0.00046796683,0.00035840334,0.0012434302,0.0004507257,0.0008094924,0.0006684965,0.00023482955,0.0016512413],"category_scores_gemma":[0.0029264914,0.000259642,0.0007504319,0.0014836009,0.00053996575,0.00020033201,0.00044592962,0.00038207276,0.00028356633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020706352,0.0026814588,0.8832308,0.00056617317,0.0010688136,0.0010395935,0.00095487386,0.013244539,0.032194357,0.00033365248,0.0010665719,0.042912867],"study_design_scores_gemma":[0.00067923014,0.0135604525,0.9624958,0.00006413175,0.00070628966,0.0007208969,0.0007337978,0.0100580035,0.008690337,0.000083903375,0.0021424058,0.00006483402],"about_ca_topic_score_codex":0.19720061,"about_ca_topic_score_gemma":0.18856698,"teacher_disagreement_score":0.8027994,"about_ca_system_score_codex":0.0073177926,"about_ca_system_score_gemma":0.002308669,"threshold_uncertainty_score":0.39210552},"labels":[],"label_agreement":null},{"id":"W4406301109","doi":"10.1177/10781552241312925","title":"Continuous versus intermittent tacrolimus for graft-versus-host disease prophylaxis in pediatric hematopoietic stem cell transplantation patients (Tic Tac)","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia; University of British Columbia","funders":"","keywords":"Medicine; Tacrolimus; Hematopoietic stem cell transplantation; Adverse effect; Graft-versus-host disease; Trough level; Internal medicine; Cohort; Retrospective cohort study; Therapeutic index; Transplantation; Surgery; Gastroenterology; Pharmacology; Drug","score_opus":0.029811183535875602,"score_gpt":0.3629448806622035,"score_spread":0.3331336971263279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406301109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980956,0.0013747155,0.000100935984,0.00003815398,0.000011779311,0.000018855537,0.000060874656,0.0000023432044,0.00029668887],"genre_scores_gemma":[0.999305,0.00032661148,0.00014589955,0.000041804233,0.000026713456,0.000022869504,0.00008253867,7.3063785e-7,0.000047743346],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994893,0.00018025427,0.000073952004,0.00007876423,0.00010554857,0.00007211116],"domain_scores_gemma":[0.99864084,0.00034546148,0.00069571397,0.000050249677,0.000047958274,0.00021971321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089654967,0.00011401513,0.0002543028,0.0002560704,0.00015000808,0.00036298105,0.00014823428,0.00016022848,0.001310031],"category_scores_gemma":[0.0018862959,0.00006161046,0.00030318953,0.00033400115,0.00015729222,0.00023561787,0.000223176,0.00026980898,0.0000891734],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019852005,0.0007589098,0.86899,0.0002065951,0.000386296,0.00023478841,0.00013277013,0.00034315928,0.001507792,0.00016069922,0.00084207876,0.10658488],"study_design_scores_gemma":[0.0023567872,0.0267387,0.9630639,0.00013441018,0.00048602046,0.001927136,0.00022719266,0.0012535404,0.0013835138,0.00010779549,0.0023101727,0.000010826586],"about_ca_topic_score_codex":0.00032959264,"about_ca_topic_score_gemma":0.00088155444,"teacher_disagreement_score":0.001310031,"about_ca_system_score_codex":0.00031902624,"about_ca_system_score_gemma":0.00038646552,"threshold_uncertainty_score":0.0047414303},"labels":[],"label_agreement":null},{"id":"W4408715532","doi":"10.1177/10781552251324522","title":"Evaluating the impact of a pharmacist-led venetoclax ramp-up clinic for chronic lymphocytic leukemia patients: A retrospective chart review","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Alberta Health Services","funders":"","keywords":"Medicine; Venetoclax; Pharmacist; Tumor lysis syndrome; Adverse effect; Pharmacy; Psychological intervention; Retrospective cohort study; Internal medicine; Pediatrics; Chronic lymphocytic leukemia; Leukemia; Family medicine; Chemotherapy; Psychiatry","score_opus":0.12355402321022381,"score_gpt":0.5734759596261295,"score_spread":0.4499219364159057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408715532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902288,0.0031325463,0.0003914869,0.00018395297,0.000022690316,0.0009054875,0.0033510474,0.000027120544,0.0017570033],"genre_scores_gemma":[0.9953827,0.0013912414,0.00074447866,0.0002003739,0.000029398376,0.00039443414,0.0015962485,0.00000789766,0.00025307154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957331,0.0012822994,0.0011222569,0.0005957763,0.0008557986,0.00041076922],"domain_scores_gemma":[0.9798007,0.0049082646,0.011748516,0.0005127642,0.0021450024,0.00088476366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002724853,0.00020641323,0.00040637667,0.0029134138,0.00064976263,0.0009864029,0.0006517125,0.0004135041,0.0016617673],"category_scores_gemma":[0.006849643,0.00041805598,0.00045548825,0.0029902833,0.0004388838,0.0007946179,0.00078699226,0.0004538571,0.00025694395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011566926,0.00009325521,0.9914384,0.0002760382,0.000039994782,0.0006772092,0.00077126006,0.000042255877,0.00015216926,0.000032158074,0.00050101033,0.0058605387],"study_design_scores_gemma":[0.0000288857,0.00050745445,0.9910471,0.00030529537,0.000060077822,0.0019109261,0.0029345064,0.00021633122,0.00031489335,0.000013408371,0.0026414788,0.000019658326],"about_ca_topic_score_codex":0.015413368,"about_ca_topic_score_gemma":0.020973643,"teacher_disagreement_score":0.015413368,"about_ca_system_score_codex":0.0018525877,"about_ca_system_score_gemma":0.002370934,"threshold_uncertainty_score":0.030647337},"labels":[],"label_agreement":null},{"id":"W4410578130","doi":"10.1177/10781552251343180","title":"Canadian monitoring program of the surface contamination with 11 antineoplastic drugs in 131 centres","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Institut National de Santé Publique du Québec; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Medicine; Docetaxel; Antineoplastic Drugs; Contamination; Gemcitabine; Vinorelbine; Biological safety; Cabazitaxel; Pharmacology; Internal medicine; Cancer; Chemotherapy","score_opus":0.033438886374667035,"score_gpt":0.4536011380359748,"score_spread":0.4201622516613078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410578130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97644424,0.0006941967,0.0016856507,0.0005954933,0.000028637973,0.001217096,0.011611561,0.00020390726,0.0075192996],"genre_scores_gemma":[0.9805778,0.0007449429,0.006936101,0.00027840625,0.000022699172,0.00038549714,0.005879094,0.000020712188,0.005154696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978725,0.00021059583,0.000093577786,0.00032658307,0.0010913014,0.00040542145],"domain_scores_gemma":[0.9948539,0.0002569835,0.0008420742,0.00012829308,0.0031971245,0.00072173437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012167762,0.0006215655,0.00029788518,0.0024135779,0.0015641013,0.0006139097,0.0012810914,0.0003476194,0.0017999876],"category_scores_gemma":[0.0027862117,0.0003964888,0.00031169385,0.0033990827,0.00040311748,0.00021258532,0.0008591138,0.00032674777,0.00033788002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002921741,0.00021720635,0.91729736,0.00039464276,0.000040419487,0.00024574425,0.0023578552,0.0006812975,0.00487737,0.00013532206,0.006867422,0.06659322],"study_design_scores_gemma":[0.000009986716,0.00017295871,0.9915774,0.000034441702,0.000010050251,0.00007704719,0.00096717104,0.0005453639,0.00093317614,0.000014028258,0.005644252,0.000014083136],"about_ca_topic_score_codex":0.94314945,"about_ca_topic_score_gemma":0.93388987,"teacher_disagreement_score":0.9800387,"about_ca_system_score_codex":0.019961303,"about_ca_system_score_gemma":0.028459122,"threshold_uncertainty_score":0.14483011},"labels":[],"label_agreement":null},{"id":"W4411574384","doi":"10.1177/10781552251351324","title":"Collaborative team-based care implementation in ambulatory gynecological and lung cancer clinics","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Interprofessional Education and Collaboration","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Ambulatory; Cancer; Lung cancer; Ambulatory care; Patient care; Intensive care medicine; Health care; Family medicine; Oncology; Nursing; Internal medicine","score_opus":0.038029446536404166,"score_gpt":0.6164147498208262,"score_spread":0.5783853032844221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411574384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943837,0.0004033803,0.0011142605,0.00056887936,0.0000571659,0.0019297504,0.000090986636,0.00005212351,0.0013998423],"genre_scores_gemma":[0.9929919,0.00021618308,0.0046237963,0.000315391,0.000038714643,0.0015131052,0.000086090484,0.0000036395877,0.00021116674],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9860655,0.008882124,0.00072628027,0.0013133452,0.0015900361,0.0014226618],"domain_scores_gemma":[0.9850466,0.0044999323,0.0032571233,0.0011186852,0.0013939248,0.0046837004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009199012,0.00023388148,0.00039149445,0.0005664693,0.0012389383,0.0013096413,0.0011335183,0.00064311933,0.0022854079],"category_scores_gemma":[0.019398313,0.00028784116,0.0007398852,0.00054874225,0.0006807911,0.0007720705,0.0029365276,0.0008788171,0.00018124002],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068423506,0.039564602,0.30066714,0.0026167387,0.0008734836,0.0005056714,0.011156742,0.004361493,0.0040164157,0.0007672678,0.0047199656,0.62390816],"study_design_scores_gemma":[0.013249653,0.16348933,0.7730733,0.001912009,0.0008867936,0.0008142026,0.014307418,0.010287045,0.0053114127,0.0010083617,0.0155168725,0.0001435401],"about_ca_topic_score_codex":0.0065434054,"about_ca_topic_score_gemma":0.009396197,"teacher_disagreement_score":0.009199012,"about_ca_system_score_codex":0.0034757922,"about_ca_system_score_gemma":0.010080409,"threshold_uncertainty_score":0.04864961},"labels":[],"label_agreement":null},{"id":"W4411712910","doi":"10.1177/10781552251352203","title":"Lactose intolerance or gastrointestinal adverse drug effect? guidance for oncology pharmacists","year":2025,"lang":"en","type":"review","venue":"Journal of Oncology Pharmacy Practice","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Lactose intolerance; Lactose; Excipient; Pharmacy; Adverse effect; Drug; Flow chart; Intensive care medicine; Internal medicine; Pharmacology; Family medicine; Food science","score_opus":0.051892064629447655,"score_gpt":0.4897379446891053,"score_spread":0.43784588005965763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411712910","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024669813,0.6199422,0.011244066,0.26355073,0.007279025,0.0015032481,0.0032051757,0.0018091792,0.08899938],"genre_scores_gemma":[0.016647719,0.7479535,0.048706707,0.10909662,0.008172616,0.0023830521,0.0041756155,0.00021022932,0.06265388],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980965,0.00053086283,0.0005802176,0.000111072484,0.0006016198,0.000079760255],"domain_scores_gemma":[0.9914887,0.0040614037,0.0012095933,0.00017316718,0.002567377,0.00049974705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024762175,0.0009707942,0.0021409772,0.0022823557,0.0004987174,0.0016356596,0.001979942,0.005878713,0.016423533],"category_scores_gemma":[0.01476242,0.000497775,0.0014463692,0.0013952983,0.0006929843,0.002792282,0.001214155,0.0044701113,0.012010547],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007087083,0.00011614988,0.00080920954,0.0049385806,0.00003552595,0.0009547866,0.00019334604,0.000119296834,0.00025540707,0.0014684919,0.5366178,0.4544205],"study_design_scores_gemma":[0.00016362192,0.00006991336,0.0021561454,0.012182797,0.00005888031,0.004627531,0.00028576015,0.00018015878,0.00016505644,0.0036955678,0.9763766,0.000037854952],"about_ca_topic_score_codex":0.0047007743,"about_ca_topic_score_gemma":0.011594011,"teacher_disagreement_score":0.016423533,"about_ca_system_score_codex":0.00087169994,"about_ca_system_score_gemma":0.003482208,"threshold_uncertainty_score":0.05494213},"labels":[],"label_agreement":null},{"id":"W4416087502","doi":"10.1177/10781552251388113","title":"Antimicrobial prophylaxis in pediatric patients with leukemia: Reducing incidence of febrile neutropenia episodes and bloodborne infections","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Dalhousie University","funders":"","keywords":"Antimicrobial; Fungemia; Bacteremia; Incidence (geometry); Febrile neutropenia; Neutropenia; Antibiotic prophylaxis","score_opus":0.011305527879133668,"score_gpt":0.33962719111917694,"score_spread":0.32832166324004325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416087502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98539954,0.012440452,0.00025992535,0.0004579433,0.00001770213,0.00004231131,0.00018486638,0.000016777152,0.0011804224],"genre_scores_gemma":[0.99593073,0.003242922,0.00054723496,0.000073040064,0.000022400904,0.00001547625,0.00011784814,9.942289e-7,0.00004921438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996983,0.00013178535,0.000035971632,0.000026452504,0.000061808554,0.000045690485],"domain_scores_gemma":[0.99894696,0.00019823732,0.00062229595,0.000015487247,0.00007886509,0.00013814788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033657427,0.000120088596,0.00023290544,0.00030398637,0.00014956247,0.0002425039,0.00013739878,0.00012954063,0.0009552904],"category_scores_gemma":[0.002717703,0.0000496208,0.00016556797,0.00035894394,0.00008341709,0.00017477266,0.00018677134,0.00022374358,0.00005224644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007143304,0.00029933653,0.8891624,0.00030979278,0.00010359217,0.00012520007,0.00007516859,0.0002578147,0.00086579233,0.00007689615,0.0008422767,0.10716744],"study_design_scores_gemma":[0.00010872318,0.002274119,0.99290776,0.00017978068,0.00012230304,0.00097205286,0.00014335634,0.0003100102,0.0008246402,0.000055241493,0.00209828,0.0000037200225],"about_ca_topic_score_codex":0.0017417779,"about_ca_topic_score_gemma":0.002887955,"teacher_disagreement_score":0.0017417779,"about_ca_system_score_codex":0.0002921751,"about_ca_system_score_gemma":0.00082732516,"threshold_uncertainty_score":0.0034632683},"labels":[],"label_agreement":null},{"id":"W4417362519","doi":"10.1177/10781552251405216","title":"Comparative incidence of peripheral neuropathy associated with taxane chemotherapy in patients with breast cancer: A network meta-analysis","year":2025,"lang":"en","type":"article","venue":"Journal of Oncology Pharmacy Practice","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Windsor Clinical Research","funders":"","keywords":"Taxane; Peripheral neuropathy; Paclitaxel; Docetaxel; Incidence (geometry); Breast cancer; Chemotherapy-induced peripheral neuropathy","score_opus":0.05753993388737121,"score_gpt":0.4269587812516558,"score_spread":0.3694188473642846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417362519","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06360084,0.92261463,0.006124035,0.00072655565,0.0003929195,0.00052705803,0.004737067,0.0001254326,0.0011514708],"genre_scores_gemma":[0.8499198,0.13937719,0.004911001,0.0007982851,0.00025289794,0.0011105327,0.002956692,0.00008705845,0.00058663415],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98367137,0.01073172,0.0021765241,0.0019441961,0.0010894708,0.00038669872],"domain_scores_gemma":[0.9727706,0.021597922,0.0029641774,0.0012295346,0.0011033666,0.0003344496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017525405,0.0023780796,0.009368029,0.005763943,0.0005038626,0.0028358435,0.0019246322,0.0016719986,0.0036883224],"category_scores_gemma":[0.030041298,0.0012107303,0.04846195,0.0064351168,0.0005136379,0.0013463655,0.0017249254,0.0018933627,0.00024837497],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032774014,0.000022069893,0.017443458,0.032799345,0.9388249,0.00010841759,0.000036175556,0.0021853384,0.00018309476,0.00013022624,0.00037487294,0.004614755],"study_design_scores_gemma":[0.0005745104,0.00019512416,0.008521255,0.0022555708,0.9857239,0.00009874615,0.000024081259,0.0012525858,0.00008686596,0.0003437041,0.0009029922,0.00002078028],"about_ca_topic_score_codex":0.0059233764,"about_ca_topic_score_gemma":0.0075886054,"teacher_disagreement_score":0.017525405,"about_ca_system_score_codex":0.001559503,"about_ca_system_score_gemma":0.0014359847,"threshold_uncertainty_score":0.09268433},"labels":[],"label_agreement":null}]}